Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
Physical measures,X4270.Volume level set by participant (left),NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],32832,-0.125255352636514,0.0305219558952668,-0.185078386191237,-0.0654323190817915,4.10054992236806e-05
Physical measures,X4270.Volume level set by participant (left),SPINK6,Serine protease inhibitor Kazal-type 6,32948,0.114348918055967,0.0305404505697334,0.0544896349392893,0.174208201172644,0.000182102107995881
Physical measures,X4270.Volume level set by participant (left),PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,31720,-0.234129521426397,0.0628027921205998,-0.357222993982773,-0.111036048870022,0.000194352905095814
Physical measures,X4270.Volume level set by participant (left),PF4,Platelet factor 4,31684,-0.0740587139948456,0.0204760164580763,-0.114191706252675,-0.033925721737016,0.000300086801261588
Physical measures,X4270.Volume level set by participant (left),ENSA,Alpha-endosulfine,31724,-0.142488258189695,0.0395593589285565,-0.220024601689665,-0.0649519146897239,0.000317867785939281
Physical measures,X4270.Volume level set by participant (left),GPC5,Glypican-5,32796,-0.109902840442785,0.0312204515956083,-0.171094925570177,-0.0487107553153923,0.000433338284120244
Physical measures,X4270.Volume level set by participant (left),DPP6,Dipeptidyl aminopeptidase-like protein 6,32832,-0.182415511335672,0.05224744439232,-0.28482050234462,-0.0800105203267253,0.000482850587000809
Physical measures,X4270.Volume level set by participant (left),CA14,Carbonic anhydrase 14,32948,-0.169177548443427,0.0484818362057997,-0.264201947406795,-0.07415314948006,0.000486212609676095
Physical measures,X4270.Volume level set by participant (left),MMP10,Stromelysin-2,32849,0.10027371248034,0.028886797676727,0.0436555890339553,0.156891835926725,0.0005204486201599
Physical measures,X4270.Volume level set by participant (left),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,32948,-0.227399484929928,0.0663368526284189,-0.357419716081629,-0.0973792537782268,0.000610853198478067
Physical measures,X4270.Volume level set by participant (left),ACRBP,Acrosin-binding protein,31724,-0.180056544060207,0.0526837372499126,-0.283316669070036,-0.0767964190503781,0.000634758976580658
Physical measures,X4270.Volume level set by participant (left),ZFYVE19,Abscission/NoCut checkpoint regulator,31720,-0.0791173429241135,0.0233525297066881,-0.124888301149222,-0.0333463846990049,0.000707614221989509
Physical measures,X4270.Volume level set by participant (left),INPP1,Inositol polyphosphate 1-phosphatase,32832,-0.108235740962793,0.0322851737737142,-0.171514681559273,-0.0449568003663128,0.000804192831205912
Physical measures,X4270.Volume level set by participant (left),RANBP1,Ran-specific GTPase-activating protein,31566,-0.132025121202254,0.0395536331548151,-0.209550242185692,-0.0545000002188167,0.000848216069439853
Physical measures,X4270.Volume level set by participant (left),TEX33,Testis-expressed protein 33,31632,-0.165072758328759,0.049858743968543,-0.262795896507103,-0.0673496201504143,0.000934510208814148
Physical measures,X4270.Volume level set by participant (left),GPR158,Probable G-protein coupled receptor 158,31752,-0.182300630628824,0.0551213428468782,-0.290338462608706,-0.0742627986489432,0.000946346865355666
Physical measures,X4270.Volume level set by participant (left),APOF,Apolipoprotein F,31772,-0.233583387981622,0.0710334292954042,-0.372808909400615,-0.09435786656263,0.00101213536282022
Physical measures,X4270.Volume level set by participant (left),SLA2,Src-like-adapter 2,31752,-0.0632067456422706,0.0193788748798375,-0.101189340406752,-0.0252241508777892,0.00111243712381106
Physical measures,X4270.Volume level set by participant (left),CETN3,Centrin-3,31720,-0.0838546438790295,0.0260376751661877,-0.134888487204757,-0.0328208005533016,0.0012848269754592
Physical measures,X4270.Volume level set by participant (left),ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",31752,-0.136590393346581,0.0428449760685629,-0.220566546440964,-0.0526142402521979,0.00143812860174983
Physical measures,X4270.Volume level set by participant (left),DUSP3,Dual specificity protein phosphatase 3,32644,-0.065817468303807,0.0207235142319159,-0.106435556198362,-0.0251993804092518,0.00149847766504537
Physical measures,X4270.Volume level set by participant (left),VGF,Neurosecretory protein VGF,31752,-0.218749178920363,0.0689023322965405,-0.353797750221582,-0.0837006076191434,0.00150531019773961
Physical measures,X4270.Volume level set by participant (left),BDNF,Brain-derived neurotrophic factor,31773,-0.0756904643335443,0.0238568665642561,-0.122449922799486,-0.0289310058676023,0.00151611037702154
Physical measures,X4270.Volume level set by participant (left),SLURP1,Secreted Ly-6/uPAR-related protein 1,31689,0.16947549380309,0.0539040427031543,0.0638235701049076,0.275127417501272,0.00167266146600417
Physical measures,X4270.Volume level set by participant (left),GORASP2,Golgi reassembly-stacking protein 2,31720,-0.136070474557074,0.0433291313336516,-0.220995571971031,-0.0511453771431166,0.00169347503280206
Physical measures,X4270.Volume level set by participant (left),TFF1,Trefoil factor 1,32827,0.0737780888394863,0.0235012007145111,0.0277157354390445,0.119840442239928,0.0016988282560109
Physical measures,X4270.Volume level set by participant (left),PRTN3,Myeloblastin,32605,0.11093323964784,0.0354510182231495,0.0414492439304672,0.180417235365213,0.00175861077079514
Physical measures,X4270.Volume level set by participant (left),VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,32852,-0.0886385759800137,0.0283464191375909,-0.144197557489692,-0.0330795944703356,0.00177177850480378
Physical measures,X4270.Volume level set by participant (left),SCRN1,Secernin-1,32843,-0.096057338312895,0.0309052766743521,-0.156631680594625,-0.035482996031165,0.00188869182423667
Physical measures,X4270.Volume level set by participant (left),RGS10,Regulator of G-protein signaling 10,31752,-0.106088559159922,0.0341547276590031,-0.173031825371568,-0.0391452929482758,0.00190234669961013
Physical measures,X4270.Volume level set by participant (left),CCL20,C-C motif chemokine 20,32961,0.0641957769813459,0.0207076652548812,0.0236087530817787,0.104782800880913,0.00194047968579802
Physical measures,X4270.Volume level set by participant (left),TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,31632,-0.0795219334285439,0.0256807406236115,-0.129856185050822,-0.0291876818062654,0.00196478214873453
Physical measures,X4270.Volume level set by participant (left),SERPINB9,Serpin B9,32796,-0.173136532278304,0.0568454462403737,-0.284553606909436,-0.0617194576471713,0.00232784019126391
Physical measures,X4270.Volume level set by participant (left),HRG,Histidine-rich glycoprotein,31741,-0.188302550831099,0.0620474192220274,-0.309915492506273,-0.0666896091559256,0.00241467170164668
Physical measures,X4270.Volume level set by participant (left),NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,31720,-0.0684582040780937,0.0226569801928898,-0.112865885256158,-0.0240505229000296,0.00252330339413511
Physical measures,X4270.Volume level set by participant (left),EIF4B,Eukaryotic translation initiation factor 4B,32796,-0.100046886316469,0.0331380327157499,-0.164997430439338,-0.0350963421935989,0.00254246338015838
Physical measures,X4270.Volume level set by participant (left),UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,31720,-0.0441930353221215,0.0147326895857675,-0.0730691069102258,-0.0153169637340171,0.0027112998897532
Physical measures,X4270.Volume level set by participant (left),FGF7,Fibroblast growth factor 7,31492,-0.0778393510461199,0.0260155295452401,-0.128829788954791,-0.0268489131374492,0.00278011883852074
Physical measures,X4270.Volume level set by participant (left),CRYGD,Gamma-crystallin D,31751,-0.0627333996842747,0.0211395322093765,-0.104166882814653,-0.0212999165538967,0.00301048650574704
Physical measures,X4270.Volume level set by participant (left),ATP6V1G1,V-type proton ATPase subunit G 1,31566,-0.0839602106901534,0.0284123193127166,-0.139648356543078,-0.0282720648372289,0.00313551122840142
Physical measures,X4270.Volume level set by participant (left),GGACT,Gamma-glutamylaminecyclotransferase,31762,-0.0850801268314623,0.0288411981159481,-0.141608875138721,-0.0285513785242041,0.00318756660779062
Physical measures,X4270.Volume level set by participant (left),EPN1,Epsin-1,31632,-0.138586802267737,0.0473042098239049,-0.23130305352259,-0.0458705510128831,0.00340284392015402
Physical measures,X4270.Volume level set by participant (left),PI3,Elafin,32701,0.0963604262729651,0.0329206462826555,0.0318359595589604,0.16088489298697,0.00343064421732822
Physical measures,X4270.Volume level set by participant (left),BMP6,Bone morphogenetic protein 6,32658,-0.118734432429719,0.0406495640204478,-0.198407577909797,-0.0390612869496418,0.00349878026046619
Physical measures,X4270.Volume level set by participant (left),LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,31752,-0.217336462681645,0.0746195618895788,-0.36359080398522,-0.0710821213780708,0.00359446001236901
Physical measures,X4270.Volume level set by participant (left),KIAA0319,Dyslexia-associated protein KIAA0319,31751,-0.185155221426748,0.0641195947085082,-0.310829627055424,-0.0594808157980722,0.00389181441454411
Physical measures,X4270.Volume level set by participant (left),JPT2,Jupiter microtubule associated homolog 2,31720,-0.0695640106373137,0.0241722887822898,-0.116941696650602,-0.0221863246240257,0.00401486017384695
Physical measures,X4270.Volume level set by participant (left),FDX1,"Adrenodoxin, mitochondrial",31495,-0.093256777915946,0.0324256544378075,-0.156811060614049,-0.0297024952178432,0.00403841470937158
Physical measures,X4270.Volume level set by participant (left),ATP6V1D,V-type proton ATPase subunit D,32832,-0.202047247261035,0.0704104998354635,-0.340051826938544,-0.0640426675835271,0.00412002207041448
Physical measures,X4270.Volume level set by participant (left),DNAJB14,DnaJ homolog subfamily B member 14,31720,-0.090186004651482,0.031512031181011,-0.151949585766263,-0.0284224235367005,0.00422149669014412
Physical measures,X4270.Volume level set by participant (left),SLC13A1,Solute carrier family 13 member 1,31724,-0.0958062781224122,0.0334919764092851,-0.161450551884611,-0.0301620043602134,0.00423989681096748
Physical measures,X4270.Volume level set by participant (left),TMEM106A,Transmembrane protein 106A,31724,-0.0795743412635856,0.0278182343332578,-0.134098080556771,-0.0250506019704003,0.00424075045283397
Physical measures,X4270.Volume level set by participant (left),CCS,Copper chaperone for superoxide dismutase,32796,-0.105534832974133,0.0369129451124182,-0.177884205394473,-0.0331854605537939,0.00425936440101304
Physical measures,X4270.Volume level set by participant (left),ATP6AP2,Renin receptor,32638,-0.117008056212676,0.0411135236049887,-0.197590562478453,-0.0364255499468979,0.00443783284211019
Physical measures,X4270.Volume level set by participant (left),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",31632,-0.119407393542844,0.0419610963867522,-0.201651142460878,-0.0371636446248095,0.00444342374797538
Physical measures,X4270.Volume level set by participant (left),MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,31720,-0.0914870855820268,0.0322173063832241,-0.154633006093146,-0.0283411650709076,0.00452737285041608
Physical measures,X4270.Volume level set by participant (left),GCLM,Glutamate--cysteine ligase regulatory subunit,31495,-0.127498913121723,0.0452563046370104,-0.216201270210263,-0.0387965560331823,0.0048559306657733
Physical measures,X4270.Volume level set by participant (left),NECAP2,Adaptin ear-binding coat-associated protein 2,31495,-0.0891533425916743,0.0317093207522258,-0.151303611266037,-0.0270030739173118,0.00494243460865806
Physical measures,X4270.Volume level set by participant (left),CCND2,G1/S-specific cyclin-D2,31632,-0.15688478172205,0.0558369297811503,-0.266325164093105,-0.0474443993509954,0.0049712327462781
Physical measures,X4270.Volume level set by participant (left),TREML1,Trem-like transcript 1 protein,31772,-0.105452127742974,0.0376459904860411,-0.179238269095614,-0.0316659863903331,0.00510442611550827
Physical measures,X4270.Volume level set by participant (left),RTBDN,Retbindin,32832,-0.169001752117496,0.060380788504561,-0.287348097586436,-0.0506554066485566,0.00513813415854615
Physical measures,X4270.Volume level set by participant (left),FGF21,Fibroblast growth factor 21,32940,0.0403414744516843,0.0144203071020966,0.0120776725315749,0.0686052763717936,0.00516008694861033
Physical measures,X4270.Volume level set by participant (left),CASP7,Caspase-7,31751,-0.0677051972186435,0.0242747152163757,-0.11528363904274,-0.0201267553945471,0.00529775034229936
Physical measures,X4270.Volume level set by participant (left),ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",31566,-0.0818075446160413,0.0293342731613805,-0.139302720012347,-0.0243123692197356,0.00530328768068869
Physical measures,X4270.Volume level set by participant (left),ABHD14B,Protein ABHD14B,32765,-0.0855491455217684,0.0306908260857988,-0.145703164649934,-0.0253951263936028,0.0053237256074013
Physical measures,X4270.Volume level set by participant (left),SUGP1,SURP and G-patch domain-containing protein 1,31720,-0.137025534174416,0.0492782990357267,-0.233611000284441,-0.0404400680643918,0.00543799257050336
Physical measures,X4270.Volume level set by participant (left),MRPL52,"39S ribosomal protein L52, mitochondrial",31466,-0.217048607664536,0.0781181609220324,-0.370160203071719,-0.0639370122573525,0.00547503311908543
Physical measures,X4270.Volume level set by participant (left),PPBP,Platelet basic protein,31692,-0.0649799918142085,0.0234395350440779,-0.110921480500601,-0.019038503127816,0.00558037338510747
Physical measures,X4270.Volume level set by participant (left),PAGR1,PAXIP1-associated glutamate-rich protein 1,31566,-0.129063723141238,0.0465738419283713,-0.220348453320846,-0.0377789929616302,0.00559903880148791
Physical measures,X4270.Volume level set by participant (left),IST1,IST1 homolog,31658,-0.0600833137161277,0.0217082983663171,-0.102631578514109,-0.0175350489181461,0.00565765774322567
Physical measures,X4270.Volume level set by participant (left),THTPA,Thiamine-triphosphatase,31705,-0.0651236088988957,0.0235333068098214,-0.111248890246146,-0.0189983275516457,0.0056656047785228
Physical measures,X4270.Volume level set by participant (left),GHRL,Appetite-regulating hormone,32864,-0.0624081967008706,0.0225759632764274,-0.106657084722668,-0.0181593086790729,0.00571497903428934
Physical measures,X4270.Volume level set by participant (left),MMP12,Macrophage metalloelastase,32874,0.0964956458391186,0.0349531618362916,0.027987448639987,0.16500384303825,0.00577920075673253
Physical measures,X4270.Volume level set by participant (left),C7,Complement component C7,31566,-0.174040097412306,0.0634359122907016,-0.298374485502081,-0.0497057093225312,0.00609179612931249
Physical measures,X4270.Volume level set by participant (left),SNAPIN,SNARE-associated protein Snapin,31752,-0.0918536029201159,0.0334839018233275,-0.157482050493838,-0.026225155346394,0.00609778908615921
Physical measures,X4270.Volume level set by participant (left),RCC1,Regulator of chromosome condensation,31724,-0.104152234177746,0.0379854796030409,-0.178603774199706,-0.0297006941557857,0.00612238802569962
Physical measures,X4270.Volume level set by participant (left),NID1,Nidogen-1,32851,-0.125686585757013,0.0458580774462141,-0.215568417551593,-0.0358047539624338,0.00614159147039457
Physical measures,X4270.Volume level set by participant (left),BCAN,Brevican core protein,32796,-0.143943863660469,0.0525757586372052,-0.246992350589392,-0.0408953767315471,0.00619671613123652
Physical measures,X4270.Volume level set by participant (left),TRIM26,Tripartite motif-containing protein 26,31492,-0.103459313186096,0.0378019347800176,-0.177551105354931,-0.0293675210172618,0.00621687883838522
Physical measures,X4270.Volume level set by participant (left),YARS1,"Tyrosine--tRNA ligase, cytoplasmic",31720,-0.04002886186102,0.0146370865054136,-0.0687175514116308,-0.0113401723104093,0.00625664952008559
Physical measures,X4270.Volume level set by participant (left),MDM1,Nuclear protein MDM1,31546,-0.171811819758553,0.0629533203538652,-0.295200327652129,-0.0484233118649776,0.00636338883797234
Physical measures,X4270.Volume level set by participant (left),ENOPH1,Enolase-phosphatase E1,31724,-0.094229740680688,0.0345340589847295,-0.161916496290758,-0.0265429850706181,0.00637446052176335
Physical measures,X4270.Volume level set by participant (left),PDGFB,Platelet-derived growth factor subunit B,32894,-0.0544271198747869,0.019962061398166,-0.0935527602151922,-0.0153014795343816,0.00641280301225035
Physical measures,X4270.Volume level set by participant (left),EGF,Pro-epidermal growth factor,32834,-0.0461798349138094,0.0169751149570124,-0.0794510602295537,-0.0129086095980651,0.00653201234341102
Physical measures,X4270.Volume level set by participant (left),CA7,Carbonic anhydrase 7,31632,-0.168739619469934,0.0620437834550175,-0.290345435041768,-0.0471338038980996,0.00654891757681655
Physical measures,X4270.Volume level set by participant (left),CDH15,Cadherin-15,32911,-0.0863688609047824,0.03175922593589,-0.148616943739127,-0.0241207780704381,0.00655076708319001
Physical measures,X4270.Volume level set by participant (left),SLC51B,Organic solute transporter subunit beta,31495,-0.0748616842453743,0.0275603568693189,-0.128879983709239,-0.0208433847815093,0.00661685236797576
Physical measures,X4270.Volume level set by participant (left),CIRBP,Cold-inducible RNA-binding protein,31720,-0.0584884173136413,0.0215592995940797,-0.100744644518038,-0.016232190109245,0.00668407347975424
Physical measures,X4270.Volume level set by participant (left),OTUD6B,Deubiquitinase OTUD6B,31720,-0.0967346094607065,0.0356603869116454,-0.166628967807531,-0.0268402511138816,0.00668903321875724
Physical measures,X4270.Volume level set by participant (left),TFF2,Trefoil factor 2,32883,0.0812787584163271,0.0299700039677982,0.0225375506394426,0.140019966193212,0.00670046287131354
Physical measures,X4270.Volume level set by participant (left),PCYT2,Ethanolamine-phosphate cytidylyltransferase,31720,-0.0737152572034686,0.0272073469728628,-0.12704165727028,-0.0203888571366576,0.00675536540856498
Physical measures,X4270.Volume level set by participant (left),SPINK8,Serine protease inhibitor Kazal-type 8,31495,-0.150117693933715,0.0554205859682714,-0.258742042431527,-0.0414933454359034,0.00676982255080969
Physical measures,X4270.Volume level set by participant (left),ZNRF4,E3 ubiquitin-protein ligase ZNRF4,31724,-0.100174117609406,0.0369916443662867,-0.172677740567328,-0.0276704946514837,0.00678323584994748
Physical measures,X4270.Volume level set by participant (left),GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,31762,-0.0887101872118932,0.0327585317847312,-0.152916909509966,-0.02450346491382,0.00678352460671035
Physical measures,X4270.Volume level set by participant (left),PQBP1,Polyglutamine-binding protein 1,32638,0.0885878155710667,0.0327728910142158,0.0243529491832037,0.15282268195893,0.00688320496903111
Physical measures,X4270.Volume level set by participant (left),DNAJC6,Putative tyrosine-protein phosphatase auxilin,31566,-0.0674639718089794,0.0250920629461801,-0.116644415183492,-0.0182835284344664,0.00718942839508252
Physical measures,X4270.Volume level set by participant (left),KLK8,Kallikrein-8,32580,0.135475193455123,0.0505999751011964,0.036299242256778,0.234651144653468,0.00743401407861595
Physical measures,X4270.Volume level set by participant (left),TMED8,Protein TMED8,31720,-0.0538664582567326,0.0201313344411891,-0.0933238737614633,-0.0144090427520019,0.00747164084328375
Physical measures,X4270.Volume level set by participant (left),CYB5R2,NADH-cytochrome b5 reductase 2,31621,-0.0958691355157526,0.0359323517675586,-0.166296544980168,-0.0254417260513377,0.0076452590182371
Physical measures,X4270.Volume level set by participant (left),ELAC1,Zinc phosphodiesterase ELAC protein 1,31752,-0.0653048611680815,0.0245320373571484,-0.113387654388092,-0.0172220679480706,0.0077829925754479
Physical measures,X4270.Volume level set by participant (left),LYZL2,Lysozyme-like protein 2,31492,-0.147206707050919,0.0553926784891931,-0.255776356889738,-0.0386370572121006,0.007888383984942
Physical measures,X4270.Volume level set by participant (left),SBSN,Suprabasin,31754,0.155491321952193,0.0585801153572205,0.0406742958520407,0.270308348052345,0.00796240219719855
Physical measures,X4270.Volume level set by participant (left),PCDH1,Protocadherin-1,32930,-0.215577833244878,0.0812713726662154,-0.37486972367066,-0.0562859428190957,0.00800211922315666
Physical measures,X4270.Volume level set by participant (left),TPMT,Thiopurine S-methyltransferase,32638,-0.065031748711048,0.0245334261585721,-0.113117263981849,-0.0169462334402466,0.00804596860562924
Physical measures,X4270.Volume level set by participant (left),HBEGF,Proheparin-binding EGF-like growth factor,32925,-0.0612927963765599,0.023182747579799,-0.106730981632966,-0.0158546111201537,0.00820987578856291
Physical measures,X4270.Volume level set by participant (left),CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,31514,-0.17932882931842,0.0678346005621314,-0.312284646420197,-0.0463730122166422,0.00821922425096933
Physical measures,X4270.Volume level set by participant (left),CCN1,CCN family member 1,32816,-0.059252385024519,0.0224222090744806,-0.103199914810501,-0.015304855238537,0.00824212526166025
Physical measures,X4270.Volume level set by participant (left),ATP2B4,Plasma membrane calcium-transporting ATPase 4,31495,-0.0797537220796395,0.0303768740604727,-0.139292395238166,-0.0202150489211131,0.00867007819171731
Physical measures,X4270.Volume level set by participant (left),HDDC2,5'-deoxynucleotidase HDDC2,31720,-0.11493256265301,0.0438296454908207,-0.200838667815018,-0.0290264574910013,0.00875182371654345
Physical measures,X4270.Volume level set by participant (left),TSNAX,Translin-associated protein X,31495,-0.133603197101507,0.0510631131368157,-0.233686898849666,-0.0335194953533486,0.00890289674715871
Physical measures,X4270.Volume level set by participant (left),EFCAB14,EF-hand calcium-binding domain-containing protein 14,31720,-0.193272433319782,0.0739639329096246,-0.338241741822646,-0.0483031248169174,0.00899056616530056
Physical measures,X4270.Volume level set by participant (left),GCG,Pro-glucagon,32638,-0.0377849219988857,0.014464193866301,-0.0661347419768356,-0.00943510202093587,0.00900865768670358
Physical measures,X4270.Volume level set by participant (left),LY6D,Lymphocyte antigen 6D,32794,0.127511167742065,0.0488812626327675,0.0317038929818404,0.223318442502289,0.0091067576983873
Physical measures,X4270.Volume level set by participant (left),FKBPL,FK506-binding protein-like,31720,-0.0913405766563404,0.0350704909685427,-0.160078738954684,-0.0226024143579966,0.00921856395127248
Physical measures,X4270.Volume level set by participant (left),CDC26,Anaphase-promoting complex subunit CDC26,31694,-0.0733747504848888,0.0282080646259815,-0.128662557151813,-0.0180869438179649,0.00930736450434617
Physical measures,X4270.Volume level set by participant (left),SUMF1,Formylglycine-generating enzyme,31508,-0.0763894900814438,0.0294175558683527,-0.134047899583415,-0.0187310805794724,0.00942957100682525
Physical measures,X4270.Volume level set by participant (left),B2M,Beta-2-microglobulin,31770,-0.173507098593148,0.0669377725124844,-0.304705132717617,-0.0423090644686785,0.00955770666293725
Physical measures,X4270.Volume level set by participant (left),SPOCK1,Testican-1,32796,-0.176927823144943,0.0685363715286253,-0.311259111341048,-0.0425965349488373,0.00985249363842285
Physical measures,X4270.Volume level set by participant (left),TST,Thiosulfate sulfurtransferase,32626,-0.0605742833034192,0.0234780692775219,-0.106591299087362,-0.0145572675194763,0.00989510575103291
Physical measures,X4270.Volume level set by participant (left),TACC3,Transforming acidic coiled-coil-containing protein 3,32832,-0.03927826107869,0.0152248488031092,-0.069118964732784,-0.00943755742459602,0.00989926733258151
Physical measures,X4270.Volume level set by participant (left),DCTN2,Dynactin subunit 2,32832,-0.0464124957028789,0.0179958882335771,-0.08168443664069,-0.0111405547650677,0.00992270611019674
Physical measures,X4270.Volume level set by participant (left),GSTT2B,Glutathione S-transferase theta-2B,31751,-0.02142545760006,0.00831574656687486,-0.0377243208711347,-0.00512659432898528,0.00999885467400642
Physical measures,X4270.Volume level set by participant (left),DARS1,"Aspartate--tRNA ligase, cytoplasmic",32776,-0.0667480747084975,0.0259097852512453,-0.117531253800938,-0.0159648956160567,0.0100060303822663
Physical measures,X4270.Volume level set by participant (left),L1CAM,Neural cell adhesion molecule L1,32881,0.154856564296884,0.0601136302743998,0.0370338489590601,0.272679279634707,0.0100089783033483
Physical measures,X4270.Volume level set by participant (left),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,32834,0.108834867371845,0.0423354161485042,0.0258574517207769,0.191812283022913,0.010163072375969
Physical measures,X4270.Volume level set by participant (left),S100P,Protein S100-P,32685,0.0797353827136237,0.0310273930138192,0.0189216924065381,0.140549073020709,0.0101908682331948
Physical measures,X4270.Volume level set by participant (left),OGFR,Opioid growth factor receptor,32832,-0.138891712474692,0.05404758743603,-0.244824983849311,-0.0329584411000729,0.0101916062207126
Physical measures,X4270.Volume level set by participant (left),KLK14,Kallikrein-14,32948,0.0944362749975336,0.036765838764304,0.0223752310194977,0.16649731897557,0.0102272192311803
Physical measures,X4270.Volume level set by participant (left),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,32796,0.141972823772422,0.0552801901637711,0.0336236510514303,0.250321996493413,0.0102377259245179
Physical measures,X4270.Volume level set by participant (left),ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",31762,-0.0583456423303777,0.0227735059969264,-0.102981714084353,-0.0137095705764019,0.0104256222586157
Physical measures,X4270.Volume level set by participant (left),LRRN1,Leucine-rich repeat neuronal protein 1,32679,-0.114711179018816,0.044849531043068,-0.202616259863229,-0.0268060981744028,0.0105535882495572
Physical measures,X4270.Volume level set by participant (left),UBE2B,Ubiquitin-conjugating enzyme E2 B,31724,-0.17567835233993,0.0686868114369271,-0.310304502756307,-0.0410522019235532,0.010556128732378
Physical measures,X4270.Volume level set by participant (left),CD226,CD226 antigen,31508,-0.125406639605059,0.0490519600930372,-0.221548481387412,-0.0292647978227061,0.0105889709651751
Physical measures,X4270.Volume level set by participant (left),NRGN,Neurogranin,31772,-0.0572395830843151,0.0223957797332987,-0.101135311361581,-0.0133438548070496,0.010612320089581
Physical measures,X4270.Volume level set by participant (left),IMPA1,Inositol monophosphatase 1,32796,-0.0742883157531954,0.0291203685546148,-0.13136423812024,-0.0172123933861504,0.0107555678990812
Physical measures,X4270.Volume level set by participant (left),SELENOP,Selenoprotein P,31770,-0.226067722763534,0.0887126479152451,-0.399944512677415,-0.0521909328496539,0.0108432284800889
Physical measures,X4270.Volume level set by participant (left),MZB1,Marginal zone B- and B1-cell-specific protein,32875,0.0886270516732529,0.034879130851875,0.0202639552035779,0.156990148142928,0.0110709578193462
Physical measures,X4270.Volume level set by participant (left),BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,31751,-0.119904623384984,0.0472086972049906,-0.212433669906766,-0.0273755768632027,0.0111079408466049
Physical measures,X4270.Volume level set by participant (left),CETN2,Centrin-2,32644,-0.0656655571955077,0.0258925784797085,-0.116415011015736,-0.014916103375279,0.0112274102796185
Physical measures,X4270.Volume level set by participant (left),CRADD,Death domain-containing protein CRADD,32776,-0.0615285914609296,0.0242752519680227,-0.109108085318254,-0.013949097603605,0.0112738313720096
Physical measures,X4270.Volume level set by participant (left),CTSE,Cathepsin E,31599,-0.097391128810017,0.0384913874947972,-0.17283424829982,-0.0219480093202145,0.0114192386606779
Physical measures,X4270.Volume level set by participant (left),SERPINE2,Glia-derived nexin,31762,-0.0780189472748509,0.0308372949615684,-0.138460045399525,-0.0175778491501769,0.011424900744479
Physical measures,X4270.Volume level set by participant (left),COMMD9,COMM domain-containing protein 9,31724,-0.126360705961292,0.0499549129666789,-0.224272335375983,-0.0284490765466016,0.0114420569770039
Physical measures,X4270.Volume level set by participant (left),APP,Amyloid-beta precursor protein,32840,-0.065800671668971,0.0260315080984004,-0.116822427541836,-0.0147789157961062,0.011497212773097
Physical measures,X4270.Volume level set by participant (left),SPARC,SPARC,32881,-0.0611696700679664,0.0242079783958998,-0.10861730772393,-0.0137220324120027,0.0115263738949887
Physical measures,X4270.Volume level set by participant (left),IL17C,Interleukin-17C,32679,0.0660986280239501,0.0261840909123186,0.0147778098358056,0.117419446212095,0.0116076231284686
Physical measures,X4270.Volume level set by participant (left),PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,31752,-0.0652326964748294,0.0258482965904361,-0.115895357792084,-0.0145700351575746,0.0116330018336996
Physical measures,X4270.Volume level set by participant (left),LRP2BP,LRP2-binding protein,31546,-0.0651133209805392,0.0258067887409005,-0.115694626912704,-0.0145320150483741,0.0116522715097163
Physical measures,X4270.Volume level set by participant (left),TARS1,"Threonine--tRNA ligase 1, cytoplasmic",31724,-0.141410045443437,0.0560784504412795,-0.251323808308345,-0.0314962825785296,0.0117002923233376
Physical measures,X4270.Volume level set by participant (left),LGALS3,Galectin-3,32857,0.145359584514392,0.0577819069881522,0.0321070468176136,0.25861212221117,0.0118982793786118
Physical measures,X4270.Volume level set by participant (left),COL24A1,Collagen alpha-1(XXIV) chain,31720,-0.0860958449398686,0.0342645154108712,-0.153254295145176,-0.018937394734561,0.0120015781438014
Physical measures,X4270.Volume level set by participant (left),ERP44,Endoplasmic reticulum resident protein 44,32816,-0.171130547400898,0.0681965214192884,-0.304795729382703,-0.0374653654190925,0.0121120642448962
Physical measures,X4270.Volume level set by participant (left),VPS4B,Vacuolar protein sorting-associated protein 4B,31724,-0.0544828218096373,0.0217283399712742,-0.0970703681533346,-0.0118952754659399,0.0121804284725681
Physical measures,X4270.Volume level set by participant (left),ACOT13,Acyl-coenzyme A thioesterase 13,31720,-0.0450467915219573,0.0180354367648064,-0.0803962475809779,-0.00969733546293674,0.0125211064976709
Physical measures,X4270.Volume level set by participant (left),BPIFB2,BPI fold-containing family B member 2,31750,0.0798476747566882,0.0319859329348679,0.0171552462043471,0.142540103309029,0.0125685759394557
Physical measures,X4270.Volume level set by participant (left),PCBP2,Poly(rC)-binding protein 2,31752,-0.0717343100322531,0.0287968397397152,-0.128176115922095,-0.0152925041424113,0.0127570877122207
Physical measures,X4270.Volume level set by participant (left),TSPYL1,Testis-specific Y-encoded-like protein 1,31508,-0.12444875493627,0.050209297919617,-0.222858978858719,-0.026038531013821,0.0132113360168756
Physical measures,X4270.Volume level set by participant (left),HS1BP3,HCLS1-binding protein 3,31566,-0.0570662278412727,0.0230258785048354,-0.10219694971075,-0.0119355059717953,0.0132203532900658
Physical measures,X4270.Volume level set by participant (left),RAPGEF2,Rap guanine nucleotide exchange factor 2,31632,-0.0941642073615902,0.0380835425843859,-0.168807950826987,-0.0195204638961938,0.0134358097984895
Physical measures,X4270.Volume level set by participant (left),TBCB,Tubulin-folding cofactor B,32796,-0.0449302008257271,0.018219784872797,-0.0806409791764092,-0.00921942247504494,0.0136813365872333
Physical measures,X4270.Volume level set by participant (left),LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,31724,-0.0998821616082186,0.0405153469281258,-0.179292241587345,-0.0204720816290921,0.0137113723374415
Physical measures,X4270.Volume level set by participant (left),TWF2,Twinfilin-2,31773,-0.0590342962009061,0.0239760998659941,-0.106027451938254,-0.0120411404635577,0.0138293798801909
Physical measures,X4270.Volume level set by participant (left),SMAD2,Mothers against decapentaplegic homolog 2,31724,-0.072102206954353,0.0293023853527611,-0.129534882245765,-0.0146695316629413,0.0138908365889102
Physical measures,X4270.Volume level set by participant (left),CASP9,Caspase-9,31508,-0.079765411297201,0.0324757875465347,-0.143417954888409,-0.0161128677059929,0.0140655269681174
Physical measures,X4270.Volume level set by participant (left),DCTPP1,dCTP pyrophosphatase 1,32864,-0.131534997690818,0.0536254731146866,-0.236640924995604,-0.0264290703860325,0.0141919594814004
Physical measures,X4270.Volume level set by participant (left),ATRAID,All-trans retinoic acid-induced differentiation factor,31720,-0.188781742926639,0.0769848917067396,-0.339672130671849,-0.0378913551814296,0.0142204840854802
Physical measures,X4270.Volume level set by participant (left),PTGES2,Prostaglandin E synthase 2,31467,-0.0931167232502164,0.0379771815631886,-0.167551999114066,-0.0186814473863668,0.0142322516354784
Physical measures,X4270.Volume level set by participant (left),FAM20A,Pseudokinase FAM20A,31762,0.171670173586972,0.0700935158494214,0.0342868825221057,0.309053464651837,0.0143405904725307
Physical measures,X4270.Volume level set by participant (left),IFNAR1,Interferon alpha/beta receptor 1,31720,-0.194781645212389,0.0797371706868199,-0.351066499758556,-0.0384967906662224,0.0145958443879139
Physical measures,X4270.Volume level set by participant (left),GMPR,GMP reductase 1,32961,-0.0888061028109312,0.0364033601787138,-0.16015668876121,-0.0174555168606522,0.014726456528604
Physical measures,X4270.Volume level set by participant (left),PSRC1,Proline/serine-rich coiled-coil protein 1,32638,-0.0713520167112485,0.0293969872351216,-0.128970111692087,-0.0137339217304102,0.0152363581291034
Physical measures,X4270.Volume level set by participant (left),MAX,Protein max,32644,-0.0418196940467448,0.0172412820073179,-0.0756126067810879,-0.00802678131240168,0.015304981374937
Physical measures,X4270.Volume level set by participant (left),TNFSF14,Tumor necrosis factor ligand superfamily member 14,32796,-0.0731089475802155,0.0301554988521026,-0.132213725330337,-0.0140041698300944,0.0153534777494866
Physical measures,X4270.Volume level set by participant (left),FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,31724,-0.141209903646959,0.0583855549067512,-0.255645591264191,-0.0267742160297264,0.015603958720054
Physical measures,X4270.Volume level set by participant (left),MTIF3,"Translation initiation factor IF-3, mitochondrial",31720,-0.0567212615801153,0.023476712412359,-0.102735617908339,-0.0107069052518917,0.0157119181303244
Physical measures,X4270.Volume level set by participant (left),SPINK1,Serine protease inhibitor Kazal-type 1,32861,0.104722706823896,0.0433812478281417,0.0196954610807384,0.189749952567054,0.0157979226249747
Physical measures,X4270.Volume level set by participant (left),IGBP1,Immunoglobulin-binding protein 1,31752,-0.0815738071225764,0.0338475961296415,-0.147915095536674,-0.015232518708479,0.0159738383324868
Physical measures,X4270.Volume level set by participant (left),PVALB,Parvalbumin alpha,32918,-0.0361453564193569,0.0150130234899665,-0.0655708824596912,-0.00671983037902257,0.0160776333308147
Physical measures,X4270.Volume level set by participant (left),BCL2L1,Bcl-2-like protein 1,31751,-0.0501466971889046,0.0208351526092894,-0.0909835963031119,-0.00930979807469726,0.0161144376631915
Physical measures,X4270.Volume level set by participant (left),BOLA1,BolA-like protein 1,31514,-0.0883739717533393,0.0367945872496461,-0.160491362762646,-0.0162565807440328,0.0163374329730337
Physical measures,X4270.Volume level set by participant (left),ADGRF5,Adhesion G protein-coupled receptor F5,31762,-0.16659297004157,0.0693883516636513,-0.302594139302327,-0.0305918007808138,0.0163787647347977
Physical measures,X4270.Volume level set by participant (left),FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",31752,-0.0608565599763351,0.0253801002090171,-0.110601556386009,-0.0111115635666615,0.0165166895295825
Physical measures,X4270.Volume level set by participant (left),CRYZL1,Quinone oxidoreductase-like protein 1,31566,-0.0565120155453156,0.0235772077605698,-0.102723342756033,-0.0103006883345987,0.0165584890566237
Physical measures,X4270.Volume level set by participant (left),CD3G,T-cell surface glycoprotein CD3 gamma chain,31508,-0.0549834415163856,0.0230542194552907,-0.100169711648755,-0.00979717138401574,0.0171051010995148
Physical measures,X4270.Volume level set by participant (left),IL2RG,Cytokine receptor common subunit gamma,31724,-0.129730466375794,0.0544412985513235,-0.236435411536388,-0.0230255212151996,0.0171985096303343
Physical measures,X4270.Volume level set by participant (left),RBM17,Splicing factor 45,31752,-0.062852601651017,0.0264143030351381,-0.114624635599888,-0.0110805677021464,0.0173601922519156
Physical measures,X4270.Volume level set by participant (left),USP25,Ubiquitin carboxyl-terminal hydrolase 25,31724,-0.0699744649380984,0.029434280187023,-0.127665654104664,-0.0122832757715333,0.0174631182456843
Physical measures,X4270.Volume level set by participant (left),OPLAH,5-oxoprolinase,31566,-0.0711370595400454,0.0299402349605396,-0.129819920062703,-0.0124541990173878,0.0175272622885744
Physical measures,X4270.Volume level set by participant (left),HIP1,Huntingtin-interacting protein 1,31495,-0.139280234717447,0.058683068530093,-0.254299049036429,-0.0242614203984647,0.0176482844251005
Physical measures,X4270.Volume level set by participant (left),NMT1,Glycylpeptide N-tetradecanoyltransferase 1,31752,-0.0714503914959788,0.0301264425227537,-0.130498218840576,-0.0124025641513815,0.0177311088923223
Physical measures,X4270.Volume level set by participant (left),PLXDC2,Plexin domain-containing protein 2,31751,-0.171165938929538,0.0722240503100524,-0.312725077537241,-0.0296068003218353,0.0178153761222453
Physical measures,X4270.Volume level set by participant (left),CLSTN1,Calsyntenin-1,32644,-0.0815155023259448,0.0344093308448461,-0.148957790781843,-0.0140732138700464,0.017858048620816
Physical measures,X4270.Volume level set by participant (left),ATXN2L,Ataxin-2-like protein,31752,-0.0936082473762642,0.0395304631195065,-0.171087955090497,-0.0161285396620315,0.0179083739547134
Physical measures,X4270.Volume level set by participant (left),PDAP1,28 kDa heat- and acid-stable phosphoprotein,31762,-0.0499682102961813,0.021122246531933,-0.0913678134987699,-0.00856860709359264,0.018021615997585
Physical measures,X4270.Volume level set by participant (left),DDHD2,Phospholipase DDHD2,31752,-0.073346216714701,0.0310664889805617,-0.134236535116602,-0.0124558983128,0.0182527024264242
Physical measures,X4270.Volume level set by participant (left),DSG3,Desmoglein-3,32916,0.119676460243126,0.0507065827757601,0.0202915580026364,0.219061362483616,0.0182873574857655
Physical measures,X4270.Volume level set by participant (left),PTPRR,Receptor-type tyrosine-protein phosphatase R,31751,-0.130691441595406,0.0553981551676586,-0.239271825724017,-0.0221110574667951,0.0183420827017308
Physical measures,X4270.Volume level set by participant (left),MPI,Mannose-6-phosphate isomerase,32832,-0.0487862113976679,0.0207412289736232,-0.0894390201859694,-0.00813340260936636,0.0186873977015807
Physical measures,X4270.Volume level set by participant (left),CLEC12A,C-type lectin domain family 12 member A,31508,-0.240530159873154,0.102518183020485,-0.441465798593305,-0.0395945211530027,0.0189903364387581
Physical measures,X4270.Volume level set by participant (left),SEPTIN9,Septin-9,32832,-0.148032566017843,0.0630984481776106,-0.27170552444596,-0.0243596075897259,0.0189948526479334
Physical measures,X4270.Volume level set by participant (left),CD84,SLAM family member 5,32843,-0.12937821149013,0.0552465436531252,-0.237661437050255,-0.0210949859300048,0.0192110068284123
Physical measures,X4270.Volume level set by participant (left),YY1,Transcriptional repressor protein YY1,31508,-0.168940092068052,0.0722860938440679,-0.310620836002425,-0.0272593481336789,0.0194594751830596
Physical measures,X4270.Volume level set by participant (left),PRR4,Proline-rich protein 4,31552,0.0690940241936087,0.0295757409554288,0.0111255719209683,0.127062476466249,0.0195078277947282
Physical measures,X4270.Volume level set by participant (left),PCNA,Proliferating cell nuclear antigen,31492,-0.0705091248743075,0.0302651169119683,-0.129828754021765,-0.0111894957268497,0.0198471281177587
Physical measures,X4270.Volume level set by participant (left),DEFA1_DEFA1B,Neutrophil defensin 1,32649,0.077879873050285,0.0334515394051078,0.0123148558162738,0.143444890284296,0.0199272419255366
Physical measures,X4270.Volume level set by participant (left),DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",32832,-0.0923162964820475,0.0397359888613975,-0.170198834650387,-0.0144337583137083,0.0201884320254556
Physical measures,X4270.Volume level set by participant (left),AK2,"Adenylate kinase 2, mitochondrial",31751,-0.0442631146482912,0.0191099751431353,-0.0817186659288364,-0.00680756336774606,0.0205711687946936
Physical measures,X4270.Volume level set by participant (left),OGA,Protein O-GlcNAcase,31720,-0.0679306450847659,0.0294093553757347,-0.125572981621206,-0.010288308548326,0.0209232972872911
Physical measures,X4270.Volume level set by participant (left),MELTF,Melanotransferrin,31762,-0.155281557635543,0.0672618257042002,-0.287114736015775,-0.0234483792553103,0.0209907309693178
Physical measures,X4270.Volume level set by participant (left),BEX3,Protein BEX3,31492,-0.10020459389909,0.0434295603710648,-0.185326532226377,-0.0150826555718025,0.0210652956597215
Physical measures,X4270.Volume level set by participant (left),AP3B1,AP-3 complex subunit beta-1,31720,-0.0618419090772535,0.0268074136307108,-0.114384439793447,-0.0092993783610603,0.0210865114750878
Physical measures,X4270.Volume level set by participant (left),STEAP4,Metalloreductase STEAP4,31514,0.0624649418430325,0.0270955055075314,0.00935775104827101,0.115572132637794,0.0211729456917422
Physical measures,X4270.Volume level set by participant (left),CEP350,Centrosome-associated protein 350,31492,-0.12966378933313,0.0562775645276965,-0.239967815807415,-0.0193597628588449,0.0212491052968415
Physical measures,X4270.Volume level set by participant (left),DDX1,ATP-dependent RNA helicase DDX1,31720,-0.0870077546583105,0.037927538887435,-0.161345730877683,-0.0126697784389379,0.0218137592777437
Physical measures,X4270.Volume level set by participant (left),GAMT,Guanidinoacetate N-methyltransferase,31495,-0.135043961697556,0.0588874603766427,-0.250463384035776,-0.0196245393593363,0.0218603878129366
Physical measures,X4270.Volume level set by participant (left),TADA3,Transcriptional adapter 3,31724,-0.117767359790469,0.0514087034183001,-0.218528418490337,-0.0170063010906006,0.0220009859062728
Physical measures,X4270.Volume level set by participant (left),AKT2,RAC-beta serine/threonine-protein kinase,31752,-0.0370208509565321,0.0161861125663738,-0.0687456315866248,-0.00529607032643944,0.0222105994086607
Physical measures,X4270.Volume level set by participant (left),IL19,Interleukin-19,32635,0.0590907302733729,0.0258418792668486,0.00844064691034953,0.109740813636396,0.0222413398375983
Physical measures,X4270.Volume level set by participant (left),EFNB2,Ephrin-B2,31546,-0.0758385220901968,0.0331875922503188,-0.140886202900822,-0.0107908412795718,0.0223313415343278
Physical measures,X4270.Volume level set by participant (left),CD5L,CD5 antigen-like,31741,-0.0981661876727184,0.0430317100084413,-0.182508339289263,-0.0138240360561733,0.0225600877040728
Physical measures,X4270.Volume level set by participant (left),ADGRV1,Adhesion G-protein coupled receptor V1,31514,-0.0681756186693221,0.0299697969415492,-0.126916420674758,-0.00943481666388567,0.0229448300318541
Physical measures,X4270.Volume level set by participant (left),CPXM1,Probable carboxypeptidase X1,32881,-0.0579968469939915,0.0255011369210423,-0.107979075359234,-0.00801461862874858,0.022972257529939
Physical measures,X4270.Volume level set by participant (left),PNMA1,Paraneoplastic antigen Ma1,31566,-0.0815155805198003,0.0358593060123471,-0.151799820304001,-0.0112313407356,0.0230411961053648
Physical measures,X4270.Volume level set by participant (left),HTR1A,5-hydroxytryptamine receptor 1A,31514,-0.0601294819532663,0.0264647386386059,-0.112000369684934,-0.00825859422159872,0.0231105016023293
Physical measures,X4270.Volume level set by participant (left),RRAS,Ras-related protein R-Ras,31546,-0.0353989024514619,0.0155934793331307,-0.065962121944398,-0.0048356829585258,0.0232285287737317
Physical measures,X4270.Volume level set by participant (left),BPIFB1,BPI fold-containing family B member 1,32847,0.0614010053037881,0.0270488145587712,0.00838532876859657,0.11441668183898,0.0232307279731774
Physical measures,X4270.Volume level set by participant (left),COL2A1,Collagen alpha-1(II) chain,31566,-0.0582387442334457,0.0256604832256859,-0.10853329135579,-0.00794419711110137,0.0232600669749142
Physical measures,X4270.Volume level set by participant (left),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,32858,0.121995491481906,0.0537741676856992,0.0165981228179357,0.227392860145876,0.0233123876729893
Physical measures,X4270.Volume level set by participant (left),PPT1,Palmitoyl-protein thioesterase 1,31546,-0.0578709434924609,0.0255248967865552,-0.107899741194109,-0.0078421457908127,0.0234035269572228
Physical measures,X4270.Volume level set by participant (left),OMG,Oligodendrocyte-myelin glycoprotein,32832,-0.0604378106387305,0.0266603929581967,-0.112692180836796,-0.00818344044066489,0.0234169084446212
Physical measures,X4270.Volume level set by participant (left),LHB,Lutropin subunit beta,32638,0.0440035776947502,0.0194127581662021,0.00595457168899409,0.0820525837005063,0.0234306542990066
Physical measures,X4270.Volume level set by participant (left),ANGPT1,Angiopoietin-1,32847,-0.0459500422323111,0.0203240980160802,-0.0857852743438282,-0.00611481012079396,0.0237914371119946
Physical measures,X4270.Volume level set by participant (left),GHRHR,Growth hormone-releasing hormone receptor,32644,-0.0710830812223442,0.0314450114226669,-0.132715303610771,-0.00945085883391707,0.023811396547642
Physical measures,X4270.Volume level set by participant (left),PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,31599,-0.0801883552763431,0.0355337325635318,-0.149834471100865,-0.0105422394518209,0.0240557044114366
Physical measures,X4270.Volume level set by participant (left),WFDC12,WAP four-disulfide core domain protein 12,32945,0.0607228814849269,0.0269192422898524,0.00796116659681617,0.113484596373038,0.0241104494422508
Physical measures,X4270.Volume level set by participant (left),DEFB116,Beta-defensin 116,31514,-0.0605730956663382,0.026861392382886,-0.113221424736795,-0.00792476659588177,0.0241599432869008
Physical measures,X4270.Volume level set by participant (left),MAPRE3,Microtubule-associated protein RP/EB family member 3,31492,-0.030937177263699,0.0137285113174329,-0.0578450594458674,-0.00402929508153049,0.024256020467199
Physical measures,X4270.Volume level set by participant (left),CD200,OX-2 membrane glycoprotein,32843,-0.150672177346335,0.0668741217026206,-0.281745455883471,-0.0195988988091982,0.0242786723263583
Physical measures,X4270.Volume level set by participant (left),DTYMK,Thymidylate kinase,31762,-0.0680940771068206,0.030223970714413,-0.12733305970707,-0.00885509450657112,0.0242875750789372
Physical measures,X4270.Volume level set by participant (left),SELE,E-selectin,32964,0.0769030497717908,0.0342340566524451,0.00980429873299847,0.144001800810583,0.0247029050094828
Physical measures,X4270.Volume level set by participant (left),MMP7,Matrilysin,32672,0.0818136083893301,0.0364510419377531,0.0103695661913339,0.153257650587326,0.0248263023650169
Physical measures,X4270.Volume level set by participant (left),CMIP,C-Maf-inducing protein,31724,-0.0557011108315495,0.0248165190372146,-0.10434148814449,-0.00706073351860884,0.0248268278627063
Physical measures,X4270.Volume level set by participant (left),RBM25,RNA-binding protein 25,31492,-0.104414776594782,0.0466351882845841,-0.195819745632567,-0.0130098075569974,0.0251865954406946
Physical measures,X4270.Volume level set by participant (left),SLITRK1,SLIT and NTRK-like protein 1,31508,-0.142416901977133,0.0636426488612607,-0.267156493745204,-0.0176773102090622,0.0252654721604114
Physical measures,X4270.Volume level set by participant (left),TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,31751,-0.0518433227367182,0.0231883001819617,-0.0972923910933632,-0.00639425438007329,0.0253957865706906
Physical measures,X4270.Volume level set by participant (left),FGFBP3,Fibroblast growth factor-binding protein 3,31751,-0.119788019558497,0.0535869430269854,-0.224818427891388,-0.0147576112256052,0.0254192581537708
Physical measures,X4270.Volume level set by participant (left),LATS1,Serine/threonine-protein kinase LATS1,31508,-0.0545205219165113,0.0244315175218651,-0.102406296259367,-0.00663474757365565,0.0256725940118189
Physical measures,X4270.Volume level set by participant (left),TBCC,Tubulin-specific chaperone C,32796,-0.0498330923312671,0.0223396987198426,-0.0936189018221587,-0.00604728284037557,0.0257259583684529
Physical measures,X4270.Volume level set by participant (left),TNFSF13,Tumor necrosis factor ligand superfamily member 13,32894,-0.144507395443385,0.064837154020036,-0.271588217322656,-0.0174265735641148,0.0258534251121738
Physical measures,X4270.Volume level set by participant (left),GSR,"Glutathione reductase, mitochondrial",31734,-0.203653669350778,0.0913941900619528,-0.382786281872206,-0.0245210568293509,0.0258886590185637
Physical measures,X4270.Volume level set by participant (left),GFRAL,GDNF family receptor alpha-like,31502,-0.0715634048073598,0.0321224235587376,-0.134523354982486,-0.00860345463223405,0.0259206417071368
Physical measures,X4270.Volume level set by participant (left),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,31514,-0.0730965516800219,0.0328192611227044,-0.137422303480522,-0.00877079987952138,0.0259598509106175
Physical measures,X4270.Volume level set by participant (left),GGCT,Gamma-glutamylcyclotransferase,31749,-0.0946274326160686,0.0425039723171993,-0.177935218357779,-0.0113196468743579,0.026020915472691
Physical measures,X4270.Volume level set by participant (left),UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,31762,-0.0733846540258374,0.0329633354079381,-0.137992791425396,-0.00877651662627875,0.0260254815101133
Physical measures,X4270.Volume level set by participant (left),STAMBP,STAM-binding protein,32776,-0.063803590374154,0.0286900414539834,-0.120036071623961,-0.00757110912434646,0.0261805876051689
Physical measures,X4270.Volume level set by participant (left),PDLIM5,PDZ and LIM domain protein 5,31752,-0.0389288097947699,0.0175053424050393,-0.073239280908647,-0.00461833868089289,0.026188457357483
Physical measures,X4270.Volume level set by participant (left),CNPY4,Protein canopy homolog 4,32832,-0.051809098491189,0.0233051849020197,-0.0974872608991476,-0.00613093608323031,0.0262357885978669
Physical measures,X4270.Volume level set by participant (left),PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,32644,-0.0361356824472186,0.0162780897745739,-0.0680407384053835,-0.00423062648905368,0.0264512024151548
Physical measures,X4270.Volume level set by participant (left),DNM1,Dynamin-1,31720,-0.0393499224048358,0.0177282610256724,-0.0740973140151537,-0.00460253079451782,0.0264733232162212
Physical measures,X4270.Volume level set by participant (left),EDF1,Endothelial differentiation-related factor 1,31752,-0.0649077729953223,0.0292586789109955,-0.122254783660874,-0.00756076232977104,0.0265551880636301
Physical measures,X4270.Volume level set by participant (left),AFAP1,Actin filament-associated protein 1,31599,-0.0509906761743503,0.0230099833608827,-0.0960902435616804,-0.00589110878702016,0.0267188486270834
Physical measures,X4270.Volume level set by participant (left),TIA1,Nucleolysin TIA-1 isoform p40,32625,-0.033027641780665,0.0149158539597792,-0.0622627155418323,-0.00379256801949778,0.0268362510469249
Physical measures,X4270.Volume level set by participant (left),FLI1,Friend leukemia integration 1 transcription factor,32638,-0.0363360718428354,0.0164325804800261,-0.0685439295836864,-0.00412821410198427,0.0270462002776065
Physical measures,X4270.Volume level set by participant (left),QSOX1,Sulfhydryl oxidase 1,31595,-0.106474090855543,0.0481576643333824,-0.200863112948973,-0.0120850687621137,0.0270685960677243
Physical measures,X4270.Volume level set by participant (left),MANSC1,MANSC domain-containing protein 1,32881,0.140038534307969,0.0633918372597853,0.0157905332787901,0.264286535337149,0.0271931407708566
Physical measures,X4270.Volume level set by participant (left),KIAA1549L,UPF0606 protein KIAA1549L,31632,-0.1598269559328,0.0724660597447437,-0.301860433032498,-0.0177934788331025,0.0274452426162789
Physical measures,X4270.Volume level set by participant (left),CCN2,CCN family member 2,32868,-0.0649342917720229,0.0294586246634895,-0.122673196112462,-0.00719538743158343,0.0275316878105455
Physical measures,X4270.Volume level set by participant (left),LPP,Lipoma-preferred partner,31495,-0.0683827562137379,0.0310545845133623,-0.129249741859928,-0.00751577056754778,0.0276938361791426
Physical measures,X4270.Volume level set by participant (left),AHSG,Alpha-2-HS-glycoprotein,31772,-0.163175045249054,0.0741033267346013,-0.308417565648873,-0.0179325248492357,0.0276945269686381
Physical measures,X4270.Volume level set by participant (left),STAT5B,Signal transducer and activator of transcription 5B,32832,-0.0292079173096127,0.0132828685525961,-0.055242339672701,-0.00317349494652436,0.0279093070801067
Physical measures,X4270.Volume level set by participant (left),AMOTL2,Angiomotin-like protein 2,31681,-0.0876463064810858,0.039885890024879,-0.165822650929849,-0.00946996203232302,0.0280192373340576
Physical measures,X4270.Volume level set by participant (left),APOA1,Apolipoprotein A-I,31770,-0.159866990582255,0.0727884941227568,-0.302532439062858,-0.0172015421016512,0.0280978149424936
Physical measures,X4270.Volume level set by participant (left),CDKN1A,Cyclin-dependent kinase inhibitor 1,32832,-0.036489989556385,0.0166200893635217,-0.0690653647088875,-0.00391461440388248,0.028150759855357
Physical measures,X4270.Volume level set by participant (left),PRCP,Lysosomal Pro-X carboxypeptidase,32894,0.119456960679437,0.0544708046556873,0.0126941835542895,0.226219737804584,0.0283295017226476
Physical measures,X4270.Volume level set by participant (left),ANGPTL4,Angiopoietin-related protein 4,32883,0.0809565877671805,0.0370521385465444,0.00833439621595343,0.153578779318408,0.0289191113824124
Physical measures,X4270.Volume level set by participant (left),CD40LG,CD40 ligand,32961,-0.0478971989833372,0.0219243604086768,-0.0908689453843438,-0.00492545258233069,0.0289394644598284
Physical measures,X4270.Volume level set by participant (left),SMPD1,Sphingomyelin phosphodiesterase,32890,0.0756435098760229,0.0346378713779192,0.00775328197530135,0.143533737776745,0.0289997840302774
Physical measures,X4270.Volume level set by participant (left),TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,31632,-0.0414801962545452,0.018999796205389,-0.0787197968171076,-0.00424059569198284,0.0290515242092123
Physical measures,X4270.Volume level set by participant (left),PROS1,Vitamin K-dependent protein S,31770,-0.173613723843097,0.0795235342420209,-0.329479850957458,-0.0177475967287365,0.0290522920770871
Physical measures,X4270.Volume level set by participant (left),CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,32638,-0.0654065277119865,0.029983444836194,-0.124174079590927,-0.00663897583304617,0.0291787132286837
Physical measures,X4270.Volume level set by participant (left),TXNDC9,Thioredoxin domain-containing protein 9,31751,-0.0811893747117676,0.0372927678041749,-0.15428319960795,-0.00809554981558484,0.0295040749486963
Physical measures,X4270.Volume level set by participant (left),CA13,Carbonic anhydrase 13,32770,-0.0371233952352897,0.0170760118840414,-0.0705923785280109,-0.00365441194256851,0.029730739528444
Physical measures,X4270.Volume level set by participant (left),TPT1,Translationally-controlled tumor protein,32679,-0.0608639540198662,0.0280020767300041,-0.115748024410674,-0.0059798836290583,0.0297653654249662
Physical measures,X4270.Volume level set by participant (left),RBPMS2,RNA-binding protein with multiple splicing 2,31566,-0.0422195683318357,0.0194289276101373,-0.0803002664477048,-0.00413887021596659,0.0298087217123593
Physical measures,X4270.Volume level set by participant (left),HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,31752,-0.0939294176472294,0.043227777716179,-0.17865586197094,-0.00920297332351858,0.0298178907682938
Physical measures,X4270.Volume level set by participant (left),SRPX,Sushi repeat-containing protein SRPX,31762,-0.124879089206465,0.0576462260173406,-0.237865692200453,-0.0118924862124779,0.0303179876686368
Physical measures,X4270.Volume level set by participant (left),DNAJC9,DnaJ homolog subfamily C member 9,31720,-0.0581378805614232,0.0268550601176928,-0.110773798392101,-0.00550196273074537,0.030427177138558
Physical measures,X4270.Volume level set by participant (left),SELL,L-selectin,31770,-0.189626799486911,0.0876084904363914,-0.361339440742238,-0.0179141582315842,0.0304573839304958
Physical measures,X4270.Volume level set by participant (left),RHOC,Rho-related GTP-binding protein RhoC,32741,-0.0332857068141651,0.0153785153748468,-0.0634275969488648,-0.00314381667946535,0.0304579989753803
Physical measures,X4270.Volume level set by participant (left),DTX3,Probable E3 ubiquitin-protein ligase DTX3,32832,-0.160521100120167,0.0743201387889685,-0.306188572146546,-0.0148536280937892,0.0308099165976744
Physical measures,X4270.Volume level set by participant (left),SF3B4,Splicing factor 3B subunit 4,32832,-0.0515185101138863,0.0238703388394902,-0.0983043742392872,-0.0047326459884854,0.0309337084058019
Physical measures,X4270.Volume level set by participant (left),FAM172A,Cotranscriptional regulator FAM172A,31566,-0.0723227851352822,0.0335348985028678,-0.138051186200903,-0.00659438406966133,0.0310643821999387
Physical measures,X4270.Volume level set by participant (left),SV2A,Synaptic vesicle glycoprotein 2A,31546,-0.069505267596929,0.0322561779111682,-0.132727376302819,-0.00628315889103927,0.0312093047601664
Physical measures,X4270.Volume level set by participant (left),MYDGF,Myeloid-derived growth factor,31762,-0.0428592298330053,0.0199024239470435,-0.0818679807692105,-0.00385047889680012,0.0313120990899794
Physical measures,X4270.Volume level set by participant (left),MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,31632,-0.0387308630239365,0.0179880564235006,-0.0739874536139976,-0.00347427243387539,0.0313381027298246
Physical measures,X4270.Volume level set by participant (left),FETUB,Fetuin-B,32872,0.11002818408997,0.051150091045164,0.00977400564144862,0.210282362538491,0.0314960163847116
Physical measures,X4270.Volume level set by participant (left),PCDH17,Protocadherin-17,32864,-0.105376346890785,0.0490023054875665,-0.201420865646415,-0.00933182813515422,0.0315472527430299
Physical measures,X4270.Volume level set by participant (left),VPS28,Vacuolar protein sorting-associated protein 28 homolog,31632,-0.0667779234556228,0.031063578199761,-0.127662536727154,-0.00589331018409128,0.0316083335776036
Physical measures,X4270.Volume level set by participant (left),NPTN,Neuroplastin,32638,-0.04593189312039,0.0213834862054961,-0.0878435260831623,-0.00402026015761774,0.0317404379940933
Physical measures,X4270.Volume level set by participant (left),CELA2A,Chymotrypsin-like elastase family member 2A,31773,0.0711561724807623,0.0331313412691293,0.00621874359326878,0.136093601368256,0.0317679056383018
Physical measures,X4270.Volume level set by participant (left),NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",31720,-0.042876803272839,0.0199715660776251,-0.0820210727849841,-0.00373253376069385,0.0318323645930736
Physical measures,X4270.Volume level set by participant (left),FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,32903,-0.0335509366439457,0.0156295009802549,-0.0641847585652452,-0.0029171147226461,0.0318483547141144
Physical measures,X4270.Volume level set by participant (left),RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,31492,-0.105165038559754,0.0490459273453133,-0.201295056156568,-0.00903502096293958,0.0320471263396554
Physical measures,X4270.Volume level set by participant (left),ATG16L1,Autophagy-related protein 16-1,31720,-0.0518731620099487,0.024195775831485,-0.0992968826396593,-0.00444944138023807,0.032072034956993
Physical measures,X4270.Volume level set by participant (left),DDC,Aromatic-L-amino-acid decarboxylase,32858,-0.0751608869739407,0.0350830879440395,-0.143923739344258,-0.00639803460362333,0.0321906405543327
Physical measures,X4270.Volume level set by participant (left),TOMM20,Mitochondrial import receptor subunit TOM20 homolog,31762,-0.0557792782006316,0.0260700674736475,-0.106876610448981,-0.00468194595228252,0.0324184007839013
Physical measures,X4270.Volume level set by participant (left),ARF6,ADP-ribosylation factor 6,31720,-0.041849298017364,0.0195657282713897,-0.0801981254292879,-0.00350047060544006,0.0324738356505977
Physical measures,X4270.Volume level set by participant (left),TBCA,Tubulin-specific chaperone A,31599,-0.05267626023689,0.0246468229655838,-0.100984033249434,-0.00436848722434573,0.0326094633475187
Physical measures,X4270.Volume level set by participant (left),ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",32833,0.0565088483274052,0.026474888133299,0.00461806758613915,0.108399629068671,0.0328344667646857
Physical measures,X4270.Volume level set by participant (left),DHODH,Dihydroorotate dehydrogenase,31495,-0.0945361398524611,0.0442907122892167,-0.181345935939326,-0.00772634376559635,0.0328380493429592
Physical measures,X4270.Volume level set by participant (left),GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,31566,-0.0833681718063257,0.0390801795777384,-0.159965323778693,-0.00677101983395852,0.0329349407525823
Physical measures,X4270.Volume level set by participant (left),COL3A1,Collagen alpha-1(III) chain,31773,-0.17828393251325,0.0835793694524107,-0.342099496639975,-0.0144683683865254,0.0329464500823441
Physical measures,X4270.Volume level set by participant (left),GRSF1,G-rich sequence factor 1,31449,-0.0540145408970036,0.025348934869266,-0.103698453240765,-0.00433062855324227,0.0331343392054725
Physical measures,X4270.Volume level set by participant (left),PSMD1,26S proteasome non-ATPase regulatory subunit 1,31752,-0.0840539682481407,0.0394911733112531,-0.161456667938197,-0.00665126855808462,0.0333328317424592
Physical measures,X4270.Volume level set by participant (left),NT5C3A,Cytosolic 5'-nucleotidase 3A,32831,-0.0446127042877771,0.020970879351554,-0.0857156278168229,-0.00350978075873118,0.0334170183247364
Physical measures,X4270.Volume level set by participant (left),XCL1,Lymphotactin,32948,0.0663892771536958,0.0312359043250353,0.00516690467662673,0.127611649630765,0.033578857853997
Physical measures,X4270.Volume level set by participant (left),MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,32776,-0.0346564849924422,0.0163166379644013,-0.0666370954026686,-0.00267587458221568,0.0336978791576715
Physical measures,X4270.Volume level set by participant (left),BCAM,Basal cell adhesion molecule,32861,-0.150693419022239,0.0710268024179703,-0.289905951761461,-0.0114808862830175,0.0338951015206044
Physical measures,X4270.Volume level set by participant (left),SATB1,DNA-binding protein SATB1,31752,-0.144905346207084,0.0683333082350994,-0.278838630347879,-0.010972062066289,0.0339893896138973
Physical measures,X4270.Volume level set by participant (left),EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",31751,-0.0746992383347502,0.0352565453315698,-0.143802067184627,-0.00559640948487339,0.0341441312106632
Physical measures,X4270.Volume level set by participant (left),EVI2B,Protein EVI2B,31492,-0.11670187498285,0.0551573412079171,-0.224810263750367,-0.00859348621533203,0.0343941753486288
Physical measures,X4270.Volume level set by participant (left),NPHS1,Nephrin,31508,-0.125549855979083,0.0593611748746082,-0.241897758733315,-0.00920195322485103,0.0344608190992476
Physical measures,X4270.Volume level set by participant (left),APOC1,Apolipoprotein C-I,31758,-0.10909889140731,0.0516110110624706,-0.210256473089752,-0.00794130972486758,0.0345577742887686
Physical measures,X4270.Volume level set by participant (left),MINK1,Misshapen-like kinase 1,31751,-0.0466055522405986,0.0220551730268236,-0.0898336913731729,-0.0033774131080243,0.0346205603806864
Physical measures,X4270.Volume level set by participant (left),GIPC3,PDZ domain-containing protein GIPC3,31720,-0.0443092733769181,0.020969107795921,-0.0854087246569233,-0.00320982209691291,0.0346258956694454
Physical measures,X4270.Volume level set by participant (left),TTF2,Transcription termination factor 2,31546,-0.086372946656514,0.0408947021130428,-0.166526562798078,-0.00621933051495001,0.0347116417104094
Physical measures,X4270.Volume level set by participant (left),MAPKAPK2,MAP kinase-activated protein kinase 2,31632,-0.0591389481489563,0.0280449659366082,-0.114107081384708,-0.00417081491320426,0.0350007816369704
Physical measures,X4270.Volume level set by participant (left),DNAJB6,DnaJ homolog subfamily B member 6,31519,-0.0521118624317177,0.0247134760383479,-0.10055027546688,-0.00367344939655577,0.035007931249888
Physical measures,X4270.Volume level set by participant (left),CLSTN3,Calsyntenin-3,31751,-0.138123675398419,0.0655226774558237,-0.266548123211834,-0.00969922758500483,0.0350599804369471
Physical measures,X4270.Volume level set by participant (left),PTH,Parathyroid hormone,31546,-0.0514588113217983,0.0244485874308319,-0.0993780426862288,-0.00353957995736778,0.0353431620925785
Physical measures,X4270.Volume level set by participant (left),KLKB1,Plasma kallikrein,31608,-0.16260438338697,0.077424757651985,-0.31435690838486,-0.0108518583890794,0.035747021868109
Physical measures,X4270.Volume level set by participant (left),NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",31762,-0.0566793334039762,0.0270001678393333,-0.109599662369069,-0.00375900443888297,0.0358290319735156
Physical measures,X4270.Volume level set by participant (left),ENO2,Gamma-enolase,32931,-0.0569597509972472,0.0271429783871939,-0.110159988636147,-0.00375951335834721,0.0358879042716561
Physical measures,X4270.Volume level set by participant (left),HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,31566,-0.12057680362277,0.0574872784526804,-0.233251869390023,-0.0079017378555163,0.0359860957876924
Physical measures,X4270.Volume level set by participant (left),NCK2,Cytoplasmic protein NCK2,32894,-0.0351371866736812,0.0167632687635356,-0.067993193450211,-0.0022811798971513,0.0361026730918512
Physical measures,X4270.Volume level set by participant (left),DIPK2B,Divergent protein kinase domain 2B,31599,-0.150117098700103,0.0716629824952351,-0.290576544390764,-0.00965765300944216,0.0362243417057611
Physical measures,X4270.Volume level set by participant (left),ASPSCR1,Tether containing UBX domain for GLUT4,31752,-0.063570574278326,0.0303502635978652,-0.123057090930142,-0.00408405762651012,0.0362415732884889
Physical measures,X4270.Volume level set by participant (left),KLK7,Kallikrein-7,31392,0.11053792228283,0.0527898434267241,0.00706982916645064,0.214006015399209,0.0363001057496579
Physical measures,X4270.Volume level set by participant (left),F11,Coagulation factor XI,31656,-0.131664340383834,0.0629125564525884,-0.254972951030908,-0.00835572973676119,0.0363979325768271
Physical measures,X4270.Volume level set by participant (left),PKN3,Serine/threonine-protein kinase N3,31632,-0.0535138236314968,0.0255739574898375,-0.103638780311578,-0.00338886695141533,0.0364250681569305
Physical measures,X4270.Volume level set by participant (left),TPD52L2,Tumor protein D54,31599,-0.0402990037462606,0.0192631825927206,-0.0780548416279931,-0.00254316586452815,0.0364690560835531
Physical measures,X4270.Volume level set by participant (left),HPSE,Heparanase,31646,-0.0452063534108722,0.0216129468141502,-0.0875677291666066,-0.00284497765513785,0.0365036871869863
Physical measures,X4270.Volume level set by participant (left),S100A3,Protein S100-A3,31724,-0.0949944341229943,0.0455587065475908,-0.184289498956272,-0.00569936928971633,0.0370924587413446
Physical measures,X4270.Volume level set by participant (left),LSM1,U6 snRNA-associated Sm-like protein LSm1,32638,-0.0660572635466442,0.0316820166207027,-0.128154016123221,-0.0039605109700669,0.0370973931996331
Physical measures,X4270.Volume level set by participant (left),MAP2,Microtubule-associated protein 2,31751,-0.0860623412822317,0.0412783127695098,-0.166967834310471,-0.00515684825399247,0.0371078472093097
Physical measures,X4270.Volume level set by participant (left),TAP1,Antigen peptide transporter 1,31632,-0.0679150930506977,0.0325822458940286,-0.131776295002994,-0.00405389109840171,0.0371545419542192
Physical measures,X4270.Volume level set by participant (left),EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,32796,-0.0395150487368878,0.0189647623197676,-0.0766859828836323,-0.00234411459014319,0.0372245883299539
Physical measures,X4270.Volume level set by participant (left),NFE2,Transcription factor NF-E2 45 kDa subunit,31566,-0.0572604014819278,0.0275187345337062,-0.111197121167992,-0.00332368179586354,0.0374871125968727
Physical measures,X4270.Volume level set by participant (left),ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,31770,-0.211540075625371,0.101986537321937,-0.411433688776367,-0.0116464624743746,0.0380933884676182
Physical measures,X4270.Volume level set by participant (left),FIS1,Mitochondrial fission 1 protein,32841,-0.046795121932518,0.0225783912633079,-0.0910487688086015,-0.00254147505643453,0.038241505212949
Physical measures,X4270.Volume level set by participant (left),PHACTR2,Phosphatase and actin regulator 2,31752,-0.0368083848153681,0.0177661125551094,-0.0716299654233825,-0.00198680420735375,0.0383136132684017
Physical measures,X4270.Volume level set by participant (left),DAB2,Disabled homolog 2,32948,-0.0326899749037165,0.0157790717849975,-0.0636169556023116,-0.00176299420512144,0.0383187904000062
Physical measures,X4270.Volume level set by participant (left),AFM,Afamin,31770,-0.214943085980255,0.103757457879515,-0.418307703424104,-0.011578468536406,0.0383358889463934
Physical measures,X4270.Volume level set by participant (left),SERPINB6,Serpin B6,32892,-0.0599478593328351,0.028990467214608,-0.116769175073467,-0.0031265435922034,0.0386828011082519
Physical measures,X4270.Volume level set by participant (left),DKK1,Dickkopf-related protein 1,32931,-0.0587321413823926,0.0284109783602658,-0.114417658968514,-0.00304662379627169,0.0387404151631024
Physical measures,X4270.Volume level set by participant (left),SORT1,Sortilin,32858,-0.0955801982568105,0.0462570151033783,-0.186243947859432,-0.00491644865418911,0.0388300922146643
Physical measures,X4270.Volume level set by participant (left),FADD,FAS-associated death domain protein,32864,-0.0482768238113772,0.023390195274506,-0.094121606549409,-0.00243204107334549,0.0390484955077914
Physical measures,X4270.Volume level set by participant (left),LDLRAP1,Low density lipoprotein receptor adapter protein 1,31752,-0.0431012366435115,0.0208896570956644,-0.0840449645510137,-0.0021575087360093,0.0391185616853984
Physical measures,X4270.Volume level set by participant (left),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,31752,-0.0340541132384219,0.0165228185187376,-0.0664388375351476,-0.00166938894169623,0.039332366694644
Physical measures,X4270.Volume level set by participant (left),MCFD2,Multiple coagulation factor deficiency protein 2,32833,-0.0797220525738015,0.0386816354222968,-0.155538058001503,-0.00390604714609967,0.0393337686254108
Physical measures,X4270.Volume level set by participant (left),LACTB2,Endoribonuclease LACTB2,32864,-0.0554277708351477,0.026938530846008,-0.108227291293323,-0.00262825037697208,0.0396606740567315
Physical measures,X4270.Volume level set by participant (left),FGF12,Fibroblast growth factor 12,31508,-0.0905711448333478,0.0440943760455239,-0.176996121882575,-0.00414616778412093,0.0400067760074168
Physical measures,X4270.Volume level set by participant (left),PPM1F,Protein phosphatase 1F,31762,-0.0785137234717191,0.0382876390627453,-0.1535574960347,-0.00346995090873825,0.0403360653764364
Physical measures,X4270.Volume level set by participant (left),REXO2,"Oligoribonuclease, mitochondrial",31495,-0.0852156665149323,0.0415925837396116,-0.166737130644571,-0.00369420238529358,0.0405139643945471
Physical measures,X4270.Volume level set by participant (left),GMFG,Glia maturation factor gamma,31762,-0.0583982910499634,0.028516719520125,-0.114291061309408,-0.00250552079051847,0.0406065716324716
Physical measures,X4270.Volume level set by participant (left),SARG,Specifically androgen-regulated gene protein,31740,-0.0386173361869124,0.0188579054471284,-0.0755788308632841,-0.00165584151054066,0.0406120797362052
Physical measures,X4270.Volume level set by participant (left),IL1RN,Interleukin-1 receptor antagonist protein,32829,0.065337871967383,0.0319493568435474,0.00271713255403015,0.127958611380736,0.0408795555232378
Physical measures,X4270.Volume level set by participant (left),PZP,Pregnancy zone protein,31770,0.0722822119182974,0.0353897052036904,0.0029183897190643,0.141646034117531,0.0411385897149827
Physical measures,X4270.Volume level set by participant (left),GPA33,Cell surface A33 antigen,32832,-0.0267495645182277,0.0130982762946535,-0.0524221860557485,-0.00107694298070688,0.0411588783403675
Physical measures,X4270.Volume level set by participant (left),TP53BP1,TP53-binding protein 1,31508,-0.0481728059114854,0.0235969643539219,-0.0944228560451723,-0.00192275577779843,0.0412370831356777
Physical measures,X4270.Volume level set by participant (left),SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,31599,-0.049399132594552,0.0242208849083019,-0.0968720670148238,-0.00192619817428018,0.0414314325576072
Physical measures,X4270.Volume level set by participant (left),LYN,Tyrosine-protein kinase Lyn,32832,-0.0432925439458067,0.0212354551302594,-0.0849140360011152,-0.00167105189049822,0.0415100805699706
Physical measures,X4270.Volume level set by participant (left),SPINK5,Serine protease inhibitor Kazal-type 5,32861,0.106185582104952,0.052103824204166,0.00406208666478716,0.208309077545118,0.0415829795934571
Physical measures,X4270.Volume level set by participant (left),SERPINA4,Kallistatin,31615,-0.17753700147433,0.0871807028379967,-0.348411179036804,-0.00666282391185696,0.0417415688415138
Physical measures,X4270.Volume level set by participant (left),LTO1,Protein LTO1 homolog,32679,-0.0874017618471267,0.0429824376698598,-0.171647339680052,-0.00315618401420142,0.0420390273096504
Physical measures,X4270.Volume level set by participant (left),MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",31566,-0.0462706607201272,0.022810159168573,-0.0909785726905303,-0.00156274874972406,0.0425424477286945
Physical measures,X4270.Volume level set by participant (left),CHMP1A,Charged multivesicular body protein 1a,32796,-0.046800536511677,0.0231368811920472,-0.0921488236480895,-0.00145224937526454,0.043126833233012
Physical measures,X4270.Volume level set by participant (left),CDK1,Cyclin-dependent kinase 1,31492,-0.112679233444189,0.055709096120245,-0.221869061839869,-0.00348940504850842,0.0431454892496162
Physical measures,X4270.Volume level set by participant (left),SEZ6L,Seizure 6-like protein,32881,-0.128817893432927,0.0637652299252152,-0.253797744086349,-0.00383804277950525,0.0433931688333614
Physical measures,X4270.Volume level set by participant (left),SCG2,Secretogranin-2,32914,-0.110632090802841,0.0547859907577761,-0.218012632688082,-0.00325154891759939,0.0434802719676619
Physical measures,X4270.Volume level set by participant (left),ICOSLG,ICOS ligand,32832,-0.183544860148967,0.0909313243813135,-0.361770255936342,-0.00531946436159283,0.043568940442458
Physical measures,X4270.Volume level set by participant (left),SUSD2,Sushi domain-containing protein 2,32861,-0.122788189552332,0.0609152071411576,-0.242181995549001,-0.00339438355566316,0.0438586092637824
Physical measures,X4270.Volume level set by participant (left),TBL1X,F-box-like/WD repeat-containing protein TBL1X,32638,-0.0432286755179976,0.0214719507997463,-0.0853136990855003,-0.00114365195049482,0.0441174881400021
Physical measures,X4270.Volume level set by participant (left),PMVK,Phosphomevalonate kinase,32630,-0.0332376991606763,0.0165133997052756,-0.0656039625830165,-0.00087143573833609,0.0441691968562696
Physical measures,X4270.Volume level set by participant (left),RILPL2,RILP-like protein 2,31762,-0.0420060679637574,0.0208882192276179,-0.0829469776498885,-0.0010651582776264,0.0443600821712098
Physical measures,X4270.Volume level set by participant (left),YTHDF3,YTH domain-containing family protein 3,32679,-0.0430677058456532,0.0214173570332997,-0.0850457256309205,-0.00108968606038586,0.0443686644980985
Physical measures,X4270.Volume level set by participant (left),ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,31508,-0.0525082001864096,0.0261286216760973,-0.10372029867156,-0.00129610170125892,0.044508120975295
Physical measures,X4270.Volume level set by participant (left),VASP,Vasodilator-stimulated phosphoprotein,31772,-0.0562102112573189,0.0279726807707,-0.111036665567891,-0.00138375694674699,0.0445214154707714
Physical measures,X4270.Volume level set by participant (left),PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",31751,-0.0422847550313921,0.0210479732360021,-0.0835387825739562,-0.00103072748882795,0.0445742832146602
Physical measures,X4270.Volume level set by participant (left),NECTIN4,Nectin-4,32881,0.118831680434321,0.0591905399315884,0.00281822216840813,0.234845138700235,0.0447142389580558
Physical measures,X4270.Volume level set by participant (left),FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,32796,-0.0384830860489954,0.0191768441773651,-0.076069700636631,-0.000896471461359828,0.0448066229354146
Physical measures,X4270.Volume level set by participant (left),ERP29,Endoplasmic reticulum resident protein 29,31599,-0.0353045545334849,0.0176084359866714,-0.0698170890673608,-0.000792019999609046,0.045000006481914
Physical measures,X4270.Volume level set by participant (left),APOA4,Apolipoprotein A-IV,31770,-0.110490384900575,0.055129925767703,-0.218545039405273,-0.00243573039587697,0.0450846499320315
Physical measures,X4270.Volume level set by participant (left),SUOX,"Sulfite oxidase, mitochondrial",31752,-0.0626683575759465,0.031283306779412,-0.123983638863594,-0.00135307628829892,0.0451843531998488
Physical measures,X4270.Volume level set by participant (left),NAA80,N-alpha-acetyltransferase 80,31546,-0.0343955243157565,0.0171707770521269,-0.0680502473379252,-0.000740801293587695,0.0451969876948378
Physical measures,X4270.Volume level set by participant (left),TLR3,Toll-like receptor 3,32961,0.0556302814365132,0.0278500118516575,0.00104425820726453,0.110216304665762,0.0458010766380153
Physical measures,X4270.Volume level set by participant (left),NGFR,Tumor necrosis factor receptor superfamily member 16,31762,-0.131390428867188,0.0658932044989063,-0.260541109685045,-0.00223974804933214,0.0461874052607706
Physical measures,X4270.Volume level set by participant (left),GTPBP2,GTP-binding protein 2,31546,-0.0513828997950387,0.0257929686075425,-0.101937118265822,-0.000828681324255537,0.0463923262310589
Physical measures,X4270.Volume level set by participant (left),CABP2,Calcium-binding protein 2,31546,-0.0625094470586779,0.0313819601977142,-0.124018089046198,-0.00100080507115813,0.0464183452678594
Physical measures,X4270.Volume level set by participant (left),TNNI3,"Troponin I, cardiac muscle",32685,0.0415640958496282,0.0208757399044514,0.000647645636903463,0.0824805460623529,0.0465090590481578
Physical measures,X4270.Volume level set by participant (left),UHRF2,E3 ubiquitin-protein ligase UHRF2,31495,-0.1146604256474,0.0576854210783699,-0.227723850961005,-0.00159700033379506,0.0468822540590547
Physical measures,X4270.Volume level set by participant (left),BRAP,BRCA1-associated protein,31649,-0.0394851230396499,0.0198651921796266,-0.078420899711718,-0.000549346367581846,0.0468849719729976
Physical measures,X4270.Volume level set by participant (left),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,32753,-0.110212483592888,0.0554575175539509,-0.218909217998632,-0.00151574918714448,0.0469162835485589
Physical measures,X4270.Volume level set by participant (left),VPS37A,Vacuolar protein sorting-associated protein 37A,32832,-0.0441618105505504,0.0222245907768976,-0.0877220084732697,-0.000601612627831129,0.0469450453609472
Physical measures,X4270.Volume level set by participant (left),LEO1,RNA polymerase-associated protein LEO1,31752,-0.132618233373813,0.066740748986239,-0.263430101386841,-0.00180636536078424,0.0469496774200057
Physical measures,X4270.Volume level set by participant (left),GMPR2,GMP reductase 2,31599,-0.0638090876846455,0.0321198368943952,-0.12676396799766,-0.000854207371630888,0.047002585967351
Physical measures,X4270.Volume level set by participant (left),KLK13,Kallikrein-13,32665,0.0818217132892696,0.0412226578173527,0.00102530396725832,0.162618122611281,0.0471896689419471
Physical measures,X4270.Volume level set by participant (left),DDX25,ATP-dependent RNA helicase DDX25,31546,-0.101068433336189,0.0509342975582611,-0.200899656550381,-0.00123721012199744,0.0472590059087336
Physical measures,X4270.Volume level set by participant (left),PHLDB1,Pleckstrin homology-like domain family B member 1,31720,-0.070456093705989,0.0355418665360299,-0.140118152116607,-0.000794035295370421,0.0474758852970854
Physical measures,X4270.Volume level set by participant (left),TARBP2,RISC-loading complex subunit TARBP2,32644,-0.0447701540375879,0.0225936793267737,-0.0890537655180644,-0.000486542557111433,0.0475625061066357
Physical measures,X4270.Volume level set by participant (left),MMUT,"Methylmalonyl-CoA mutase, mitochondrial",31495,-0.0804198399512576,0.0405964987510429,-0.159988977503302,-0.000850702399213574,0.0476321511162398
Physical measures,X4270.Volume level set by participant (left),NMI,N-myc-interactor,31692,-0.0557345219207544,0.0281509681612632,-0.11091041951683,-0.00055862432467866,0.0477560371174465
Physical measures,X4270.Volume level set by participant (left),MGMT,Methylated-DNA--protein-cysteine methyltransferase,32843,-0.028941554831815,0.0146249599211588,-0.0576064762772863,-0.000276633386343723,0.0478560597514791
Physical measures,X4270.Volume level set by participant (left),RAB11FIP3,Rab11 family-interacting protein 3,31762,-0.0373245638928552,0.018877060624888,-0.0743236027176358,-0.000325525068074616,0.0480487151844065
Physical measures,X4270.Volume level set by participant (left),PRR5,Proline-rich protein 5,31508,-0.0851620952829761,0.0430952431564712,-0.16962877186966,-0.000695418696292471,0.0481751799322531
Physical measures,X4270.Volume level set by participant (left),COL5A1,Collagen alpha-1(V) chain,31599,-0.10196066199121,0.0516368209589488,-0.20316883107075,-0.00075249291167076,0.0483521560257376
Physical measures,X4270.Volume level set by participant (left),CMC1,COX assembly mitochondrial protein homolog,31762,-0.0437826461156898,0.0221751425916638,-0.087245925595351,-0.000319366636028745,0.0483708281720431
Physical measures,X4270.Volume level set by participant (left),PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,31720,-0.0340127951915807,0.0172274037349327,-0.0677785065120487,-0.000247083871112677,0.0483777783638286
Physical measures,X4270.Volume level set by participant (left),PDGFA,Platelet-derived growth factor subunit A,32964,-0.0465966236802043,0.0236118705778791,-0.0928758900128472,-0.000317357347561303,0.0484755917628398
Physical measures,X4270.Volume level set by participant (left),ERCC1,DNA excision repair protein ERCC-1,31492,-0.12136803818268,0.0615376107158002,-0.241981755185648,-0.000754321179711304,0.048616234740035
Physical measures,X4270.Volume level set by participant (left),PSMC3,26S proteasome regulatory subunit 6A,31492,-0.129122308247776,0.0654855694433337,-0.25747402435671,-0.00077059213884198,0.0486722423397943
Physical measures,X4270.Volume level set by participant (left),CD86,T-lymphocyte activation antigen CD86,31720,-0.134257409095681,0.0681248821521102,-0.267782178113817,-0.000732640077544866,0.0487870270253768
Physical measures,X4270.Volume level set by participant (left),AGRP,Agouti-related protein,32961,-0.0623608940102888,0.031647922990725,-0.12439082307211,-0.000330964948467884,0.0488162101372393
Physical measures,X4270.Volume level set by participant (left),PSAP,Prosaposin,31689,-0.140295362638586,0.0712126182530119,-0.279872094414489,-0.000718630862682174,0.0488631057682396
Physical measures,X4270.Volume level set by participant (left),PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",31752,-0.0519420507660699,0.026367133132183,-0.103621631705148,-0.000262469826991248,0.0488785179721119
Physical measures,X4270.Volume level set by participant (left),GUCY2C,Heat-stable enterotoxin receptor,31632,-0.0450989641840482,0.0229142453390402,-0.090010885048567,-0.00018704331952954,0.0490848201398329
Physical measures,X4270.Volume level set by participant (left),NFKBIE,NF-kappa-B inhibitor epsilon,32638,-0.0709278489166181,0.0360601051089191,-0.1416056549301,-0.000250042903136655,0.049222273540898
Physical measures,X4270.Volume level set by participant (left),EDAR,Tumor necrosis factor receptor superfamily member EDAR,32843,-0.0365748099687216,0.0186188006420174,-0.0730676592270756,-8.19607103675693e-05,0.0495142789144688
Physical measures,X4270.Volume level set by participant (left),FABP9,Fatty acid-binding protein 9,32843,0.060395387897147,0.0307484025488239,0.000128518901452247,0.120662256892842,0.0495400537546353
Physical measures,X4270.Volume level set by participant (left),KIT,Mast/stem cell growth factor receptor Kit,32872,0.115539189689565,0.0588591485679094,0.00017525849646241,0.230903120882667,0.0496794994726764
Physical measures,X4270.Volume level set by participant (left),ARID3A,AT-rich interactive domain-containing protein 3A,31514,-0.0982119504877903,0.0500745186929298,-0.196358007125933,-6.58938496479744e-05,0.049878395215112
Physical measures,X4270.Volume level set by participant (left),PRDX5,"Peroxiredoxin-5, mitochondrial",32961,-0.0519132961203787,0.0264717175815761,-0.103797862580268,-2.87296604895709e-05,0.049899531731586
Physical measures,X4270.Volume level set by participant (left),INSL4,Early placenta insulin-like peptide,31724,-0.0706908664814417,0.0360621736145053,-0.141372726765872,-9.00619701134364e-06,0.0500018773179632
Physical measures,X4270.Volume level set by participant (left),HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",31566,-0.0796602573919666,0.0406451493452641,-0.159324750108684,4.23532475114785e-06,0.0500439726101166
Physical measures,X4270.Volume level set by participant (left),SYTL4,Synaptotagmin-like protein 4,31762,-0.0519305939650842,0.0265154384655703,-0.103900853357602,3.96654274336036e-05,0.0502060343088517
Physical measures,X4270.Volume level set by participant (left),TXLNA,Alpha-taxilin,32796,-0.0404149688986125,0.020639728107757,-0.0808688359898162,3.88981925912024e-05,0.0502475559406115
Physical measures,X4270.Volume level set by participant (left),TXN,Thioredoxin,31640,-0.0959557361349455,0.0491710269868063,-0.192330949029086,0.000419476759194806,0.0510371272618449
Physical measures,X4270.Volume level set by participant (left),DOK1,Docking protein 1,31751,-0.0303645127262115,0.015579205527966,-0.0608997555610249,0.000170730108601958,0.0513259093113074
Physical measures,X4270.Volume level set by participant (left),DFFA,DNA fragmentation factor subunit alpha,32961,-0.0518117521628258,0.0265898867192521,-0.10392793013256,0.000304425806908405,0.0513797609100503
Physical measures,X4270.Volume level set by participant (left),CDKN2D,Cyclin-dependent kinase 4 inhibitor D,32832,-0.0374896849224895,0.0192414372597039,-0.0752029019515091,0.000223532106530075,0.0514003245203253
Physical measures,X4270.Volume level set by participant (left),CD164L2,CD164 sialomucin-like 2 protein,31546,-0.10558557533558,0.0544095934755658,-0.212228378547689,0.00105722787652912,0.0523471004435822
Physical measures,X4270.Volume level set by participant (left),CASP8,Caspase-8,32925,-0.055538209405068,0.0286270073407854,-0.111647143793007,0.000570724982871411,0.0524029684127441
Physical measures,X4270.Volume level set by participant (left),TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,31720,-0.0379706185700021,0.0195753753923298,-0.0763383543389685,0.000397117198964216,0.0524502700747373
Physical measures,X4270.Volume level set by participant (left),AKAP12,A-kinase anchor protein 12,31599,-0.186723004116427,0.0963647630870718,-0.375597939767087,0.0021519315342341,0.0526999789705752
Physical measures,X4270.Volume level set by participant (left),MTSS2,Protein MTSS 2,31724,-0.0400314434032754,0.0206603285058214,-0.0805256872746854,0.000462800468134475,0.0527078677650109
Physical measures,X4270.Volume level set by participant (left),ATP1B4,Protein ATP1B4,31492,-0.0939818312453757,0.0485344036900592,-0.189109262477892,0.00114559998714028,0.052856089867466
Physical measures,X4270.Volume level set by participant (left),NAA10,N-alpha-acetyltransferase 10,31495,-0.0789668920222365,0.0408172826810655,-0.158968766077125,0.00103498203265193,0.0530709645565243
Physical measures,X4270.Volume level set by participant (left),SERPINH1,Serpin H1,31632,-0.0309432634357993,0.015999788085632,-0.0623028480836379,0.000416321212039408,0.0531519128228984
Physical measures,X4270.Volume level set by participant (left),LAT,Linker for activation of T-cells family member 1,32961,-0.0438106270436712,0.0226608065921452,-0.0882258079642758,0.000604553876933332,0.0532275790032819
Physical measures,X4270.Volume level set by participant (left),RALB,Ras-related protein Ral-B,31508,-0.131024915422221,0.0677999616642143,-0.263912840284081,0.00186300943963927,0.0533320079714837
Physical measures,X4270.Volume level set by participant (left),JAM3,Junctional adhesion molecule C,31599,-0.075441702512963,0.0390933978819907,-0.152064762361665,0.00118135733573883,0.0536704799129635
Physical measures,X4270.Volume level set by participant (left),TIMP3,Metalloproteinase inhibitor 3,32894,-0.0257566925660894,0.0133823663905473,-0.0519861306915621,0.000472745559383234,0.0543015338913036
Physical measures,X4270.Volume level set by participant (left),CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",31547,-0.0525207675883943,0.0272984377839603,-0.106025705644956,0.00098417046816781,0.0543980291447012
Physical measures,X4270.Volume level set by participant (left),MRPS16,"28S ribosomal protein S16, mitochondrial",31508,-0.127512284780194,0.0663017208949382,-0.257463657734272,0.00243908817388522,0.0544904923690823
Physical measures,X4270.Volume level set by participant (left),TERF1,Telomeric repeat-binding factor 1,31508,-0.13358560384587,0.0694886129760926,-0.269783285279012,0.00261207758727111,0.0545913053283322
Physical measures,X4270.Volume level set by participant (left),NID2,Nidogen-2,32861,-0.0452422636380222,0.0235389240403633,-0.0913785547571342,0.000894027481089799,0.0546348854769983
Physical measures,X4270.Volume level set by participant (left),SMS,Spermine synthase,31514,-0.0607779702439492,0.0316215530960645,-0.122756214312236,0.00120027382433725,0.054637499914934
Physical measures,X4270.Volume level set by participant (left),DBI,Acyl-CoA-binding protein,32816,-0.0425632217453988,0.0221917602165814,-0.0860590717698984,0.000932628279100761,0.0551460677944347
Physical measures,X4270.Volume level set by participant (left),YJU2,Splicing factor YJU2,31724,-0.121010923523688,0.0630991789244265,-0.244685314215564,0.00266346716818772,0.0551739392832245
Physical measures,X4270.Volume level set by participant (left),ERBIN,Erbin,32832,-0.0331990684738701,0.0173116186026838,-0.0671298409351303,0.000731703987390073,0.0551765522734192
Physical measures,X4270.Volume level set by participant (left),CDNF,Cerebral dopamine neurotrophic factor,32832,-0.103966369283777,0.0543029727884109,-0.210400195949063,0.0024674573815081,0.0555802569655446
Physical measures,X4270.Volume level set by participant (left),PALM,Paralemmin-1,31674,-0.133083090097842,0.0696150932710902,-0.269528672909179,0.00336249271349426,0.0559513901982822
Physical measures,X4270.Volume level set by participant (left),UBXN1,UBX domain-containing protein 1,31599,-0.057954787273011,0.0303173068922137,-0.11737670878175,0.00146713423572784,0.0559634812353887
Physical measures,X4270.Volume level set by participant (left),CDSN,Corneodesmosin,32943,0.0772365350601679,0.0404483912631912,-0.00204231181568687,0.156515381936023,0.0562280460702028
Physical measures,X4270.Volume level set by participant (left),PRC1,Protein regulator of cytokinesis 1,31724,-0.0841685908174378,0.0441432882205479,-0.170689435729712,0.00235225409483607,0.0565941564700219
Physical measures,X4270.Volume level set by participant (left),FXYD5,FXYD domain-containing ion transport regulator 5,32679,-0.052633821192341,0.0276407775251624,-0.106809745141659,0.00154210275697732,0.0569154729252016
Physical measures,X4270.Volume level set by participant (left),MITD1,MIT domain-containing protein 1,32796,-0.0354426729397146,0.0186250309124145,-0.0719477335280471,0.00106238764861788,0.0570779934899353
Physical measures,X4270.Volume level set by participant (left),COX6B1,Cytochrome c oxidase subunit 6B1,31762,-0.114212975549231,0.0600203713489126,-0.2318529033931,0.00342695229463745,0.0570894592429841
Physical measures,X4270.Volume level set by participant (left),SIRT2,NAD-dependent protein deacetylase sirtuin-2,32832,-0.0398285996458375,0.0209409490992485,-0.0808728598803646,0.00121566058868951,0.0572099382469199
Physical measures,X4270.Volume level set by participant (left),XIAP,E3 ubiquitin-protein ligase XIAP,31508,-0.0663063567954525,0.0348709743851543,-0.134653466590355,0.00204075299944995,0.0572771177127208
Physical measures,X4270.Volume level set by participant (left),USO1,General vesicular transport factor p115,32832,-0.0382443038730577,0.0201163445202078,-0.077672339132665,0.00118373138654954,0.0573136366046554
Physical measures,X4270.Volume level set by participant (left),SLMAP,Sarcolemmal membrane-associated protein,31720,-0.0442304443674982,0.0232801408683952,-0.0898595204695528,0.00139863173455634,0.0574799754656881
Physical measures,X4270.Volume level set by participant (left),HBZ,Hemoglobin subunit zeta,31762,0.0334196001301124,0.0175927772127278,-0.0010622432068341,0.0679014434670589,0.0575193294856998
Physical measures,X4270.Volume level set by participant (left),FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,32796,-0.0801242870150464,0.0421860620247511,-0.162808968583559,0.00256039455346573,0.0575562922786914
Physical measures,X4270.Volume level set by participant (left),SNX5,Sorting nexin-5,31566,-0.126030466959522,0.0664336244927316,-0.256240370965276,0.004179437046232,0.0578536211629987
Physical measures,X4270.Volume level set by participant (left),PPIB,Peptidyl-prolyl cis-trans isomerase B,32821,-0.0348456461626766,0.0183706890766348,-0.0708521967528809,0.00116090442752764,0.057885590537282
Physical measures,X4270.Volume level set by participant (left),AOC1,Amiloride-sensitive amine oxidase [copper-containing],32679,-0.0597021425659347,0.0314912981021192,-0.121425086846088,0.00202080171421888,0.0580152200837975
Physical measures,X4270.Volume level set by participant (left),PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",31599,-0.0391685280628134,0.0206854171811472,-0.0797119457378619,0.00137488961223506,0.058324251141612
Physical measures,X4270.Volume level set by participant (left),STXBP1,Syntaxin-binding protein 1,31752,-0.0496617240702564,0.0262277248539421,-0.101068064783983,0.00174461664347018,0.0583303606076599
Physical measures,X4270.Volume level set by participant (left),TREM2,Triggering receptor expressed on myeloid cells 2,32834,0.0634055359634755,0.033493166193811,-0.00224106977639406,0.129052141703345,0.0583782228142701
Physical measures,X4270.Volume level set by participant (left),ATOX1,Copper transport protein ATOX1,32881,-0.0463752675467701,0.0245157035352438,-0.094426046475848,0.00167551138230766,0.0585688957490604
Physical measures,X4270.Volume level set by participant (left),PDIA4,Protein disulfide-isomerase A4,31773,-0.0614905544603232,0.0325131527175277,-0.125216333786678,0.00223522486603115,0.0586272598326027
Physical measures,X4270.Volume level set by participant (left),CHEK2,Serine/threonine-protein kinase Chk2,32685,0.0966477969411971,0.0511112529323072,-0.00353025880612497,0.196825852688519,0.0586664362351664
Physical measures,X4270.Volume level set by participant (left),GALNT7,N-acetylgalactosaminyltransferase 7,32832,-0.1587203908379,0.0839386968998561,-0.323240236761618,0.00579945508581814,0.0586687659360208
Physical measures,X4270.Volume level set by participant (left),PLA2G4A,Cytosolic phospholipase A2,32894,-0.0379835696484498,0.0201038570609818,-0.0773871294879741,0.00141999019107447,0.0588746369056799
Physical measures,X4270.Volume level set by participant (left),MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,31724,-0.0354378037894228,0.0187640883882054,-0.0722154170303054,0.00133980945145978,0.0589826125487646
Physical measures,X4270.Volume level set by participant (left),TSC22D1,TSC22 domain family protein 1,31752,-0.0551930447156085,0.029232787458037,-0.112489308133361,0.00210321870214396,0.0590555323183441
Physical measures,X4270.Volume level set by participant (left),SAT2,Thialysine N-epsilon-acetyltransferase,31632,-0.0550270036983521,0.0292021012987183,-0.11226312224384,0.00220911484713579,0.0595548388191445
Physical measures,X4270.Volume level set by participant (left),DGKA,Diacylglycerol kinase alpha,31508,-0.072952246884116,0.0387150505505801,-0.148833745963253,0.00292925219502099,0.0595571570731106
Physical measures,X4270.Volume level set by participant (left),GPI,Glucose-6-phosphate isomerase,31772,-0.081122779826283,0.0430714602850088,-0.1655428419849,0.00329728233233427,0.0596765784237332
Physical measures,X4270.Volume level set by participant (left),BIRC2,Baculoviral IAP repeat-containing protein 2,32638,-0.0535131856453567,0.0284223866018469,-0.109221063384977,0.0021946920942631,0.0597628377092298
Physical measures,X4270.Volume level set by participant (left),AP2B1,AP-2 complex subunit beta,31546,-0.0762220063141469,0.040484176659597,-0.155570992566957,0.00312697993866322,0.0597705914209889
Physical measures,X4270.Volume level set by participant (left),RPE,Ribulose-phosphate 3-epimerase,31632,-0.0541625799023007,0.0287898556772818,-0.110590697029773,0.00226553722517162,0.0599674228155379
Physical measures,X4270.Volume level set by participant (left),RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,31566,-0.183293723516617,0.0974484885122717,-0.37429276100067,0.00770531396743532,0.060019217265387
Physical measures,X4270.Volume level set by participant (left),IL7,Interleukin-7,32843,-0.0497415073513609,0.0264581743520396,-0.101599529081359,0.00211651437863681,0.0601397038985483
Physical measures,X4270.Volume level set by participant (left),GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,31720,-0.0526543018986753,0.0280319680170104,-0.107596959212016,0.002288355414665,0.0603680823030831
Physical measures,X4270.Volume level set by participant (left),ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,31566,-0.105584024540749,0.056271421936745,-0.215876011536769,0.00470796245527161,0.0606471065324549
Physical measures,X4270.Volume level set by participant (left),GCC1,GRIP and coiled-coil domain-containing protein 1,31751,-0.0354721888291097,0.0189092078579366,-0.0725342362306655,0.00158985857244612,0.0607029656706505
Physical measures,X4270.Volume level set by participant (left),STAB2,Stabilin-2,31773,0.132568777588573,0.0706843097169376,-0.00597246945662433,0.271110024633771,0.0607600853769166
Physical measures,X4270.Volume level set by participant (left),CDC37,Hsp90 co-chaperone Cdc37,32881,-0.0399541067994678,0.0213231971834006,-0.081747573278933,0.00183935967999739,0.0609987161150577
Physical measures,X4270.Volume level set by participant (left),ICAM1,Intercellular adhesion molecule 1,32797,0.115324607967157,0.0616388802512942,-0.00548759732537987,0.236136813259694,0.0613816491610198
Physical measures,X4270.Volume level set by participant (left),ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,32685,-0.121488926697046,0.0649588915766066,-0.248808354187194,0.00583050079310335,0.0614831390047617
Physical measures,X4270.Volume level set by participant (left),ATP6V1G2,V-type proton ATPase subunit G 2,31495,-0.0392600083834047,0.0210240663151931,-0.0804671783611831,0.00194716159437367,0.0618862636692391
Physical measures,X4270.Volume level set by participant (left),YWHAQ,14-3-3 protein theta,31599,-0.0528568750072615,0.0283437817315035,-0.108410687201008,0.00269693718648535,0.0622403988978927
Physical measures,X4270.Volume level set by participant (left),JCHAIN,Immunoglobulin J chain,32679,-0.0532746204596657,0.0286219016389254,-0.10937354767196,0.00282430675262808,0.0627317535400417
Physical measures,X4270.Volume level set by participant (left),VTCN1,V-set domain-containing T-cell activation inhibitor 1,32638,0.0974591177182868,0.0523656020143654,-0.00517746222986942,0.200095697666443,0.0627594403467052
Physical measures,X4270.Volume level set by participant (left),SLC12A2,Solute carrier family 12 member 2,31495,-0.140927782707027,0.0757938937495267,-0.289483814456099,0.00762824904204565,0.0630152398330864
Physical measures,X4270.Volume level set by participant (left),DSG4,Desmoglein-4,32794,0.0661137539575679,0.035575053135322,-0.00361335018766323,0.135840858102799,0.0631408202272287
Physical measures,X4270.Volume level set by participant (left),RAB2B,Ras-related protein Rab-2B,31724,-0.0622765655092797,0.033523764983512,-0.127983144876963,0.00343001385840377,0.0632512516032803
Physical measures,X4270.Volume level set by participant (left),GP5,Platelet glycoprotein V,31599,-0.102747626020127,0.0553236105225141,-0.211181902644255,0.00568665060400059,0.063319097768774
Physical measures,X4270.Volume level set by participant (left),ANKRA2,Ankyrin repeat family A protein 2,31492,-0.0688056295462691,0.0370667200107197,-0.14145640076728,0.0038451416747415,0.0634544211647676
Physical measures,X4270.Volume level set by participant (left),LAMA4,Laminin subunit alpha-4,32894,-0.0976329238010526,0.052613419588518,-0.200755226194548,0.0054893785924427,0.0635337632697541
Physical measures,X4270.Volume level set by participant (left),DCTD,Deoxycytidylate deaminase,31599,-0.0407913843886383,0.0219841334793245,-0.0838802860081142,0.00229751723083764,0.0635640059741093
Physical measures,X4270.Volume level set by participant (left),IL2RA,Interleukin-2 receptor subunit alpha,32794,0.0828223109831704,0.044671244798536,-0.00473332882196011,0.170377950788301,0.0637662676852946
Physical measures,X4270.Volume level set by participant (left),FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,31752,0.153089808566667,0.0826199381613533,-0.00884527022958514,0.31502488736292,0.0639282413581735
Physical measures,X4270.Volume level set by participant (left),SORBS1,Sorbin and SH3 domain-containing protein 1,31752,-0.0984845044253347,0.053170093826617,-0.202697888325504,0.00572887947483464,0.0640267269320491
Physical measures,X4270.Volume level set by participant (left),KIFBP,KIF-binding protein,32832,-0.0400334427505041,0.0216256351721358,-0.0824196876878902,0.00235280218688199,0.064173191867104
Physical measures,X4270.Volume level set by participant (left),VAV3,Guanine nucleotide exchange factor VAV3,31514,-0.0390210549830549,0.0210809796382677,-0.0803397750740597,0.00229766510794989,0.0642069637112821
Physical measures,X4270.Volume level set by participant (left),TIMP2,Metalloproteinase inhibitor 2,31762,-0.15661354338231,0.0847155089374592,-0.32265594089973,0.00942885413511002,0.064538519757749
Physical measures,X4270.Volume level set by participant (left),THSD1,Thrombospondin type-1 domain-containing protein 1,31455,-0.10926981370353,0.0591292959678667,-0.225163233800549,0.00662360639348891,0.0646439645527205
Physical measures,X4270.Volume level set by participant (left),KCNIP4,Kv channel-interacting protein 4,32644,0.0608574309079476,0.0329499441027528,-0.00372445953344776,0.125439321349343,0.0647856700594694
Physical measures,X4270.Volume level set by participant (left),SIGLEC8,Sialic acid-binding Ig-like lectin 8,31566,-0.0818728433475908,0.0443713529710094,-0.168840695170769,0.00509500847558758,0.0650506672480512
Physical measures,X4270.Volume level set by participant (left),PDZD2,PDZ domain-containing protein 2,31495,-0.0596323263686705,0.0323539055507375,-0.123045981248116,0.00378132851077505,0.0653493601790229
Physical measures,X4270.Volume level set by participant (left),F2R,Proteinase-activated receptor 1,32883,-0.0541058791265904,0.0293674502437322,-0.111666081604306,0.00345432335112471,0.0654530021475838
Physical measures,X4270.Volume level set by participant (left),KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,32638,0.0266502636881056,0.0144699082592763,-0.00171075650007596,0.0550112838762871,0.0655423158486183
Physical measures,X4270.Volume level set by participant (left),CXCL5,C-X-C motif chemokine 5,32835,-0.0279829856181212,0.015199848689346,-0.0577746890492395,0.00180871781299697,0.0656539367165259
Physical measures,X4270.Volume level set by participant (left),OXT,Oxytocin-neurophysin 1,32931,0.0226803968028559,0.012334477639508,-0.00149517937057982,0.0468559729762917,0.0659801600557606
Physical measures,X4270.Volume level set by participant (left),CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,31752,-0.0435681960645845,0.0237057154774605,-0.090031398400407,0.002895006271238,0.0661180698273446
Physical measures,X4270.Volume level set by participant (left),CXCL6,C-X-C motif chemokine 6,32961,-0.0422208880250014,0.0229827636151854,-0.0872671047107647,0.00282532866076201,0.0662325299771013
Physical measures,X4270.Volume level set by participant (left),DTD1,D-aminoacyl-tRNA deacylase 1,31599,-0.0432729138806464,0.0235608110824948,-0.0894521036023362,0.00290627584104328,0.0663002380288677
Physical measures,X4270.Volume level set by participant (left),PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,31724,-0.0439294327294035,0.023990789414419,-0.0909513799816648,0.00309251452285783,0.0671240806187946
Physical measures,X4270.Volume level set by participant (left),HARS1,"Histidine--tRNA ligase, cytoplasmic",32861,-0.0425955961001497,0.0232651472906585,-0.0881952847898405,0.00300409258954098,0.0671521291768255
Physical measures,X4270.Volume level set by participant (left),CD101,Immunoglobulin superfamily member 2,31720,-0.0874681908088795,0.047807720341408,-0.181171322678039,0.00623494106028023,0.0673501963328941
Physical measures,X4270.Volume level set by participant (left),SLC39A5,Zinc transporter ZIP5,32843,-0.059659208541062,0.0326202843203832,-0.123594965809013,0.004276548726889,0.0674478727704866
Physical measures,X4270.Volume level set by participant (left),LGALS4,Galectin-4,32834,0.0602050347839363,0.0329258632169031,-0.00432965712119363,0.124739726689066,0.067507304369826
Physical measures,X4270.Volume level set by participant (left),HDGFL2,Hepatoma-derived growth factor-related protein 2,31751,-0.0599594307251663,0.0327983131372252,-0.124244124474128,0.00432526302379512,0.0675684762840033
Physical measures,X4270.Volume level set by participant (left),C1QL2,Complement C1q-like protein 2,31508,-0.0891793290943863,0.0487900761110209,-0.184807878271987,0.00644922008321465,0.0676159795966664
Physical measures,X4270.Volume level set by participant (left),CHGB,Secretogranin-1,32896,-0.0802756816479357,0.0439501936995578,-0.166418061299069,0.00586669800319764,0.06780573300464
Physical measures,X4270.Volume level set by participant (left),IGSF21,Immunoglobulin superfamily member 21,31566,0.0941284910398915,0.0515534121388593,-0.00691619675227274,0.195173178832056,0.0679124494278459
Physical measures,X4270.Volume level set by participant (left),GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",31566,-0.0483253410913092,0.0264781253262184,-0.100222466730697,0.00357178454807895,0.0680239940493958
Physical measures,X4270.Volume level set by participant (left),PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,31492,-0.0603202250847012,0.0330608681539386,-0.125119526666421,0.00447907649701856,0.0681125421940096
Physical measures,X4270.Volume level set by participant (left),USP8,Ubiquitin carboxyl-terminal hydrolase 8,32685,-0.0339412851539745,0.0186092245665068,-0.0704153653043279,0.00253279499637882,0.0682016525584144
Physical measures,X4270.Volume level set by participant (left),LAMP3,Lysosome-associated membrane glycoprotein 3,32946,0.0621089355364149,0.0340619106027669,-0.00465240924500817,0.128870280317838,0.0682736906937152
Physical measures,X4270.Volume level set by participant (left),SNX2,Sorting nexin-2,31724,-0.0446288739617644,0.0245549960699412,-0.0927566662588491,0.00349891833532028,0.0691775901408651
Physical measures,X4270.Volume level set by participant (left),GSN,Gelsolin,31745,-0.201519474430278,0.110951225903893,-0.418983877201908,0.0159449283413524,0.0693640451925006
Physical measures,X4270.Volume level set by participant (left),VASH1,Tubulinyl-Tyr carboxypeptidase 1,32843,-0.0391929057297413,0.0215808476050431,-0.0814913670356257,0.00310555557614308,0.0693888728985179
Physical measures,X4270.Volume level set by participant (left),PLPBP,Pyridoxal phosphate homeostasis protein,32864,-0.0485935886555857,0.0267835438960712,-0.101089334691885,0.00390215738071386,0.0696636515062446
Physical measures,X4270.Volume level set by participant (left),CSDE1,Cold shock domain-containing protein E1,31495,-0.0299309626000711,0.01650302185624,-0.0622768854383016,0.00241496023815927,0.0697684855333748
Physical measures,X4270.Volume level set by participant (left),ART3,Ecto-ADP-ribosyltransferase 3,32878,-0.0958206765560255,0.0528357275799002,-0.19937870261263,0.00773734950057879,0.0697789790263511
Physical measures,X4270.Volume level set by participant (left),FRZB,Secreted frizzled-related protein 3,32766,-0.119222202104994,0.0657564453653864,-0.248104835021151,0.00966043081116347,0.0698519572471763
Physical measures,X4270.Volume level set by participant (left),STOML2,"Stomatin-like protein 2, mitochondrial",31492,-0.0393653059429007,0.0217146398385826,-0.0819260000265226,0.00319538814072117,0.0698948063017869
Physical measures,X4270.Volume level set by participant (left),DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,32843,-0.0267450635134857,0.0147610721374407,-0.0556767649028695,0.00218663787589813,0.070040515336091
Physical measures,X4270.Volume level set by participant (left),EPCAM,Epithelial cell adhesion molecule,32851,-0.0327408836086274,0.0180789006750837,-0.0681755289317914,0.00269376171453659,0.0701742702353039
Physical measures,X4270.Volume level set by participant (left),NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,31566,-0.143981740285064,0.0796288624916208,-0.300054310768641,0.0120908301985129,0.0706205540581016
Physical measures,X4270.Volume level set by participant (left),SAG,S-arrestin,31514,-0.068840671247265,0.0380860825886192,-0.143489393120959,0.0058080506264286,0.0707232991121291
Physical measures,X4270.Volume level set by participant (left),IL6,Interleukin-6,32832,0.0436424270230809,0.0241490532342181,-0.0036897173159865,0.0909745713621483,0.0707629296251531
Physical measures,X4270.Volume level set by participant (left),CD36,Platelet glycoprotein 4,31508,-0.0790193405480406,0.0437943510717681,-0.164856268648706,0.00681758755262489,0.0712193625936711
Physical measures,X4270.Volume level set by participant (left),TRIM5,Tripartite motif-containing protein 5,32843,-0.0373212722223404,0.0206877761351272,-0.0778693134471897,0.00322676900250893,0.0712608317600749
Physical measures,X4270.Volume level set by participant (left),IFNL2,Interferon lambda-2,31514,-0.0579147362146142,0.0321083595413201,-0.120847120915602,0.00501764848637331,0.0713133303308493
Physical measures,X4270.Volume level set by participant (left),RAP1A,Ras-related protein Rap-1A,31508,-0.053882528668975,0.0298903259023035,-0.11246756743749,0.00470251009953986,0.0714787138502612
Physical measures,X4270.Volume level set by participant (left),CEP164,Centrosomal protein of 164 kDa,32679,-0.0496313955652048,0.0275560917031955,-0.103641335303468,0.00437854417305836,0.071720599307004
Physical measures,X4270.Volume level set by participant (left),CSNK2A1,Casein kinase II subunit alpha,31752,-0.0799743322706439,0.044406558169605,-0.16701118628307,0.007062521741782,0.0717477245616626
Physical measures,X4270.Volume level set by participant (left),EFCAB2,Dynein regulatory complex protein 8,31632,-0.106039863549687,0.0589167484122047,-0.221516690437608,0.00943696333823457,0.0719269852824555
Physical measures,X4270.Volume level set by participant (left),CLU,Clusterin,31770,-0.106156037852871,0.0592148379815374,-0.222217120296685,0.00990504459094192,0.0730548004567448
Physical measures,X4270.Volume level set by participant (left),SEC31A,Protein transport protein Sec31A,31566,-0.0489105658246752,0.0272998728731762,-0.102418316656101,0.00459718500675013,0.0732356357191998
Physical measures,X4270.Volume level set by participant (left),CDH23,Cadherin-23,31751,-0.134669002412219,0.0752113837163289,-0.282083314496223,0.0127453096717857,0.0734054532253239
Physical measures,X4270.Volume level set by participant (left),VWC2L,von Willebrand factor C domain-containing protein 2-like,31752,-0.0765210151751105,0.0427380647666335,-0.160287622117712,0.00724559176749112,0.0734174972941509
Physical measures,X4270.Volume level set by participant (left),EHBP1,EH domain-binding protein 1,31762,-0.0469186242005564,0.0262049991706471,-0.0982804225750248,0.00444317417391202,0.0734205957097096
Physical measures,X4270.Volume level set by participant (left),ACP5,Tartrate-resistant acid phosphatase type 5,32872,0.0925477115899207,0.051706347934812,-0.00879673036231084,0.193892153542152,0.0735081662877832
Physical measures,X4270.Volume level set by participant (left),SSNA1,Sjoegren syndrome nuclear autoantigen 1,31720,-0.0718799317804546,0.0401606872094456,-0.150594878710968,0.00683501515005872,0.0735232292233392
Physical measures,X4270.Volume level set by participant (left),TFF3,Trefoil factor 3,32856,0.0635010567559651,0.0354956764666684,-0.00607046911870487,0.133072582630635,0.0736516742117456
Physical measures,X4270.Volume level set by participant (left),QDPR,Dihydropteridine reductase,32826,-0.0737343109292396,0.0412919102328643,-0.154666454985654,0.00719783312717449,0.0741842067365419
Physical measures,X4270.Volume level set by participant (left),PTPRK,Receptor-type tyrosine-protein phosphatase kappa,31720,-0.162520698518236,0.0910195282570816,-0.340918973902116,0.0158775768656436,0.0742093186943223
Physical measures,X4270.Volume level set by participant (left),AP3S2,AP-3 complex subunit sigma-2,31751,-0.0727760570845938,0.0407822144000074,-0.152709197308608,0.00715708313942076,0.0743800984016971
Physical measures,X4270.Volume level set by participant (left),AARSD1,Alanyl-tRNA editing protein Aarsd1,32832,-0.0555878270096536,0.0311541668133145,-0.11664999396375,0.00547433994444287,0.074411605940579
Physical measures,X4270.Volume level set by participant (left),RBFOX3,RNA binding protein fox-1 homolog 3,31752,-0.0971071482094384,0.0544408374887019,-0.203811189687294,0.00959689326841737,0.0745077891762204
Physical measures,X4270.Volume level set by participant (left),SCRIB,Protein scribble homolog,31566,-0.0396267093426509,0.0222330573784546,-0.0832035018044219,0.00395008311912017,0.0747343388898183
Physical measures,X4270.Volume level set by participant (left),GP1BB,Platelet glycoprotein Ib beta chain,31495,-0.0537450507147959,0.0301551858774085,-0.112849215034516,0.00535911360492471,0.0747429688084846
Physical measures,X4270.Volume level set by participant (left),F2,Prothrombin,31770,-0.237444440904948,0.133345055510272,-0.49880074970508,0.0239118678951839,0.0750036559874725
Physical measures,X4270.Volume level set by participant (left),MSRA,Mitochondrial peptide methionine sulfoxide reductase,32881,-0.043488410336443,0.024470842583686,-0.0914512618004675,0.00447444112758155,0.0755769086885675
Physical measures,X4270.Volume level set by participant (left),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",32832,-0.0906586103516863,0.0510273536070332,-0.190672223421471,0.00935500271809886,0.0756569484121749
Physical measures,X4270.Volume level set by participant (left),PLAT,Tissue-type plasminogen activator,32922,0.0621580538859638,0.0349861637764338,-0.00641482711584652,0.130730934887774,0.0756599312912052
Physical measures,X4270.Volume level set by participant (left),OTUD7B,OTU domain-containing protein 7B,31752,-0.0550411114649246,0.0309898355700041,-0.115781189182133,0.00569896625228335,0.0757546279680515
Physical measures,X4270.Volume level set by participant (left),GRAP2,GRB2-related adapter protein 2,32864,-0.0247045577707557,0.0139198747005031,-0.0519875121837418,0.00257839664223034,0.0759698784750496
Physical measures,X4270.Volume level set by participant (left),SIAE,Sialate O-acetylesterase,32869,-0.0652700212727161,0.0368072175039769,-0.137412167580511,0.00687212503507859,0.0762137769011108
Physical measures,X4270.Volume level set by participant (left),EVPL,Envoplakin,31632,-0.104191415049199,0.0587707950899099,-0.219382173425422,0.0109993433270248,0.0762938381430081
Physical measures,X4270.Volume level set by participant (left),PRDX1,Peroxiredoxin-1,32592,-0.0335366686858025,0.0189228958728347,-0.0706255445965586,0.00355220722495349,0.0763829738857825
Physical measures,X4270.Volume level set by participant (left),CORO6,Coronin-6,31514,-0.0923774441114296,0.0521455567204025,-0.194582735283419,0.00982784706055939,0.076512323476227
Physical measures,X4270.Volume level set by participant (left),MESD,LRP chaperone MESD,32861,-0.0256306412557026,0.0144818726624389,-0.0540151116740828,0.0027538291626777,0.0767871550638831
Physical measures,X4270.Volume level set by participant (left),KAZN,Kazrin,31720,-0.0356576992100477,0.020176607652456,-0.0752038502088615,0.00388845178876602,0.0772202917114185
Physical measures,X4270.Volume level set by participant (left),DUOX2,Dual oxidase 2,32685,-0.0421560771912365,0.0238719700045728,-0.0889451384001991,0.00463298401772617,0.0774432356385941
Physical measures,X4270.Volume level set by participant (left),ESPL1,Separin,31492,-0.0682839180748225,0.0387351524125242,-0.14420481680337,0.00763698065372499,0.077967328106512
Physical measures,X4270.Volume level set by participant (left),RABGAP1L,Rab GTPase-activating protein 1-like,32679,-0.0528039950754245,0.0299642427063988,-0.111533910779966,0.00592592062911727,0.0780644877495607
Physical measures,X4270.Volume level set by participant (left),SWAP70,Switch-associated protein 70,31720,-0.103165762385334,0.0586163460056619,-0.218053800556431,0.0117222757857634,0.0784438402617984
Physical measures,X4270.Volume level set by participant (left),FLT3LG,Fms-related tyrosine kinase 3 ligand,32961,-0.0900453814006261,0.051164238760095,-0.190327289370412,0.0102365265691601,0.0784535996202732
Physical measures,X4270.Volume level set by participant (left),CEP170,Centrosomal protein of 170 kDa,31566,-0.0452429208321427,0.0257219178692382,-0.0956578798558496,0.00517203819156417,0.0786299711441652
Physical measures,X4270.Volume level set by participant (left),PCDHB15,Protocadherin beta-15,31724,-0.087679071252367,0.0498550171088069,-0.185394904785628,0.0100367622808945,0.0786706112619826
Physical measures,X4270.Volume level set by participant (left),VEGFA,Vascular endothelial growth factor A,32933,-0.0534882935661615,0.0304160976935677,-0.113103845045554,0.00612725791323116,0.078687329008863
Physical measures,X4270.Volume level set by participant (left),LZTFL1,Leucine zipper transcription factor-like protein 1,31599,-0.0511538704894802,0.029151588686932,-0.108290984315867,0.00598324333690651,0.0793409577293518
Physical measures,X4270.Volume level set by participant (left),L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,31762,-0.039353319600805,0.0224316717627993,-0.0833193962558916,0.00461275705428155,0.0794069111718984
Physical measures,X4270.Volume level set by participant (left),GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,32843,-0.0313975456791282,0.0179241470873606,-0.0665288739703549,0.00373378261209853,0.0798612954031811
Physical measures,X4270.Volume level set by participant (left),CCL28,C-C motif chemokine 28,32821,-0.0519947385426873,0.0296843968485707,-0.110176156365886,0.00618667928051127,0.0798794459511533
Physical measures,X4270.Volume level set by participant (left),MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",31752,-0.0837441645203619,0.0478261718629333,-0.177483461371711,0.00999513233098744,0.0799828369688692
Physical measures,X4270.Volume level set by participant (left),BRD1,Bromodomain-containing protein 1,31632,-0.112454728632897,0.0642428644950489,-0.238370743043193,0.0134612857773992,0.0800780005662227
Physical measures,X4270.Volume level set by participant (left),KLK3,Prostate-specific antigen,31773,0.0442247842502943,0.0252898520728486,-0.00534332581248903,0.0937928943130776,0.080378806484258
Physical measures,X4270.Volume level set by participant (left),PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,31752,-0.0978028404022584,0.0559522738064433,-0.207469297062887,0.0118636162583705,0.0805082950679632
Physical measures,X4270.Volume level set by participant (left),RANBP2,E3 SUMO-protein ligase RanBP2,31514,-0.10618838081102,0.060814604133182,-0.225385004912057,0.0130082432900164,0.080833709310385
Physical measures,X4270.Volume level set by participant (left),CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",32776,-0.0317768462404496,0.0181995069838963,-0.0674478799288862,0.0038941874479871,0.0808405629395345
Physical measures,X4270.Volume level set by participant (left),TNR,Tenascin-R,32796,-0.071031445131172,0.0406832119539727,-0.150770540560959,0.00870765029861449,0.0808514907964756
Physical measures,X4270.Volume level set by participant (left),ARHGAP25,Rho GTPase-activating protein 25,32638,-0.0510648564939522,0.0292720950809913,-0.108438162852695,0.00630844986479071,0.0811088172030742
Physical measures,X4270.Volume level set by participant (left),UROD,Uroporphyrinogen decarboxylase,31599,-0.0536557179124009,0.0307612679873632,-0.113947803167633,0.00663636734283096,0.0811530900153917
Physical measures,X4270.Volume level set by participant (left),SERPINE1,Plasminogen activator inhibitor 1,32964,-0.0435912236886865,0.024994405870737,-0.0925802591953311,0.0053978118179581,0.081186015396933
Physical measures,X4270.Volume level set by participant (left),ECHS1,"Enoyl-CoA hydratase, mitochondrial",31566,-0.0375808504143445,0.0215551449267632,-0.0798289344708004,0.00466723364211134,0.0812906205774395
Physical measures,X4270.Volume level set by participant (left),PGLYRP2,N-acetylmuramoyl-L-alanine amidase,31676,-0.114116395507841,0.0655206765370594,-0.242536921520478,0.0143041305047952,0.0816028911073556
Physical measures,X4270.Volume level set by participant (left),MIA,Melanoma-derived growth regulatory protein,32881,0.0827763743694245,0.0475670432204734,-0.0104550303427032,0.176007779081552,0.0818572581244085
Physical measures,X4270.Volume level set by participant (left),MYL6B,Myosin light chain 6B,31546,-0.0391940818303037,0.0225223942536313,-0.083337974567421,0.00494981090681357,0.0818591798839828
Physical measures,X4270.Volume level set by participant (left),TBC1D23,TBC1 domain family member 23,32832,-0.0324700502181121,0.0186883846700621,-0.0690992841714338,0.00415918373520952,0.0823428888887739
Physical measures,X4270.Volume level set by participant (left),CTSH,Pro-cathepsin H,32651,-0.0425828951332794,0.024518669850398,-0.0906394880400595,0.00547369777350069,0.0824656625208743
Physical measures,X4270.Volume level set by participant (left),TXNRD1,"Thioredoxin reductase 1, cytoplasmic",32861,-0.0664131887617633,0.0382472037555394,-0.141377708122621,0.00855133059909399,0.0825239206803542
Physical measures,X4270.Volume level set by participant (left),MRPL24,"39S ribosomal protein L24, mitochondrial",31495,-0.0891161112254292,0.0513575324190251,-0.189776874766718,0.01154465231586,0.0827439569137621
Physical measures,X4270.Volume level set by participant (left),CIAPIN1,Anamorsin,32881,-0.0501740960739594,0.0289202171023998,-0.106857721594663,0.00650952944674426,0.0827901644173147
Physical measures,X4270.Volume level set by participant (left),ELN,Elastin,31762,-0.101263978903863,0.0583921780031746,-0.215712647790086,0.0131846899823588,0.0829208151774415
Physical measures,X4270.Volume level set by participant (left),SERPINA9,Serpin A9,32782,-0.0422191613738303,0.0243459704034613,-0.0899372633646144,0.0054989406169538,0.082928962218852
Physical measures,X4270.Volume level set by participant (left),HSPB1,Heat shock protein beta-1,32688,-0.0456193066187248,0.026311260883496,-0.0971893779503769,0.0059507647129273,0.082982816084749
Physical measures,X4270.Volume level set by participant (left),GNPDA1,Glucosamine-6-phosphate isomerase 1,31566,-0.106839945271282,0.0616902973274519,-0.227752928033088,0.0140730374905238,0.0833356762928588
Physical measures,X4270.Volume level set by participant (left),DNM3,Dynamin-3,31752,-0.0630919876328099,0.0364686912636575,-0.134570622509579,0.00838664724395878,0.0836637428845918
Physical measures,X4270.Volume level set by participant (left),IPCEF1,Interactor protein for cytohesin exchange factors 1,32778,-0.035065507429353,0.020280089985244,-0.0748144838004312,0.00468346894172528,0.0838328430317195
Physical measures,X4270.Volume level set by participant (left),IGFL4,Insulin growth factor-like family member 4,31508,-0.0467204264046689,0.0270473514378241,-0.0997332352228042,0.00629238241346645,0.0841439930950187
Physical measures,X4270.Volume level set by participant (left),BLMH,Bleomycin hydrolase,32964,-0.0958041862497485,0.0554717971028418,-0.204528908571318,0.0129205360718214,0.0841873729446137
Physical measures,X4270.Volume level set by participant (left),CRKL,Crk-like protein,32871,-0.0296534481807994,0.0171732426318611,-0.0633130037392471,0.00400610737764831,0.0842515482576413
Physical measures,X4270.Volume level set by participant (left),SMAD3,Mothers against decapentaplegic homolog 3,31724,-0.0673248543695238,0.0390411634536631,-0.143845534738703,0.00919582599965579,0.0846644699932232
Physical measures,X4270.Volume level set by participant (left),FOXO1,Forkhead box protein O1,32843,-0.0360133356138671,0.0209040116243728,-0.0769851983976377,0.00495852716990346,0.084959954301877
Physical measures,X4270.Volume level set by participant (left),VIM,Vimentin,32685,0.0262069122078091,0.0152178742728792,-0.0036201213670342,0.0560339457826523,0.0850839460363831
Physical measures,X4270.Volume level set by participant (left),VEGFC,Vascular endothelial growth factor C,32881,-0.0531750748396194,0.0308893865938978,-0.113718272563659,0.00736812288442021,0.0852003218339273
Physical measures,X4270.Volume level set by participant (left),TPPP2,Tubulin polymerization-promoting protein family member 2,31632,-0.0438193080378773,0.0255013865987126,-0.093802025771354,0.00616340969559945,0.0857797831420516
Physical measures,X4270.Volume level set by participant (left),TYMP,Thymidine phosphorylase,32801,-0.0445364788798999,0.025934621093054,-0.0953683362222856,0.00629537846248591,0.0859663787147274
Physical measures,X4270.Volume level set by participant (left),SLIT2,Slit homolog 2 protein,32644,-0.0567057320515537,0.0330319914890857,-0.121448435370162,0.00803697126705423,0.0860708587749954
Physical measures,X4270.Volume level set by participant (left),CHL1,Neural cell adhesion molecule L1-like protein,32859,-0.0935610889189942,0.0545145888360652,-0.200409683037682,0.0132875051996937,0.0861492936055009
Physical measures,X4270.Volume level set by participant (left),ARFIP1,Arfaptin-1,31752,-0.0494919973979888,0.028853332330206,-0.106044528765193,0.00706053396921502,0.0863302913284821
Physical measures,X4270.Volume level set by participant (left),ZNF75D,Zinc finger protein 75D,31632,-0.0576712687943656,0.0336452895042236,-0.123616036222644,0.00827349863391266,0.0865509144623639
Physical measures,X4270.Volume level set by participant (left),NRN1,Neuritin,31752,-0.0923912695833653,0.053940194062354,-0.198114049945579,0.0133315107788486,0.0867800863219087
Physical measures,X4270.Volume level set by participant (left),PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,32864,-0.0363433953620196,0.0212188702575835,-0.0779323810668834,0.00524559034284408,0.0867862566642513
Physical measures,X4270.Volume level set by participant (left),MYCBP2,E3 ubiquitin-protein ligase MYCBP2,31752,-0.0519767415961206,0.0303576938532819,-0.111477821548553,0.0075243383563119,0.0869094455398075
Physical measures,X4270.Volume level set by participant (left),DKK4,Dickkopf-related protein 4,32773,-0.0655910290456055,0.0383227005693493,-0.14070352216153,0.00952146407031915,0.0870153416274812
Physical measures,X4270.Volume level set by participant (left),HPCAL1,Hippocalcin-like protein 1,32961,-0.0411952085025306,0.0240712523730463,-0.0883748631537013,0.0059844461486402,0.0870439321780265
Physical measures,X4270.Volume level set by participant (left),MOG,Myelin-oligodendrocyte glycoprotein,32948,-0.0921949784450849,0.0538748701058524,-0.197789723852556,0.0133997669623857,0.0870636024184282
Physical measures,X4270.Volume level set by participant (left),SRC,Proto-oncogene tyrosine-protein kinase Src,32863,-0.025017992034305,0.0146256755804468,-0.0536843161719807,0.00364833210337072,0.0871981396844054
Physical measures,X4270.Volume level set by participant (left),SCG3,Secretogranin-3,32864,-0.0905809336994807,0.053004729468988,-0.194470203458697,0.0133083360597358,0.0874999230095647
Physical measures,X4270.Volume level set by participant (left),AP1G2,AP-1 complex subunit gamma-like 2,31724,-0.0421000311737146,0.0246549659246433,-0.0904237643860155,0.00622370203858626,0.0877560137899212
Physical measures,X4270.Volume level set by participant (left),REPS1,RalBP1-associated Eps domain-containing protein 1,31508,-0.0887259786479218,0.0519652914817187,-0.190577949952091,0.013125992656247,0.0877867609542685
Physical measures,X4270.Volume level set by participant (left),NLGN1,Neuroligin-1,31546,-0.0517629934332292,0.0303342420560127,-0.111218107863014,0.00769212099655567,0.087970100335295
Physical measures,X4270.Volume level set by participant (left),PTTG1,Securin,31632,0.0829743760423971,0.048656797924717,-0.0123929478900483,0.178341699974843,0.0881786990585236
Physical measures,X4270.Volume level set by participant (left),GOT1,"Aspartate aminotransferase, cytoplasmic",31773,-0.0812239918113775,0.0477513580319152,-0.174816653553931,0.0123686699311762,0.0889864924787975
Physical measures,X4270.Volume level set by participant (left),PLEKHO1,Pleckstrin homology domain-containing family O member 1,31751,-0.0483513042728685,0.0284472587313562,-0.104107931386327,0.00740532284058958,0.0892301127644194
Physical measures,X4270.Volume level set by participant (left),ST13,Hsc70-interacting protein,31599,-0.0652431260057778,0.0383961239408741,-0.140499528929891,0.0100132769183354,0.0893195917299513
Physical measures,X4270.Volume level set by participant (left),BAMBI,BMP and activin membrane-bound inhibitor homolog,32638,-0.0994234219284888,0.0585135993174382,-0.214110076590668,0.0152632327336901,0.0893262423929254
Physical measures,X4270.Volume level set by participant (left),PILRB,Paired immunoglobulin-like type 2 receptor beta,32864,0.0515919585292339,0.0303881974590429,-0.00796890849049027,0.111152825548958,0.0895870609236898
Physical measures,X4270.Volume level set by participant (left),ABCA2,ATP-binding cassette sub-family A member 2,31495,-0.0973927123519646,0.0573787968855243,-0.209855154247592,0.015069729543663,0.0896686085053405
Physical measures,X4270.Volume level set by participant (left),CWC15,Spliceosome-associated protein CWC15 homolog,31672,-0.0560662249184451,0.0330472001082253,-0.120838737130567,0.00870628729367655,0.0898216379856748
Physical measures,X4270.Volume level set by participant (left),CXCL3,C-X-C motif chemokine 3,32842,-0.0303518377360343,0.0178960785026816,-0.0654281516012902,0.00472447612922168,0.089919608232373
Physical measures,X4270.Volume level set by participant (left),CSF1,Macrophage colony-stimulating factor 1,32894,0.110795056741811,0.0653760449765119,-0.0173419914121525,0.238932104895774,0.0901602222169964
Physical measures,X4270.Volume level set by participant (left),CHMP6,Charged multivesicular body protein 6,31762,-0.0603004831211111,0.0355904281237168,-0.130057722243596,0.00945675600137384,0.0902497353712345
Physical measures,X4270.Volume level set by participant (left),DBNL,Drebrin-like protein,32894,-0.0327303987686411,0.0193535727800587,-0.0706634014175562,0.00520260388027393,0.0908367011489755
Physical measures,X4270.Volume level set by participant (left),FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,31762,-0.0475119453962354,0.0280970572989181,-0.102582177702115,0.00755828690964407,0.0908774662686557
Physical measures,X4270.Volume level set by participant (left),MANF,Mesencephalic astrocyte-derived neurotrophic factor,32894,-0.0249703643854735,0.0147720795460369,-0.0539236402957059,0.00398291152475891,0.0909906099930019
Physical measures,X4270.Volume level set by participant (left),ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,31495,-0.0663029770911072,0.0392319336593439,-0.143197567063421,0.0105916128812068,0.0910638725771055
Physical measures,X4270.Volume level set by participant (left),FLT3,Receptor-type tyrosine-protein kinase FLT3,32638,-0.103022603333832,0.0609721628560664,-0.222528042531722,0.016482835864058,0.091127353693107
Physical measures,X4270.Volume level set by participant (left),CST7,Cystatin-F,32853,0.0313137792834421,0.0185543606773185,-0.00505276764410218,0.0676803262109864,0.0915078180905352
Physical measures,X4270.Volume level set by participant (left),FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,31752,-0.0345323476885312,0.020462762823489,-0.0746393628225696,0.00557466744550721,0.0915333037668437
Physical measures,X4270.Volume level set by participant (left),APLP1,Amyloid-like protein 1,32864,-0.0572305298735179,0.0339188070408315,-0.123711391673548,0.00925033192651184,0.0915841444643164
Physical measures,X4270.Volume level set by participant (left),GLRX5,"Glutaredoxin-related protein 5, mitochondrial",31599,-0.0390820917822617,0.0231633292802695,-0.0844822171715899,0.00631803360706662,0.0915975601420699
Physical measures,X4270.Volume level set by participant (left),FHIT,Bis(5'-adenosyl)-triphosphatase,32644,-0.0427653532176283,0.0253523085009055,-0.092455877879403,0.00692517144414642,0.0916691476592257
Physical measures,X4270.Volume level set by participant (left),SNAP25,Synaptosomal-associated protein 25,31514,-0.0733444354302136,0.043481884457002,-0.158568928965938,0.0118800581055103,0.0916861533909936
Physical measures,X4270.Volume level set by participant (left),PPP1R2,Protein phosphatase inhibitor 2,32864,-0.037138542965629,0.02203706878234,-0.0803311977790155,0.00605411184775745,0.0919699990359937
Physical measures,X4270.Volume level set by participant (left),COPB2,Coatomer subunit beta',31495,-0.0780566938447066,0.0463719111228529,-0.168945639645498,0.0128322519560852,0.0923627033669027
Physical measures,X4270.Volume level set by participant (left),DMP1,Dentin matrix acidic phosphoprotein 1,31566,-0.0538877562404642,0.0320212236663232,-0.116649354626458,0.00887384214552932,0.0924395788296137
Physical measures,X4270.Volume level set by participant (left),CDH22,Cadherin-22,31632,-0.121723964727261,0.0724161672165484,-0.263659652471696,0.0202117230171736,0.0928235322214395
Physical measures,X4270.Volume level set by participant (left),NCAN,Neurocan core protein,32931,-0.0773645078482944,0.0460452990002819,-0.167613293888847,0.0128842781922581,0.0929562479786641
Physical measures,X4270.Volume level set by participant (left),SYAP1,Synapse-associated protein 1,31599,-0.0599132724852879,0.0356616676169545,-0.129810141014519,0.00998359604394294,0.0929885761476379
Physical measures,X4270.Volume level set by participant (left),TRIAP1,TP53-regulated inhibitor of apoptosis 1,32948,-0.0456647920139196,0.0272175926262373,-0.0990112735613446,0.00768168953350553,0.0934268954716954
Physical measures,X4270.Volume level set by participant (left),DIABLO,"Diablo homolog, mitochondrial",32822,-0.02721202163005,0.0162194265555712,-0.0590020976789696,0.0045780544188696,0.0934322550896471
Physical measures,X4270.Volume level set by participant (left),TRIM58,E3 ubiquitin-protein ligase TRIM58,31724,-0.0401007794948606,0.0239061893193141,-0.0869569105607162,0.00675535157099506,0.0934996509225446
Physical measures,X4270.Volume level set by participant (left),CD163,Scavenger receptor cysteine-rich type 1 protein M130,32878,0.0677295846851253,0.0404050490303266,-0.0114643114143149,0.146923480784565,0.0937208981996453
Physical measures,X4270.Volume level set by participant (left),DOK2,Docking protein 2,32864,-0.0239360297963207,0.0142837916117487,-0.0519322613553481,0.00406020176270666,0.0938223699146047
Physical measures,X4270.Volume level set by participant (left),DAG1,Dystroglycan,32894,-0.0593101768981911,0.0353988558564001,-0.128691934376735,0.010071580580353,0.0938741460271976
Physical measures,X4270.Volume level set by participant (left),AHCY,Adenosylhomocysteinase,32864,-0.0435955936698217,0.0261197194764712,-0.0947902438437052,0.00759905650406181,0.0951386376507092
Physical measures,X4270.Volume level set by participant (left),ARAF,Serine/threonine-protein kinase A-Raf,31632,-0.0502361233183232,0.0301207377634034,-0.109272769334594,0.00880052269794752,0.0953907471290427
Physical measures,X4270.Volume level set by participant (left),SAFB2,Scaffold attachment factor B2,31752,-0.123739815677978,0.07426206918619,-0.26929347128291,0.0218138399269545,0.0957016068941963
Physical measures,X4270.Volume level set by participant (left),MDH1,"Malate dehydrogenase, cytoplasmic",31725,-0.0839480696987917,0.0504229393002379,-0.182777030727258,0.0148808913296746,0.0959768357829716
Physical measures,X4270.Volume level set by participant (left),IL36G,Interleukin-36 gamma,31481,0.0492808400454859,0.0296019168481584,-0.00873891697690454,0.107300597067876,0.0959966933767174
Physical measures,X4270.Volume level set by participant (left),ITGA6,Integrin alpha-6,32843,-0.0519437807723192,0.0312111691547329,-0.113117672315596,0.00923011077095733,0.0960935767475897
Physical measures,X4270.Volume level set by participant (left),SKIV2L,Helicase SKI2W,31495,-0.0831775657492336,0.0500250305036916,-0.181226625536469,0.014871494038002,0.0964097714786478
Physical measures,X4270.Volume level set by participant (left),MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,32843,-0.0297814479329783,0.0179120445354388,-0.0648890552224383,0.00532615935648177,0.0964175597643743
Physical measures,X4270.Volume level set by participant (left),SMAD1,Mothers against decapentaplegic homolog 1,32638,-0.0361260986021516,0.0217387946764813,-0.0787341361680549,0.00648193896375167,0.0965833465104529
Physical measures,X4270.Volume level set by participant (left),UMOD,Uromodulin,32929,-0.0544658407431984,0.032786348788951,-0.118727084369542,0.00979540288314558,0.0967007704704247
Physical measures,X4270.Volume level set by participant (left),LAT2,Linker for activation of T-cells family member 2,32832,-0.0238729166629853,0.0143840946284044,-0.052065742134658,0.00431990880868745,0.0970148896653758
Physical measures,X4270.Volume level set by participant (left),LRRC37A2,Leucine-rich repeat-containing protein 37A2,31720,-0.077817128353965,0.0469354971129542,-0.169810702695355,0.0141764459874252,0.0973656683548369
Physical measures,X4270.Volume level set by participant (left),TPRKB,EKC/KEOPS complex subunit TPRKB,31492,-0.0509301009615957,0.0307411255684331,-0.111182707075724,0.00932250515253316,0.097612853772078
Physical measures,X4270.Volume level set by participant (left),CCDC80,Coiled-coil domain-containing protein 80,32864,0.0859312664166402,0.0518927568105526,-0.0157785369320428,0.187641069765323,0.0977689268035344
Physical measures,X4270.Volume level set by participant (left),UNG,Uracil-DNA glycosylase,31724,-0.0978882168918313,0.0591170599794927,-0.213757654451637,0.0179812206679744,0.0977947406753705
Physical measures,X4270.Volume level set by participant (left),ARHGAP30,Rho GTPase-activating protein 30,31632,-0.0821462226750639,0.0496558833628181,-0.179471754066187,0.0151793087160597,0.09810494582158
Physical measures,X4270.Volume level set by participant (left),SNCA,Alpha-synuclein,31599,-0.0303096321663881,0.0183482289319721,-0.0662721608730534,0.00565289654027718,0.0985933804240481
Physical measures,X4270.Volume level set by participant (left),GFRA2,GDNF family receptor alpha-2,32832,-0.136241597199645,0.0825318991698603,-0.298004119572571,0.0255209251732814,0.0988195351720664
Physical measures,X4270.Volume level set by participant (left),PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,31297,-0.0332607077707269,0.0201741637530765,-0.0728020687267568,0.00628065318530294,0.0992557950009021
Physical measures,X4270.Volume level set by participant (left),RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,32638,-0.0432953941164614,0.0263212742882172,-0.094885091721367,0.00829430348844423,0.100029935881887
Physical measures,X4270.Volume level set by participant (left),EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,31566,-0.0767375615045237,0.0467830734855524,-0.168432385536206,0.014957262527159,0.100986807269974
Physical measures,X4270.Volume level set by participant (left),TNFSF12,Tumor necrosis factor ligand superfamily member 12,32961,-0.0967542991935141,0.0590103749367927,-0.212414634069628,0.0189060356825995,0.101119803648373
Physical measures,X4270.Volume level set by participant (left),TUBB3,Tubulin beta-3 chain,31514,-0.115976095261697,0.0707590912021677,-0.254663914017945,0.0227117234945521,0.101248650721106
Physical measures,X4270.Volume level set by participant (left),CCL17,C-C motif chemokine 17,32823,-0.0315711958171692,0.0192639084618119,-0.0693284564023205,0.006186064767982,0.101273778963569
Physical measures,X4270.Volume level set by participant (left),IRAK4,Interleukin-1 receptor-associated kinase 4,32843,-0.0289329334217136,0.0176604207973535,-0.0635473581845266,0.00568149134109928,0.101395743129854
Physical measures,X4270.Volume level set by participant (left),TLR4,Toll-like receptor 4,31508,-0.118541394949158,0.07238923629048,-0.260424298078499,0.0233415081801824,0.10155559955993
Physical measures,X4270.Volume level set by participant (left),GSTM4,Glutathione S-transferase Mu 4,31495,-0.0487072733684414,0.0297476676918101,-0.107012702044389,0.00959815530750634,0.101599079690392
Physical measures,X4270.Volume level set by participant (left),ITGB1BP2,Integrin beta-1-binding protein 2,32685,-0.0263548744431582,0.0161046964825629,-0.0579200795489815,0.00521033066266512,0.101776646507818
Physical measures,X4270.Volume level set by participant (left),PPME1,Protein phosphatase methylesterase 1,32832,-0.0488168908503319,0.0298352707350475,-0.107294021491025,0.00966023979036115,0.101829871774814
Physical measures,X4270.Volume level set by participant (left),STK11,Serine/threonine-protein kinase STK11,32685,-0.0412493974711872,0.025211921486136,-0.0906647635840137,0.00816596864163936,0.101852898439655
Physical measures,X4270.Volume level set by participant (left),LIPF,Gastric triacylglycerol lipase,31566,-0.0563930387396517,0.0344779252604731,-0.123969772250179,0.0111836947708755,0.101958451718778
Physical measures,X4270.Volume level set by participant (left),MGLL,Monoglyceride lipase,32883,-0.0334667288386713,0.0204713747840826,-0.0735906234154732,0.00665716573813055,0.102124591718399
Physical measures,X4270.Volume level set by participant (left),GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,31398,0.065772457534932,0.0402333722658824,-0.0130849521061975,0.144629867176061,0.102138274883129
Physical measures,X4270.Volume level set by participant (left),RNASEH2A,Ribonuclease H2 subunit A,31752,-0.0634818273341643,0.0388446772180793,-0.1396173946816,0.0126537400132712,0.102246735025212
Physical measures,X4270.Volume level set by participant (left),RNASET2,Ribonuclease T2,32904,-0.109408749763406,0.0670557783580488,-0.240838075345182,0.0220205758183693,0.102796903363713
Physical measures,X4270.Volume level set by participant (left),KYAT1,Kynurenine--oxoglutarate transaminase 1,32835,-0.0511937389349034,0.0313962830754381,-0.112730453762762,0.0103429758929552,0.103016845928623
Physical measures,X4270.Volume level set by participant (left),CD3D,T-cell surface glycoprotein CD3 delta chain,31514,-0.101271909747715,0.0621218480262264,-0.223030731879118,0.0204869123836891,0.103097427446498
Physical measures,X4270.Volume level set by participant (left),LONP1,"Lon protease homolog, mitochondrial",31566,-0.038648759218566,0.0237459586795767,-0.0851908382305363,0.00789331979340437,0.103652085004762
Physical measures,X4270.Volume level set by participant (left),LBP,Lipopolysaccharide-binding protein,32878,0.0473188379252025,0.0291587049423098,-0.00983222376172476,0.10446989961213,0.104666460208296
Physical measures,X4270.Volume level set by participant (left),MYO6,Unconventional myosin-VI,31752,-0.0844314645767087,0.0520798637102815,-0.18650799744886,0.017645068295443,0.105016406184727
Physical measures,X4270.Volume level set by participant (left),RAD23B,UV excision repair protein RAD23 homolog B,32638,-0.0625860931005829,0.0386351987865673,-0.138311082722255,0.0131388965210889,0.105284496409738
Physical measures,X4270.Volume level set by participant (left),DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",31720,-0.0327954776593293,0.0202521103479837,-0.0724896139413774,0.00689865862271875,0.105409747401431
Physical measures,X4270.Volume level set by participant (left),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,32796,0.0741847920230153,0.0458221406238573,-0.015626603599745,0.163996187645776,0.10548845147117
Physical measures,X4270.Volume level set by participant (left),IL20RB,Interleukin-20 receptor subunit beta,31508,-0.0772928527927161,0.0477567668868292,-0.170896115890901,0.0163104103054691,0.10560278636859
Physical measures,X4270.Volume level set by participant (left),MEGF10,Multiple epidermal growth factor-like domains protein 10,32834,-0.0694551885891455,0.042927870163412,-0.153593814109433,0.014683436931142,0.105708323345268
Physical measures,X4270.Volume level set by participant (left),BST2,Bone marrow stromal antigen 2,32931,0.0524366094755036,0.0324417274445146,-0.0111491763157449,0.116022395266752,0.106057289056492
Physical measures,X4270.Volume level set by participant (left),STXBP3,Syntaxin-binding protein 3,32638,-0.0634395687367608,0.0392571333775891,-0.140383550156835,0.0135044126833138,0.106130034748547
Physical measures,X4270.Volume level set by participant (left),ACTA2,"Actin, aortic smooth muscle",32685,-0.0630487886800857,0.0390576053645178,-0.139601695194541,0.0135041178343692,0.106508700630698
Physical measures,X4270.Volume level set by participant (left),ABRAXAS2,BRISC complex subunit Abraxas 2,31495,-0.0509568881369861,0.0315988371538344,-0.112890608958501,0.0109768326845293,0.106868633670838
Physical measures,X4270.Volume level set by participant (left),NUDT5,ADP-sugar pyrophosphatase,32861,-0.0559875471549183,0.0347301374867315,-0.124058616628912,0.0120835223190755,0.106980937135708
Physical measures,X4270.Volume level set by participant (left),TMEM132A,Transmembrane protein 132A,31566,-0.0493505353478244,0.0306340690670108,-0.109393310719166,0.0106922400235167,0.107227452597138
Physical measures,X4270.Volume level set by participant (left),CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,31752,-0.0298235143923469,0.0185346551350694,-0.0661514384570829,0.00650440967238904,0.107641557619424
Physical measures,X4270.Volume level set by participant (left),SHH,Sonic hedgehog protein,31508,-0.0742280802690808,0.0461515594127268,-0.164685136718025,0.0162289761798638,0.107798795939149
Physical measures,X4270.Volume level set by participant (left),SEPTIN8,Septin-8,31725,-0.0968918095135757,0.0602542185435479,-0.214990077858929,0.0212064588317782,0.107864333463413
Physical measures,X4270.Volume level set by participant (left),MIF,Macrophage migration inhibitory factor,32837,-0.0438672023633471,0.0272985052043256,-0.0973722725638253,0.00963786783713114,0.108101567670412
Physical measures,X4270.Volume level set by participant (left),ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,32864,-0.0571147984064012,0.0355627457926774,-0.126817780160049,0.0125881833472465,0.108302633423631
Physical measures,X4270.Volume level set by participant (left),NENF,Neudesin,31724,-0.0280635012826637,0.0174744329639904,-0.0623133898920849,0.00618638732675755,0.108319584018312
Physical measures,X4270.Volume level set by participant (left),SCN2B,Sodium channel subunit beta-2,31546,-0.111915363974758,0.0697254029313625,-0.248577153720228,0.0247464257707129,0.108515676855248
Physical measures,X4270.Volume level set by participant (left),NAP1L4,Nucleosome assembly protein 1-like 4,31694,-0.0844010528321413,0.052652407144684,-0.187599770835722,0.0187976651714393,0.108978153250985
Physical measures,X4270.Volume level set by participant (left),ITGB6,Integrin beta-6,32679,-0.0949237442081673,0.059218814393954,-0.210992620420317,0.0211451320039825,0.108985448623347
Physical measures,X4270.Volume level set by participant (left),FUT8,"Alpha-(1,6)-fucosyltransferase",32796,-0.0483325411236279,0.0301630993138129,-0.107452215778701,0.0107871335314454,0.10910847019355
Physical measures,X4270.Volume level set by participant (left),PBLD,Phenazine biosynthesis-like domain-containing protein,32644,-0.0559544504598623,0.0349348690130106,-0.124426793725363,0.0125178928056384,0.109262553911041
Physical measures,X4270.Volume level set by participant (left),ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,32796,-0.0811794096757162,0.0507551055885158,-0.180659416629207,0.0183005972777748,0.109759706632805
Physical measures,X4270.Volume level set by participant (left),DLG4,Disks large homolog 4,31751,-0.0439640252522015,0.027498180246171,-0.0978604585346966,0.00993240803029363,0.109905628525041
Physical measures,X4270.Volume level set by participant (left),RP2,Protein XRP2,32832,-0.0665469050307076,0.0417228794325414,-0.148323748718489,0.0152299386570736,0.110753299236871
Physical measures,X4270.Volume level set by participant (left),PARK7,Parkinson disease protein 7,32861,-0.0547409180848251,0.0343315158820123,-0.122030689213569,0.0125488530439191,0.110863671001837
Physical measures,X4270.Volume level set by participant (left),NT5C1A,Cytosolic 5'-nucleotidase 1A,31751,-0.101210067246767,0.0634762920903208,-0.225623599743796,0.0232034652502617,0.110874310588324
Physical measures,X4270.Volume level set by participant (left),FMR1,Synaptic functional regulator FMR1,32638,-0.078237140609362,0.0490936786235264,-0.174460750711474,0.0179864694927497,0.111055031285067
Physical measures,X4270.Volume level set by participant (left),CCAR2,Cell cycle and apoptosis regulator protein 2,31751,-0.0594027159589617,0.0373015676541494,-0.132513788561095,0.0137083566431712,0.11131265568384
Physical measures,X4270.Volume level set by participant (left),ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,32685,-0.0899845439941517,0.0565250106929613,-0.200773564952356,0.0208044769640524,0.11143354374955
Physical measures,X4270.Volume level set by participant (left),HMMR,Hyaluronan mediated motility receptor,31466,-0.0683994716044146,0.042995966469402,-0.152671565884443,0.0158726226756133,0.111688376525649
Physical measures,X4270.Volume level set by participant (left),PPP3R1,Calcineurin subunit B type 1,32796,-0.0668299993843779,0.0420112814758902,-0.149172111077123,0.0155121123083669,0.111698269364441
Physical measures,X4270.Volume level set by participant (left),ARSB,Arylsulfatase B,32832,-0.050338106855188,0.0316469514191408,-0.112366131636704,0.011689917926328,0.111731552758576
Physical measures,X4270.Volume level set by participant (left),KLRC1,NKG2-A/NKG2-B type II integral membrane protein,31514,-0.0532369115497063,0.0334722341976877,-0.118842490577174,0.0123686674777616,0.111768015890634
Physical measures,X4270.Volume level set by participant (left),RAB27B,Ras-related protein Rab-27B,31762,-0.0400519655104373,0.0252012693511504,-0.0894464534386921,0.00934252241781752,0.112036387682363
Physical measures,X4270.Volume level set by participant (left),EGFR,Epidermal growth factor receptor,32964,-0.166994128642553,0.105098913358999,-0.372987998826191,0.0389997415410847,0.112112410853371
Physical measures,X4270.Volume level set by participant (left),IL12RB2,Interleukin-12 receptor subunit beta-2,31508,-0.0745047984374298,0.0469045601429179,-0.166437736317549,0.0174281394426893,0.11222958515762
Physical measures,X4270.Volume level set by participant (left),BAG6,Large proline-rich protein BAG6,32685,-0.0743933410870919,0.0468410440541819,-0.166201787433288,0.0174151052591047,0.112275051250519
Physical measures,X4270.Volume level set by participant (left),HHEX,Hematopoietically-expressed homeobox protein HHEX,31751,-0.0418133346089252,0.0263437311751264,-0.093447047712173,0.00982037849432259,0.112502584712786
Physical measures,X4270.Volume level set by participant (left),CDC42BPB,Serine/threonine-protein kinase MRCK beta,31720,-0.0302684449733407,0.0190737090099442,-0.0676529146328314,0.00711602468614998,0.112571068059297
Physical measures,X4270.Volume level set by participant (left),MMP9,Matrix metalloproteinase-9,32852,0.0448690905151813,0.0282834796703105,-0.0105665296386272,0.10030471066899,0.11268234451065
Physical measures,X4270.Volume level set by participant (left),NARS1,"Asparagine--tRNA ligase, cytoplasmic",31752,-0.0720191300396109,0.0454024536436186,-0.161007939181103,0.0169696791018816,0.112725245432913
Physical measures,X4270.Volume level set by participant (left),RGCC,Regulator of cell cycle RGCC,31752,-0.042135885032027,0.0265854879982011,-0.0942434415085011,0.00997167144444715,0.113024478524468
Physical measures,X4270.Volume level set by participant (left),GNLY,Granulysin,32861,0.0514111393493549,0.0324383863272121,-0.0121680978519809,0.114990376550691,0.113027414352354
Physical measures,X4270.Volume level set by participant (left),FST,Follistatin,32883,0.0526690379491341,0.0333298739904435,-0.0126575150721352,0.117995590970403,0.114088091518948
Physical measures,X4270.Volume level set by participant (left),PILRA,Paired immunoglobulin-like type 2 receptor alpha,32861,0.0663075768482465,0.0419830932359987,-0.015979285894311,0.148594439590804,0.114282330305642
Physical measures,X4270.Volume level set by participant (left),CNTNAP4,Contactin-associated protein-like 4,31546,-0.0305641780739316,0.019364457284477,-0.0685185143515066,0.00739015820364333,0.114522991372697
Physical measures,X4270.Volume level set by participant (left),AIF1L,Allograft inflammatory factor 1-like,31566,-0.0556002147409045,0.0352269001841769,-0.124644939101891,0.0134445096200821,0.114527350020615
Physical measures,X4270.Volume level set by participant (left),HTR1B,5-hydroxytryptamine receptor 1B,31514,-0.0737483736961351,0.0467495889840446,-0.165377568104862,0.0178808207125923,0.114717452170483
Physical measures,X4270.Volume level set by participant (left),SDK2,Protein sidekick-2,31599,-0.0855793294351297,0.0542575264448098,-0.191924081266957,0.0207654223966974,0.114771923376444
Physical measures,X4270.Volume level set by participant (left),NEXN,Nexilin,31772,-0.0444880960424866,0.02821270042362,-0.0997849888727818,0.0108087967878086,0.114862701180878
Physical measures,X4270.Volume level set by participant (left),IL13RA1,Interleukin-13 receptor subunit alpha-1,32758,0.121834690795757,0.0773398097711176,-0.0297513363556335,0.273420717947147,0.115218933433467
Physical measures,X4270.Volume level set by participant (left),CC2D1A,Coiled-coil and C2 domain-containing protein 1A,32796,-0.0379529258358278,0.0241024381917428,-0.0851937046916436,0.0092878530199881,0.115372461098682
Physical measures,X4270.Volume level set by participant (left),TPPP3,Tubulin polymerization-promoting protein family member 3,32644,-0.0700645652395653,0.0444994893224209,-0.15728356431151,0.0171544338323797,0.115407307961763
Physical measures,X4270.Volume level set by participant (left),IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,31632,-0.0839918721201069,0.0533582499350262,-0.188574041992758,0.0205902977525444,0.115502231841351
Physical measures,X4270.Volume level set by participant (left),CRYBB1,Beta-crystallin B1,31762,-0.0481568513245201,0.0305965304541357,-0.108126051014626,0.011812348365586,0.115543273288785
Physical measures,X4270.Volume level set by participant (left),COL1A1,Collagen alpha-1(I) chain,32964,-0.105736663024234,0.0675667939523011,-0.238167579170744,0.0266942531222766,0.117636311983312
Physical measures,X4270.Volume level set by participant (left),FAM13A,Protein FAM13A,31720,-0.0458021030500628,0.0292701742702894,-0.10317164461983,0.0115674385197044,0.11766900775853
Physical measures,X4270.Volume level set by participant (left),EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",31680,-0.029387776130414,0.0188148434099851,-0.0662648692139848,0.00748931695315684,0.118341106873719
Physical measures,X4270.Volume level set by participant (left),THAP12,52 kDa repressor of the inhibitor of the protein kinase,31481,-0.0364086929317346,0.0233177156891701,-0.0821114156825079,0.00929402981903882,0.118466777306836
Physical measures,X4270.Volume level set by participant (left),GJA8,Gap junction alpha-8 protein,31492,-0.0541273467079174,0.0346951700336167,-0.122129879973806,0.0138751865579713,0.118781735323089
Physical measures,X4270.Volume level set by participant (left),SMTN,Smoothelin,31717,-0.0300947517313077,0.0192932831669129,-0.0679095867384569,0.00772008327584162,0.118834104334233
Physical measures,X4270.Volume level set by participant (left),CASP2,Caspase-2,32843,-0.0399925684956108,0.0256667047602251,-0.0902993098256519,0.0103141728344303,0.119233003219465
Physical measures,X4270.Volume level set by participant (left),FXN,"Frataxin, mitochondrial",32948,-0.0382904697493234,0.0245908827757112,-0.0864885999897173,0.00990766049107054,0.119481517691629
Physical measures,X4270.Volume level set by participant (left),TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,31762,-0.0769261642820939,0.0494716595419895,-0.173890616984393,0.0200382884202054,0.119997042371177
Physical measures,X4270.Volume level set by participant (left),ASRGL1,Isoaspartyl peptidase/L-asparaginase,31566,-0.0322196922263115,0.0207270864323154,-0.0728447816336497,0.00840539718102663,0.120112759978974
Physical measures,X4270.Volume level set by participant (left),GOLGA3,Golgin subfamily A member 3,31752,-0.0411821139615062,0.026572289058753,-0.0932638005166621,0.0108995725936496,0.121226202894199
Physical measures,X4270.Volume level set by participant (left),ARHGEF1,Rho guanine nucleotide exchange factor 1,31751,-0.0357844043142348,0.0230980725058983,-0.0810566264257955,0.00948781779732596,0.121364711719042
Physical measures,X4270.Volume level set by participant (left),BATF,Basic leucine zipper transcriptional factor ATF-like,31546,-0.0385037866101487,0.0248820163907565,-0.0872725387360315,0.0102649655157341,0.121794891113826
Physical measures,X4270.Volume level set by participant (left),BAG4,BAG family molecular chaperone regulator 4,31508,-0.0644038536594229,0.0416996950914427,-0.146135256038651,0.0173275487198048,0.122516335993109
Physical measures,X4270.Volume level set by participant (left),RPA2,Replication protein A 32 kDa subunit,31508,-0.100052341161848,0.0647824129261552,-0.227025870497113,0.0269211881734159,0.122523946286154
Physical measures,X4270.Volume level set by participant (left),CCN5,CCN family member 5,32861,0.0689133943625256,0.0446486993920355,-0.018598056445864,0.156424845170915,0.122754845311058
Physical measures,X4270.Volume level set by participant (left),NPTXR,Neuronal pentraxin receptor,32864,-0.0777832802534092,0.0504837701905634,-0.176731469826914,0.0211649093200951,0.123410811594414
Physical measures,X4270.Volume level set by participant (left),RLN2,Prorelaxin H2,31585,-0.0209337585111839,0.0136076107445321,-0.0476046755704668,0.00573715854809897,0.123995224260198
Physical measures,X4270.Volume level set by participant (left),APRT,Adenine phosphoribosyltransferase,32790,-0.0607404361191158,0.0395462366985617,-0.138251060048297,0.016770187810065,0.12458984297125
Physical measures,X4270.Volume level set by participant (left),ARID4B,AT-rich interactive domain-containing protein 4B,32644,-0.0656409522591771,0.0427662490253134,-0.149462800348791,0.0181808958304373,0.124849955545013
Physical measures,X4270.Volume level set by participant (left),CRELD1,Protein disulfide isomerase CRELD1,31599,0.0843115806672951,0.0549690039431493,-0.0234276670612774,0.192050828395868,0.125119207905837
Physical measures,X4270.Volume level set by participant (left),SPINT2,Kunitz-type protease inhibitor 2,32894,-0.0623159884525671,0.0406742578503928,-0.142037533839337,0.0174055569342029,0.125539107811863
Physical measures,X4270.Volume level set by participant (left),RTN4R,Reticulon-4 receptor,32948,0.0805415570274395,0.0526273910866386,-0.0226081295023721,0.183691243557251,0.125949756258944
Physical measures,X4270.Volume level set by participant (left),EDN1,Endothelin-1,31566,-0.108258285313771,0.070739961329353,-0.246908609519303,0.0303920388917609,0.125966335915068
Physical measures,X4270.Volume level set by participant (left),MTSS1,Protein MTSS 1,31720,-0.0280298329340307,0.0183348698806215,-0.0639661779000489,0.00790651203198749,0.126361268982709
Physical measures,X4270.Volume level set by participant (left),C1QA,Complement C1q subcomponent subunit A,32929,-0.113877304737432,0.0745698427805565,-0.260034196587323,0.0322795871124587,0.126765371228009
Physical measures,X4270.Volume level set by participant (left),NTRK3,NT-3 growth factor receptor,32931,-0.122424377175589,0.0801777845546702,-0.279572834902742,0.034724080551565,0.126817909215821
Physical measures,X4270.Volume level set by participant (left),WDR46,WD repeat-containing protein 46,31724,-0.0897685509892691,0.0587907992563047,-0.204998517531626,0.025461415553088,0.126822390575755
Physical measures,X4270.Volume level set by participant (left),CTSF,Cathepsin F,32881,0.0645291615150861,0.0423147675933623,-0.0184077829679041,0.147466105998076,0.127299228630344
Physical measures,X4270.Volume level set by participant (left),SUGT1,Protein SGT1 homolog,32638,-0.0354115528528119,0.023237747771542,-0.0809575384850342,0.0101344327794103,0.127574578538346
Physical measures,X4270.Volume level set by participant (left),MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,32883,-0.035882163817961,0.0235769861163538,-0.0820930566060145,0.0103287289700926,0.128065487349054
Physical measures,X4270.Volume level set by participant (left),TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,32851,0.0540714401427666,0.0355388606389156,-0.0155847267095079,0.123727606995041,0.128176195896224
Physical measures,X4270.Volume level set by participant (left),CD58,Lymphocyte function-associated antigen 3,32822,0.151190935686414,0.0994379187893922,-0.0437073851407944,0.346089256513623,0.128431811590195
Physical measures,X4270.Volume level set by participant (left),PLA2G7,Platelet-activating factor acetylhydrolase,32861,-0.0834905798369621,0.0549135740170228,-0.191121184910327,0.0241400252364025,0.128445694037138
Physical measures,X4270.Volume level set by participant (left),NFAT5,Nuclear factor of activated T-cells 5,31508,-0.0346359226075123,0.0228078155876403,-0.0793392411592872,0.0100673959442627,0.128904850666107
Physical measures,X4270.Volume level set by participant (left),LXN,Latexin,32728,-0.0372887847784067,0.0245633685749311,-0.0854329871852716,0.0108554176284583,0.129033727250251
Physical measures,X4270.Volume level set by participant (left),MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",31546,-0.0612263479541056,0.0404034993501983,-0.140417206680494,0.017964510772283,0.129719259897229
Physical measures,X4270.Volume level set by participant (left),DXO,Decapping and exoribonuclease protein,31751,-0.0694584868174938,0.0458481043337768,-0.159320771311696,0.0204037976767088,0.129820156904926
Physical measures,X4270.Volume level set by participant (left),EIF4E,Eukaryotic translation initiation factor 4E,31508,-0.036490660567014,0.0240984933134655,-0.0837237074614064,0.0107423863273784,0.130008865054929
Physical measures,X4270.Volume level set by participant (left),LEFTY2,Left-right determination factor 2,32940,-0.0468429850154294,0.0309671287759053,-0.107538557416204,0.0138525873853449,0.130398823932617
Physical measures,X4270.Volume level set by participant (left),CD48,CD48 antigen,32883,0.0917448013436849,0.0607475235110959,-0.0273203447380631,0.210809947425433,0.131011087437141
Physical measures,X4270.Volume level set by participant (left),DKKL1,Dickkopf-like protein 1,32832,-0.0310483262869695,0.0205725126849785,-0.0713704511495274,0.00927379857558834,0.131279301968064
Physical measures,X4270.Volume level set by participant (left),LCN2,Neutrophil gelatinase-associated lipocalin,32579,0.0718563513007713,0.047717613389666,-0.021670170942974,0.165382873544517,0.132137708115547
Physical measures,X4270.Volume level set by participant (left),SEZ6L2,Seizure 6-like protein 2,32832,-0.108374602910967,0.0720591612366465,-0.249610558934794,0.0328613531128606,0.132625065679543
Physical measures,X4270.Volume level set by participant (left),TXNL1,Thioredoxin-like protein 1,31504,-0.0305536307220825,0.0203558974287508,-0.0704511896824341,0.00934392823826912,0.133404139995172
Physical measures,X4270.Volume level set by participant (left),SNX18,Sorting nexin-18,31720,-0.0646421070421877,0.043075172344754,-0.149069444837906,0.0197852307535301,0.13347818559741
Physical measures,X4270.Volume level set by participant (left),PTPN9,Tyrosine-protein phosphatase non-receptor type 9,31489,-0.0772078700480051,0.0514550194478671,-0.178059708165825,0.0236439680698143,0.13352827692815
Physical measures,X4270.Volume level set by participant (left),ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,31720,-0.104252496097377,0.0695437825566132,-0.240558309908339,0.0320533177135854,0.133890062295272
Physical measures,X4270.Volume level set by participant (left),HTRA2,"Serine protease HTRA2, mitochondrial",32881,-0.0420233406376766,0.0280379061264281,-0.0969776366454757,0.0129309553701226,0.133959352880828
Physical measures,X4270.Volume level set by participant (left),CASP3,Caspase-3,32964,-0.0304715029878868,0.0203362806725555,-0.0703306131060955,0.00938760713032184,0.134068890554194
Physical measures,X4270.Volume level set by participant (left),CFHR5,Complement factor H-related protein 5,31666,0.0734536278347585,0.0490315346190418,-0.0226481800185634,0.16955543568808,0.134150445888271
Physical measures,X4270.Volume level set by participant (left),CERT,Ceramide transfer protein,32644,-0.044575421194873,0.0297730304260348,-0.102930560829901,0.0137797184401552,0.134383807557342
Physical measures,X4270.Volume level set by participant (left),VPS53,Vacuolar protein sorting-associated protein 53 homolog,32832,-0.0331202202727301,0.0221469337563212,-0.0765282104351195,0.0102877698896594,0.134825296523906
Physical measures,X4270.Volume level set by participant (left),OSM,Oncostatin-M,32788,0.0361753855808683,0.0242001441837759,-0.0112568970193326,0.0836076681810692,0.134991105168262
Physical measures,X4270.Volume level set by participant (left),APPL2,DCC-interacting protein 13-beta,31599,-0.0275688995450101,0.0184496320563326,-0.0637301783754221,0.00859237928540185,0.135143471985543
Physical measures,X4270.Volume level set by participant (left),ADGRG2,Adhesion G-protein coupled receptor G2,32864,-0.0956752847070208,0.0640562832189104,-0.221225599816085,0.0298750304020437,0.135311902914412
Physical measures,X4270.Volume level set by participant (left),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,32796,-0.0893668001129902,0.0598498635963761,-0.206672532761887,0.0279389325359069,0.135424602383753
Physical measures,X4270.Volume level set by participant (left),RAB6A,Ras-related protein Rab-6A,32843,-0.0521278888422136,0.0349537954930176,-0.120637328008528,0.0163815503241009,0.135908162358561
Physical measures,X4270.Volume level set by participant (left),MCAM,Cell surface glycoprotein MUC18,32878,-0.0771618992566197,0.0517924133243153,-0.178675029372278,0.0243512308590383,0.136303883192594
Physical measures,X4270.Volume level set by participant (left),LETM1,Mitochondrial proton/calcium exchanger protein,31752,-0.0560326353254722,0.037640642828941,-0.129808295270196,0.0177430246192521,0.136627282208388
Physical measures,X4270.Volume level set by participant (left),DUSP13,Dual specificity protein phosphatase 13 isoform A,31724,-0.0712819594642857,0.0479054960836887,-0.165176731788315,0.0226128128597441,0.136798814742629
Physical measures,X4270.Volume level set by participant (left),MNAT1,CDK-activating kinase assembly factor MAT1,31632,0.0633463493310142,0.0425806532792641,-0.0201117310963435,0.146804429758372,0.136876117939856
Physical measures,X4270.Volume level set by participant (left),FARSA,Phenylalanine--tRNA ligase alpha subunit,31546,-0.0443530829705744,0.0298255855849864,-0.102811230717148,0.014105064775999,0.137034266277946
Physical measures,X4270.Volume level set by participant (left),GRP,Gastrin-releasing peptide,31566,-0.0576826881472248,0.0387988397552524,-0.13372841406752,0.0183630377730699,0.137131905006944
Physical measures,X4270.Volume level set by participant (left),VAMP8,Vesicle-associated membrane protein 8,31508,-0.0354473588091744,0.0238977175392953,-0.0822868851861933,0.0113921675678445,0.138037340496112
Physical measures,X4270.Volume level set by participant (left),OTOA,Otoancorin,31514,-0.0564222614020091,0.0380774620919068,-0.131054087102147,0.0182095642981283,0.138441145857017
Physical measures,X4270.Volume level set by participant (left),GSTP1,Glutathione S-transferase P,32597,-0.0374015475642248,0.0252721503311373,-0.0869349622132538,0.0121318670848043,0.138922355739023
Physical measures,X4270.Volume level set by participant (left),CREB3,Cyclic AMP-responsive element-binding protein 3,31492,-0.0555357420480543,0.0375910986326173,-0.129214295367984,0.0181428112718756,0.139619325055579
Physical measures,X4270.Volume level set by participant (left),WASF3,Wiskott-Aldrich syndrome protein family member 3,32644,-0.0298144720863866,0.0202015735243461,-0.0694095561941049,0.00978061202133167,0.140020289330336
Physical measures,X4270.Volume level set by participant (left),MICALL2,MICAL-like protein 2,31546,-0.0393448966793887,0.026663809747793,-0.091605963785063,0.0129161704262857,0.140094510353408
Physical measures,X4270.Volume level set by participant (left),LTB,Lymphotoxin-beta,31724,-0.082543877090435,0.0559711033555485,-0.19224723966731,0.02715948548644,0.140317448781826
Physical measures,X4270.Volume level set by participant (left),METAP1D,"Methionine aminopeptidase 1D, mitochondrial",32843,-0.0319580805469196,0.0216735648557828,-0.074438267664254,0.0105221065704148,0.140376994021051
Physical measures,X4270.Volume level set by participant (left),CEBPB,CCAAT/enhancer-binding protein beta,32685,0.0653816772083149,0.0443761379804343,-0.0215955532333363,0.152358907649966,0.140691789958489
Physical measures,X4270.Volume level set by participant (left),TNFSF11,Tumor necrosis factor ligand superfamily member 11,32843,-0.0409120838325627,0.0277750865421375,-0.0953512534551521,0.0135270857900268,0.14079208998372
Physical measures,X4270.Volume level set by participant (left),GFRA3,GDNF family receptor alpha-3,32765,-0.0931994021971621,0.0632836127461861,-0.217235283179687,0.0308364787853627,0.140860370881998
Physical measures,X4270.Volume level set by participant (left),ESAM,Endothelial cell-selective adhesion molecule,32964,-0.0812949441607788,0.055242645547435,-0.189570529433751,0.0269806411121939,0.141164152001616
Physical measures,X4270.Volume level set by participant (left),CANT1,Soluble calcium-activated nucleotidase 1,32841,-0.128351743123033,0.087231403602574,-0.299325294184078,0.0426218079380116,0.141219707873619
Physical measures,X4270.Volume level set by participant (left),CCL5,C-C motif chemokine 5,32878,-0.0245937128820715,0.0167167834239931,-0.057358608393098,0.008171182628955,0.141272246407528
Physical measures,X4270.Volume level set by participant (left),CRYBB2,Beta-crystallin B2,31751,0.0528201831420956,0.0359302992097272,-0.0176032033089698,0.123243569593161,0.141581714477337
Physical measures,X4270.Volume level set by participant (left),GPR15L,Protein GPR15L,31720,0.0467380984270302,0.0317941807155287,-0.0155784957754061,0.109054692629466,0.141596234681337
Physical measures,X4270.Volume level set by participant (left),PAPPA,Pappalysin-1,32679,-0.0541118286705363,0.0368195961209299,-0.126278237067559,0.0180545797264863,0.141692922825401
Physical measures,X4270.Volume level set by participant (left),CFHR4,Complement factor H-related protein 4,31756,0.0401208917932429,0.0273100070790603,-0.0134067220817153,0.093648505668201,0.141847900511124
Physical measures,X4270.Volume level set by participant (left),PTPN1,Tyrosine-protein phosphatase non-receptor type 1,32796,-0.0321232545638095,0.0218799732641009,-0.0750080021614472,0.0107614930338281,0.142096558852642
Physical measures,X4270.Volume level set by participant (left),VCPKMT,Protein-lysine methyltransferase METTL21D,31492,-0.0341881561462332,0.0232877300651507,-0.0798321070739285,0.0114557947814622,0.142124823414045
Physical measures,X4270.Volume level set by participant (left),KHK,Ketohexokinase,31566,-0.0467615591912971,0.0318583280744327,-0.109203882217185,0.0156807638345909,0.142200194438903
Physical measures,X4270.Volume level set by participant (left),LYAR,Cell growth-regulating nucleolar protein,32638,0.0513449223729683,0.0349943725801328,-0.017244047884092,0.119933892630029,0.142348333529245
Physical measures,X4270.Volume level set by participant (left),ZNRD2,Protein ZNRD2,31720,-0.042086413208388,0.028702740389204,-0.0983437843712279,0.014170957954452,0.142610532743352
Physical measures,X4270.Volume level set by participant (left),PDLIM7,PDZ and LIM domain protein 7,32894,-0.0198575510611577,0.0135511751447477,-0.0464178543448633,0.00670275222254788,0.142853491719393
Physical measures,X4270.Volume level set by participant (left),TNFAIP8,Tumor necrosis factor alpha-induced protein 8,32679,-0.0705396450069466,0.048224225483807,-0.165059126955208,0.0239798369413152,0.143573381331279
Physical measures,X4270.Volume level set by participant (left),TNFAIP2,Tumor necrosis factor alpha-induced protein 2,31720,-0.0628416163780914,0.0429748583217735,-0.147072338688768,0.0213891059325848,0.143702321950447
Physical measures,X4270.Volume level set by participant (left),EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,31752,-0.0417139847632353,0.0285744673288504,-0.097719940727782,0.0142919712013115,0.144375464026071
Physical measures,X4270.Volume level set by participant (left),POLR2A,DNA-directed RNA polymerase II subunit RPB1,31508,-0.101234103798242,0.069403340321721,-0.237264650828815,0.0347964432323311,0.144706825175774
Physical measures,X4270.Volume level set by participant (left),MAVS,Mitochondrial antiviral-signaling protein,32638,-0.0271790665039029,0.0186476046795703,-0.0637283716758607,0.00937023866805498,0.145011493837363
Physical measures,X4270.Volume level set by participant (left),IMPG1,Interphotoreceptor matrix proteoglycan 1,31514,0.100816844478482,0.069204942696553,-0.0348248432067621,0.236458532163726,0.145216287689822
Physical measures,X4270.Volume level set by participant (left),DRAXIN,Draxin,32796,-0.0589442816729291,0.0404851599487338,-0.138295195172447,0.0204066318265891,0.145442178790313
Physical measures,X4270.Volume level set by participant (left),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,31539,-0.0793711466654397,0.0546171316692836,-0.186420724737236,0.0276784314063563,0.146201331117988
Physical measures,X4270.Volume level set by participant (left),GET3,ATPase GET3,31762,-0.0525091096495023,0.0361348564451477,-0.123333428281992,0.0183152089829873,0.146223809814336
Physical measures,X4270.Volume level set by participant (left),HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,32843,-0.0646307026721454,0.044480009334521,-0.151811520967807,0.0225501156235157,0.146250898990959
Physical measures,X4270.Volume level set by participant (left),YOD1,Ubiquitin thioesterase OTU1,31495,-0.0485394577964264,0.0334201607754586,-0.114042972916325,0.0169640573234723,0.146431389854313
Physical measures,X4270.Volume level set by participant (left),ATP5IF1,"ATPase inhibitor, mitochondrial",32894,-0.0234846025158485,0.0161773291015656,-0.0551921675549171,0.00822296252322005,0.146620225548706
Physical measures,X4270.Volume level set by participant (left),ITGB1BP1,Integrin beta-1-binding protein 1,32638,0.0628446868949599,0.0433433678128934,-0.0221083140183111,0.147797687808231,0.147114824565682
Physical measures,X4270.Volume level set by participant (left),INSR,Insulin receptor,31508,-0.179291215300505,0.123663415358618,-0.421671509403396,0.0630890788023867,0.147146307669587
Physical measures,X4270.Volume level set by participant (left),FAM3C,Protein FAM3C,32858,-0.087208627202113,0.0601833203428823,-0.205167935074162,0.0307506806699363,0.147358540466489
Physical measures,X4270.Volume level set by participant (left),TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",31546,-0.0393412857155612,0.0271547372461117,-0.0925645707179401,0.0138819992868178,0.14743937331478
Physical measures,X4270.Volume level set by participant (left),CBLIF,Cobalamin binding intrinsic factor,32858,-0.0366993238249247,0.0253408943161456,-0.08636747668457,0.0129688290347206,0.147588910677653
Physical measures,X4270.Volume level set by participant (left),MED18,Mediator of RNA polymerase II transcription subunit 18,32638,-0.0343719722527826,0.0237564081970762,-0.080934532319052,0.0121905878134867,0.147974505208986
Physical measures,X4270.Volume level set by participant (left),IQGAP2,Ras GTPase-activating-like protein IQGAP2,32832,-0.0448964197765213,0.0310624321775637,-0.105778786844546,0.0159859472915036,0.14839152425585
Physical measures,X4270.Volume level set by participant (left),NXPH1,Neurexophilin-1,32644,-0.0674258734618831,0.0466510572610841,-0.158861945693608,0.0240101987698419,0.148402700721988
Physical measures,X4270.Volume level set by participant (left),PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,31599,-0.069512952633484,0.0481137638071114,-0.163815929695422,0.0247900244284544,0.14856516209607
Physical measures,X4270.Volume level set by participant (left),COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",32832,-0.0370314208426533,0.0256768043601048,-0.0873579573884588,0.0132951157031522,0.14927721385668
Physical measures,X4270.Volume level set by participant (left),GAS2,Growth arrest-specific protein 2,31632,-0.0514564028248731,0.0357343965233742,-0.121495820010686,0.0185830143609403,0.14991662463477
Physical measures,X4270.Volume level set by participant (left),ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,31724,-0.0641781614203178,0.0445810960270608,-0.151557109633357,0.0232007867927215,0.150025399454073
Physical measures,X4270.Volume level set by participant (left),KRT14,"Keratin, type I cytoskeletal 14",32411,0.0884406611620155,0.0614442989417758,-0.031990164763865,0.208871487087896,0.150084269525903
Physical measures,X4270.Volume level set by participant (left),ATXN10,Ataxin-10,32644,-0.036182496006468,0.0251515854963029,-0.0854796035792217,0.0131146115662857,0.150306006319993
Physical measures,X4270.Volume level set by participant (left),EREG,Proepiregulin,32776,-0.031820301966176,0.0221206687115872,-0.0751768126408868,0.0115362087085349,0.150330937773901
Physical measures,X4270.Volume level set by participant (left),PNLIPRP2,Pancreatic lipase-related protein 2,32834,0.00846615203431617,0.0058872689069279,-0.00307289502326251,0.0200051990918948,0.150456437107341
Physical measures,X4270.Volume level set by participant (left),COMMD1,COMM domain-containing protein 1,31566,-0.0481193885089115,0.0334633763464173,-0.113707606147889,0.0174688291300665,0.150482704025343
Physical measures,X4270.Volume level set by participant (left),BECN1,Beclin-1,31566,-0.048613476901747,0.0338088539264476,-0.114878830597584,0.0176518767940903,0.150505353125921
Physical measures,X4270.Volume level set by participant (left),MVK,Mevalonate kinase,32679,-0.0328720442654976,0.0228642336157085,-0.0776859421522862,0.011941853621291,0.150553002306854
Physical measures,X4270.Volume level set by participant (left),FABP6,Gastrotropin,32674,0.0469146867837777,0.0326665421608385,-0.0171117358514657,0.110941109419021,0.150989658849537
Physical measures,X4270.Volume level set by participant (left),AIF1,Allograft inflammatory factor 1,32638,0.0496080978114689,0.0345552028313897,-0.0181200997380549,0.117336295360993,0.151146494261561
Physical measures,X4270.Volume level set by participant (left),TANK,TRAF family member-associated NF-kappa-B activator,32679,-0.0362172721822322,0.0252468392335017,-0.0857010770798955,0.0132665327154312,0.151457404134064
Physical measures,X4270.Volume level set by participant (left),IL17D,Interleukin-17D,32679,-0.0750422041799732,0.052330029239177,-0.17760906148876,0.0275246531288138,0.15160259119035
Physical measures,X4270.Volume level set by participant (left),ADGRE2,Adhesion G protein-coupled receptor E2,32894,-0.0868787753251462,0.0606635294326998,-0.205779293013238,0.0320217423629455,0.152137857242964
Physical measures,X4270.Volume level set by participant (left),STK4,Serine/threonine-protein kinase 4,32864,-0.0290068164032058,0.0202554761328447,-0.0687075496235814,0.0106939168171699,0.152164775743617
Physical measures,X4270.Volume level set by participant (left),CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",32800,0.0384087907471068,0.0268262241492295,-0.0141706085853829,0.0909881900795965,0.15224667713006
Physical measures,X4270.Volume level set by participant (left),CEP43,Centrosomal protein 43,32621,-0.03715253284231,0.0259710736263259,-0.0880558371499087,0.0137507714652887,0.152599170498259
Physical measures,X4270.Volume level set by participant (left),TGFB1,Transforming growth factor beta-1 proprotein,32946,-0.0630895840988853,0.0441085573087141,-0.149542356423965,0.0233631882261944,0.152658083664329
Physical measures,X4270.Volume level set by participant (left),CTLA4,Cytotoxic T-lymphocyte protein 4,31773,-0.0983006789340495,0.0687852429016692,-0.233119755021321,0.0365183971532221,0.153016284514297
Physical measures,X4270.Volume level set by participant (left),VSIG4,V-set and immunoglobulin domain-containing protein 4,32845,0.0648304082686967,0.0453876083973072,-0.0241293041900255,0.153790120727419,0.153219462342827
Physical measures,X4270.Volume level set by participant (left),CTSC,Dipeptidyl peptidase 1,32839,-0.0552813806865775,0.0387100019285546,-0.131152984466544,0.0205902230933894,0.153300642869569
Physical measures,X4270.Volume level set by participant (left),CDC27,Cell division cycle protein 27 homolog,32638,-0.0398420419296427,0.02790790734308,-0.0945415403220794,0.014857456462794,0.153435246941552
Physical measures,X4270.Volume level set by participant (left),SEL1L,Protein sel-1 homolog 1,31566,-0.0956086387601082,0.0670094779338492,-0.226947215510453,0.0357299379902362,0.153680165342154
Physical measures,X4270.Volume level set by participant (left),S100A4,Protein S100-A4,32881,-0.0468123300624817,0.0328123830525301,-0.111124600845441,0.0174999407204773,0.153710644451945
Physical measures,X4270.Volume level set by participant (left),CDKL5,Cyclin-dependent kinase-like 5,31514,-0.0562304440020517,0.0394235274890379,-0.133500557880566,0.0210396698764627,0.153817686331819
Physical measures,X4270.Volume level set by participant (left),TP53I3,Quinone oxidoreductase PIG3,31414,-0.0568087635051003,0.0398438571384517,-0.134902723496466,0.0212851964862651,0.153971823929878
Physical measures,X4270.Volume level set by participant (left),LARP1,La-related protein 1,31724,-0.0453740692593461,0.0318287430210757,-0.107758405580655,0.0170102670619624,0.154032495749669
Physical measures,X4270.Volume level set by participant (left),MTDH,Protein LYRIC,31508,-0.0326201884693965,0.0228895347327604,-0.0774836765456068,0.0122432996068139,0.154165173304301
Physical measures,X4270.Volume level set by participant (left),RARRES1,Retinoic acid receptor responder protein 1,32638,-0.0738662289348353,0.0518862988914371,-0.175563374762052,0.0278309168923814,0.154592860677598
Physical measures,X4270.Volume level set by participant (left),PRKG1,cGMP-dependent protein kinase 1,31599,-0.0228853969361206,0.0160897195746311,-0.0544212473023975,0.00865045343015639,0.154961665171384
Physical measures,X4270.Volume level set by participant (left),PKD2,Polycystin-2,31495,-0.0476526197288107,0.0335228368946729,-0.11335738004237,0.0180521405847482,0.155213118565472
Physical measures,X4270.Volume level set by participant (left),WASL,Neural Wiskott-Aldrich syndrome protein,31508,-0.0472432192342063,0.0332373278202079,-0.112388381761814,0.0179019432934013,0.155244080307854
Physical measures,X4270.Volume level set by participant (left),CD300E,CMRF35-like molecule 2,32913,0.0643034266217954,0.0452473411756571,-0.0243813620824926,0.152988215326083,0.155306534709303
Physical measures,X4270.Volume level set by participant (left),SIGLEC1,Sialoadhesin,32894,0.0585552816933602,0.0412217231083309,-0.0222392955989685,0.139349858985689,0.155497933151881
Physical measures,X4270.Volume level set by participant (left),CD300LG,CMRF35-like molecule 9,32861,-0.0672798338121874,0.0473966010800166,-0.16017717192902,0.0256175043046451,0.15578573422451
Physical measures,X4270.Volume level set by participant (left),IFNGR2,Interferon gamma receptor 2,32796,-0.0468700253576002,0.0330647404682413,-0.111676916675353,0.0179368659601529,0.156364994342076
Physical measures,X4270.Volume level set by participant (left),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,32850,0.0806640157134512,0.0569245343139517,-0.0309080715418942,0.192236102968797,0.156507573523824
Physical measures,X4270.Volume level set by participant (left),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,32931,0.0561794621712341,0.0396568265968912,-0.0215479179586727,0.133906842301141,0.15662244575482
Physical measures,X4270.Volume level set by participant (left),MARS1,"Methionine--tRNA ligase, cytoplasmic",31578,-0.0346525673239702,0.0244673983649122,-0.082608668119198,0.0133035334712577,0.156735344291803
Physical measures,X4270.Volume level set by participant (left),LACRT,Extracellular glycoprotein lacritin,31707,-0.0583709586993438,0.0412216326799734,-0.139165358752092,0.022423441353404,0.156807207094439
Physical measures,X4270.Volume level set by participant (left),GGT1,Glutathione hydrolase 1 proenzyme,32843,0.0498677185665863,0.0352190465714914,-0.0191616127135368,0.118897049846709,0.156830566723741
Physical measures,X4270.Volume level set by participant (left),SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,32858,0.0219206208035895,0.0154938530976055,-0.00844733126771731,0.0522885728748963,0.15716332222427
Physical measures,X4270.Volume level set by participant (left),SPRY2,Protein sprouty homolog 2,32679,-0.0273697931794224,0.0193675682009174,-0.0653302268532206,0.0105906404943758,0.157639124859376
Physical measures,X4270.Volume level set by participant (left),ANXA4,Annexin A4,32819,-0.0347065777194554,0.0245637785199746,-0.0828515836186055,0.0134384281796948,0.15771491096845
Physical measures,X4270.Volume level set by participant (left),HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,32638,-0.0336407909850421,0.023823509607592,-0.0803348698159224,0.0130532878458382,0.157960760776674
Physical measures,X4270.Volume level set by participant (left),ACAN,Aggrecan core protein,32793,-0.0877266218868138,0.0621413698817352,-0.209523706855015,0.0340704630813872,0.158065333786623
Physical measures,X4270.Volume level set by participant (left),NEK7,Serine/threonine-protein kinase Nek7,31632,-0.0387272074831924,0.0274518090612754,-0.0925327532432921,0.0150783382769074,0.158363024611124
Physical measures,X4270.Volume level set by participant (left),THPO,Thrombopoietin,32685,-0.0647365936297615,0.0458948521963868,-0.15469050393468,0.0252173166751566,0.158415109994735
Physical measures,X4270.Volume level set by participant (left),CILP,Cartilage intermediate layer protein 1,31773,-0.0516980248481618,0.0366623184486591,-0.123556169007534,0.0201601193112101,0.158545533978376
Physical measures,X4270.Volume level set by participant (left),MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",31566,-0.108517542966652,0.0770196980072303,-0.259476151060824,0.0424410651275189,0.158887862724973
Physical measures,X4270.Volume level set by participant (left),SCT,Secretin,31546,-0.0661114841773043,0.0469454559546651,-0.158124577848448,0.0259016094938392,0.159094076570152
Physical measures,X4270.Volume level set by participant (left),DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,31751,-0.057332100108057,0.0407767674083031,-0.137254564228331,0.022590364012217,0.15976376775265
Physical measures,X4270.Volume level set by participant (left),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,32861,0.0712591986186695,0.0507104332735851,-0.0281332505975574,0.170651647834896,0.159991074538134
Physical measures,X4270.Volume level set by participant (left),CNST,Consortin,32864,-0.0240468357066723,0.0171230922143867,-0.0576080964468702,0.00951442503352561,0.160248788675783
Physical measures,X4270.Volume level set by participant (left),NT5E,5'-nucleotidase,32881,0.0435701746152774,0.0310332580128599,-0.017255011089928,0.104395360320483,0.160358271869594
Physical measures,X4270.Volume level set by participant (left),NUMB,Protein numb homolog,31508,-0.0355737707268102,0.0253578933583482,-0.0852752417091727,0.0141277002555522,0.160696889113091
Physical measures,X4270.Volume level set by participant (left),VIPR1,Vasoactive intestinal polypeptide receptor 1,31566,-0.109338815842409,0.0780226214878777,-0.26226315395865,0.0435855222738308,0.161142770266479
Physical measures,X4270.Volume level set by participant (left),PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",31773,-0.0455515903950005,0.0325258248362891,-0.109302207074127,0.0181990262841261,0.161410479074098
Physical measures,X4270.Volume level set by participant (left),MCTS1,Malignant T-cell-amplified sequence 1,31720,-0.106913922344884,0.0763411907293157,-0.256542656174343,0.042714811484575,0.161410639967645
Physical measures,X4270.Volume level set by participant (left),PMCH,Pro-MCH,31495,-0.0344844365718226,0.0246267838960396,-0.0827529330080603,0.0137840598644151,0.161469608323488
Physical measures,X4270.Volume level set by participant (left),PSPN,Persephin,32843,-0.0253325041318207,0.0180958114945331,-0.0608002946611056,0.0101352863974642,0.161574871970527
Physical measures,X4270.Volume level set by participant (left),SERPINA7,Thyroxine-binding globulin,31770,0.146406675398638,0.10463858509829,-0.0586849513940101,0.351498302191286,0.161802650836322
Physical measures,X4270.Volume level set by participant (left),CLUL1,Clusterin-like protein 1,32856,-0.0525266411076154,0.0376001289683736,-0.126222893885628,0.021169611670397,0.162453951103563
Physical measures,X4270.Volume level set by participant (left),GRN,Progranulin,32816,0.0991320841934895,0.0709804257761772,-0.0399895503278179,0.238253718714797,0.162565027536923
Physical measures,X4270.Volume level set by participant (left),OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,31632,-0.0434795044580419,0.0311338092743967,-0.10450177063586,0.0175427617197757,0.162592858914609
Physical measures,X4270.Volume level set by participant (left),NXPH3,Neurexophilin-3,31508,-0.0934214151947611,0.0669309993598787,-0.224606173940123,0.0377633435506012,0.162819196292456
Physical measures,X4270.Volume level set by participant (left),SPON1,Spondin-1,32864,0.074582163587758,0.0534590785804757,-0.0301976304299745,0.17936195760549,0.163012194431612
Physical measures,X4270.Volume level set by participant (left),DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",32843,-0.0260053677411231,0.0186527325496773,-0.0625647235384905,0.0105539880562444,0.163296113136362
Physical measures,X4270.Volume level set by participant (left),GATA3,Trans-acting T-cell-specific transcription factor GATA-3,31492,-0.109686825741787,0.0786811488644847,-0.263901877516177,0.044528226032603,0.163337848177164
Physical measures,X4270.Volume level set by participant (left),PPIE,Peptidyl-prolyl cis-trans isomerase E,31632,-0.0457751212595383,0.0328480759438663,-0.110157350109516,0.0186071075904398,0.163496296364324
Physical measures,X4270.Volume level set by participant (left),PODXL,Podocalyxin,32832,-0.157042980952013,0.112710463297333,-0.377955489014786,0.0638695271107596,0.16355425221769
Physical measures,X4270.Volume level set by participant (left),RFC4,Replication factor C subunit 4,31724,-0.129950293971379,0.0933248479553912,-0.312866995963946,0.0529664080211876,0.163825202172535
Physical measures,X4270.Volume level set by participant (left),DEFB104A_DEFB104B,Beta-defensin 104,31514,-0.0500816980803836,0.0359846195707057,-0.120611552438967,0.0204481562781996,0.164037699622079
Physical measures,X4270.Volume level set by participant (left),CR2,Complement receptor type 2,32878,-0.0524924566906572,0.0377468462841314,-0.126476275407555,0.0214913620262404,0.164367480558798
Physical measures,X4270.Volume level set by participant (left),BRD2,Bromodomain-containing protein 2,31514,-0.0826201890002041,0.0594374786939979,-0.19911764724044,0.0338772692400317,0.164558620051976
Physical measures,X4270.Volume level set by participant (left),HCLS1,Hematopoietic lineage cell-specific protein,32961,-0.045232829454693,0.0325415614797223,-0.109014289954949,0.0185486310455627,0.164562333644389
Physical measures,X4270.Volume level set by participant (left),TTN,Titin,31495,-0.0386607841682585,0.0278299895934049,-0.0932075637713321,0.0158859954348151,0.164819433718225
Physical measures,X4270.Volume level set by participant (left),ADGRD1,Adhesion G-protein coupled receptor D1,31599,0.0724856472792284,0.0521943758965809,-0.0298153294780701,0.174786624036527,0.164944639535143
Physical measures,X4270.Volume level set by participant (left),AAMDC,Mth938 domain-containing protein,31566,-0.0534552936564295,0.0385088113391263,-0.128932563881117,0.022021976568258,0.165137153514936
Physical measures,X4270.Volume level set by participant (left),GLOD4,Glyoxalase domain-containing protein 4,32830,-0.0711986630403911,0.0512954121961556,-0.171737670944856,0.0293403448640739,0.165167784300408
Physical measures,X4270.Volume level set by participant (left),STAU1,Double-stranded RNA-binding protein Staufen homolog 1,31492,-0.042611060670668,0.0307211986414569,-0.102824610007923,0.0176024886665875,0.165474758730438
Physical measures,X4270.Volume level set by participant (left),AMIGO2,Amphoterin-induced protein 2,32832,-0.105436163211846,0.0760492516214561,-0.2544926963899,0.0436203699662078,0.165653315545173
Physical measures,X4270.Volume level set by participant (left),POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",32832,-0.0757461560492452,0.0547083549051106,-0.182974531663262,0.0314822195647715,0.166226211629955
Physical measures,X4270.Volume level set by participant (left),CA4,Carbonic anhydrase 4,32964,-0.101473246888133,0.0733288027391163,-0.245197700256801,0.0422512064805351,0.166450090312711
Physical measures,X4270.Volume level set by participant (left),FGFR4,Fibroblast growth factor receptor 4,31599,-0.0536799078042906,0.0387964060649945,-0.12972086369168,0.0223610480830985,0.166511411199165
Physical measures,X4270.Volume level set by participant (left),SCP2,Non-specific lipid-transfer protein,32638,-0.0301621976623381,0.0218331860871413,-0.072955242393135,0.0126308470684588,0.167165361277054
Physical measures,X4270.Volume level set by participant (left),STK24,Serine/threonine-protein kinase 24,32644,-0.0391539663420534,0.028358824134633,-0.0947372616459341,0.0164293289618273,0.167417882893192
Physical measures,X4270.Volume level set by participant (left),AGRN,Agrin,32894,0.0720647034634923,0.0522248184423724,-0.0302959406835576,0.174425347610542,0.167653504234801
Physical measures,X4270.Volume level set by participant (left),IL31,Interleukin-31,31508,-0.04900726236497,0.0355295201046036,-0.118645121769993,0.0206305970400531,0.167830520076967
Physical measures,X4270.Volume level set by participant (left),ARL13B,ADP-ribosylation factor-like protein 13B,31495,-0.0399223046813417,0.0289443526787349,-0.0966532359316621,0.0168086265689788,0.167849515884458
Physical measures,X4270.Volume level set by participant (left),INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",31566,-0.0514219099375477,0.0373006299806861,-0.124531144699692,0.0216873248245971,0.168064258325073
Physical measures,X4270.Volume level set by participant (left),SIGLEC5,Sialic acid-binding Ig-like lectin 5,32861,0.0195897773866515,0.0142174567977738,-0.00827643793698525,0.0474559927102882,0.168278341095509
Physical measures,X4270.Volume level set by participant (left),GDNF,Glial cell line-derived neurotrophic factor,32644,-0.0636738358042123,0.0462282397517598,-0.154281185717662,0.0269335141092369,0.168430013461829
Physical measures,X4270.Volume level set by participant (left),EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,31495,-0.0788131005681539,0.0572208219211814,-0.190965911533669,0.0333397103973617,0.168444446577388
Physical measures,X4270.Volume level set by participant (left),IL25,Interleukin-25,31474,-0.082471138723158,0.0598813231119122,-0.199838532022506,0.03489625457619,0.168477603657425
Physical measures,X4270.Volume level set by participant (left),HAVCR2,Hepatitis A virus cellular receptor 2,32861,0.0731516959705519,0.0531390165497401,-0.0310007764669386,0.177304168408042,0.168667141950223
Physical measures,X4270.Volume level set by participant (left),ESYT2,Extended synaptotagmin-2,31751,-0.0326055059432249,0.0237031819294968,-0.0790637425250387,0.0138527306385888,0.168992291380514
Physical measures,X4270.Volume level set by participant (left),TFPI,Tissue factor pathway inhibitor,32810,-0.0741826479273523,0.0539330106734667,-0.179891348847347,0.0315260529926424,0.169023606225079
Physical measures,X4270.Volume level set by participant (left),TMSB10,Thymosin beta-10,32861,-0.0312486529428785,0.0227285529146805,-0.0757966166556522,0.0132993107698952,0.169208067181185
Physical measures,X4270.Volume level set by participant (left),AXIN1,Axin-1,32843,-0.0260948155622821,0.0189827376326434,-0.0633009813222633,0.011111350197699,0.169271088918193
Physical measures,X4270.Volume level set by participant (left),CSF3,Granulocyte colony-stimulating factor,32679,0.0489315590048667,0.0356505312410275,-0.0209434822275472,0.118806600237281,0.16993224079608
Physical measures,X4270.Volume level set by participant (left),AZU1,Azurocidin,32544,0.0301334661231494,0.0219715430008979,-0.0129307581586105,0.0731976904049092,0.170261752072538
Physical measures,X4270.Volume level set by participant (left),SEMA7A,Semaphorin-7A,32922,-0.0868785661702079,0.0634877206508799,-0.211314498645933,0.0375573663055167,0.171211136438347
Physical measures,X4270.Volume level set by participant (left),CST6,Cystatin-M,32618,0.0511297110507251,0.0374136277641254,-0.0222009993669608,0.124460421468411,0.171783737521643
Physical measures,X4270.Volume level set by participant (left),CAPN3,Calpain-3,31724,-0.0723078454478727,0.0529187733804519,-0.176028641273558,0.0314129503778129,0.171854703331875
Physical measures,X4270.Volume level set by participant (left),TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",31508,0.0464308621055389,0.0340088683272965,-0.0202265198159622,0.11308824402704,0.172212307332926
Physical measures,X4270.Volume level set by participant (left),AZI2,5-azacytidine-induced protein 2,31752,-0.0477338876327976,0.0349650197853078,-0.116265326412001,0.0207975511464058,0.172232338240243
Physical measures,X4270.Volume level set by participant (left),SERPINF2,Alpha-2-antiplasmin,31610,-0.198170086250389,0.145178071309845,-0.482719106017686,0.0863789335169073,0.172288318765101
Physical measures,X4270.Volume level set by participant (left),KITLG,Kit ligand,32864,-0.0643032049996376,0.0471215254573935,-0.156661394896129,0.0280549848968536,0.17240510057429
Physical measures,X4270.Volume level set by participant (left),GH2,Growth hormone variant,32638,-0.0146185863400341,0.0107183184434083,-0.0356264904891144,0.00638931780904623,0.172637788533359
Physical measures,X4270.Volume level set by participant (left),TXNDC5,Thioredoxin domain-containing protein 5,32931,-0.0345120479200658,0.0253058334617063,-0.0841114815050102,0.0150873856648786,0.172664966247947
Physical measures,X4270.Volume level set by participant (left),PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,32843,-0.06078746800812,0.0445884845524529,-0.148180897730928,0.0266059617146875,0.172822251818221
Physical measures,X4270.Volume level set by participant (left),IL10RB,Interleukin-10 receptor subunit beta,32894,0.0843656746455512,0.0619391487883232,-0.0370350569795623,0.205766406270665,0.173208654482916
Physical measures,X4270.Volume level set by participant (left),LEP,Leptin,32864,0.0343600732085777,0.0252278461757621,-0.015086505295916,0.0838066517130713,0.173235137394795
Physical measures,X4270.Volume level set by participant (left),CHRM1,Muscarinic acetylcholine receptor M1,31546,-0.0751609079478796,0.0551943199750603,-0.183341775098998,0.0330199592032387,0.173316479017797
Physical measures,X4270.Volume level set by participant (left),LAMA1,Laminin subunit alpha-1,31495,-0.0502106582274055,0.0368882608468244,-0.122511649487181,0.0220903330323703,0.173504747890593
Physical measures,X4270.Volume level set by participant (left),FGF19,Fibroblast growth factor 19,32894,-0.0312498810394314,0.0229762194755306,-0.0762832712114714,0.0137835091326085,0.173833264361754
Physical measures,X4270.Volume level set by participant (left),SFTPA1,Pulmonary surfactant-associated protein A1,32638,-0.0406458165570311,0.0298851544784576,-0.0992207193348079,0.0179290862207458,0.173843618237899
Physical measures,X4270.Volume level set by participant (left),KLK10,Kallikrein-10,32863,0.0591158916557518,0.0434808662140125,-0.0261066061237126,0.144338389435216,0.173995652841253
Physical measures,X4270.Volume level set by participant (left),PLSCR3,Phospholipid scramblase 3,31734,-0.0445126522238311,0.0327427322624724,-0.108688407458277,0.0196631030106149,0.174037711142525
Physical measures,X4270.Volume level set by participant (left),DENR,Density-regulated protein,31508,-0.0489941782780477,0.0360464215719303,-0.119645164559031,0.0216568080029357,0.174124349897569
Physical measures,X4270.Volume level set by participant (left),IRAK1,Interleukin-1 receptor-associated kinase 1,32679,-0.0342283364537816,0.0252380855144821,-0.0836949840621664,0.0152383111546033,0.1750646675989
Physical measures,X4270.Volume level set by participant (left),KLK15,Kallikrein-15,31708,-0.0526478650908861,0.0388345998470168,-0.128763680791039,0.0234679506092667,0.175235318903023
Physical measures,X4270.Volume level set by participant (left),NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",32843,-0.0250260282266765,0.0184730689228369,-0.0612332433154368,0.0111811868620838,0.17553754662573
Physical measures,X4270.Volume level set by participant (left),CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,31495,-0.048775523479804,0.0360034299817414,-0.119342246244017,0.0217911992844092,0.175538413769506
Physical measures,X4270.Volume level set by participant (left),ANXA10,Annexin A10,32644,0.0305993260192629,0.0225912930767132,-0.013679608411095,0.0748782604496209,0.175619955606823
Physical measures,X4270.Volume level set by participant (left),AMIGO1,Amphoterin-induced protein 1,31546,-0.0523461799381079,0.0387205181166207,-0.128238395446684,0.0235460355704687,0.176447834605177
Physical measures,X4270.Volume level set by participant (left),KCTD5,BTB/POZ domain-containing protein KCTD5,31572,-0.0644237173736855,0.0476654811131887,-0.157848060355535,0.0290006256081643,0.176549326049113
Physical measures,X4270.Volume level set by participant (left),COL28A1,Collagen alpha-1(XXVIII) chain,31546,-0.0357240954369667,0.026448517360067,-0.087563189462698,0.0161149985887646,0.176830325504215
Physical measures,X4270.Volume level set by participant (left),ARHGAP45,Rho GTPase-activating protein 45,31599,-0.0342692086892035,0.0253788974970752,-0.0840118477834709,0.0154734304050639,0.176958220055561
Physical measures,X4270.Volume level set by participant (left),LTA4H,Leukotriene A-4 hydrolase,32948,-0.0420239229596292,0.0311550011586319,-0.103087725230548,0.0190398793112892,0.177413617998444
Physical measures,X4270.Volume level set by participant (left),APOD,Apolipoprotein D,31433,-0.0658964849711957,0.0488778416800349,-0.161697054664064,0.0299040847216726,0.177638488912101
Physical measures,X4270.Volume level set by participant (left),RABEP1,Rab GTPase-binding effector protein 1,31599,-0.0370305631241821,0.0274731284840388,-0.0908778949528981,0.0168167687045338,0.17773548134389
Physical measures,X4270.Volume level set by participant (left),PAXX,Protein PAXX,31599,-0.0606396133902198,0.0450047789749931,-0.148848980181206,0.0275697534007667,0.177889656018188
Physical measures,X4270.Volume level set by participant (left),EP300,Histone acetyltransferase p300,31508,-0.0901097422943126,0.0669382744137369,-0.221308760145237,0.0410892755566117,0.178290282525851
Physical measures,X4270.Volume level set by participant (left),TGFA,Protransforming growth factor alpha,32843,0.0528744347650394,0.0392926830198951,-0.0241392239539549,0.129888093484034,0.178447455660994
Physical measures,X4270.Volume level set by participant (left),PEAR1,Platelet endothelial aggregation receptor 1,32964,-0.0996701074241184,0.0741345543977412,-0.244973834043691,0.0456336191954542,0.178836833232919
Physical measures,X4270.Volume level set by participant (left),BCL7A,B-cell CLL/lymphoma 7 protein family member A,31492,-0.0425890130244773,0.0316800749940045,-0.104681960012726,0.0195039339637716,0.178876182951446
Physical measures,X4270.Volume level set by participant (left),CCDC134,Coiled-coil domain-containing protein 134,31724,-0.0559298370688208,0.0416190908540248,-0.137503255142709,0.0256435810050679,0.179035512553533
Physical measures,X4270.Volume level set by participant (left),LEG1,Protein LEG1 homolog,31348,0.0403119308816983,0.0300274125331677,-0.0185417976833103,0.0991656594467069,0.179473245835475
Physical measures,X4270.Volume level set by participant (left),TJAP1,Tight junction-associated protein 1,32881,-0.0286412139869635,0.0213610681141429,-0.0705089074906835,0.0132264795167566,0.180014700567922
Physical measures,X4270.Volume level set by participant (left),ADGRB3,Adhesion G protein-coupled receptor B3,32778,-0.0712917744213173,0.0531736944012132,-0.175512215447695,0.0329286666050606,0.180041026614096
Physical measures,X4270.Volume level set by participant (left),SELPLG,P-selectin glycoprotein ligand 1,32843,-0.0785640782881963,0.0586103054834937,-0.193440277035844,0.0363121204594513,0.180133585803559
Physical measures,X4270.Volume level set by participant (left),STIP1,Stress-induced-phosphoprotein 1,32837,-0.0371362697769992,0.0277115174592519,-0.091450843997133,0.0171783044431345,0.180245999693339
Physical measures,X4270.Volume level set by participant (left),SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",31566,-0.0854339075961084,0.0638468288168579,-0.21057369207715,0.0397058768849331,0.18090096003782
Physical measures,X4270.Volume level set by participant (left),ARHGAP1,Rho GTPase-activating protein 1,32638,-0.0512360383304371,0.0382994675472369,-0.126302994723021,0.0238309180621471,0.181004733645534
Physical measures,X4270.Volume level set by participant (left),CPLX2,Complexin-2,31492,-0.0888041367703981,0.0663923442974356,-0.218933131593372,0.0413248580525758,0.181077854750988
Physical measures,X4270.Volume level set by participant (left),CRYM,Ketimine reductase mu-crystallin,31514,-0.035320428058012,0.0264216488690845,-0.0871068598414177,0.0164660037253937,0.181328073681208
Physical measures,X4270.Volume level set by participant (left),NCS1,Neuronal calcium sensor 1,32948,-0.0815824011017226,0.0610484986915584,-0.201237458537177,0.0380726563337318,0.181467085222025
Physical measures,X4270.Volume level set by participant (left),GKN1,Gastrokine-1,32497,-0.0824789982134679,0.0618096652836357,-0.203625942169394,0.0386679457424581,0.1821070321803
Physical measures,X4270.Volume level set by participant (left),RWDD1,RWD domain-containing protein 1,32931,-0.0380088109885521,0.0285179357766896,-0.0939039651108636,0.0178863431337594,0.182629709729052
Physical measures,X4270.Volume level set by participant (left),DNMBP,Dynamin-binding protein,32796,-0.0363444522705055,0.0272736827025926,-0.0898008703675869,0.0171119658265759,0.18270259998591
Physical measures,X4270.Volume level set by participant (left),TOP1,DNA topoisomerase 1,31720,-0.0229342432794291,0.0172342948723074,-0.0567134612291517,0.0108449746702935,0.183315528817504
Physical measures,X4270.Volume level set by participant (left),APOM,Apolipoprotein M,32872,-0.0846017772633459,0.0635791497284427,-0.209216910731094,0.0400133562044018,0.183336939576642
Physical measures,X4270.Volume level set by participant (left),CCL8,C-C motif chemokine 8,32933,-0.0373479696418117,0.0280721753832932,-0.0923694333930663,0.0176734941094429,0.183411194591011
Physical measures,X4270.Volume level set by participant (left),IMPACT,Protein IMPACT,31751,-0.0500693015373056,0.0376769056248293,-0.123916036561971,0.0237774334873599,0.183915359250676
Physical measures,X4270.Volume level set by participant (left),C5,Complement C5,31770,-0.172664037026919,0.129960115026287,-0.42738586247844,0.0820577884246032,0.184020781687133
Physical measures,X4270.Volume level set by participant (left),ZBTB16,Zinc finger and BTB domain-containing protein 16,32638,-0.0319648642049093,0.0240651730441596,-0.0791326033714621,0.0152028749616436,0.184125985001633
Physical measures,X4270.Volume level set by participant (left),NRP1,Neuropilin-1,32908,-0.0823466903654868,0.0620206816069317,-0.203907226315073,0.0392138455840993,0.184300981188499
Physical measures,X4270.Volume level set by participant (left),SDC4,Syndecan-4,32864,-0.0491515076166376,0.0370343445526188,-0.12173882293977,0.0234358077064952,0.184480432436137
Physical measures,X4270.Volume level set by participant (left),BRSK2,Serine/threonine-protein kinase BRSK2,31752,-0.0657462901618905,0.0495519201501219,-0.162868053656129,0.0313754733323485,0.184607894186388
Physical measures,X4270.Volume level set by participant (left),CCL15,C-C motif chemokine 15,32964,-0.0512349531718683,0.0386748024018139,-0.127037565879424,0.024567659535687,0.185282981297291
Physical measures,X4270.Volume level set by participant (left),PYY,Peptide YY,31495,-0.0301863262201428,0.022790839108069,-0.0748563708719581,0.0144837184316725,0.185378743976498
Physical measures,X4270.Volume level set by participant (left),ADGRE5,Adhesion G protein-coupled receptor E5,32898,-0.0767575314242942,0.0580528671821953,-0.190541151101397,0.0370260882528086,0.186134857459878
Physical measures,X4270.Volume level set by participant (left),NCAM1,Neural cell adhesion molecule 1,32878,-0.0749340413769687,0.0566942684857297,-0.186054807608999,0.0361867248550614,0.186294399581754
Physical measures,X4270.Volume level set by participant (left),ITGAL,Integrin alpha-L,31508,-0.0620968564494423,0.0469942691536815,-0.154205623990658,0.0300119110917735,0.186417290557953
Physical measures,X4270.Volume level set by participant (left),HK2,Hexokinase-2,32685,0.0829037224857149,0.0627902468152833,-0.0401651612722404,0.20597260624367,0.186759776552289
Physical measures,X4270.Volume level set by participant (left),NOP56,Nucleolar protein 56,31495,-0.0239670118781927,0.0181638796436008,-0.0595682159796503,0.0116341922232649,0.18704577202669
Physical measures,X4270.Volume level set by participant (left),AGBL2,Cytosolic carboxypeptidase 2,31514,-0.0291649475780263,0.0221428399508239,-0.0725649138816412,0.0142350187255886,0.187835272674908
Physical measures,X4270.Volume level set by participant (left),LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,31495,-0.0395982100256638,0.0300765965469356,-0.0985483392576576,0.0193519192063299,0.188019376149265
Physical measures,X4270.Volume level set by participant (left),CTF1,Cardiotrophin-1,32685,-0.0278045258236468,0.0211237050360254,-0.0692069876942567,0.013597936046963,0.188117211303784
Physical measures,X4270.Volume level set by participant (left),CACYBP,Calcyclin-binding protein,31578,-0.0268403466155317,0.0203986775918346,-0.0668217546955274,0.0131410614644641,0.188284116528649
Physical measures,X4270.Volume level set by participant (left),GYS1,"Glycogen [starch] synthase, muscle",32685,-0.0254067332281852,0.0193146663594455,-0.0632634792926984,0.012450012836328,0.188405845896424
Physical measures,X4270.Volume level set by participant (left),BID,BH3-interacting domain death agonist,32843,-0.034013718751698,0.0258704030955041,-0.084719708818886,0.01669227131549,0.188619633105461
Physical measures,X4270.Volume level set by participant (left),HSP90B1,Endoplasmin,32593,-0.0334106658658845,0.0254213906283937,-0.0832365914975362,0.0164152597657672,0.188788634290489
Physical measures,X4270.Volume level set by participant (left),PRSS27,Serine protease 27,32822,-0.0557827025723393,0.0424691940179084,-0.13902232284744,0.0274569177027611,0.189052785929901
Physical measures,X4270.Volume level set by participant (left),DRG2,Developmentally-regulated GTP-binding protein 2,32832,-0.0409326486059625,0.0312063468121642,-0.102097088357804,0.0202317911458794,0.189662700491984
Physical measures,X4270.Volume level set by participant (left),MYBPC2,"Myosin-binding protein C, fast-type",31566,-0.031956272755683,0.0243920711919598,-0.0797647322919242,0.0158521867805582,0.190198019437535
Physical measures,X4270.Volume level set by participant (left),CTRC,Chymotrypsin-C,32850,-0.0366368074709548,0.0279878897344656,-0.0914930713505073,0.0182194564085978,0.190559834442303
Physical measures,X4270.Volume level set by participant (left),CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,31514,-0.0462075937241396,0.0353018978716818,-0.115399313552636,0.0229841261043567,0.190598521499327
Physical measures,X4270.Volume level set by participant (left),SCARB1,Scavenger receptor class B member 1,32644,-0.0407964585643418,0.0311805944983882,-0.101910423781183,0.0203175066524991,0.190774432461551
Physical measures,X4270.Volume level set by participant (left),TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,31546,-0.0498945092811858,0.0381887479836815,-0.124744455329201,0.0249554367668299,0.191413588941896
Physical measures,X4270.Volume level set by participant (left),LTBP3,Latent-transforming growth factor beta-binding protein 3,32638,0.0410796153453788,0.031443238714202,-0.0205491325344572,0.102708363225215,0.191427369335032
Physical measures,X4270.Volume level set by participant (left),BIN2,Bridging integrator 2,32861,-0.0249880951055928,0.0191287856533657,-0.0624805149861896,0.012504324775004,0.191481061060257
Physical measures,X4270.Volume level set by participant (left),HYAL1,Hyaluronidase-1,32802,0.098013279454727,0.0750925443191391,-0.0491681074107857,0.24519466632024,0.191847058581074
Physical measures,X4270.Volume level set by participant (left),EFHD1,EF-hand domain-containing protein D1,31752,-0.0749841492404599,0.057466673330149,-0.187618828967552,0.0376505304866321,0.191989335122499
Physical measures,X4270.Volume level set by participant (left),GLRX,Glutaredoxin-1,32824,0.0389673992092402,0.0299310339686918,-0.0196974273693957,0.0976322257878762,0.192981911614426
Physical measures,X4270.Volume level set by participant (left),MDK,Midkine,32855,-0.0448352937829748,0.0344532582589034,-0.112363679970425,0.0226930924044758,0.193176528001005
Physical measures,X4270.Volume level set by participant (left),CFD,Complement factor D,31770,-0.140347011400554,0.107966707360697,-0.35196175782752,0.0712677350264113,0.193669681807782
Physical measures,X4270.Volume level set by participant (left),C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,31752,-0.0794338347045679,0.0611383544857864,-0.199265009496709,0.0403973400875734,0.193897082579202
Physical measures,X4270.Volume level set by participant (left),SH3BP1,SH3 domain-binding protein 1,31720,-0.0531415976762643,0.0409092344180049,-0.133323697135554,0.0270405017830253,0.193977835300808
Physical measures,X4270.Volume level set by participant (left),NINJ1,Ninjurin-1,32638,-0.0393308293540336,0.0302941289648392,-0.0987073221251184,0.0200456634170511,0.19421882082767
Physical measures,X4270.Volume level set by participant (left),LAMTOR5,Ragulator complex protein LAMTOR5,31724,-0.063650327624548,0.0490421535281352,-0.159772948539693,0.0324722932905971,0.194370176038126
Physical measures,X4270.Volume level set by participant (left),KEL,Kell blood group glycoprotein,32644,0.0657649058058309,0.0506941150355434,-0.0335955596638341,0.165125371275496,0.194565931070411
Physical measures,X4270.Volume level set by participant (left),IGLC2,Immunoglobulin lambda constant 2,31755,-0.110026721373458,0.0848874894412331,-0.276406200678275,0.0563527579313586,0.194962517282548
Physical measures,X4270.Volume level set by participant (left),DTNB,Dystrobrevin beta,31698,-0.0553084664554463,0.042728351960769,-0.139056036298553,0.028439103387661,0.195558266817268
Physical measures,X4270.Volume level set by participant (left),BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,31495,-0.100004725493044,0.0773194515951958,-0.251550850619628,0.0515413996335398,0.195913027208381
Physical measures,X4270.Volume level set by participant (left),BTC,Probetacellulin,32638,-0.0309438890047021,0.0239744478418724,-0.077933806774772,0.0160460287653678,0.196840728836732
Physical measures,X4270.Volume level set by participant (left),PLIN3,Perilipin-3,32864,-0.0526770395364591,0.0408231571764902,-0.13269042760238,0.0273363485294617,0.196954840551797
Physical measures,X4270.Volume level set by participant (left),ARG1,Arginase-1,32867,0.0436898405738716,0.0338589262983668,-0.0226736549709273,0.11005333611867,0.196962554884814
Physical measures,X4270.Volume level set by participant (left),SULT1A1,Sulfotransferase 1A1,32931,-0.0178993548760819,0.0138766119040657,-0.0450975142080506,0.00929880445588691,0.197120447648658
Physical measures,X4270.Volume level set by participant (left),SSBP1,"Single-stranded DNA-binding protein, mitochondrial",31508,-0.0735594611930477,0.0570289658259376,-0.185336234211885,0.0382173118257899,0.197137804308826
Physical measures,X4270.Volume level set by participant (left),ERMAP,Erythroid membrane-associated protein,31508,-0.0578474274072732,0.0448562556680453,-0.145765688516642,0.0300708337020957,0.197222391502704
Physical measures,X4270.Volume level set by participant (left),PRELP,Prolargin,32834,-0.101453427187636,0.078674516640316,-0.255655479802655,0.0527486254273836,0.197245911721471
Physical measures,X4270.Volume level set by participant (left),VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,32931,-0.032548657941846,0.0252877985662483,-0.0821127431316927,0.0170154272480007,0.198082194778076
Physical measures,X4270.Volume level set by participant (left),SH2B3,SH2B adapter protein 3,32638,-0.0243129110900377,0.018898773343572,-0.0613545068434388,0.0127286846633633,0.198309217351153
Physical measures,X4270.Volume level set by participant (left),CD302,CD302 antigen,32832,-0.0773226405878601,0.0601500506117579,-0.195216739786906,0.0405714586111854,0.198652255628239
Physical measures,X4270.Volume level set by participant (left),NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,31724,-0.04253608429462,0.0331634690521399,-0.107536483636814,0.0224643150475742,0.199663526784582
Physical measures,X4270.Volume level set by participant (left),ZBTB17,Zinc finger and BTB domain-containing protein 17,32685,0.0533827831105759,0.0416533688390807,-0.0282578198140223,0.135023386035174,0.200018152001899
Physical measures,X4270.Volume level set by participant (left),IL33,Interleukin-33,32679,-0.0567256029902319,0.0442724875141021,-0.143499678517872,0.0300484725374083,0.200127844401204
Physical measures,X4270.Volume level set by participant (left),PPCDC,Phosphopantothenoylcysteine decarboxylase,32931,-0.0465037476384521,0.0363234845493166,-0.117697777355113,0.0246902820782084,0.200484103628939
Physical measures,X4270.Volume level set by participant (left),PLXNB3,Plexin-B3,32847,-0.0461477614547131,0.0360615742728607,-0.11682844702952,0.0245329241200939,0.200686004188807
Physical measures,X4270.Volume level set by participant (left),P4HB,Protein disulfide-isomerase,32817,-0.0572738929297039,0.0447943714155358,-0.145070860904154,0.0305230750447462,0.201072586179338
Physical measures,X4270.Volume level set by participant (left),SUSD1,Sushi domain-containing protein 1,32685,-0.0471158507101532,0.0368846122812527,-0.119409690781409,0.0251779893611021,0.201499970818022
Physical measures,X4270.Volume level set by participant (left),PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",31508,-0.0561735443052193,0.043983924348653,-0.142382036028579,0.0300349474181406,0.201592292014203
Physical measures,X4270.Volume level set by participant (left),WFDC2,WAP four-disulfide core domain protein 2,32383,0.0659689178072213,0.051706963620725,-0.0353767308893997,0.167314566503842,0.202052983072968
Physical measures,X4270.Volume level set by participant (left),CSPG5,Chondroitin sulfate proteoglycan 5,31514,-0.0549611396083226,0.0431953287574719,-0.139623983972968,0.0297017047563223,0.203274606905199
Physical measures,X4270.Volume level set by participant (left),S100A16,Protein S100-A16,32629,-0.0360337008888647,0.0283241212929867,-0.0915489786231187,0.0194815768453892,0.203338901255779
Physical measures,X4270.Volume level set by participant (left),TSPAN7,Tetraspanin-7,31514,-0.0271051362870735,0.0213283350381442,-0.0689086729618361,0.0146984003876892,0.203820293158037
Physical measures,X4270.Volume level set by participant (left),ID4,DNA-binding protein inhibitor ID-4,31632,-0.0552296259041518,0.0434934532513025,-0.140476794276705,0.030017542468401,0.204180487191348
Physical measures,X4270.Volume level set by participant (left),RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",31752,-0.0284509996473935,0.0224095626019475,-0.0723737423472105,0.0154717430524235,0.204267477986801
Physical measures,X4270.Volume level set by participant (left),SPART,Spartin,31599,-0.0341140506231913,0.0268867175510765,-0.0868120170233013,0.0185839157769187,0.2045481472065
Physical measures,X4270.Volume level set by participant (left),MAGED1,Melanoma-associated antigen D1,32638,-0.0467804096187418,0.0368781074722962,-0.119061500264442,0.0255006810269588,0.204647969504707
Physical measures,X4270.Volume level set by participant (left),ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",32832,-0.0498801586876878,0.0393235649007582,-0.126954345893174,0.0271940285177984,0.204668558370448
Physical measures,X4270.Volume level set by participant (left),SIGLEC10,Sialic acid-binding Ig-like lectin 10,32843,-0.0675863158781369,0.0532986526307806,-0.172051675034467,0.0368790432781932,0.204806542907655
Physical measures,X4270.Volume level set by participant (left),ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,31495,-0.0835664138747913,0.0659226624928158,-0.21277483236071,0.0456420046111276,0.204964075933017
Physical measures,X4270.Volume level set by participant (left),ELAVL4,ELAV-like protein 4,31514,-0.030511388931273,0.0240806329556518,-0.0777094295243506,0.0166866516618046,0.205175637625733
Physical measures,X4270.Volume level set by participant (left),PCDH9,Protocadherin-9,31720,-0.0751052273839582,0.0592981602989948,-0.191329621569988,0.0411191668020717,0.205346893618662
Physical measures,X4270.Volume level set by participant (left),TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,32878,0.0512112922332454,0.0404354302921219,-0.0280421511393137,0.130464735605804,0.205368446331561
Physical measures,X4270.Volume level set by participant (left),NOMO1,Nodal modulator 1,32861,0.0924940481963187,0.0730481327673275,-0.0506802920276432,0.235668388420281,0.205471804653341
Physical measures,X4270.Volume level set by participant (left),FAM171B,Protein FAM171B,31724,-0.0920892889505837,0.0727449650190686,-0.234669420387958,0.0504908424867907,0.205579324577447
Physical measures,X4270.Volume level set by participant (left),SCGN,Secretagogin,32679,-0.0512631671200206,0.040521653107428,-0.130685607210579,0.0281592729705382,0.205875786154505
Physical measures,X4270.Volume level set by participant (left),PACS2,Phosphofurin acidic cluster sorting protein 2,31495,-0.0426776498650319,0.033745206308493,-0.108818254229678,0.0234629544996143,0.206016577733705
Physical measures,X4270.Volume level set by participant (left),MZT1,Mitotic-spindle organizing protein 1,32638,-0.0387562857647412,0.0306727782623561,-0.0988749311589592,0.0213623596294767,0.206428707225825
Physical measures,X4270.Volume level set by participant (left),SNAP29,Synaptosomal-associated protein 29,32881,-0.0247053756542396,0.0195565646461342,-0.0630362423606626,0.0136254910521835,0.20652198924799
Physical measures,X4270.Volume level set by participant (left),SLC34A3,Sodium-dependent phosphate transport protein 2C,31492,-0.052574732058607,0.0416197261179451,-0.134149395249779,0.0289999311325654,0.206549925152174
Physical measures,X4270.Volume level set by participant (left),HEG1,Protein HEG homolog 1,31599,0.0960584727691498,0.0761026634833992,-0.0531027476583126,0.245219693196612,0.206906886306814
Physical measures,X4270.Volume level set by participant (left),REN,Renin,32864,0.0334063662444475,0.0264697026923501,-0.0184742510325587,0.0852869835214537,0.206959717312484
Physical measures,X4270.Volume level set by participant (left),COCH,Cochlin,31762,-0.0541859239483646,0.0429374524473921,-0.138343330745253,0.0299714828485239,0.206995609667679
Physical measures,X4270.Volume level set by participant (left),PEPD,Xaa-Pro dipeptidase,31772,-0.0969035970708092,0.0768450665873887,-0.247519927582091,0.0537127334404726,0.207336815673258
Physical measures,X4270.Volume level set by participant (left),MYH9,Myosin-9,31773,-0.0224095538448705,0.0177745320883244,-0.0572476367379863,0.0124285290482453,0.207429783027628
Physical measures,X4270.Volume level set by participant (left),CLEC2L,C-type lectin domain family 2 member L,31546,-0.0478976819467195,0.0380160242539982,-0.122409089484556,0.0266137255911171,0.207731436764489
Physical measures,X4270.Volume level set by participant (left),CCL14,C-C motif chemokine 14,32810,0.0550080289107787,0.0436744937284076,-0.0305939787969001,0.140610036618458,0.207882611872587
Physical measures,X4270.Volume level set by participant (left),CPE,Carboxypeptidase E,32906,-0.0554387126838066,0.0440295588161456,-0.141736647963452,0.0308592225958387,0.208017731629127
Physical measures,X4270.Volume level set by participant (left),CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,32685,0.0438543366237047,0.0348315313592292,-0.0244154648403844,0.112124138087794,0.208048726723517
Physical measures,X4270.Volume level set by participant (left),STAT2,Signal transducer and activator of transcription 2,31508,-0.0331034648330319,0.0263116264052748,-0.0846742525873705,0.0184673229213067,0.208382917474113
Physical measures,X4270.Volume level set by participant (left),NFX1,Transcriptional repressor NF-X1,31495,-0.0389168379694448,0.0309345880263339,-0.0995486305010592,0.0217149545621697,0.208417077183226
Physical measures,X4270.Volume level set by participant (left),GZMB,Granzyme B,32843,-0.0349163862873442,0.0277845172269102,-0.0893740400520882,0.0195412674773998,0.20890040590907
Physical measures,X4270.Volume level set by participant (left),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,32878,-0.05519342607947,0.0439213434960422,-0.141279259331713,0.0308924071727727,0.20891568440167
Physical measures,X4270.Volume level set by participant (left),DNAJB2,DnaJ homolog subfamily B member 2,31599,-0.0476408462311461,0.0379309416240121,-0.12198549181421,0.0267037993519177,0.209157880737193
Physical measures,X4270.Volume level set by participant (left),CLEC1B,C-type lectin domain family 1 member B,32931,-0.0223392520822509,0.0177993946614227,-0.0572260656186394,0.0125475614541377,0.209490468540501
Physical measures,X4270.Volume level set by participant (left),CXCL12,Stromal cell-derived factor 1,32679,-0.0541129488124973,0.0431266951402251,-0.138641271287338,0.0304153736623438,0.209605080348725
Physical measures,X4270.Volume level set by participant (left),CDH3,Cadherin-3,32931,0.0615157270577281,0.0490394262174461,-0.0346015483284663,0.157633002443922,0.209724015469841
Physical measures,X4270.Volume level set by participant (left),NUDT16,U8 snoRNA-decapping enzyme,31712,-0.0292786564922768,0.0233478127830219,-0.0750403695469998,0.0164830565624461,0.209871579118054
Physical measures,X4270.Volume level set by participant (left),CRISP3,Cysteine-rich secretory protein 3,31701,-0.0927143013937315,0.0739388674172896,-0.237634481531619,0.0522058787441561,0.209904170972809
Physical measures,X4270.Volume level set by participant (left),YES1,Tyrosine-protein kinase Yes,32832,-0.019773419451486,0.0157740468583432,-0.0506905512938387,0.0111437123908666,0.210041447341656
Physical measures,X4270.Volume level set by participant (left),ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,32964,-0.0935506747244988,0.0746519531606103,-0.239868502919295,0.0527671534702973,0.210180491435317
Physical measures,X4270.Volume level set by participant (left),CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,32920,-0.0219495621383801,0.0175273821261848,-0.0563032311057024,0.0124041068289422,0.210492458131636
Physical measures,X4270.Volume level set by participant (left),NUP50,Nuclear pore complex protein Nup50,31495,-0.0760367105866219,0.060748431538752,-0.195103636402576,0.043030215229332,0.210730169215478
Physical measures,X4270.Volume level set by participant (left),PRSS8,Prostasin,32819,0.0541480896583338,0.0433020907503316,-0.0307240082123162,0.139020187528984,0.211159529643944
Physical measures,X4270.Volume level set by participant (left),WASF1,Wiskott-Aldrich syndrome protein family member 1,32685,-0.0228093765953292,0.0182416927344585,-0.0585630943548678,0.0129443411642094,0.211187349532575
Physical measures,X4270.Volume level set by participant (left),TNIP1,TNFAIP3-interacting protein 1,31751,-0.0294469574438456,0.0235527324345549,-0.0756103130155732,0.016716398127882,0.21124294210258
Physical measures,X4270.Volume level set by participant (left),MSTN,Growth/differentiation factor 8,32685,-0.0417926310141537,0.033504654583962,-0.107461753998719,0.0238764919704117,0.21229573818947
Physical measures,X4270.Volume level set by participant (left),SAMD9L,Sterile alpha motif domain-containing protein 9-like,32843,-0.0302166877610167,0.0242311045552281,-0.0777096526892638,0.0172762771672303,0.212422448672144
Physical measures,X4270.Volume level set by participant (left),EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,32685,0.061484969422708,0.0493143153268154,-0.0351710886178502,0.158141027463266,0.212504826371869
Physical measures,X4270.Volume level set by participant (left),SPINK4,Serine protease inhibitor Kazal-type 4,32843,-0.0347975045019555,0.027926884783419,-0.0895341986774567,0.0199391896735456,0.212788933581238
Physical measures,X4270.Volume level set by participant (left),RBM19,Probable RNA-binding protein 19,31495,-0.0561550312149161,0.0450931002849689,-0.144537507773455,0.0322274453436231,0.213054892279142
Physical measures,X4270.Volume level set by participant (left),BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,31762,-0.0705550942378082,0.0566570750655589,-0.181602961366304,0.0404927728906873,0.213058184639478
Physical measures,X4270.Volume level set by participant (left),DNAJB8,DnaJ homolog subfamily B member 8,32685,-0.0399485658854269,0.0321010080727703,-0.102866541708057,0.022969409937203,0.213361706610547
Physical measures,X4270.Volume level set by participant (left),IL13RA2,Interleukin-13 receptor subunit alpha-2,31514,-0.0882089308825306,0.0709505500540351,-0.227272008988439,0.0508541472233782,0.213815585692819
Physical measures,X4270.Volume level set by participant (left),PDGFRB,Platelet-derived growth factor receptor beta,32964,-0.0600031609465314,0.0482659027442769,-0.154604330325314,0.0345980084322514,0.21383387166764
Physical measures,X4270.Volume level set by participant (left),OPHN1,Oligophrenin-1,31751,-0.0237927092113039,0.0191444585923955,-0.061315848052399,0.0137304296297913,0.213978944792078
Physical measures,X4270.Volume level set by participant (left),MEP1B,Meprin A subunit beta,32864,-0.0183038989611731,0.0147292827714139,-0.0471732931931444,0.0105654952707982,0.214015299258768
Physical measures,X4270.Volume level set by participant (left),DNPEP,Aspartyl aminopeptidase,31751,-0.0431127179971584,0.0347044329933955,-0.111133406664214,0.0249079706698968,0.214169193769474
Physical measures,X4270.Volume level set by participant (left),STX5,Syntaxin-5,31508,-0.0605293443595426,0.0487261242844182,-0.156032547957002,0.034973859237917,0.214187615330309
Physical measures,X4270.Volume level set by participant (left),PITHD1,PITH domain-containing protein 1,31481,-0.0317113360677518,0.0255302452420869,-0.081750616742242,0.0183279446067384,0.214234748550313
Physical measures,X4270.Volume level set by participant (left),TNFSF10,Tumor necrosis factor ligand superfamily member 10,32961,-0.0809203748684122,0.0651633139189127,-0.208640470149481,0.0467997204126566,0.21433913681855
Physical measures,X4270.Volume level set by participant (left),REG3A,Regenerating islet-derived protein 3-alpha,32964,0.0355395844899,0.0286368449347142,-0.0205886315821398,0.0916678005619397,0.214621483981554
Physical measures,X4270.Volume level set by participant (left),SMOC1,SPARC-related modular calcium-binding protein 1,32948,-0.0648423551980451,0.0522501096300398,-0.167252570072923,0.037567859676833,0.214638010307102
Physical measures,X4270.Volume level set by participant (left),SEMA6C,Semaphorin-6C,31508,-0.0936847444028384,0.0755370226776456,-0.241737308851024,0.0543678200453469,0.214921237887737
Physical measures,X4270.Volume level set by participant (left),GOLM2,Protein GOLM2,32931,0.0937299292039743,0.0756024374710125,-0.0544508482392102,0.241910706647159,0.215091114312966
Physical measures,X4270.Volume level set by participant (left),NGRN,Neugrin,31751,-0.110547742717318,0.0892120483304133,-0.285403357444928,0.0643078720102919,0.215324194672594
Physical measures,X4270.Volume level set by participant (left),PRUNE2,Protein prune homolog 2,31632,-0.0930784617664524,0.0751561868019522,-0.240384587898279,0.0542276643653739,0.215580347736901
Physical measures,X4270.Volume level set by participant (left),PSMD9,26S proteasome non-ATPase regulatory subunit 9,32832,-0.0374300401339735,0.030288939411476,-0.0967963613804665,0.0219362811125194,0.21657793831413
Physical measures,X4270.Volume level set by participant (left),TXNDC15,Thioredoxin domain-containing protein 15,32881,0.0782745400832393,0.0633642342649129,-0.04591935907599,0.202468439242469,0.216746936109041
Physical measures,X4270.Volume level set by participant (left),SERPINB1,Leukocyte elastase inhibitor,32828,-0.0247913622737409,0.0200739338962941,-0.0641362727104773,0.0145535481629955,0.216861870395851
Physical measures,X4270.Volume level set by participant (left),ASGR1,Asialoglycoprotein receptor 1,32796,0.0738408047467814,0.0598359330419254,-0.0434376240153923,0.191119233508955,0.217215046845956
Physical measures,X4270.Volume level set by participant (left),IL36A,Interleukin-36 alpha,31508,-0.0427815372401305,0.0346945894867469,-0.110782932634154,0.0252198581538933,0.21758025333098
Physical measures,X4270.Volume level set by participant (left),PTPN6,Tyrosine-protein phosphatase non-receptor type 6,32883,-0.0248687107792137,0.0202314385981255,-0.0645223304315396,0.0147849088731122,0.219024697927936
Physical measures,X4270.Volume level set by participant (left),SAA4,Serum amyloid A-4 protein,31770,-0.0729210036005863,0.0593497855351371,-0.189246583249455,0.0434045760482825,0.219234004670813
Physical measures,X4270.Volume level set by participant (left),FNDC1,Fibronectin type III domain-containing protein 1,31751,-0.0521904605756922,0.0425169370682282,-0.13552365722942,0.0311427360780351,0.219663222210834
Physical measures,X4270.Volume level set by participant (left),CCL21,C-C motif chemokine 21,32894,0.0537661334022621,0.043827374336565,-0.0321355202974053,0.139667787101929,0.219940813028567
Physical measures,X4270.Volume level set by participant (left),SCGB3A1,Secretoglobin family 3A member 1,31599,0.0990686820831322,0.0807789761162769,-0.0592581111047705,0.257395475271035,0.220079247134836
Physical measures,X4270.Volume level set by participant (left),ITPA,Inosine triphosphate pyrophosphatase,31495,-0.035999567943586,0.029373207704792,-0.0935710550449783,0.0215719191578063,0.220390073644295
Physical measures,X4270.Volume level set by participant (left),PBK,Lymphokine-activated killer T-cell-originated protein kinase,31492,-0.0801059456176148,0.0654348184133424,-0.208358189707766,0.0481462984725362,0.22091089841673
Physical measures,X4270.Volume level set by participant (left),CDON,Cell adhesion molecule-related/down-regulated by oncogenes,32864,0.0786639365675692,0.0642749518113172,-0.0473149689826125,0.204642842117751,0.22103476712605
Physical measures,X4270.Volume level set by participant (left),BACH1,Transcription regulator protein BACH1,32843,-0.0299441823548753,0.0244726105836891,-0.0779104990989059,0.0180221343891553,0.2211430363206
Physical measures,X4270.Volume level set by participant (left),GBP4,Guanylate-binding protein 4,32644,-0.0431658832195823,0.0352810252128825,-0.112316692636832,0.0259849261976674,0.22117856110097
Physical measures,X4270.Volume level set by participant (left),PLXNA4,Plexin-A4,32843,-0.0264875794987077,0.0216981854844569,-0.0690160230482433,0.0160408640508278,0.222221127981008
Physical measures,X4270.Volume level set by participant (left),NACC1,Nucleus accumbens-associated protein 1,31724,-0.0439130772133042,0.0359813454810363,-0.114436514356135,0.0266103599295269,0.222334688279332
Physical measures,X4270.Volume level set by participant (left),NUDC,Nuclear migration protein nudC,32961,-0.0336409099221243,0.0275829380519929,-0.0877034685040304,0.0204216486597818,0.222637730561584
Physical measures,X4270.Volume level set by participant (left),GP6,Platelet glycoprotein VI,32846,-0.0241938549923411,0.019859911597796,-0.0631192817240212,0.014731571739339,0.223170204971448
Physical measures,X4270.Volume level set by participant (left),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,32834,0.0710434132727913,0.058344378994985,-0.0433115695573792,0.185398396102962,0.223386554512508
Physical measures,X4270.Volume level set by participant (left),CHM,Rab proteins geranylgeranyltransferase component A 1,31546,-0.0403193060164424,0.0331412700923006,-0.105276195397352,0.0246375833644668,0.223797986364133
Physical measures,X4270.Volume level set by participant (left),NPY,Pro-neuropeptide Y,32948,-0.0310958115063634,0.0256013342344699,-0.0812744266059244,0.0190828035931975,0.224543834108795
Physical measures,X4270.Volume level set by participant (left),GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,31514,-0.0386565712812098,0.0318282288443526,-0.101039899816141,0.0237267572537212,0.224580096539274
Physical measures,X4270.Volume level set by participant (left),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,32898,0.0601668395407192,0.0495629649780542,-0.036976571816267,0.157310250897705,0.22479948693314
Physical measures,X4270.Volume level set by participant (left),NIT2,Omega-amidase NIT2,31735,-0.0335720719141412,0.0276905734761267,-0.0878455959273495,0.0207014520990671,0.225395400679118
Physical measures,X4270.Volume level set by participant (left),ARMCX2,Armadillo repeat-containing X-linked protein 2,31514,-0.039365239962277,0.0324705091005652,-0.103007437799385,0.0242769578748308,0.225420364700581
Physical measures,X4270.Volume level set by participant (left),NADK,NAD kinase,32864,0.0383451965018243,0.0316408398517889,-0.0236708496076818,0.10036124261133,0.225586555048147
Physical measures,X4270.Volume level set by participant (left),GABARAP,Gamma-aminobutyric acid receptor-associated protein,31724,-0.0483581207511832,0.0399211240688532,-0.126603523926135,0.029887282423769,0.225800900788269
Physical measures,X4270.Volume level set by participant (left),CNTN4,Contactin-4,32861,-0.0863793230459005,0.0713117990313187,-0.226150449147285,0.0533918030554842,0.225815800632684
Physical measures,X4270.Volume level set by participant (left),CBLN4,Cerebellin-4,32948,-0.0667293491171081,0.0550941507295044,-0.174713884546937,0.0412551863127206,0.225855039664245
Physical measures,X4270.Volume level set by participant (left),GGH,Gamma-glutamyl hydrolase,32685,0.0614237898571728,0.0507435749867543,-0.0380336171168656,0.160881196831211,0.2261294030139
Physical measures,X4270.Volume level set by participant (left),MST1,Hepatocyte growth factor-like protein,31639,-0.0385524292251245,0.0318489197304811,-0.100976311896867,0.0238714534466186,0.226132168128562
Physical measures,X4270.Volume level set by participant (left),CLTA,Clathrin light chain A,32685,-0.045693919086289,0.0377507024880088,-0.119685295962786,0.0282974577902083,0.226153107528729
Physical measures,X4270.Volume level set by participant (left),BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,32931,0.0447405638057237,0.0369724730673466,-0.0277254834062756,0.117206611017723,0.226270258889061
Physical measures,X4270.Volume level set by participant (left),LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,31546,-0.0240738139166658,0.0199150857307339,-0.0631073819489042,0.0149597541155726,0.226768049003479
Physical measures,X4270.Volume level set by participant (left),LPO,Lactoperoxidase,32600,0.0360838031977368,0.0298937672158216,-0.0225079805452736,0.0946755869407472,0.227438720540785
Physical measures,X4270.Volume level set by participant (left),ECM1,Extracellular matrix protein 1,31551,-0.0650548770258703,0.0539019180983242,-0.170702636498586,0.0405928824468451,0.227503131581362
Physical measures,X4270.Volume level set by participant (left),ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,32685,-0.0693840135535939,0.0575798920748759,-0.182240602020351,0.0434725749131629,0.228233991510051
Physical measures,X4270.Volume level set by participant (left),ENG,Endoglin,32964,-0.119837829840462,0.0994854364681795,-0.314829285318094,0.07515362563717,0.228398114478186
Physical measures,X4270.Volume level set by participant (left),METAP2,Methionine aminopeptidase 2,32940,-0.0386688427446557,0.0321266447396077,-0.101637066434287,0.0242993809449754,0.228761006495211
Physical measures,X4270.Volume level set by participant (left),FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,32931,0.0457033975059666,0.0379960013689363,-0.0287687651771485,0.120175560189082,0.229066721384382
Physical measures,X4270.Volume level set by participant (left),TDRKH,Tudor and KH domain-containing protein,32644,-0.0235932697063798,0.0196162997847303,-0.0620412172844511,0.0148546778716915,0.229110142254219
Physical measures,X4270.Volume level set by participant (left),FABP4,"Fatty acid-binding protein, adipocyte",32964,0.042179840350371,0.0350887519134111,-0.0265941133999147,0.110953794100657,0.229359908350663
Physical measures,X4270.Volume level set by participant (left),NME1,Nucleoside diphosphate kinase A,31508,-0.111450740834548,0.0929752688694748,-0.293682267818719,0.0707807861496223,0.2306763930546
Physical measures,X4270.Volume level set by participant (left),CFP,Properdin,31770,-0.105560166582517,0.0881191063084993,-0.278273614947176,0.0671532817821412,0.230981742135984
Physical measures,X4270.Volume level set by participant (left),NFIC,Nuclear factor 1 C-type,31752,-0.0551128528752006,0.0460603271621976,-0.145391094113108,0.0351653883627068,0.231523304009043
Physical measures,X4270.Volume level set by participant (left),LGALS9,Galectin-9,32842,0.0660190337822915,0.0552636720893052,-0.0422977635127467,0.17433583107733,0.232267469416643
Physical measures,X4270.Volume level set by participant (left),FLT1,Vascular endothelial growth factor receptor 1,32809,0.0876049605775089,0.0733349063469037,-0.0561314558624224,0.23134137701744,0.232279915859093
Physical measures,X4270.Volume level set by participant (left),ACYP1,Acylphosphatase-1,31568,-0.0376032519918704,0.0314809973574876,-0.0993060068125461,0.0240995028288054,0.232329136118904
Physical measures,X4270.Volume level set by participant (left),IMMT,MICOS complex subunit MIC60,31724,-0.0529858372317096,0.0444060011116004,-0.140021599410446,0.0340499249470272,0.232821803877043
Physical measures,X4270.Volume level set by participant (left),OBP2B,Odorant-binding protein 2b,32764,-0.0327764213459148,0.0274770204875477,-0.0866313815015083,0.0210785388096787,0.232953398931874
Physical measures,X4270.Volume level set by participant (left),SIGLEC6,Sialic acid-binding Ig-like lectin 6,32948,0.0622946035795635,0.0522352275138155,-0.0400864423475149,0.164675649506642,0.233065679554003
Physical measures,X4270.Volume level set by participant (left),TEF,Thyrotroph embryonic factor,31495,0.0543192582594404,0.0456202918615019,-0.0350965137891032,0.143735030307984,0.233815496618461
Physical measures,X4270.Volume level set by participant (left),APOB,Apolipoprotein B-100,31772,-0.104416478850591,0.0877735950437191,-0.276452725136281,0.0676197674350981,0.234234830747468
Physical measures,X4270.Volume level set by participant (left),FABP5,Fatty acid-binding protein 5,32898,-0.0304786011568692,0.02569747422556,-0.0808456506389668,0.0198884483252284,0.235632024799606
Physical measures,X4270.Volume level set by participant (left),MEPE,Matrix extracellular phosphoglycoprotein,32834,-0.0776021352687658,0.0654757458511037,-0.205934597136929,0.0507303265993975,0.235968076264375
Physical measures,X4270.Volume level set by participant (left),RAB33A,Ras-related protein Rab-33A,31495,-0.0362123095932721,0.0305993613420414,-0.0961870578236732,0.023762438637129,0.236674243385787
Physical measures,X4270.Volume level set by participant (left),CTSD,Cathepsin D,32258,0.0571922731873348,0.0483568026929757,-0.0375870600908976,0.151971606465567,0.236955962007026
Physical measures,X4270.Volume level set by participant (left),IFT20,Intraflagellar transport protein 20 homolog,31546,-0.0527920345242587,0.0446594767647877,-0.140324608983243,0.0347405399347251,0.237202012663815
Physical measures,X4270.Volume level set by participant (left),NPHS2,Podocin,31508,-0.0232104583654739,0.0196432957088625,-0.0617113179548444,0.0152904012238967,0.237402416543468
Physical measures,X4270.Volume level set by participant (left),RSPO3,R-spondin-3,32948,-0.0746284381229007,0.063177999166532,-0.198457316489303,0.049200440243502,0.23753794914318
Physical measures,X4270.Volume level set by participant (left),EXTL1,Exostosin-like 1,31495,-0.0506989816120377,0.0429265531128069,-0.134835025713139,0.0334370624890638,0.237614333758171
Physical measures,X4270.Volume level set by participant (left),RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,31514,-0.0426888624686335,0.0362260294539726,-0.11369188019842,0.0283141552611528,0.238672622941315
Physical measures,X4270.Volume level set by participant (left),BCL2L15,Bcl-2-like protein 15,31508,0.0403470906824409,0.034257595238459,-0.0267977959849386,0.10749197734982,0.238930528532382
Physical measures,X4270.Volume level set by participant (left),PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,32638,-0.0321429301037377,0.0272935626278856,-0.0856383128543934,0.021352452646918,0.238958373552825
Physical measures,X4270.Volume level set by participant (left),UGDH,UDP-glucose 6-dehydrogenase,31495,-0.0228859656970645,0.019437908265715,-0.0609842658978659,0.0152123345037368,0.239077273922871
Physical measures,X4270.Volume level set by participant (left),REEP4,Receptor expression-enhancing protein 4,31752,-0.0347354243369151,0.0295547033498238,-0.0926626429025698,0.0231917942287396,0.239913141111673
Physical measures,X4270.Volume level set by participant (left),HNF1A,Hepatocyte nuclear factor 1-alpha,31546,-0.0327805954305148,0.0278924951998749,-0.0874498860222697,0.0218886951612401,0.239931985362091
Physical measures,X4270.Volume level set by participant (left),LYPD8,Ly6/PLAUR domain-containing protein 8,32638,-0.0382124209462711,0.0325265247531987,-0.10196440946254,0.0255395675699983,0.240103423769093
Physical measures,X4270.Volume level set by participant (left),CCL7,C-C motif chemokine 7,32843,0.0346660814264163,0.0295476571540831,-0.0232473265955865,0.0925794894484192,0.240736281418562
Physical measures,X4270.Volume level set by participant (left),ADA2,Adenosine deaminase 2,32774,-0.0499218596882121,0.0425654482732144,-0.133350138303712,0.0335064189272882,0.240896984557988
Physical measures,X4270.Volume level set by participant (left),SOD3,Extracellular superoxide dismutase,31772,-0.0369589029321586,0.0315210091620505,-0.0987400808897776,0.0248222750254603,0.241025071456978
Physical measures,X4270.Volume level set by participant (left),BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",32843,-0.0440546659871289,0.037608938492495,-0.117768185432419,0.0296588534581612,0.241473861058579
Physical measures,X4270.Volume level set by participant (left),HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,31508,-0.0732065534497911,0.0625076250693333,-0.195721498585684,0.0493083916861022,0.241570178695549
Physical measures,X4270.Volume level set by participant (left),FSTL3,Follistatin-related protein 3,32840,0.0693039800745579,0.0591872512154197,-0.0467030323076648,0.185310992456781,0.241659000744058
Physical measures,X4270.Volume level set by participant (left),CD164,Sialomucin core protein 24,32861,-0.0697731930827827,0.0596023682836551,-0.186593834918747,0.0470474487531813,0.241772647205499
Physical measures,X4270.Volume level set by participant (left),NOS2,"Nitric oxide synthase, inducible",31495,-0.0601654723596669,0.0514654276949758,-0.161037710641819,0.0407067659224858,0.242421453498107
Physical measures,X4270.Volume level set by participant (left),ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,32894,-0.0478352735192681,0.0409662097889087,-0.128129044705529,0.0324584976669929,0.2429681747716
Physical measures,X4270.Volume level set by participant (left),NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,31498,-0.0669873893836914,0.0574373978382917,-0.179564689146743,0.0455899103793603,0.24354260365654
Physical measures,X4270.Volume level set by participant (left),IGFBP4,Insulin-like growth factor-binding protein 4,32745,0.0533388721248652,0.045735941392289,-0.0363035730040213,0.142981317253752,0.243550612736998
Physical measures,X4270.Volume level set by participant (left),FHIP2A,FHF complex subunit HOOK interacting protein 2A,31495,-0.0488178420610834,0.0419664308100839,-0.131072046448848,0.033436362326681,0.244760670406268
Physical measures,X4270.Volume level set by participant (left),KYNU,Kynureninase,32961,-0.043485966110281,0.0374044897094103,-0.116798765940725,0.0298268337201631,0.245027681639242
Physical measures,X4270.Volume level set by participant (left),MN1,Transcriptional activator MN1,31546,-0.041367568931661,0.0356044212708016,-0.111152234622432,0.0284170967591102,0.245325964335777
Physical measures,X4270.Volume level set by participant (left),PRAME,Melanoma antigen preferentially expressed in tumors,31492,-0.0935031726301078,0.0804788591467007,-0.251241736557641,0.0642353912974256,0.245338753432678
Physical measures,X4270.Volume level set by participant (left),CA9,Carbonic anhydrase 9,32948,-0.0458228506883511,0.0394515992428637,-0.123147985204364,0.0315022838276617,0.245471011124444
Physical measures,X4270.Volume level set by participant (left),AKT1S1,Proline-rich AKT1 substrate 1,32644,-0.0321491886884548,0.0276870603698027,-0.0864158270132682,0.0221174496363586,0.245607202704076
Physical measures,X4270.Volume level set by participant (left),IL1R2,Interleukin-1 receptor type 2,32821,0.102518089572231,0.0882948880600984,-0.0705398910255624,0.275576070170023,0.245637262013262
Physical measures,X4270.Volume level set by participant (left),BAX,Apoptosis regulator BAX,32629,-0.0228315093782613,0.0196752479480492,-0.0613949953564378,0.0157319765999151,0.245910314903176
Physical measures,X4270.Volume level set by participant (left),CD27,CD27 antigen,32881,0.0522369917047853,0.0450394690280906,-0.0360403675902723,0.140514350999843,0.246159000922782
Physical measures,X4270.Volume level set by participant (left),SESTD1,SEC14 domain and spectrin repeat-containing protein 1,32644,-0.0323534139038236,0.0278961224878521,-0.0870298139800136,0.0223229861723665,0.246169207892935
Physical measures,X4270.Volume level set by participant (left),NCF2,Neutrophil cytosol factor 2,32824,0.0240874902459248,0.0207810342302926,-0.0166433368454487,0.0648183173372982,0.246442517484701
Physical measures,X4270.Volume level set by participant (left),ADGRE1,Adhesion G protein-coupled receptor E1,31720,-0.0434938104119255,0.0375456707034085,-0.117083324990606,0.0300957041667551,0.246726211179519
Physical measures,X4270.Volume level set by participant (left),NUB1,NEDD8 ultimate buster 1,32843,-0.0246159732124909,0.0212734484128047,-0.0663119321015882,0.0170799856766063,0.247253335308441
Physical measures,X4270.Volume level set by participant (left),MMP13,Collagenase 3,32644,-0.0646625948658188,0.0558895898498746,-0.174206190971573,0.0448810012399354,0.247315971979964
Physical measures,X4270.Volume level set by participant (left),EPHX2,Bifunctional epoxide hydrolase 2,32685,-0.0319737128797798,0.0276573345854841,-0.0861820886673287,0.022234662907769,0.247685339234453
Physical measures,X4270.Volume level set by participant (left),SPINT1,Kunitz-type protease inhibitor 1,32819,0.0769779465474811,0.0667231453424839,-0.0537994183237875,0.20775531141875,0.248657328034354
Physical measures,X4270.Volume level set by participant (left),GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",31514,-0.0421047719638982,0.0365007085973882,-0.113646160814779,0.0294366168869825,0.248727713441689
Physical measures,X4270.Volume level set by participant (left),LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,32964,-0.0281675065419102,0.0244276569806107,-0.0760457142239071,0.0197107011400867,0.248900040503862
Physical measures,X4270.Volume level set by participant (left),PAEP,Glycodelin,32796,-0.0134550613501431,0.0116727906642265,-0.0363337310520269,0.00942360835174079,0.249070170062579
Physical measures,X4270.Volume level set by participant (left),CREBZF,CREB/ATF bZIP transcription factor,31492,-0.0885510124201128,0.0768428580363382,-0.239163014171336,0.06206098933111,0.249207265856391
Physical measures,X4270.Volume level set by participant (left),RLN1,Prorelaxin H1,31752,-0.0276245483191118,0.0239846310328658,-0.0746344251435289,0.0193853285053053,0.249454446050829
Physical measures,X4270.Volume level set by participant (left),NAGK,N-acetyl-D-glucosamine kinase,31547,-0.0417415180414559,0.036265259830074,-0.112821427308401,0.029338391225489,0.24976573648377
Physical measures,X4270.Volume level set by participant (left),DEFB103A_DEFB103B,Beta-defensin 103,31466,-0.0577995840799886,0.0502678661327399,-0.156324601700159,0.0407254335401816,0.250249377937579
Physical measures,X4270.Volume level set by participant (left),F3,Tissue factor,32901,-0.0712631865654848,0.0620938681361814,-0.1929671681124,0.0504407949814308,0.251135750191918
Physical measures,X4270.Volume level set by participant (left),CLGN,Calmegin,31546,0.0544467199196456,0.0474411380337863,-0.0385379106265756,0.147431350465867,0.251140998602614
Physical measures,X4270.Volume level set by participant (left),BMPER,BMP-binding endothelial regulator protein,31599,0.102247198911062,0.0891128383331128,-0.0724139642218392,0.276908362043963,0.251255865412792
Physical measures,X4270.Volume level set by participant (left),GFER,FAD-linked sulfhydryl oxidase ALR,32638,-0.031351515249784,0.0273374255957721,-0.0849328694174973,0.0222298389179293,0.251481108708319
Physical measures,X4270.Volume level set by participant (left),CIT,Citron Rho-interacting kinase,31546,0.0476269046597073,0.0416047058009808,-0.0339183187102151,0.12917212802963,0.252349212430309
Physical measures,X4270.Volume level set by participant (left),PMM2,Phosphomannomutase 2,31495,-0.0389160606874537,0.0340101141015384,-0.105575884326469,0.0277437629515615,0.252556008752211
Physical measures,X4270.Volume level set by participant (left),ROBO4,Roundabout homolog 4,31566,-0.128914734062064,0.112688875663201,-0.349784930361938,0.0919554622378093,0.252664115219378
Physical measures,X4270.Volume level set by participant (left),IL13,Interleukin-13,32679,0.0416360461349344,0.0364075856925513,-0.0297228218224662,0.112994914092335,0.252816839667273
Physical measures,X4270.Volume level set by participant (left),SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,31546,-0.0481832273313401,0.0421490819002995,-0.130795427855927,0.0344289731932468,0.253006969522146
Physical measures,X4270.Volume level set by participant (left),SDCCAG8,Serologically defined colon cancer antigen 8,31724,-0.0210956483865897,0.0184551781840122,-0.0572677976272535,0.0150765008540742,0.253042362807234
Physical measures,X4270.Volume level set by participant (left),SCAMP3,Secretory carrier-associated membrane protein 3,32832,-0.0234590047333407,0.020533102022725,-0.0637038846978817,0.0167858752312003,0.253278044964574
Physical measures,X4270.Volume level set by participant (left),GAST,Gastrin,31751,0.0203728167268723,0.017841142041234,-0.0145958216739462,0.0553414551276909,0.253529862960455
Physical measures,X4270.Volume level set by participant (left),IL4R,Interleukin-4 receptor subunit alpha,32843,0.053711782255001,0.047060924043394,-0.0385276288700513,0.145951193380053,0.253765374128978
Physical measures,X4270.Volume level set by participant (left),LGMN,Legumain,32894,-0.0545986433617053,0.0479247644424292,-0.148531181668867,0.0393338949454561,0.254626020440045
Physical measures,X4270.Volume level set by participant (left),CXCL17,C-X-C motif chemokine 17,32961,0.0439344172200035,0.0385666879967928,-0.0316562912537103,0.119525125693717,0.25465788803599
Physical measures,X4270.Volume level set by participant (left),ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,31770,-0.0850638979027679,0.0746892773408421,-0.231454881490818,0.0613270856852825,0.254777805338178
Physical measures,X4270.Volume level set by participant (left),EZR,Ezrin,32931,0.0809932391422982,0.0712016851192469,-0.0585620636914258,0.220548541976022,0.255351620724454
Physical measures,X4270.Volume level set by participant (left),MSLN,Mesothelin,32821,0.0374432810222656,0.0329506183654332,-0.0271399309739834,0.102026493018515,0.255842468047851
Physical measures,X4270.Volume level set by participant (left),ADD1,Alpha-adducin,31599,-0.0353296171370765,0.031104239960577,-0.0962939274598074,0.0256346931856544,0.256056334807111
Physical measures,X4270.Volume level set by participant (left),CCL27,C-C motif chemokine 27,32864,0.0315124589614707,0.0277789011101425,-0.0229341872144086,0.0859591051373499,0.256655898679195
Physical measures,X4270.Volume level set by participant (left),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,32946,0.0552103724769515,0.0487788329754743,-0.0403961401549781,0.150816885108881,0.257726948665682
Physical measures,X4270.Volume level set by participant (left),TNN,Tenascin-N,31773,-0.0511529255428541,0.0452585236210439,-0.1398596318401,0.0375537807543919,0.258410013818397
Physical measures,X4270.Volume level set by participant (left),GIGYF2,GRB10-interacting GYF protein 2,31752,-0.0280392575981895,0.0248083521691524,-0.0766636278497281,0.0205851126533492,0.258411751654336
Physical measures,X4270.Volume level set by participant (left),APOE,Apolipoprotein E,31770,-0.0301644685399414,0.0267327739250075,-0.0825607054329562,0.0222317683530733,0.259197793965996
Physical measures,X4270.Volume level set by participant (left),ICA1,Islet cell autoantigen 1,32679,-0.0253293386406765,0.0224793578245915,-0.0693888799768759,0.0187302026955228,0.259865277256385
Physical measures,X4270.Volume level set by participant (left),CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,31632,-0.0329096971014743,0.0292161690131857,-0.0901733883673183,0.0243539941643697,0.260022287574714
Physical measures,X4270.Volume level set by participant (left),FOXO3,Forkhead box protein O3,32638,-0.0205623895387328,0.0182661096874948,-0.0563639645262227,0.0152391854487571,0.260317982423603
Physical measures,X4270.Volume level set by participant (left),FRMD4B,FERM domain-containing protein 4B,31495,-0.0298943810049157,0.0266021567742696,-0.0820346082824841,0.0222458462726526,0.261151136374341
Physical measures,X4270.Volume level set by participant (left),SOST,Sclerostin,32858,-0.0498344042614262,0.0443861031654704,-0.136831166465748,0.0371623579428959,0.261574543440465
Physical measures,X4270.Volume level set by participant (left),BLVRB,Flavin reductase,32861,0.0280571042756293,0.0250056683295483,-0.0209540056502854,0.077068214201544,0.261879722740097
Physical measures,X4270.Volume level set by participant (left),TPSD1,Tryptase delta,31752,-0.0626531640748307,0.0558701745318714,-0.172158706157299,0.0468523780076372,0.262149100765614
Physical measures,X4270.Volume level set by participant (left),DCUN1D1,DCN1-like protein 1,31514,-0.0295644868233558,0.0263882043939996,-0.0812853674355949,0.0221563937888833,0.262592351119639
Physical measures,X4270.Volume level set by participant (left),RABEPK,Rab9 effector protein with kelch motifs,32638,-0.0321479251006364,0.028710668724243,-0.0884208358001527,0.02412498559888,0.262863521955084
Physical measures,X4270.Volume level set by participant (left),PNLIP,Pancreatic triacylglycerol lipase,31772,-0.0362105620755041,0.0323467046736785,-0.099610103235914,0.0271889790849058,0.262981631975475
Physical measures,X4270.Volume level set by participant (left),NTRK2,BDNF/NT-3 growth factors receptor,32864,-0.0759973955106271,0.0679418072132355,-0.209163337648569,0.0571685466273145,0.263355186206189
Physical measures,X4270.Volume level set by participant (left),GART,Trifunctional purine biosynthetic protein adenosine-3,31752,-0.0855727063581348,0.0766140580529251,-0.235736260141868,0.0645908474255985,0.264057342619942
Physical measures,X4270.Volume level set by participant (left),PCARE,Photoreceptor cilium actin regulator,31514,0.0262179973445396,0.0234988509087484,-0.0198397504366073,0.0722757451256865,0.264579609265388
Physical measures,X4270.Volume level set by participant (left),ANGPTL1,Angiopoietin-related protein 1,32685,-0.0665420531030691,0.0598577000093035,-0.183863145121304,0.0507790389151658,0.266310042995887
Physical measures,X4270.Volume level set by participant (left),MMP1,Interstitial collagenase,32503,-0.0211911828457976,0.019068052058709,-0.0585645648808672,0.0161821991892721,0.266450834140102
Physical measures,X4270.Volume level set by participant (left),FN1,Fibronectin,31770,-0.0821156473498081,0.0739020842086369,-0.226963732398736,0.0627324376991201,0.266541380369658
Physical measures,X4270.Volume level set by participant (left),RETN,Resistin,32809,0.044367445002151,0.0399641198829121,-0.0339622299683568,0.122697119972659,0.266950463600514
Physical measures,X4270.Volume level set by participant (left),RAB10,Ras-related protein Rab-10,31762,-0.0406343159934301,0.0366019643837302,-0.112374166185541,0.0311055341986811,0.266960593444311
Physical measures,X4270.Volume level set by participant (left),CSF2RB,Cytokine receptor common subunit beta,31508,-0.0519170805944738,0.0468152950518193,-0.14367505889604,0.0398408977070919,0.267475033138817
Physical measures,X4270.Volume level set by participant (left),ACE2,Angiotensin-converting enzyme 2,32685,0.0399048798620956,0.0360380902637767,-0.0307297770549066,0.110539536779098,0.268195603620961
Physical measures,X4270.Volume level set by participant (left),ERVV_1,,31495,-0.0465588568360491,0.0420659747417518,-0.129008167329883,0.0358904536577845,0.268412865883082
Physical measures,X4270.Volume level set by participant (left),TPP1,Tripeptidyl-peptidase 1,32784,-0.0416383187527161,0.0376771033676639,-0.115485441353337,0.0322088038479051,0.269130519854674
Physical measures,X4270.Volume level set by participant (left),SELP,P-selectin,32878,-0.0330285997940775,0.0299062179937673,-0.0916447870618614,0.0255875874737063,0.269446633843354
Physical measures,X4270.Volume level set by participant (left),PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,32837,-0.0100625783481864,0.00911950393083042,-0.027936806052614,0.00781164935624124,0.269877481188501
Physical measures,X4270.Volume level set by participant (left),MNDA,Myeloid cell nuclear differentiation antigen,32852,0.0196887895937592,0.0178501962162839,-0.0152975949901572,0.0546751741776755,0.270056129781394
Physical measures,X4270.Volume level set by participant (left),DKK3,Dickkopf-related protein 3,32964,-0.0648803184412799,0.0588518604407642,-0.180229964905178,0.050469328022618,0.270301992761742
Physical measures,X4270.Volume level set by participant (left),CST5,Cystatin-D,32697,-0.0350146353896406,0.0317637763099543,-0.0972716369571511,0.0272423661778699,0.270341806353189
Physical measures,X4270.Volume level set by participant (left),PARD3,Partitioning defective 3 homolog,31632,-0.0296914908642676,0.0269553192320354,-0.082523916559057,0.0231409348305218,0.270709892675528
Physical measures,X4270.Volume level set by participant (left),WFDC1,WAP four-disulfide core domain protein 1,31560,-0.040565323812345,0.0368686383105297,-0.112827854900983,0.0316972072762931,0.271250477967505
Physical measures,X4270.Volume level set by participant (left),PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",32816,-0.0266435697026745,0.0242255616090586,-0.0741256704564294,0.0208385310510803,0.271443500024878
Physical measures,X4270.Volume level set by participant (left),HEXIM1,Protein HEXIM1,32843,-0.024220705041015,0.0220494753711214,-0.0674376767684129,0.018996266686383,0.272028408142482
Physical measures,X4270.Volume level set by participant (left),KIF22,Kinesin-like protein KIF22,31495,-0.0186981407417754,0.017032408834212,-0.0520816620568309,0.0146853805732801,0.272327430760127
Physical measures,X4270.Volume level set by participant (left),GBP6,Guanylate-binding protein 6,31495,-0.048745906818583,0.0444616768053632,-0.135890793357095,0.0383989797199288,0.272956810318131
Physical measures,X4270.Volume level set by participant (left),PRTG,Protogenin,32948,-0.0749507986497162,0.0683720965516128,-0.208960107890877,0.0590585105914448,0.273011956852124
Physical measures,X4270.Volume level set by participant (left),RILP,Rab-interacting lysosomal protein,32925,-0.0328128717498699,0.0299534531847054,-0.0915216399918925,0.0258958964921528,0.273343368066938
Physical measures,X4270.Volume level set by participant (left),CLEC4M,C-type lectin domain family 4 member M,31762,-0.0452817806086767,0.0413693971764401,-0.126365799074499,0.0358022378571459,0.273737596900303
Physical measures,X4270.Volume level set by participant (left),ATG4A,Cysteine protease ATG4A,32638,-0.0325911273665986,0.0298125829941974,-0.0910237900352255,0.0258415353020283,0.274335835398085
Physical measures,X4270.Volume level set by participant (left),CPM,Carboxypeptidase M,32888,0.0536926675878829,0.0491790156571677,-0.0426982031001658,0.150083538275932,0.274958939661354
Physical measures,X4270.Volume level set by participant (left),TRIM24,Transcription intermediary factor 1-alpha,31619,-0.0336107085786839,0.0308522200074592,-0.094081059793304,0.0268596426359361,0.276007090606653
Physical measures,X4270.Volume level set by participant (left),HEPACAM2,HEPACAM family member 2,31751,-0.0509543935878931,0.0468045233659009,-0.142691259385059,0.0407824722092728,0.276335399463864
Physical measures,X4270.Volume level set by participant (left),IL17A,Interleukin-17A,32668,0.0461998251500543,0.0424599867811079,-0.0370217489409171,0.129421399241026,0.276589961286001
Physical measures,X4270.Volume level set by participant (left),HSD17B3,Testosterone 17-beta-dehydrogenase 3,31495,-0.0454181435682276,0.0417466944787454,-0.127241664746569,0.0364053776101134,0.276653362593229
Physical measures,X4270.Volume level set by participant (left),CXCL10,C-X-C motif chemokine 10,32894,-0.0292610943876415,0.026918215425774,-0.0820207966221587,0.0234986078468756,0.277049498373486
Physical measures,X4270.Volume level set by participant (left),ZP3,Zona pellucida sperm-binding protein 3,31566,-0.00857557004815277,0.00789339167216429,-0.0240466177255948,0.00689547762928925,0.277325449637437
Physical measures,X4270.Volume level set by participant (left),CRIP2,Cysteine-rich protein 2,32796,-0.0522672134013074,0.0481665328819891,-0.146673617850006,0.0421391910473913,0.277890941971997
Physical measures,X4270.Volume level set by participant (left),TJP3,Tight junction protein ZO-3,31514,-0.0527149677269422,0.0486268275659755,-0.148023549756254,0.0425936143023697,0.278367168106209
Physical measures,X4270.Volume level set by participant (left),RGL2,Ral guanine nucleotide dissociation stimulator-like 2,31632,-0.0339869803128407,0.0313588853121298,-0.0954503955246151,0.0274764348989337,0.278484001489047
Physical measures,X4270.Volume level set by participant (left),SFTPA2,Pulmonary surfactant-associated protein A2,32638,-0.039231466443707,0.0362052297685427,-0.110193716790051,0.0317307839026367,0.278578340396192
Physical measures,X4270.Volume level set by participant (left),SHD,SH2 domain-containing adapter protein D,31481,-0.0268765200798037,0.0248175379127418,-0.0755188943887777,0.0217658542291703,0.278858321436987
Physical measures,X4270.Volume level set by participant (left),GDF2,Growth/differentiation factor 2,32864,-0.0515910313875201,0.0476805937301836,-0.14504499509868,0.0418629323236397,0.279275652845952
Physical measures,X4270.Volume level set by participant (left),CLEC14A,C-type lectin domain family 14 member A,32861,0.0621915670519183,0.0574793242148791,-0.0504679084092448,0.174851042513081,0.279289731167157
Physical measures,X4270.Volume level set by participant (left),PFDN2,Prefoldin subunit 2,32644,-0.0356575466668226,0.033095662616572,-0.100525045395304,0.0292099520616586,0.281327426711402
Physical measures,X4270.Volume level set by participant (left),EHD3,EH domain-containing protein 3,31566,-0.0196194502260377,0.0182335301715895,-0.0553571693623531,0.0161182689102777,0.281956742673976
Physical measures,X4270.Volume level set by participant (left),CCN3,CCN family member 3,32947,-0.05655990420846,0.0525913941535341,-0.159639036749387,0.0465192283324668,0.282197705288335
Physical measures,X4270.Volume level set by participant (left),PDCL2,Phosducin-like protein 2,31492,0.0410828701414323,0.0382585952394043,-0.0339039765278,0.116069716810665,0.282937029240073
Physical measures,X4270.Volume level set by participant (left),ECI2,Enoyl-CoA delta isomerase 2,31495,-0.0355935553365458,0.0331631665677487,-0.100593361809333,0.0294062511362416,0.28317684387075
Physical measures,X4270.Volume level set by participant (left),CSF1R,Macrophage colony-stimulating factor 1 receptor,31772,-0.0556490683309562,0.0518580457408915,-0.157290837983104,0.0459927013211912,0.283257265798693
Physical measures,X4270.Volume level set by participant (left),PRG3,Proteoglycan 3,31773,-0.0415792655289231,0.0388155838239338,-0.117657809823833,0.034499278765987,0.284112053700055
Physical measures,X4270.Volume level set by participant (left),SLC28A1,Sodium/nucleoside cotransporter 1,31492,-0.0372932030660185,0.0348219879934742,-0.105544299533228,0.0309578934011909,0.284218108183688
Physical measures,X4270.Volume level set by participant (left),LCP1,Plastin-2,31773,0.044635883152896,0.0416792593532572,-0.037055465179488,0.12632723148528,0.284230193781869
Physical measures,X4270.Volume level set by participant (left),GPD1,Glycerol-3-phosphate dehydrogenase,31724,-0.0401129558764247,0.0374639109560767,-0.113542221350335,0.0333163095974857,0.284333056295847
Physical measures,X4270.Volume level set by participant (left),IGF1R,Insulin-like growth factor 1 receptor,32832,-0.0855502600992889,0.0799031302320432,-0.242160395354094,0.0710598751555158,0.284344532611634
Physical measures,X4270.Volume level set by participant (left),CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,32638,0.0396201776878381,0.0370097566357229,-0.0329189453181787,0.112159300693855,0.284408762860764
Physical measures,X4270.Volume level set by participant (left),TLR1,Toll-like receptor 1,31508,-0.0844489351831943,0.0789541078075222,-0.239198986485938,0.0703011161195492,0.284835322876865
Physical measures,X4270.Volume level set by participant (left),GNPDA2,Glucosamine-6-phosphate isomerase 2,31599,-0.058766728958434,0.0549711151205535,-0.166510114594719,0.0489766566778508,0.285081656837986
Physical measures,X4270.Volume level set by participant (left),PSME1,Proteasome activator complex subunit 1,32790,-0.0519032276246662,0.0485704529084077,-0.147101315325145,0.0432948600758129,0.28527103206872
Physical measures,X4270.Volume level set by participant (left),CDAN1,Codanin-1,31751,-0.093168549098076,0.0873643931287192,-0.264402759630366,0.0780656614342136,0.286259155996109
Physical measures,X4270.Volume level set by participant (left),NTproBNP,N-terminal prohormone of brain natriuretic peptide,32864,0.0201843949612856,0.0189588857426187,-0.016975021094247,0.0573438110168182,0.28706726650068
Physical measures,X4270.Volume level set by participant (left),IL16,Pro-interleukin-16,32961,0.0450847137392873,0.0423559045282245,-0.0379328591360328,0.128102286614607,0.287164140922199
Physical measures,X4270.Volume level set by participant (left),EIF5,Eukaryotic translation initiation factor 5,31495,-0.0496235863839378,0.0467287426298883,-0.141211921938519,0.0419647491706433,0.288292004443999
Physical measures,X4270.Volume level set by participant (left),PXN,Paxillin,32644,0.0354881318063018,0.033444266048962,-0.0300626296496638,0.101038893262267,0.288667920110247
Physical measures,X4270.Volume level set by participant (left),LAYN,Layilin,32776,-0.0579535839175203,0.054631634876796,-0.165031588276041,0.0491244204409999,0.288806670179282
Physical measures,X4270.Volume level set by participant (left),CD63,CD63 antigen,32778,-0.0362217859090781,0.0341681514811279,-0.103191362812089,0.0307477909939325,0.289126116297001
Physical measures,X4270.Volume level set by participant (left),COL9A1,Collagen alpha-1(IX) chain,32843,-0.0413711463367552,0.0390664039905552,-0.117941298158243,0.0351990054847329,0.289630309323487
Physical measures,X4270.Volume level set by participant (left),TAX1BP1,Tax1-binding protein 1,31751,-0.0325009935645551,0.0306932441381599,-0.0926597520753485,0.0276577649462383,0.289678974926091
Physical measures,X4270.Volume level set by participant (left),RBP1,Retinol-binding protein 1,31546,-0.029493495946933,0.0278575440306545,-0.0840942822470157,0.0251072903531498,0.289758034541766
Physical measures,X4270.Volume level set by participant (left),LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,31495,-0.0409135596514663,0.0387216552900893,-0.116808004020041,0.0349808847171087,0.290724574172383
Physical measures,X4270.Volume level set by participant (left),NTF4,Neurotrophin-4,32638,0.0466253292864723,0.0442051523954941,-0.0400167694086963,0.133267427981641,0.291569288423966
Physical measures,X4270.Volume level set by participant (left),DNAJA2,DnaJ homolog subfamily A member 2,32920,-0.0230761051938774,0.021902909382311,-0.066005807583207,0.0198535971954522,0.292110927231245
Physical measures,X4270.Volume level set by participant (left),CSTB,Cystatin-B,32718,-0.0414956234298705,0.0394063946867882,-0.118732157015975,0.0357409101562343,0.292361701845045
Physical measures,X4270.Volume level set by participant (left),ITGB2,Integrin beta-2,32785,-0.0642008876415722,0.0609830669886651,-0.183727698939356,0.0553259236562114,0.292476850957224
Physical measures,X4270.Volume level set by participant (left),MOCS2,Molybdopterin synthase catalytic subunit,31599,-0.0312819206800687,0.0297284251389731,-0.089549633952456,0.0269857925923185,0.292714871871354
Physical measures,X4270.Volume level set by participant (left),SSH3,Protein phosphatase Slingshot homolog 3,31492,-0.0718258135153704,0.0682824817538564,-0.205659477752929,0.0620078507221883,0.292882303360841
Physical measures,X4270.Volume level set by participant (left),TALDO1,Transaldolase,31750,-0.0479479480638456,0.0456005526441942,-0.137325031246466,0.041429135118775,0.293071623215545
Physical measures,X4270.Volume level set by participant (left),KLK6,Kallikrein-6,32866,-0.0615369941197306,0.0585819120114673,-0.176357541662206,0.0532835534227452,0.293542407324086
Physical measures,X4270.Volume level set by participant (left),UBQLN3,Ubiquilin-3,31495,-0.045656495428359,0.0434916140523172,-0.130900058970901,0.0395870681141826,0.293853899494793
Physical measures,X4270.Volume level set by participant (left),BAG3,BAG family molecular chaperone regulator 3,32778,-0.0449356186291892,0.0428184044060609,-0.128859691265069,0.0389884540066902,0.294001178680088
Physical measures,X4270.Volume level set by participant (left),ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,31495,-0.0375691693473268,0.0358113831611217,-0.107759480343125,0.0326211416484717,0.294172418250506
Physical measures,X4270.Volume level set by participant (left),PMS1,PMS1 protein homolog 1,31546,-0.0414839356453798,0.0395751122635312,-0.119051155681901,0.0360832843911413,0.294564278222129
Physical measures,X4270.Volume level set by participant (left),ITGB1,Integrin beta-1,32835,-0.0832533725504804,0.0795976367183532,-0.239264740518453,0.0727579954174917,0.295622594634323
Physical measures,X4270.Volume level set by participant (left),CLEC4G,C-type lectin domain family 4 member G,32843,-0.0538449000531654,0.0514822275521201,-0.154750066055321,0.04706026594899,0.295638600078043
Physical measures,X4270.Volume level set by participant (left),QPCT,Glutaminyl-peptide cyclotransferase,32844,0.0669017949225388,0.0639868954340975,-0.0585125201282923,0.19231610997337,0.295794844079442
Physical measures,X4270.Volume level set by participant (left),S100A13,Protein S100-A13,31508,-0.0608293569149794,0.058221372442669,-0.174943246902611,0.0532845330726519,0.296151092898085
Physical measures,X4270.Volume level set by participant (left),PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,31743,-0.0268427083731207,0.0256925725696919,-0.0772001506097167,0.0235147338634753,0.296163502537483
Physical measures,X4270.Volume level set by participant (left),BANK1,B-cell scaffold protein with ankyrin repeats,32843,-0.0184026626508432,0.0176161069152036,-0.0529302322046422,0.0161249069029558,0.29621297123068
Physical measures,X4270.Volume level set by participant (left),CHP1,Calcineurin B homologous protein 1,31514,-0.0283780406997329,0.0271989624915653,-0.0816880071832009,0.0249319257837351,0.296819132007395
Physical measures,X4270.Volume level set by participant (left),SCARF1,Scavenger receptor class F member 1,32964,-0.0413036969313975,0.0396178285764524,-0.118954640941244,0.0363472470784492,0.29718293168068
Physical measures,X4270.Volume level set by participant (left),TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,31495,-0.0451317997019315,0.0433110677848759,-0.130021492560288,0.0397578931564253,0.297426840878384
Physical measures,X4270.Volume level set by participant (left),MUC2,Mucin-2,31773,-0.0226610064636342,0.0218145869086008,-0.0654175968044918,0.0200955838772234,0.298929223902905
Physical measures,X4270.Volume level set by participant (left),COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",31566,-0.0458434483017015,0.0442259579971365,-0.132526325976089,0.0408394293726861,0.299967288956291
Physical measures,X4270.Volume level set by participant (left),CD69,Early activation antigen CD69,32813,-0.0209831725991846,0.0202435032177005,-0.0606604389058776,0.0186940937075084,0.299978942489453
Physical measures,X4270.Volume level set by participant (left),CFI,Complement factor I,31770,-0.100994602884884,0.0974701674642507,-0.292036131114816,0.090046925345047,0.30015960179361
Physical measures,X4270.Volume level set by participant (left),SLC27A4,Long-chain fatty acid transport protein 4,32644,-0.0224987719725401,0.0217402151827641,-0.0651095937307578,0.0201120497856776,0.300747910530088
Physical measures,X4270.Volume level set by participant (left),FMNL1,Formin-like protein 1,32644,0.0295957882298202,0.0286056713600959,-0.0264713276359677,0.0856629040956081,0.300878355728884
Physical measures,X4270.Volume level set by participant (left),SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,32882,0.0272125494268694,0.0263158277312197,-0.0243664729263212,0.07879157178006,0.301128653455281
Physical measures,X4270.Volume level set by participant (left),TRIM21,E3 ubiquitin-protein ligase TRIM21,32843,-0.024253966045117,0.0234598244366721,-0.0702352219409942,0.0217272898507602,0.301233604277989
Physical measures,X4270.Volume level set by participant (left),LY9,T-lymphocyte surface antigen Ly-9,32748,0.0634544361024841,0.0613791380094778,-0.0568486743960924,0.183757546601061,0.301252604144166
Physical measures,X4270.Volume level set by participant (left),SUSD4,Sushi domain-containing protein 4,31724,-0.0475072899348117,0.0460414571261235,-0.137748545902014,0.0427339660323904,0.302180115547044
Physical measures,X4270.Volume level set by participant (left),ANGPTL2,Angiopoietin-related protein 2,32854,0.0453524632415723,0.0439564948276897,-0.0408022666206994,0.131507193103844,0.302213272196473
Physical measures,X4270.Volume level set by participant (left),SNAP23,Synaptosomal-associated protein 23,32864,-0.0215015368986336,0.0208410600380815,-0.0623500145732734,0.0193469407760061,0.3022445510738
Physical measures,X4270.Volume level set by participant (left),C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",31752,-0.032081722174928,0.0311114986661374,-0.0930602595605572,0.0288968152107012,0.302485513156963
Physical measures,X4270.Volume level set by participant (left),CD99L2,CD99 antigen-like protein 2,32861,0.0742446269279304,0.0720073327859388,-0.0668897453325098,0.215378999188371,0.302535536399705
Physical measures,X4270.Volume level set by participant (left),LSM8,U6 snRNA-associated Sm-like protein LSm8,31632,-0.0242119368320314,0.0235124729907754,-0.0702963838939512,0.0218725102298884,0.303160078047973
Physical measures,X4270.Volume level set by participant (left),BCHE,Cholinesterase,31625,-0.074589815327622,0.0725991439291715,-0.216884137428798,0.0677045067735541,0.304254734628888
Physical measures,X4270.Volume level set by participant (left),ICAM5,Intercellular adhesion molecule 5,32864,0.0389608661231292,0.0379501257546168,-0.0354213803559198,0.113343112602178,0.304620714834439
Physical measures,X4270.Volume level set by participant (left),PTPRS,Receptor-type tyrosine-protein phosphatase S,32964,0.0711777095401048,0.0693537645132256,-0.0647556689058173,0.207111087986027,0.304777874236872
Physical measures,X4270.Volume level set by participant (left),SPTLC1,Serine palmitoyltransferase 1,31751,-0.0572367730748575,0.0557816860569271,-0.166568877746435,0.0520953315967196,0.304882800575225
Physical measures,X4270.Volume level set by participant (left),MMP8,Neutrophil collagenase,32923,0.0238183054380174,0.0232523509838001,-0.0217563024902308,0.0693929133662656,0.305702217438358
Physical measures,X4270.Volume level set by participant (left),RNF41,E3 ubiquitin-protein ligase NRDP1,32638,-0.0275950931822194,0.0269431454979554,-0.0804036583582121,0.0252134719937732,0.305770391575726
Physical measures,X4270.Volume level set by participant (left),APOH,Beta-2-glycoprotein 1,32861,-0.0526011368675373,0.0513633021873145,-0.153273209154674,0.048070935419599,0.30581576746881
Physical measures,X4270.Volume level set by participant (left),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,32931,0.0666525610198883,0.0650925779142027,-0.060928891691949,0.194234013731726,0.30587883511419
Physical measures,X4270.Volume level set by participant (left),UBAC1,Ubiquitin-associated domain-containing protein 1,32832,-0.0531300808444697,0.051888249718457,-0.154831050292645,0.048570888603706,0.305894631784199
Physical measures,X4270.Volume level set by participant (left),CAPS,Calcyphosin,31751,-0.0234005048865828,0.0228607666767429,-0.0682076075729989,0.0214065977998333,0.306051003086658
Physical measures,X4270.Volume level set by participant (left),IL20RA,Interleukin-20 receptor subunit alpha,32679,0.0404399434944117,0.0395966990838749,-0.037169586709983,0.118049473698806,0.307142327493937
Physical measures,X4270.Volume level set by participant (left),MRC1,Macrophage mannose receptor 1,31772,0.0733313173459451,0.0718960289281366,-0.0675848993532027,0.214247534045093,0.307777022043128
Physical measures,X4270.Volume level set by participant (left),CHI3L1,Chitinase-3-like protein 1,32630,0.0239725569304899,0.0235039105020209,-0.022095107653471,0.0700402215144508,0.307785496304482
Physical measures,X4270.Volume level set by participant (left),SERPINI1,Neuroserpin,31578,-0.064823578518043,0.0635675108848373,-0.189415899852324,0.0597687428162381,0.307874470963679
Physical measures,X4270.Volume level set by participant (left),CLEC1A,C-type lectin domain family 1 member A,32685,-0.056045282979679,0.054994098275387,-0.163833715599437,0.0517431496400795,0.308176557418173
Physical measures,X4270.Volume level set by participant (left),GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,32638,-0.027807999352913,0.0273205773823336,-0.0813563310222868,0.0257403323164607,0.308781663089556
Physical measures,X4270.Volume level set by participant (left),SKAP2,Src kinase-associated phosphoprotein 2,32894,-0.0168879680817303,0.0165963829844337,-0.0494168787312204,0.0156409425677599,0.308909991902085
Physical measures,X4270.Volume level set by participant (left),CDHR1,Cadherin-related family member 1,32644,0.0415951337033945,0.040924722928109,-0.0386173232356991,0.121807590642488,0.309475726595319
Physical measures,X4270.Volume level set by participant (left),IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,31495,-0.0420746470900677,0.0414324578918949,-0.123282264558182,0.0391329703780464,0.30989989759888
Physical measures,X4270.Volume level set by participant (left),CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,31566,-0.0274695117239771,0.0270504693493347,-0.080488431648673,0.0255494082007188,0.309903666194619
Physical measures,X4270.Volume level set by participant (left),FGF9,Fibroblast growth factor 9,31481,-0.0520536062947729,0.0512913526111348,-0.152584657412597,0.0484774448230513,0.310204201681391
Physical measures,X4270.Volume level set by participant (left),RNF43,E3 ubiquitin-protein ligase RNF43,31632,-0.0341017912534718,0.033617198286112,-0.0999914998942513,0.0317879173873077,0.310416345132303
Physical measures,X4270.Volume level set by participant (left),PDGFC,Platelet-derived growth factor C,32638,-0.0623770404949374,0.0615104850207011,-0.182937591135512,0.0581835101456367,0.310568756270036
Physical measures,X4270.Volume level set by participant (left),KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,31492,-0.0248307609246608,0.0244982734894487,-0.0728473769639803,0.0231858551146586,0.310819228656174
Physical measures,X4270.Volume level set by participant (left),ORM1,Alpha-1-acid glycoprotein 1,31751,0.10105795313364,0.099744099223629,-0.0944404813446725,0.296556387611953,0.311008970408345
Physical measures,X4270.Volume level set by participant (left),NECTIN1,Nectin-1,31508,-0.0652029496799579,0.0643722758487822,-0.191372610343571,0.0609667109836552,0.311137969381071
Physical measures,X4270.Volume level set by participant (left),ATRN,"Attractin, Isoform 2",31770,-0.122737588746601,0.12141570863437,-0.360712377669966,0.115237200176763,0.312101341588691
Physical measures,X4270.Volume level set by participant (left),WASHC3,WASH complex subunit 3,31751,-0.025591607165944,0.0253330012508927,-0.0752442896176936,0.0240610752858056,0.312426508075085
Physical measures,X4270.Volume level set by participant (left),SEMA4D,Semaphorin-4D,32931,-0.0576790244213747,0.0571876198079942,-0.169766759245043,0.0544087104022938,0.313196849559136
Physical measures,X4270.Volume level set by participant (left),DBN1,Drebrin,31508,-0.0379498086323879,0.0376280684417914,-0.111700822778299,0.0358012055135233,0.313222158538377
Physical measures,X4270.Volume level set by participant (left),CDA,Cytidine deaminase,31752,0.0427595165936805,0.0424118967149078,-0.0403678009675387,0.1258868341549,0.313391163587616
Physical measures,X4270.Volume level set by participant (left),CD82,CD82 antigen,31632,-0.0476452410675598,0.0472669679144213,-0.140288498179826,0.0449980160447059,0.313484459526559
Physical measures,X4270.Volume level set by participant (left),AREG,Amphiregulin,32832,0.0364011069126439,0.0361283799480724,-0.034410517785578,0.107212731610866,0.313698285795755
Physical measures,X4270.Volume level set by participant (left),MAPT,Microtubule-associated protein tau,32644,-0.0332945938734837,0.033075722272787,-0.0981230095281461,0.0315338217811788,0.314146460192726
Physical measures,X4270.Volume level set by participant (left),RAD51,DNA repair protein RAD51 homolog 1,31632,-0.0370069189368506,0.0369036990917417,-0.109338169156664,0.0353243312829631,0.31599004567324
Physical measures,X4270.Volume level set by participant (left),CGA,Glycoprotein hormones alpha chain,32861,0.0192571042631548,0.0192089295013885,-0.0183923975595665,0.0569066060858762,0.316125293934135
Physical measures,X4270.Volume level set by participant (left),SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,31724,-0.0267420845562196,0.0266917419609982,-0.079057898799776,0.0255737296873368,0.316429457512232
Physical measures,X4270.Volume level set by participant (left),ACHE,Acetylcholinesterase,31599,0.0621366115360479,0.0620214959029049,-0.0594255204336456,0.183698743505741,0.316444452474303
Physical measures,X4270.Volume level set by participant (left),M6PR,Cation-dependent mannose-6-phosphate receptor,31566,-0.051209440605101,0.051115509668488,-0.151395839555337,0.0489769583451354,0.316453493146533
Physical measures,X4270.Volume level set by participant (left),CALB1,Calbindin,32832,-0.0427733550035207,0.0427394476881913,-0.126542672472376,0.0409959624653343,0.316953724704282
Physical measures,X4270.Volume level set by participant (left),RICTOR,Rapamycin-insensitive companion of mTOR,31508,-0.0400796478896671,0.0401223241307126,-0.118719403185864,0.0385601074065296,0.317857143650879
Physical measures,X4270.Volume level set by participant (left),MYH7B,Myosin-7B,31492,-0.0460726089181995,0.0461292701939183,-0.136485978498279,0.0443407606618803,0.317936982698685
Physical measures,X4270.Volume level set by participant (left),NELL1,Protein kinase C-binding protein NELL1,32881,-0.0423865329027592,0.0424695698613995,-0.125626889831102,0.0408538240255838,0.318284419110501
Physical measures,X4270.Volume level set by participant (left),C3,Complement C3,31344,-0.0397900100761768,0.0398923768632066,-0.117979068728062,0.0383990485757082,0.318586191217119
Physical measures,X4270.Volume level set by participant (left),EBI3_IL27,Interleukin-27,32940,0.0549500337462154,0.0551212525207801,-0.0530876211945135,0.162987688686944,0.31884264538016
Physical measures,X4270.Volume level set by participant (left),GPRC5C,G-protein coupled receptor family C group 5 member C,31724,-0.0360885628174573,0.036241175114888,-0.107121266042638,0.0349441404077232,0.319383335850527
Physical measures,X4270.Volume level set by participant (left),SPON2,Spondin-2,32837,0.0510258890754792,0.0512818395154269,-0.0494865163747575,0.151538294525716,0.319758741351438
Physical measures,X4270.Volume level set by participant (left),KLK4,Kallikrein-4,32948,-0.0279917449689604,0.0281461753148803,-0.0831582485861258,0.027174758648205,0.31999953301351
Physical measures,X4270.Volume level set by participant (left),SRPK2,SRSF protein kinase 2,32843,-0.0206447097614237,0.0207622836378727,-0.0613387856916542,0.0200493661688069,0.320085551081681
Physical measures,X4270.Volume level set by participant (left),MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,31514,-0.0624425367589247,0.0627985819897608,-0.185527757458856,0.0606426839410064,0.320093503970842
Physical measures,X4270.Volume level set by participant (left),NAMPT,Nicotinamide phosphoribosyltransferase,32638,0.033225607939458,0.0334344620144326,-0.0323059376088298,0.0987571534877458,0.320370374044994
Physical measures,X4270.Volume level set by participant (left),DYNLT1,Dynein light chain Tctex-type 1,31546,0.0253493241113048,0.0255107158797649,-0.0246516790130344,0.075350327235644,0.320413107678875
Physical measures,X4270.Volume level set by participant (left),EGFL7,Epidermal growth factor-like protein 7,32638,-0.0443186362981516,0.0446315363173512,-0.13179644748016,0.0431591748838567,0.320742567809679
Physical measures,X4270.Volume level set by participant (left),TDP1,Tyrosyl-DNA phosphodiesterase 1,31724,-0.0284314295764849,0.028638262318379,-0.0845624237205077,0.0276995645675379,0.320848833267486
Physical measures,X4270.Volume level set by participant (left),TAGLN3,Transgelin-3,31492,0.0328707195772925,0.0332134333962541,-0.0322276098793655,0.0979690490339506,0.32236122229999
Physical measures,X4270.Volume level set by participant (left),CASP1,Caspase-1,32644,0.0244535318170235,0.0247149171060704,-0.0239877057108746,0.0728947693449215,0.322483005868333
Physical measures,X4270.Volume level set by participant (left),SSB,Lupus La protein,32644,-0.0287532829601605,0.0290812353082851,-0.0857525041643992,0.0282459382440782,0.322825984263736
Physical measures,X4270.Volume level set by participant (left),DCN,Decorin,32685,-0.0805386487568212,0.0814937298531277,-0.240266359268952,0.0791890617553091,0.32304248892421
Physical measures,X4270.Volume level set by participant (left),FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,32865,0.0338361840275933,0.0342746150692216,-0.0333420615080811,0.101014429563268,0.323567073041255
Physical measures,X4270.Volume level set by participant (left),STX4,Syntaxin-4,32832,-0.02453980401198,0.0248692582742921,-0.0732835502295926,0.0242039422056325,0.323790579640517
Physical measures,X4270.Volume level set by participant (left),NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,31508,-0.0442946156871249,0.0448901928285216,-0.132279393631027,0.0436901622567774,0.323804982087256
Physical measures,X4270.Volume level set by participant (left),FES,Tyrosine-protein kinase Fes/Fps,32638,0.0375362909686766,0.0380526043666265,-0.0370468135899113,0.112119395527265,0.323948568102641
Physical measures,X4270.Volume level set by participant (left),FCRL3,Fc receptor-like protein 3,32679,-0.0323942917434571,0.0328399217027497,-0.0967605382808465,0.0319719547939323,0.323949104534051
Physical measures,X4270.Volume level set by participant (left),EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,32864,-0.0262578651196034,0.0266192409678836,-0.0784315774166553,0.0259158471774485,0.323951478840531
Physical measures,X4270.Volume level set by participant (left),CD74,HLA class II histocompatibility antigen gamma chain,32931,0.0503769370240044,0.0510981785870924,-0.0497754930066967,0.150529367054705,0.324215763848599
Physical measures,X4270.Volume level set by participant (left),PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",31495,-0.031903001952607,0.0323601720911142,-0.0953289392511908,0.0315229353459769,0.324226963244353
Physical measures,X4270.Volume level set by participant (left),CASP4,Caspase-4,31632,-0.0119049063796601,0.012080530078813,-0.0355827453341336,0.0117729325748134,0.324427753025619
Physical measures,X4270.Volume level set by participant (left),KIAA1549,UPF0606 protein KIAA1549,31632,-0.0292016155456941,0.0297068177030764,-0.0874269782437238,0.0290237471523356,0.325641135093923
Physical measures,X4270.Volume level set by participant (left),CD244,Natural killer cell receptor 2B4,32961,0.0624264767885956,0.0637015949769814,-0.0624286493662879,0.187281602943479,0.327120594066795
Physical measures,X4270.Volume level set by participant (left),DDX53,Probable ATP-dependent RNA helicase DDX53,31546,0.0547093070730579,0.0559112584240864,-0.0548767594381516,0.164295373584267,0.327856656473233
Physical measures,X4270.Volume level set by participant (left),NFKB1,Nuclear factor NF-kappa-B p105 subunit,31495,-0.0282580544385245,0.0288796676971635,-0.084862203124965,0.028346094247916,0.32787009475229
Physical measures,X4270.Volume level set by participant (left),KIRREL2,Kin of IRRE-like protein 2,32644,-0.0423870944269064,0.0433219851521464,-0.127298185325113,0.0425239964713006,0.327893621047019
Physical measures,X4270.Volume level set by participant (left),TK1,"Thymidine kinase, cytosolic",31632,-0.0438302528853574,0.0448555960549916,-0.131747221153141,0.044086715382426,0.328529656862519
Physical measures,X4270.Volume level set by participant (left),SLAMF1,Signaling lymphocytic activation molecule,32679,0.0285645594002067,0.0292359397759707,-0.0287378825606959,0.0858670013611094,0.328578244781147
Physical measures,X4270.Volume level set by participant (left),COMP,Cartilage oligomeric matrix protein,32758,0.051016702940207,0.0522453664323902,-0.0513842152672777,0.153417621147692,0.328851810826023
Physical measures,X4270.Volume level set by participant (left),COL15A1,Collagen alpha-1(XV) chain,31773,-0.0779168606671982,0.079831852411345,-0.234387291393434,0.078553570059038,0.329088273516671
Physical measures,X4270.Volume level set by participant (left),MAPK9,Mitogen-activated protein kinase 9,32843,-0.0380907159442693,0.0390287300327367,-0.114587026808433,0.0384055949198946,0.329107572508382
Physical measures,X4270.Volume level set by participant (left),C8B,Complement component C8 beta chain,31770,-0.0629118083307743,0.0644858482187063,-0.189304070839439,0.0634804541778901,0.329297068711451
Physical measures,X4270.Volume level set by participant (left),BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,31508,-0.0427511889673211,0.043831080502058,-0.128660106751355,0.0431577288167126,0.329411376133909
Physical measures,X4270.Volume level set by participant (left),CD300LF,CMRF35-like molecule 1,32948,0.0273066927203872,0.0280202070774493,-0.0276129131514134,0.0822262985921878,0.329816558446756
Physical measures,X4270.Volume level set by participant (left),SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",31508,-0.040725802751221,0.0418299350901955,-0.122712475528004,0.0412608700255621,0.330283877062074
Physical measures,X4270.Volume level set by participant (left),FOLR1,Folate receptor alpha,32843,-0.0608276174056148,0.0626766868122232,-0.183673923557572,0.0620186887463427,0.331824315208649
Physical measures,X4270.Volume level set by participant (left),LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,31762,-0.025955711588485,0.0267586849660336,-0.0784027341219109,0.0264913109449409,0.332080156357497
Physical measures,X4270.Volume level set by participant (left),ITGAM,Integrin alpha-M,32861,-0.0531661515869356,0.0548135056491935,-0.160600622659355,0.0542683194854837,0.332099380102103
Physical measures,X4270.Volume level set by participant (left),ITGA2,Integrin alpha-2,31599,-0.0569470385139407,0.0587317711078524,-0.172061309885331,0.05816723285745,0.332270170528185
Physical measures,X4270.Volume level set by participant (left),IL6R,Interleukin-6 receptor subunit alpha,32778,-0.0495623122818535,0.0511455725839609,-0.149807634546417,0.0506830099827098,0.332549504995401
Physical measures,X4270.Volume level set by participant (left),TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,31599,-0.0309127791430992,0.0319428141596136,-0.0935206948959418,0.0316951366097433,0.333197605559841
Physical measures,X4270.Volume level set by participant (left),SLC1A4,Neutral amino acid transporter A,31546,-0.0365959081308443,0.03784544058082,-0.110772971669252,0.0375811554075628,0.33358283102607
Physical measures,X4270.Volume level set by participant (left),SULT2A1,Bile salt sulfotransferase,32843,-0.0292947553259175,0.0303023860501209,-0.0886874319841545,0.0300979213323194,0.333696320252259
Physical measures,X4270.Volume level set by participant (left),NUCB2,Nucleobindin-2,32937,-0.0439657387650293,0.0454829529157848,-0.133112326479968,0.0451808489499089,0.333748724763288
Physical measures,X4270.Volume level set by participant (left),OGN,Mimecan,32861,0.042806616293556,0.044293921772151,-0.0440094703798599,0.129622702966972,0.3338590804772
Physical measures,X4270.Volume level set by participant (left),OSBPL2,Oxysterol-binding protein-related protein 2,31751,-0.0472126541662749,0.0488818874255215,-0.143021153520297,0.0485958451877472,0.334148003345659
Physical measures,X4270.Volume level set by participant (left),NHLRC3,NHL repeat-containing protein 3,31402,0.0613398784965994,0.0635461168289099,-0.063210510488064,0.185890267481263,0.334434895740374
Physical measures,X4270.Volume level set by participant (left),C1R,Complement C1r subcomponent,31770,-0.0945147025847211,0.0979711374191822,-0.286538131926318,0.097508726756876,0.334714645420413
Physical measures,X4270.Volume level set by participant (left),ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,31566,-0.0489377148966105,0.0507499034839925,-0.148407525725236,0.0505320959320149,0.334929930387347
Physical measures,X4270.Volume level set by participant (left),GPR37,Prosaposin receptor GPR37,32685,-0.0262953837375954,0.0273173170154213,-0.0798373250878211,0.0272465576126303,0.335779562172717
Physical measures,X4270.Volume level set by participant (left),LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,32964,0.0595839900781577,0.0619606376158448,-0.0618588596488981,0.181026839805213,0.336254701452157
Physical measures,X4270.Volume level set by participant (left),MPO,Myeloperoxidase,32861,0.0353973175201142,0.0368216273561963,-0.0367730720980306,0.107567707138259,0.336417799304495
Physical measures,X4270.Volume level set by participant (left),IL3,Interleukin-3,31492,0.0331672404893443,0.0345307136450207,-0.0345129582548963,0.100847439233585,0.336826932637978
Physical measures,X4270.Volume level set by participant (left),AKT3,RAC-gamma serine/threonine-protein kinase,32599,-0.0292058777751924,0.0304292056279096,-0.0888471208058951,0.0304353652555104,0.337183665637802
Physical measures,X4270.Volume level set by participant (left),SCN4B,Sodium channel subunit beta-4,31566,-0.0463251363034004,0.0483018888361684,-0.14099683842229,0.0483465658154896,0.337551041170586
Physical measures,X4270.Volume level set by participant (left),FOLR3,Folate receptor gamma,32856,0.00865655880780052,0.00903688174697502,-0.00905572941627053,0.0263688470318716,0.3381316950135
Physical measures,X4270.Volume level set by participant (left),CD40,Tumor necrosis factor receptor superfamily member 5,32842,-0.0329990149845121,0.0344624260307026,-0.100545370004689,0.034547340035665,0.33832254472489
Physical measures,X4270.Volume level set by participant (left),PDGFRA,Platelet-derived growth factor receptor alpha,32864,-0.0576412285408069,0.060204793320191,-0.175642623448381,0.0603601663667674,0.338381396385877
Physical measures,X4270.Volume level set by participant (left),MATN3,Matrilin-3,32778,-0.05255380141621,0.0549235740408974,-0.160204006536369,0.055096403703949,0.338667266833615
Physical measures,X4270.Volume level set by participant (left),PDIA3,Protein disulfide-isomerase A3,31599,0.0770631044494114,0.0805803680476962,-0.0808744169240732,0.235000625822896,0.338924885590887
Physical measures,X4270.Volume level set by participant (left),MYOM1,Myomesin-1,31514,-0.0431763150550384,0.0451513939587577,-0.131673047214204,0.0453204171041267,0.338972862063824
Physical measures,X4270.Volume level set by participant (left),IL1R1,Interleukin-1 receptor type 1,32843,-0.073745592436185,0.0771508197499181,-0.224961199146024,0.0774700142736545,0.339167326470939
Physical measures,X4270.Volume level set by participant (left),BABAM1,BRISC and BRCA1-A complex member 1,31508,-0.0675037084400473,0.0707338681660255,-0.206142090045457,0.0711346731653626,0.339944968885083
Physical measures,X4270.Volume level set by participant (left),CCL4,C-C motif chemokine 4,32853,-0.0254537307003669,0.0266742537227056,-0.0777352679968699,0.0268278065961362,0.3399861050666
Physical measures,X4270.Volume level set by participant (left),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",32638,-0.0320466773862501,0.0336729318504535,-0.098045623813139,0.0339522690406388,0.341273129993096
Physical measures,X4270.Volume level set by participant (left),FGF20,Fibroblast growth factor 20,31508,-0.043965184016638,0.0462005922560349,-0.134518344838466,0.0465879768051904,0.341322273792571
Physical measures,X4270.Volume level set by participant (left),ARTN,Artemin,32679,-0.0371498613211261,0.0390576409898956,-0.113702837661321,0.0394031150190694,0.341551892483348
Physical measures,X4270.Volume level set by participant (left),ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",32638,-0.020426721172108,0.0215038795199484,-0.0625743250312068,0.0217208826869907,0.342184831792924
Physical measures,X4270.Volume level set by participant (left),BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",31514,-0.0365170219279175,0.038468682947157,-0.111915640504345,0.0388815966485102,0.342515203151821
Physical measures,X4270.Volume level set by participant (left),MUC16,Mucin-16,32832,-0.00871683684955441,0.00918965397571351,-0.0267285586419529,0.00929488494284407,0.342875609938058
Physical measures,X4270.Volume level set by participant (left),ERBB4,Receptor tyrosine-protein kinase erbB-4,32881,-0.0684432973836066,0.0721874311430578,-0.209930662424,0.0730440676567866,0.343087073670135
Physical measures,X4270.Volume level set by participant (left),DDR1,Epithelial discoidin domain-containing receptor 1,32931,0.0698486972482423,0.073725214348271,-0.0746527228743689,0.214350117370854,0.343450362951356
Physical measures,X4270.Volume level set by participant (left),ALCAM,CD166 antigen,32964,0.0838404502261173,0.0885047401546174,-0.0896288404769329,0.257309740929167,0.34351160068892
Physical measures,X4270.Volume level set by participant (left),GAD2,Glutamate decarboxylase 2,31508,-0.0437525339446131,0.0461989405519332,-0.134302457426402,0.0467973895371761,0.343645138704297
Physical measures,X4270.Volume level set by participant (left),CD59,CD59 glycoprotein,32499,0.0819218567261015,0.086530891012294,-0.0876786896579948,0.251522403110198,0.343800121604476
Physical measures,X4270.Volume level set by participant (left),SPTBN2,"Spectrin beta chain, non-erythrocytic 2",31514,-0.0597971840066494,0.0631780541513302,-0.183626170143256,0.0640318021299577,0.343930325492869
Physical measures,X4270.Volume level set by participant (left),DPP10,Inactive dipeptidyl peptidase 10,32843,-0.0475722750141577,0.0503219345488093,-0.146203266729824,0.0510587167015086,0.344501251434442
Physical measures,X4270.Volume level set by participant (left),ENO1,Alpha-enolase,32852,-0.0219473449268084,0.0232207974002929,-0.0674601078313824,0.0235654179777657,0.34460312770339
Physical measures,X4270.Volume level set by participant (left),EPHB4,Ephrin type-B receptor 4,32964,0.0695970845755912,0.073645368290273,-0.0747478372733438,0.213942006424526,0.344668633093909
Physical measures,X4270.Volume level set by participant (left),PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,32881,-0.0174516766700393,0.0184758669733823,-0.0536643759378687,0.0187610225977901,0.344905772606178
Physical measures,X4270.Volume level set by participant (left),BOLA2_BOLA2B,BolA-like protein 2,31566,-0.0363481898691068,0.0386392119929601,-0.112081045375309,0.0393846656370949,0.346884360908149
Physical measures,X4270.Volume level set by participant (left),GSTA1,Glutathione S-transferase A1,32852,0.0194165193989677,0.0206441616173313,-0.0210460373710017,0.0598790761689371,0.346969401244795
Physical measures,X4270.Volume level set by participant (left),LMOD1,Leiomodin-1,31752,-0.0512604006776873,0.0545205307710511,-0.158120640988947,0.0555998396335728,0.347141909180033
Physical measures,X4270.Volume level set by participant (left),PFDN4,Prefoldin subunit 4,31492,-0.0346017252077954,0.0368322182238163,-0.106792872926475,0.0375894225108845,0.347533704954831
Physical measures,X4270.Volume level set by participant (left),NELL2,Protein kinase C-binding protein NELL2,32894,-0.0561900470391793,0.0598429953799924,-0.173482317983964,0.0611022239056058,0.347777524749104
Physical measures,X4270.Volume level set by participant (left),ROBO1,Roundabout homolog 1,32864,-0.0696626925765472,0.0741991036858646,-0.215092935800842,0.0757675506477475,0.347826975903506
Physical measures,X4270.Volume level set by participant (left),EPHA1,Ephrin type-A receptor 1,32882,0.0491947537650577,0.0524173087321666,-0.0535431713499888,0.151932678880104,0.348001776676355
Physical measures,X4270.Volume level set by participant (left),TYRO3,Tyrosine-protein kinase receptor TYRO3,32864,-0.0568207644439459,0.0605605103294735,-0.175519364689714,0.0618778358018223,0.348142263377007
Physical measures,X4270.Volume level set by participant (left),LUZP2,Leucine zipper protein 2,31724,-0.04135861699469,0.044120255306367,-0.127834317395169,0.0451170834057893,0.348578263375168
Physical measures,X4270.Volume level set by participant (left),CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,32872,-0.0617922876760985,0.0659704566445952,-0.191094382699505,0.0675098073473081,0.348955467742318
Physical measures,X4270.Volume level set by participant (left),CFC1,Cryptic protein,32638,-0.0336440465712593,0.0359233669369601,-0.104053845767701,0.0367657526251825,0.349015608249318
Physical measures,X4270.Volume level set by participant (left),SERPINA12,Serpin A12,32597,0.0130187327389172,0.0139103765784585,-0.0142456053548615,0.0402830708326959,0.349350134837387
Physical measures,X4270.Volume level set by participant (left),PRND,Prion-like protein doppel,31751,-0.0363940647143949,0.0389490100096634,-0.112734124333335,0.0399459949045454,0.350124747134231
Physical measures,X4270.Volume level set by participant (left),NRCAM,Neuronal cell adhesion molecule,32864,-0.0572840439688301,0.0613163707989008,-0.177464130734676,0.0628960427970155,0.350206532665094
Physical measures,X4270.Volume level set by participant (left),CCN4,CCN family member 4,32948,-0.0395108269752578,0.0423032698023784,-0.122425235787919,0.0434035818374039,0.35033392242117
Physical measures,X4270.Volume level set by participant (left),FBLN2,Fibulin-2,31773,-0.0604110991915991,0.0646843792628371,-0.18719248254676,0.0663702841635617,0.350365185892719
Physical measures,X4270.Volume level set by participant (left),PLAUR,Urokinase plasminogen activator surface receptor,32769,0.0603070739280765,0.0646151423547806,-0.0663386050872934,0.186952752943446,0.350676325510039
Physical measures,X4270.Volume level set by participant (left),AOC3,Membrane primary amine oxidase,32878,-0.0530137603350911,0.056904739795333,-0.164547050333944,0.0585195296637616,0.351556377379566
Physical measures,X4270.Volume level set by participant (left),CRHBP,Corticotropin-releasing factor-binding protein,32834,0.0574541831061889,0.0617193574671844,-0.0635157575294926,0.17842412374187,0.351933418186293
Physical measures,X4270.Volume level set by participant (left),LYPD3,Ly6/PLAUR domain-containing protein 3,32830,0.0463205607677211,0.049762117117211,-0.0512131887820125,0.143854310317455,0.351961480771363
Physical measures,X4270.Volume level set by participant (left),TOR1AIP1,Torsin-1A-interacting protein 1,31566,-0.0369722849616846,0.0397240446588815,-0.114831412493092,0.0408868425697232,0.352023392956798
Physical measures,X4270.Volume level set by participant (left),ATXN3,Ataxin-3,31751,-0.0306438276119607,0.0329345924147525,-0.0951956287448755,0.0339079735209541,0.352169190354302
Physical measures,X4270.Volume level set by participant (left),PRG2,Bone marrow proteoglycan,31773,-0.036160551244907,0.0388720759670562,-0.112349820140337,0.0400287176505231,0.352272676598699
Physical measures,X4270.Volume level set by participant (left),ABO,Histo-blood group ABO system transferase,31772,-0.0127756158580585,0.0137574110205848,-0.0397401414584046,0.0141889097422877,0.353106523375054
Physical measures,X4270.Volume level set by participant (left),RANGAP1,Ran GTPase-activating protein 1,32638,0.0317822482343123,0.0342269433794611,-0.0353025607894314,0.098867057258056,0.353135465034361
Physical measures,X4270.Volume level set by participant (left),ALDH2,"Aldehyde dehydrogenase, mitochondrial",31724,-0.0359333786338783,0.0387024079540826,-0.11179009822388,0.0399233409561236,0.35320098492753
Physical measures,X4270.Volume level set by participant (left),PDCD6,Programmed cell death protein 6,32864,-0.0228527348278098,0.0246507814668118,-0.071168266502761,0.0254627968471414,0.353920632031016
Physical measures,X4270.Volume level set by participant (left),TFAP2A,Transcription factor AP-2-alpha,31514,0.0318891968960649,0.0344505932548917,-0.0356339658835227,0.0994123596756525,0.354657015861916
Physical measures,X4270.Volume level set by participant (left),NIT1,Deaminated glutathione amidase,31566,-0.0455595767106562,0.0492387064742172,-0.142067441400122,0.0509482879788096,0.354849408726063
Physical measures,X4270.Volume level set by participant (left),SPRR1B,Cornifin-B,31632,-0.0205708492615451,0.0222366287040706,-0.0641546415215234,0.0230129429984332,0.354948612920589
Physical measures,X4270.Volume level set by participant (left),LRRC59,Leucine-rich repeat-containing protein 59,31762,-0.0381768160480224,0.0412768102247206,-0.119079364088475,0.0427257319924299,0.355047513078678
Physical measures,X4270.Volume level set by participant (left),STX16,Syntaxin-16,32638,-0.0271339075530599,0.0293513244736867,-0.0846625035214859,0.0303946884153661,0.355276151657531
Physical measures,X4270.Volume level set by participant (left),ESM1,Endothelial cell-specific molecule 1,32834,-0.0460821822508011,0.0498748175388535,-0.143836824626954,0.0516724601253518,0.35553360231502
Physical measures,X4270.Volume level set by participant (left),MASP1,Mannan-binding lectin serine protease 1,32776,-0.06785507848093,0.0734543027423801,-0.211825511855995,0.0761153548941349,0.355629686629562
Physical measures,X4270.Volume level set by participant (left),GLP1R,Glucagon-like peptide 1 receptor,31514,-0.050579601048871,0.0547534503039478,-0.157896363644609,0.0567371615468667,0.355635150011418
Physical measures,X4270.Volume level set by participant (left),BRD3,Bromodomain-containing protein 3,31495,-0.0401137112959196,0.043452628258911,-0.125280862683385,0.045053440091546,0.355953218246998
Physical measures,X4270.Volume level set by participant (left),DAAM1,Disheveled-associated activator of morphogenesis 1,31599,-0.0227638044400354,0.0246795807867298,-0.0711357827820258,0.025608173901955,0.356362275310506
Physical measures,X4270.Volume level set by participant (left),LCAT,Phosphatidylcholine-sterol acyltransferase,31772,-0.0825664324405099,0.0895747564074937,-0.258132954999197,0.0930000901181777,0.356681863169781
Physical measures,X4270.Volume level set by participant (left),NOTCH3,Neurogenic locus notch homolog protein 3,32964,-0.0457702255957313,0.04973439297948,-0.143249635835512,0.0517091846440494,0.357443933363091
Physical measures,X4270.Volume level set by participant (left),EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,32936,-0.0531115269252331,0.0577648414130705,-0.166330616094851,0.0601075622443851,0.357887916855
Physical measures,X4270.Volume level set by participant (left),TMPRSS11D,Transmembrane protease serine 11D,31725,0.0502590041053028,0.0546931412676188,-0.05693955277923,0.157457560989836,0.358161948593808
Physical measures,X4270.Volume level set by participant (left),C2,Complement C2,32872,0.0721433858849972,0.0785262503508014,-0.0817680648025735,0.226054836572568,0.358268313130878
Physical measures,X4270.Volume level set by participant (left),KRT19,"Keratin, type I cytoskeletal 19",32833,0.0241495113259252,0.0262996432746396,-0.0273977894923684,0.0756968121442188,0.358515395529177
Physical measures,X4270.Volume level set by participant (left),CEP112,Centrosomal protein of 112 kDa,31495,0.0420133510229865,0.0457620165937221,-0.0476802015007088,0.131706903546682,0.358604179811226
Physical measures,X4270.Volume level set by participant (left),ATP6V1F,V-type proton ATPase subunit F,32624,-0.0241990568191078,0.0263954764938263,-0.0759341907470074,0.0275360771087918,0.359278963028757
Physical measures,X4270.Volume level set by participant (left),WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",32864,0.0471518249011173,0.0515244114040226,-0.053836021450767,0.148139671253002,0.360144944849306
Physical measures,X4270.Volume level set by participant (left),SERPINC1,Antithrombin-III,31758,-0.12333901722091,0.134895794990802,-0.387734775402882,0.141056740961062,0.360572387030807
Physical measures,X4270.Volume level set by participant (left),CTSZ,Cathepsin Z,32834,0.0511433170399167,0.0559365214246091,-0.0584922649523172,0.160778899032151,0.360578586789224
Physical measures,X4270.Volume level set by participant (left),LECT2,Leukocyte cell-derived chemotaxin-2,31762,-0.026583418576371,0.0290949103520379,-0.0836094428663652,0.0304426057136232,0.360913248519476
Physical measures,X4270.Volume level set by participant (left),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",31751,-0.0464820146588182,0.0509251942611005,-0.146295395410575,0.0533313660929387,0.361401485641435
Physical measures,X4270.Volume level set by participant (left),LMOD2,Leiomodin-2,31514,-0.0292747760391988,0.0320819846208745,-0.0921554658961128,0.0336059138177152,0.361534893373627
Physical measures,X4270.Volume level set by participant (left),MRI1,Methylthioribose-1-phosphate isomerase,31546,-0.026725841417836,0.0293146438205595,-0.0841825433061327,0.0307308604704607,0.361961004260178
Physical measures,X4270.Volume level set by participant (left),FGFBP2,Fibroblast growth factor-binding protein 2,31773,-0.0361536757721348,0.0396700792265078,-0.11390703105609,0.0415996795118204,0.362134126825648
Physical measures,X4270.Volume level set by participant (left),MMP3,Stromelysin-1,32861,-0.0327917786146968,0.0359947119076787,-0.103341413953747,0.0377578567243535,0.362311052753737
Physical measures,X4270.Volume level set by participant (left),MMP15,Matrix metalloproteinase-15,31762,0.0352060861391984,0.0386639958352198,-0.0405753456978325,0.110987517976229,0.362552338656379
Physical measures,X4270.Volume level set by participant (left),ANGPT2,Angiopoietin-2,32948,0.0403691163590676,0.044369947314793,-0.0465959803779267,0.127334213096062,0.362936221860065
Physical measures,X4270.Volume level set by participant (left),MSR1,Macrophage scavenger receptor types I and II,32931,0.0339842515138106,0.037367992617551,-0.0392570140165894,0.107225517044211,0.363137789783795
Physical measures,X4270.Volume level set by participant (left),UNC79,Protein unc-79 homolog,31492,-0.0336645170872546,0.0371036023461981,-0.106387577685803,0.0390585435112937,0.364270865920927
Physical measures,X4270.Volume level set by participant (left),MORC3,MORC family CW-type zinc finger protein 3,31751,-0.06462844731456,0.0713440845615987,-0.204462853055293,0.0752059584261735,0.36503247136276
Physical measures,X4270.Volume level set by participant (left),PTGR1,Prostaglandin reductase 1,31762,-0.0225469562643613,0.0249224653826579,-0.0713949884143708,0.0263010758856482,0.365660398401168
Physical measures,X4270.Volume level set by participant (left),CCL23,C-C motif chemokine 23,32894,0.0372470653944629,0.0411716512692334,-0.0434493710932346,0.11794350188216,0.36566041174144
Physical measures,X4270.Volume level set by participant (left),RNF168,E3 ubiquitin-protein ligase RNF168,31508,0.0428055731915262,0.0474191498599196,-0.0501359605339163,0.135747106916969,0.366710144158142
Physical measures,X4270.Volume level set by participant (left),BMP10,Bone morphogenetic protein 10,31599,-0.0648985335720005,0.0719689977023674,-0.205957769068641,0.0761607019246396,0.367214142808408
Physical measures,X4270.Volume level set by participant (left),HLA_E,,32843,-0.0564448548079588,0.0626758411694431,-0.179289503500067,0.0663997938841497,0.367833737398476
Physical measures,X4270.Volume level set by participant (left),GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,31632,-0.0259462220725492,0.0288649611096953,-0.082521545847552,0.0306291017024535,0.368742855924849
Physical measures,X4270.Volume level set by participant (left),GAGE2A,G antigen 2A,31492,-0.0289281547166178,0.0322075445120851,-0.0920549419603045,0.0341986325270689,0.369118230643024
Physical measures,X4270.Volume level set by participant (left),BTN3A2,Butyrophilin subfamily 3 member A2,32843,-0.0427343811810425,0.0475962323658221,-0.136022996618054,0.0505542342559688,0.369288430757797
Physical measures,X4270.Volume level set by participant (left),INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",32832,-0.0167539732544187,0.0186676528963895,-0.0533425729313421,0.0198346264225047,0.369483269880726
Physical measures,X4270.Volume level set by participant (left),GUK1,Guanylate kinase,31495,-0.0424882665213786,0.0474192329459431,-0.135429963095427,0.05045343005267,0.370273884312283
Physical measures,X4270.Volume level set by participant (left),TIGAR,"Fructose-2,6-bisphosphatase TIGAR",32624,0.0332774444912885,0.037143233912605,-0.0395232939774173,0.106078182959994,0.370318979952373
Physical measures,X4270.Volume level set by participant (left),C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,32878,0.037066425780457,0.0414308999712213,-0.0441381381631367,0.118270989724051,0.370994600377045
Physical measures,X4270.Volume level set by participant (left),CSRP3,Cysteine and glycine-rich protein 3,31495,0.0189155229095284,0.0211445422050989,-0.0225277798124654,0.0603588256315221,0.371038887751724
Physical measures,X4270.Volume level set by participant (left),NEFL,Neurofilament light polypeptide,32622,-0.0374078753061344,0.0418557793067731,-0.11944520274741,0.0446294521351409,0.371489523194239
Physical measures,X4270.Volume level set by participant (left),MORN4,MORN repeat-containing protein 4,31492,0.0228403942128671,0.0255573418799009,-0.0272519958717388,0.0729327842974729,0.371514851099786
Physical measures,X4270.Volume level set by participant (left),STAM,Signal transducing adapter molecule 1,31724,-0.0459184893381635,0.0514716570624856,-0.146802937180635,0.0549659585043082,0.372360143050798
Physical measures,X4270.Volume level set by participant (left),ZNF174,Zinc finger protein 174,31508,-0.0501961308962903,0.0562947509249225,-0.160533842709138,0.0601415809165578,0.372599897341493
Physical measures,X4270.Volume level set by participant (left),CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,31720,-0.0212106186881818,0.0237889465300265,-0.0678369538870336,0.0254157165106701,0.372625794184102
Physical measures,X4270.Volume level set by participant (left),ANK2,Ankyrin-2,31495,0.025787914765274,0.0290113133689187,-0.0310742594378067,0.0826500889683547,0.374089317929688
Physical measures,X4270.Volume level set by participant (left),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,32864,0.0492369899022946,0.0554173512802779,-0.0593810186070501,0.157854998411639,0.374308469899676
Physical measures,X4270.Volume level set by participant (left),PLIN1,Perilipin-1,32644,0.044989261914552,0.0506482516653471,-0.0542813113495282,0.144259835178632,0.374420506784826
Physical measures,X4270.Volume level set by participant (left),RPS10,40S ribosomal protein S10,31495,-0.0418563045530082,0.0472484813878701,-0.134463328073234,0.0507507189672173,0.375712160069816
Physical measures,X4270.Volume level set by participant (left),ARHGEF12,Rho guanine nucleotide exchange factor 12,32843,-0.0157055606283307,0.0177453747786492,-0.0504864951944832,0.0190753739378218,0.376152854914465
Physical measures,X4270.Volume level set by participant (left),ACE,Angiotensin-converting enzyme,31772,-0.0680277679430719,0.0769480363844769,-0.218845919256647,0.0827903833705029,0.376683073316326
Physical measures,X4270.Volume level set by participant (left),VMO1,Vitelline membrane outer layer protein 1 homolog,32832,-0.0227953273728184,0.0258012030415351,-0.0733656853342272,0.0277750305885904,0.37699060642601
Physical measures,X4270.Volume level set by participant (left),ARNT,Aryl hydrocarbon receptor nuclear translocator,32679,-0.0406341914508215,0.0460235034924251,-0.130840258295975,0.0495718753943317,0.377313905058445
Physical measures,X4270.Volume level set by participant (left),SCARB2,Lysosome membrane protein 2,32613,-0.0570800445952998,0.064676148802638,-0.18384529624847,0.0696852070578706,0.377502783386021
Physical measures,X4270.Volume level set by participant (left),ADM,Pro-adrenomedullin,32948,0.0551626116872788,0.0625060764745633,-0.0673492982028654,0.177674521577423,0.377521188686411
Physical measures,X4270.Volume level set by participant (left),KIAA2013,Uncharacterized protein KIAA2013,31724,-0.0284256075128585,0.0322344461543734,-0.0916051219754303,0.0347539069497133,0.377890576367707
Physical measures,X4270.Volume level set by participant (left),UPK3A,Uroplakin-3a,31514,-0.0367941625431878,0.041736497279357,-0.118597697210728,0.045009372124352,0.378030355578671
Physical measures,X4270.Volume level set by participant (left),TXK,Tyrosine-protein kinase TXK,31632,-0.0233296393924364,0.0264887545246329,-0.075247598260717,0.0285883194758441,0.37848716017766
Physical measures,X4270.Volume level set by participant (left),GUCA2A,Guanylin,32812,-0.0481174426716951,0.0546387269950934,-0.155209347582078,0.058974462238688,0.378532445246912
Physical measures,X4270.Volume level set by participant (left),BTNL10,Butyrophilin-like protein 10,31492,0.0453142919051554,0.0514706084410714,-0.0555681006393445,0.146196684449655,0.378674931649552
Physical measures,X4270.Volume level set by participant (left),IGSF3,Immunoglobulin superfamily member 3,32832,-0.0430137905330571,0.0488638470431358,-0.138786930737603,0.0527593496714892,0.378732080845825
Physical measures,X4270.Volume level set by participant (left),DBH,Dopamine beta-hydroxylase,31762,0.0157645310386352,0.0179106983665699,-0.0193404377598418,0.0508694998371122,0.378791832867599
Physical measures,X4270.Volume level set by participant (left),FASLG,Tumor necrosis factor ligand superfamily member 6,32961,-0.0407342452387738,0.0463248395901658,-0.131530930835499,0.0500624403579511,0.379252337140529
Physical measures,X4270.Volume level set by participant (left),FLT4,Vascular endothelial growth factor receptor 3,32881,0.0438566569687276,0.0499844840633754,-0.0541129317954882,0.141826245732944,0.380289846706585
Physical measures,X4270.Volume level set by participant (left),SRP14,Signal recognition particle 14 kDa protein,32832,-0.0255330411707798,0.0292415628070926,-0.0828465042726812,0.0317804219311216,0.382590338264709
Physical measures,X4270.Volume level set by participant (left),ICAM4,Intercellular adhesion molecule 4,32843,-0.0284081031817774,0.0325582247948063,-0.0922222237795977,0.0354060174160429,0.38294137711048
Physical measures,X4270.Volume level set by participant (left),NEDD9,Enhancer of filamentation 1,31508,0.0505695889670324,0.0579827134530961,-0.063076529401036,0.164215707335101,0.383154266741766
Physical measures,X4270.Volume level set by participant (left),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,32638,0.0251373206375461,0.0288293751952011,-0.031368254745048,0.0816428960201402,0.383268084598795
Physical measures,X4270.Volume level set by participant (left),SCGB2A2,Mammaglobin-A,31495,-0.0553552610911838,0.063506763309827,-0.179828517178445,0.0691179949960772,0.383430279004438
Physical measures,X4270.Volume level set by participant (left),FAM3B,Protein FAM3B,32832,-0.0403071106602355,0.0462843227732961,-0.131024383295896,0.0504101619754247,0.383854552689507
Physical measures,X4270.Volume level set by participant (left),GIPC2,PDZ domain-containing protein GIPC2,31751,-0.0558127795988978,0.0640969896188731,-0.181442879251889,0.0698173200540934,0.383914393288654
Physical measures,X4270.Volume level set by participant (left),PSMG4,Proteasome assembly chaperone 4,31508,-0.0301859830884661,0.0347100664463303,-0.0982177133232736,0.0378457471463413,0.384513120347636
Physical measures,X4270.Volume level set by participant (left),ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,31495,-0.0444311197320236,0.0511056043128445,-0.144598104185199,0.0557358647211516,0.384656714805973
Physical measures,X4270.Volume level set by participant (left),ANXA11,Annexin A11,32831,-0.0241688569742029,0.0278119788217937,-0.0786803354649186,0.0303426215165127,0.384865521678812
Physical measures,X4270.Volume level set by participant (left),TP53INP1,Tumor protein p53-inducible nuclear protein 1,32685,-0.0468892909405519,0.0539674016043887,-0.152665398085154,0.05888681620405,0.3849557150771
Physical measures,X4270.Volume level set by participant (left),EDNRB,Endothelin receptor type B,31508,0.0392599902691095,0.0452874873896416,-0.049503485014588,0.128023465552807,0.386020774848722
Physical measures,X4270.Volume level set by participant (left),SPRR3,Small proline-rich protein 3,31751,0.0257788976878722,0.029738856178772,-0.0325092604225208,0.0840670557982653,0.386054803597243
Physical measures,X4270.Volume level set by participant (left),OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",31566,-0.0242703110533917,0.0280392609730347,-0.0792272625605397,0.0306866404537564,0.38674577147598
Physical measures,X4270.Volume level set by participant (left),IL18,Interleukin-18,32818,0.0315502734680392,0.0364615696879648,-0.0399144031203717,0.10301495005645,0.386896168585977
Physical measures,X4270.Volume level set by participant (left),ITGA11,Integrin alpha-11,32843,-0.0436301684144722,0.0505307706267131,-0.14267047884283,0.0554101420138855,0.387919962078099
Physical measures,X4270.Volume level set by participant (left),TMPRSS5,Transmembrane protease serine 5,32742,0.0396652996945309,0.0460058855640291,-0.0505062360109662,0.129836835400028,0.388612412795578
Physical measures,X4270.Volume level set by participant (left),RAB6B,Ras-related protein Rab-6B,32644,0.0326665292311934,0.0378911338655578,-0.0416000931452999,0.106933151607687,0.388647571972604
Physical measures,X4270.Volume level set by participant (left),BSND,Barttin,31492,-0.0522321635220395,0.0606096222915116,-0.171027023213402,0.0665626961693232,0.388835649262566
Physical measures,X4270.Volume level set by participant (left),FDX2,"Ferredoxin-2, mitochondrial",31495,-0.0306971392304415,0.0356357592374819,-0.100543227335906,0.039148948875023,0.389037171888246
Physical measures,X4270.Volume level set by participant (left),MEGF11,Multiple epidermal growth factor-like domains protein 11,31495,-0.0557590397490254,0.0647299303873457,-0.182629703308223,0.0711116238101722,0.389039073980753
Physical measures,X4270.Volume level set by participant (left),HLA_DRA,,32815,0.0415367814068591,0.048244452609809,-0.0530223457083666,0.136095908522085,0.389280421417597
Physical measures,X4270.Volume level set by participant (left),ALPP,"Alkaline phosphatase, placental type",32832,0.014000191889246,0.016326170437576,-0.0179991021684029,0.0459994859468949,0.391174584815557
Physical measures,X4270.Volume level set by participant (left),FAM171A2,Protein FAM171A2,31752,-0.0107426526770553,0.0125312034840411,-0.0353038115057759,0.0138185061516652,0.39132049655349
Physical measures,X4270.Volume level set by participant (left),ANXA1,Annexin A1,31558,0.0379175473589404,0.0442309605970482,-0.048775135411274,0.124610230129155,0.391326481680245
Physical measures,X4270.Volume level set by participant (left),MSLNL,Mesothelin-like protein,31546,-0.0480174812939526,0.0560618369284319,-0.157898681673679,0.0618637190857739,0.391742877325735
Physical measures,X4270.Volume level set by participant (left),UBE2Z,Ubiquitin-conjugating enzyme E2 Z,31508,-0.028960688333781,0.0338505265188856,-0.0953077203107967,0.0373863436432347,0.39227566755034
Physical measures,X4270.Volume level set by participant (left),LIF,Leukemia inhibitory factor,32644,0.0277135055591954,0.0323935634170965,-0.0357778787383138,0.0912048898567045,0.392283875208982
Physical measures,X4270.Volume level set by participant (left),MYH4,Myosin-4,31495,-0.0368327772714762,0.0430864374060235,-0.121282194587282,0.04761664004433,0.392656706385928
Physical measures,X4270.Volume level set by participant (left),IGFBP3,Insulin-like growth factor-binding protein 3,32878,-0.052380343024971,0.0613157024271383,-0.172559119782162,0.0677984337322201,0.392976497947007
Physical measures,X4270.Volume level set by participant (left),IGFBP6,Insulin-like growth factor-binding protein 6,32802,-0.0546743945111061,0.0640043143787324,-0.180122850693422,0.0707740616712093,0.393000550246681
Physical measures,X4270.Volume level set by participant (left),FEN1,Flap endonuclease 1,32638,0.0239878728792694,0.0280854341621566,-0.0310595780785576,0.0790353238370964,0.393070856471857
Physical measures,X4270.Volume level set by participant (left),ARHGEF10,Rho guanine nucleotide exchange factor 10,31752,-0.0185916602713235,0.0217739384409756,-0.0612685796156357,0.0240852590729887,0.393214466087227
Physical measures,X4270.Volume level set by participant (left),ZP4,Zona pellucida sperm-binding protein 4,31492,-0.0560335759809228,0.0656292135258713,-0.184666834491631,0.072599682529785,0.393248080548936
Physical measures,X4270.Volume level set by participant (left),S100A14,Protein S100-A14,31752,-0.0332087696059696,0.0389055840051195,-0.109463714256004,0.0430461750440647,0.393367346853727
Physical measures,X4270.Volume level set by participant (left),CST1,Cystatin-SN,30704,-0.0191474453018291,0.0224613348417655,-0.0631716615916895,0.0248767709880312,0.393987295201751
Physical measures,X4270.Volume level set by participant (left),PTS,6-pyruvoyl tetrahydrobiopterin synthase,32613,0.0275147668591465,0.0323032370260245,-0.0357995777118616,0.0908291114301545,0.394367843556017
Physical measures,X4270.Volume level set by participant (left),EEF1D,Elongation factor 1-delta,31762,-0.0187105666572636,0.0220026852143959,-0.0618358296774796,0.0244146963629525,0.395141566780141
Physical measures,X4270.Volume level set by participant (left),SPESP1,Sperm equatorial segment protein 1,31762,-0.0579300340658857,0.0681335091816067,-0.191471712061835,0.0756116439300634,0.395215812359309
Physical measures,X4270.Volume level set by participant (left),BRDT,Bromodomain testis-specific protein,31495,-0.0475129726850353,0.055885549970508,-0.157048650627231,0.0620227052571603,0.395249741645881
Physical measures,X4270.Volume level set by participant (left),CRLF1,Cytokine receptor-like factor 1,32894,0.055361328466932,0.0651727210197093,-0.0723772047316983,0.183099861665562,0.395650380599977
Physical measures,X4270.Volume level set by participant (left),BTD,Biotinidase,31770,0.0795893556523217,0.0938865906633009,-0.104428362047748,0.263607073352391,0.396620681982199
Physical measures,X4270.Volume level set by participant (left),PDIA2,Protein disulfide-isomerase A2,31492,-0.0444245011560878,0.0524222905771782,-0.147172190687357,0.0583231883751815,0.396779102723176
Physical measures,X4270.Volume level set by participant (left),SCGB1A1,Uteroglobin,32879,-0.0267426264183635,0.0315782476810773,-0.0886359918732749,0.035150739036548,0.397090843707044
Physical measures,X4270.Volume level set by participant (left),BCL7B,B-cell CLL/lymphoma 7 protein family member B,31724,-0.0359940921321679,0.0425944311687887,-0.119479177222994,0.047490992958658,0.398112991999324
Physical measures,X4270.Volume level set by participant (left),POMC,Pro-opiomelanocortin,31566,0.0242544126889254,0.0287026347883925,-0.0320027514963239,0.0805115768741747,0.398123734258648
Physical measures,X4270.Volume level set by participant (left),VSNL1,Visinin-like protein 1,31751,0.0450954815994567,0.0533838198724196,-0.0595368053504857,0.149727768549399,0.398281289355384
Physical measures,X4270.Volume level set by participant (left),COPE,Coatomer subunit epsilon,32644,0.0317914732331935,0.0376511028078771,-0.0420046882702457,0.105587634736633,0.398485512748213
Physical measures,X4270.Volume level set by participant (left),PHLDB2,Pleckstrin homology-like domain family B member 2,31492,0.0186061982956621,0.0220906681494892,-0.0246915112773367,0.0619039078686608,0.399665997472416
Physical measures,X4270.Volume level set by participant (left),IL5RA,Interleukin-5 receptor subunit alpha,32843,-0.026700503656316,0.0317197467182391,-0.0888712072240646,0.0354701999114326,0.399943139071933
Physical measures,X4270.Volume level set by participant (left),PGA4,Pepsin A-4,31772,-0.0270998260125258,0.0322543538826585,-0.0903183596225364,0.0361187075974849,0.400826559507712
Physical measures,X4270.Volume level set by participant (left),CSPG4,Chondroitin sulfate proteoglycan 4,31773,-0.050158485036991,0.0597359139435291,-0.167240876366308,0.066923906292326,0.401118532620976
Physical measures,X4270.Volume level set by participant (left),HMOX1,Heme oxygenase 1,32756,-0.0304560062672249,0.0362987644674574,-0.101601584623441,0.0406895720889916,0.401471102520166
Physical measures,X4270.Volume level set by participant (left),PGD,"6-phosphogluconate dehydrogenase, decarboxylating",31762,-0.0321787998532472,0.0383688648489919,-0.107381774957271,0.0430241752507768,0.401680130255059
Physical measures,X4270.Volume level set by participant (left),COL4A1,Collagen alpha-1(IV) chain,32864,-0.0362034263356968,0.0431821212302396,-0.120840383946967,0.0484335312755728,0.401834386464692
Physical measures,X4270.Volume level set by participant (left),PDCD5,Programmed cell death protein 5,32931,-0.0252539277972938,0.0301308011770092,-0.0843102981042318,0.0338024425096443,0.401972342780225
Physical measures,X4270.Volume level set by participant (left),COL4A4,Collagen alpha-4(IV) chain,31624,-0.0329937333850399,0.039366173408834,-0.110151433266355,0.0441639664962748,0.401986894744885
Physical measures,X4270.Volume level set by participant (left),ADAMTSL5,ADAMTS-like protein 5,31762,-0.0418544570558064,0.0500356785153947,-0.13992438694598,0.0562154728343671,0.402903341842457
Physical measures,X4270.Volume level set by participant (left),CTNNA1,Catenin alpha-1,31514,-0.0465657872822673,0.0556754259600338,-0.155689622163934,0.0625580475993989,0.402967538195337
Physical measures,X4270.Volume level set by participant (left),CNTNAP2,Contactin-associated protein-like 2,32843,-0.034212761322616,0.0409114872593784,-0.114399276350998,0.0459737537057657,0.403029238734541
Physical measures,X4270.Volume level set by participant (left),IDS,Iduronate 2-sulfatase,32961,-0.15570770286659,0.186230256840625,-0.520719006274216,0.209303600541036,0.403118839027758
Physical measures,X4270.Volume level set by participant (left),APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,32832,0.0310918935438045,0.0372072723264673,-0.0418343602160715,0.10401814730368,0.403379590289379
Physical measures,X4270.Volume level set by participant (left),CTHRC1,Collagen triple helix repeat-containing protein 1,31773,-0.0602516888041315,0.0721744471433141,-0.201713605205027,0.0812102275967642,0.403851946001931
Physical measures,X4270.Volume level set by participant (left),CCL3,C-C motif chemokine 3,32843,0.0205285145910577,0.024605070394809,-0.0276974233827679,0.0687544525648832,0.4041225971242
Physical measures,X4270.Volume level set by participant (left),SORCS2,VPS10 domain-containing receptor SorCS2,32638,0.0420338019307414,0.0504562048963527,-0.0568603596661099,0.140927963527593,0.404825116417602
Physical measures,X4270.Volume level set by participant (left),GM2A,Ganglioside GM2 activator,31573,0.0474274517531369,0.0569358781017741,-0.0641668693263404,0.159021772832614,0.404871866358152
Physical measures,X4270.Volume level set by participant (left),SMAD5,Mothers against decapentaplegic homolog 5,32832,-0.0692266606083348,0.0833263328900049,-0.232546273072744,0.0940929518560747,0.406114546784892
Physical measures,X4270.Volume level set by participant (left),GSAP,Gamma-secretase-activating protein,32638,0.0170062655619885,0.0204924729137064,-0.0231589813488761,0.0571715124728532,0.406629978070665
Physical measures,X4270.Volume level set by participant (left),SPARCL1,SPARC-like protein 1,32847,-0.0502947909089363,0.0606211389602503,-0.169112223271027,0.0685226414531543,0.406754423192845
Physical measures,X4270.Volume level set by participant (left),CCL16,C-C motif chemokine 16,32964,0.0259819031157591,0.0313282813114694,-0.0354215282547209,0.0873853344862391,0.406931874395988
Physical measures,X4270.Volume level set by participant (left),BOC,Brother of CDO,32685,-0.060740290512622,0.0732571136165897,-0.204324233201138,0.0828436521758938,0.407048494678295
Physical measures,X4270.Volume level set by participant (left),IL6ST,Interleukin-6 receptor subunit beta,32864,-0.0807955933780594,0.0974861749235145,-0.271868496228148,0.110277309472029,0.407245070427354
Physical measures,X4270.Volume level set by participant (left),PRSS22,Brain-specific serine protease 4,31508,-0.0485187750265527,0.0585417734740863,-0.163260651035762,0.0662231009826565,0.40724971554909
Physical measures,X4270.Volume level set by participant (left),DSG2,Desmoglein-2,32861,-0.0532597389022699,0.0642772958699064,-0.179243238807286,0.0727237610027466,0.407356538850033
Physical measures,X4270.Volume level set by participant (left),VAT1,Synaptic vesicle membrane protein VAT-1 homolog,32832,-0.0720378242338486,0.0870001833129891,-0.242558183527307,0.09848253505961,0.407681644721581
Physical measures,X4270.Volume level set by participant (left),DCTN1,Dynactin subunit 1,32948,-0.0224710043609702,0.0271395683382252,-0.0756645583038916,0.0307225495819511,0.40770389762399
Physical measures,X4270.Volume level set by participant (left),INSL5,Insulin-like peptide INSL5,31720,-0.0173258294328611,0.0209328762000955,-0.0583542667850484,0.0237026079193261,0.40787400576842
Physical measures,X4270.Volume level set by participant (left),FZD8,Frizzled-8,31514,-0.038513320162163,0.0465373271675871,-0.129726481410634,0.0526998410863078,0.40793470966714
Physical measures,X4270.Volume level set by participant (left),CD177,CD177 antigen,32849,0.0113908613360216,0.0137652246405977,-0.0155889789595499,0.038370701631593,0.407970019019848
Physical measures,X4270.Volume level set by participant (left),IGFBP1,Insulin-like growth factor-binding protein 1,32960,0.0111657635069854,0.0135584683507426,-0.0154088344604701,0.037740361474441,0.41023001091531
Physical measures,X4270.Volume level set by participant (left),SCPEP1,Retinoid-inducible serine carboxypeptidase,31541,-0.0331852435991195,0.0403044534092501,-0.11218197228125,0.0458114850830108,0.410326493821586
Physical measures,X4270.Volume level set by participant (left),GBA,Lysosomal acid glucosylceramidase,31546,-0.0314956374973715,0.038287871892726,-0.106539866407114,0.0435485914123714,0.410760521533611
Physical measures,X4270.Volume level set by participant (left),CDC123,Cell division cycle protein 123 homolog,31492,-0.0266384517579454,0.0323983073736031,-0.0901391342102074,0.0368622306943166,0.41097887899828
Physical measures,X4270.Volume level set by participant (left),EGLN1,Egl nine homolog 1,32843,0.0268690881855449,0.032685302212549,-0.0371941041510512,0.0909322805221409,0.411067906902643
Physical measures,X4270.Volume level set by participant (left),AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,31301,-0.0343860381422133,0.0418347565903675,-0.116382161059334,0.0476100847749069,0.4111322455058
Physical measures,X4270.Volume level set by participant (left),NFASC,Neurofascin,32961,-0.0498046610031067,0.0607087473449054,-0.168793805799121,0.0691844837929079,0.412017074489145
Physical measures,X4270.Volume level set by participant (left),POF1B,Protein POF1B,31508,0.0363983849229477,0.0444277996282391,-0.0506801023484009,0.123476872194296,0.412657647079796
Physical measures,X4270.Volume level set by participant (left),IGDCC4,Immunoglobulin superfamily DCC subclass member 4,31773,-0.0631588695398242,0.0771163777495003,-0.214306969928845,0.0879892308491964,0.412806972918658
Physical measures,X4270.Volume level set by participant (left),TCN1,Transcobalamin-1,31601,-0.050523535112222,0.0616961733809308,-0.171448034938846,0.0704009647144022,0.412863706646435
Physical measures,X4270.Volume level set by participant (left),UROS,Uroporphyrinogen-III synthase,31546,-0.0247563126252003,0.0302395852025685,-0.0840258996222346,0.034513274371834,0.412998760912668
Physical measures,X4270.Volume level set by participant (left),DDT,D-dopachrome decarboxylase,31773,-0.0384578476797705,0.0469829628432187,-0.130544454852479,0.0536287594929382,0.413068549387033
Physical measures,X4270.Volume level set by participant (left),PRDX6,Peroxiredoxin-6,32948,-0.0217102802365739,0.0265312346012832,-0.0737115000550889,0.0302909395819411,0.413212295961369
Physical measures,X4270.Volume level set by participant (left),MORF4L2,Mortality factor 4-like protein 2,31492,-0.0434373273307071,0.0531027446766161,-0.147518706896875,0.0606440522354604,0.413390452638361
Physical measures,X4270.Volume level set by participant (left),CLIP2,CAP-Gly domain-containing linker protein 2,32843,-0.0127216179866164,0.0156068116160279,-0.0433109687540311,0.0178677327807982,0.415018138528871
Physical measures,X4270.Volume level set by participant (left),ABL1,Tyrosine-protein kinase ABL1,32832,-0.0203014973466627,0.0249066695927607,-0.0691185697484736,0.0285155750551483,0.415035084207244
Physical measures,X4270.Volume level set by participant (left),GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,31632,-0.0224998495396253,0.0276110917997549,-0.076617589467145,0.0316178903878944,0.41516342968363
Physical measures,X4270.Volume level set by participant (left),MTR,Methionine synthase,31495,-0.0249391722707348,0.0306493380404063,-0.0850118748299312,0.0351335302884616,0.415845847734826
Physical measures,X4270.Volume level set by participant (left),HAO1,Hydroxyacid oxidase 1,32948,0.0107655247861197,0.013263230668896,-0.0152304073249166,0.0367614568971559,0.416995425701134
Physical measures,X4270.Volume level set by participant (left),IGFBP2,Insulin-like growth factor-binding protein 2,32940,-0.0223223049863919,0.0275152880363745,-0.0762522695376859,0.0316076595649021,0.417232380377345
Physical measures,X4270.Volume level set by participant (left),HPGDS,Hematopoietic prostaglandin D synthase,32638,0.038293014229751,0.0472185180433543,-0.0542552811352234,0.130841309594725,0.417402307431569
Physical measures,X4270.Volume level set by participant (left),PADI4,Protein-arginine deiminase type-4,32629,0.0200989380927591,0.0247929510034666,-0.0284952458740353,0.0686931220595536,0.417576368070575
Physical measures,X4270.Volume level set by participant (left),ATP5F1D,"ATP synthase subunit delta, mitochondrial",31495,-0.0306507093305788,0.0378578282165531,-0.104852052635023,0.0435506339738653,0.418179986428412
Physical measures,X4270.Volume level set by participant (left),IL11,Interleukin-11,32679,-0.0223082183155671,0.0275992989259148,-0.07640284421036,0.0317864075792258,0.418945864333436
Physical measures,X4270.Volume level set by participant (left),ACSL1,Long-chain-fatty-acid--CoA ligase 1,31495,-0.0463155420463312,0.0573298509489644,-0.158682049906301,0.066050965813639,0.419185828098476
Physical measures,X4270.Volume level set by participant (left),HSPA1A,Heat shock 70 kDa protein 1A,32882,-0.0201395093129203,0.0249560668128475,-0.0690534002661015,0.0287743816402608,0.419688608611382
Physical measures,X4270.Volume level set by participant (left),PCDH7,Protocadherin-7,31720,-0.0466202060524323,0.057934830240119,-0.160172473323066,0.0669320612182008,0.421016688203201
Physical measures,X4270.Volume level set by participant (left),C4BPB,C4b-binding protein beta chain,32881,0.0347412076596764,0.0431794086715053,-0.049890433336474,0.119372848655827,0.421084379805422
Physical measures,X4270.Volume level set by participant (left),AKR1B1,Aldo-keto reductase family 1 member B1,32638,-0.0192125201390206,0.0239099235355089,-0.066075970268618,0.0276509299905768,0.421685897531684
Physical measures,X4270.Volume level set by participant (left),SOX9,Transcription factor SOX-9,31546,-0.0613516598956832,0.0763635200293854,-0.211024159153279,0.0883208393619122,0.421759290017695
Physical measures,X4270.Volume level set by participant (left),DCDC2C,Doublecortin domain-containing protein 2C,31492,-0.0252503759809685,0.03144215700017,-0.0868770037013017,0.0363762517393647,0.421957034441866
Physical measures,X4270.Volume level set by participant (left),DDX39A,ATP-dependent RNA helicase DDX39A,31508,0.0711167149992635,0.0885820209480572,-0.102504046058929,0.244737476057456,0.422095274458465
Physical measures,X4270.Volume level set by participant (left),RTKN2,Rhotekin-2,31495,0.0304706708797147,0.0379855588032395,-0.0439810243746347,0.104922366134064,0.422482722457057
Physical measures,X4270.Volume level set by participant (left),CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",31508,-0.0593131284767299,0.0739961320447867,-0.204345547284512,0.0857192903310521,0.422826267302539
Physical measures,X4270.Volume level set by participant (left),NLGN2,Neuroligin-2,31514,-0.0352326417044443,0.0440590288768651,-0.1215883383031,0.0511230548942112,0.42392739607137
Physical measures,X4270.Volume level set by participant (left),SNX9,Sorting nexin-9,32864,-0.020842180685126,0.0261009359760246,-0.0720000151981341,0.0303156538278822,0.424588497556951
Physical measures,X4270.Volume level set by participant (left),LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,31546,0.0376384182638705,0.0471960783683445,-0.0548658953380847,0.130142731865826,0.425190935873907
Physical measures,X4270.Volume level set by participant (left),MCEMP1,Mast cell-expressed membrane protein 1,31508,-0.0179697194686739,0.0225891732036019,-0.0622444989477337,0.0263050600103858,0.426346580092864
Physical measures,X4270.Volume level set by participant (left),RPGR,X-linked retinitis pigmentosa GTPase regulator,31546,-0.0390761229751859,0.0491912881657804,-0.135491047780115,0.0573388018297436,0.427004133133062
Physical measures,X4270.Volume level set by participant (left),PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,32843,0.0227259414887565,0.0286125400765562,-0.0333546370612937,0.0788065200388066,0.427062116115378
Physical measures,X4270.Volume level set by participant (left),FAM3D,Protein FAM3D,31720,-0.0186248766617727,0.0234500051883194,-0.0645868868308786,0.0273371335073333,0.427081090335742
Physical measures,X4270.Volume level set by participant (left),NEO1,Neogenin,31752,-0.0703363597526068,0.0885897358143901,-0.243972241948811,0.103299522443598,0.42724487843887
Physical measures,X4270.Volume level set by participant (left),THBD,Thrombomodulin,32864,-0.0511848671496359,0.0644865806837589,-0.177578565289803,0.0752088309905315,0.427374155894274
Physical measures,X4270.Volume level set by participant (left),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,32832,-0.0452612440823816,0.057043880307471,-0.157067249485025,0.0665447613202615,0.427538953396226
Physical measures,X4270.Volume level set by participant (left),GRK5,G protein-coupled receptor kinase 5,32685,-0.026985967310402,0.034061399190036,-0.0937463097228725,0.0397743751020686,0.428222123548199
Physical measures,X4270.Volume level set by participant (left),LIFR,Leukemia inhibitory factor receptor,32843,-0.0555013241417204,0.0701205441948108,-0.19293759076355,0.0819349424801087,0.428665583347836
Physical measures,X4270.Volume level set by participant (left),PLG,Plasminogen,31547,-0.0715286131508509,0.0904702483847992,-0.248850299985057,0.105793073683356,0.429183556921874
Physical measures,X4270.Volume level set by participant (left),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,32948,-0.0464034195371512,0.058696934297664,-0.161449410760573,0.0686425716862702,0.429221718787036
Physical measures,X4270.Volume level set by participant (left),PROCR,Endothelial protein C receptor,31495,-0.0453198358735977,0.0573891892515869,-0.157802646806708,0.0671629750595127,0.429731666088251
Physical measures,X4270.Volume level set by participant (left),MRPL28,"39S ribosomal protein L28, mitochondrial",31752,0.0442123284145361,0.0560263612784541,-0.0655993396912339,0.154023996520306,0.430057178935145
Physical measures,X4270.Volume level set by participant (left),GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,32638,-0.0108929618899568,0.013815317703494,-0.0379709845888049,0.0161850608088914,0.43044320988777
Physical measures,X4270.Volume level set by participant (left),FCRL5,Fc receptor-like protein 5,32861,0.0240218047386378,0.03051021137088,-0.035778209548287,0.0838218190255627,0.431105613424795
Physical measures,X4270.Volume level set by participant (left),ULBP2,UL16-binding protein 2,32796,-0.0375358498522996,0.0476839748722389,-0.130996440601888,0.0559247408972886,0.431197650997491
Physical measures,X4270.Volume level set by participant (left),ODAM,Odontogenic ameloblast-associated protein,32629,0.026486361122253,0.0337122530925416,-0.0395896549391286,0.0925623771836345,0.432088070740341
Physical measures,X4270.Volume level set by participant (left),CRELD2,Protein disulfide isomerase CRELD2,32883,-0.0260190066304048,0.0331441762142136,-0.0909815920102633,0.0389435787494538,0.432459533951007
Physical measures,X4270.Volume level set by participant (left),FGF6,Fibroblast growth factor 6,31508,0.0377838572364154,0.0481310488477432,-0.0565529985051613,0.132120712977992,0.432465908964699
Physical measures,X4270.Volume level set by participant (left),XPNPEP2,Xaa-Pro aminopeptidase 2,32881,0.0135521016364252,0.0173082592407331,-0.0203720864754118,0.0474762897482621,0.433656675602013
Physical measures,X4270.Volume level set by participant (left),FOXJ3,Forkhead box protein J3,31508,-0.0348579836490132,0.0445437233336421,-0.122163681382952,0.0524477140849254,0.433911787486055
Physical measures,X4270.Volume level set by participant (left),PRL,Prolactin,32931,-0.0171592108585103,0.0219431085735778,-0.0601677036627228,0.0258492819457022,0.434243027125102
Physical measures,X4270.Volume level set by participant (left),CD4,T-cell surface glycoprotein CD4,32831,-0.046257381422654,0.0591687670039894,-0.162228164750473,0.0697134019051652,0.434360316252319
Physical measures,X4270.Volume level set by participant (left),HJV,Hemojuvelin,31752,0.0340163222055005,0.0435413111555492,-0.051324647659376,0.119357292070377,0.434683332584067
Physical measures,X4270.Volume level set by participant (left),CLEC11A,C-type lectin domain family 11 member A,32841,-0.0283631174594914,0.0363309629245325,-0.0995718047915751,0.0428455698725923,0.435007077823464
Physical measures,X4270.Volume level set by participant (left),PRKAB1,5'-AMP-activated protein kinase subunit beta-1,32679,-0.0247366650222642,0.0317412999183754,-0.08694961286228,0.0374762828177516,0.435811502587363
Physical measures,X4270.Volume level set by participant (left),SCARA5,Scavenger receptor class A member 5,32931,0.0460558285453748,0.0591040856025349,-0.0697881792355935,0.161899836326343,0.435863062128605
Physical measures,X4270.Volume level set by participant (left),ADA,Adenosine deaminase,32961,-0.0376241068188778,0.0483292071596342,-0.132349352851761,0.0571011392140053,0.436296759049054
Physical measures,X4270.Volume level set by participant (left),CCDC50,Coiled-coil domain-containing protein 50,31752,-0.0208311645040935,0.0267779355311144,-0.0733159181450778,0.0316535891368907,0.436637900808677
Physical measures,X4270.Volume level set by participant (left),KRT17,"Keratin, type I cytoskeletal 17",31495,0.0397843723178012,0.0511538293030525,-0.0604771331161816,0.140045877751784,0.436746493178636
Physical measures,X4270.Volume level set by participant (left),CHGA,Chromogranin-A,31773,-0.0202948860838273,0.0260954553049753,-0.0714419784815789,0.0308522063139243,0.436758972547008
Physical measures,X4270.Volume level set by participant (left),CARHSP1,Calcium-regulated heat-stable protein 1,32644,-0.0259888885668191,0.0334709542029722,-0.0915919588046445,0.0396141816710064,0.437497788738608
Physical measures,X4270.Volume level set by participant (left),IKBKG,NF-kappa-B essential modulator,32843,-0.0156667523784324,0.0202752264782475,-0.0554061962757976,0.0240726915189327,0.439717805192548
Physical measures,X4270.Volume level set by participant (left),PTPRH,Receptor-type tyrosine-protein phosphatase H,31720,-0.0314849272674806,0.0408478195641589,-0.111546653613232,0.0485767990782709,0.440856966371348
Physical measures,X4270.Volume level set by participant (left),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",32809,-0.013030271398552,0.0169211577978017,-0.0461957406822433,0.0201351978851393,0.441285875668206
Physical measures,X4270.Volume level set by participant (left),PSME2,Proteasome activator complex subunit 2,32751,-0.0376043498840868,0.048849385361553,-0.133349145192731,0.0581404454245572,0.441437868152575
Physical measures,X4270.Volume level set by participant (left),FTCD,Formimidoyltransferase-cyclodeaminase,31725,-0.0184492896048226,0.0239695855999283,-0.065429677380682,0.0285310981710368,0.441503480522348
Physical measures,X4270.Volume level set by participant (left),CNPY2,Protein canopy homolog 2,32685,-0.0227414278694907,0.029630376573948,-0.0808169659544287,0.0353341102154474,0.442802550104629
Physical measures,X4270.Volume level set by participant (left),PDCD1LG2,Programmed cell death 1 ligand 2,32832,-0.0421792942382476,0.0549655819645262,-0.149911834888719,0.0655532464122238,0.442877914564652
Physical measures,X4270.Volume level set by participant (left),SHISA5,Protein shisa-5,31773,-0.0660620529900457,0.086091568972007,-0.234801528175179,0.102677422195088,0.442898508527632
Physical measures,X4270.Volume level set by participant (left),SDHB,Succinate dehydrogenase,31720,-0.0228886007549848,0.0298561602489163,-0.0814066748428609,0.0356294733328912,0.443325111736933
Physical measures,X4270.Volume level set by participant (left),PCDH12,Protocadherin-12,31752,-0.0600400683707539,0.0783465802793565,-0.213599365718293,0.0935192289767847,0.443497332433578
Physical measures,X4270.Volume level set by participant (left),CD274,Programmed cell death 1 ligand 1,32796,-0.0400354488130212,0.0522701582694125,-0.14248495902107,0.0624140613950273,0.443736296440513
Physical measures,X4270.Volume level set by participant (left),GDF15,Growth/differentiation factor 15,32964,0.0304632849432702,0.0398470475309402,-0.0476369282173726,0.108563498103913,0.444585912234444
Physical measures,X4270.Volume level set by participant (left),RBPMS,RNA-binding protein with multiple splicing,31508,0.022399923191501,0.0293318205565813,-0.0350904450993982,0.0798902914824003,0.445085624012983
Physical measures,X4270.Volume level set by participant (left),IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",32644,-0.0268515525640194,0.0352060537876096,-0.0958554179877343,0.0421523128596954,0.445664591356609
Physical measures,X4270.Volume level set by participant (left),CXCL8,Interleukin-8,32810,0.0200486462506223,0.0262989055498131,-0.0314972086270113,0.0715945011282559,0.445878595928109
Physical measures,X4270.Volume level set by participant (left),CD28,T-cell-specific surface glycoprotein CD28,32638,0.0382618713490443,0.0502940683619614,-0.0603145026404,0.136838245338489,0.446819019695109
Physical measures,X4270.Volume level set by participant (left),PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,32685,0.0239162130104434,0.0314956947330019,-0.0378153486662403,0.085647774687127,0.447664316300663
Physical measures,X4270.Volume level set by participant (left),GC,Vitamin D-binding protein,31770,-0.0583365320858073,0.0770934847484645,-0.209439762192798,0.0927666980211832,0.449252998410479
Physical measures,X4270.Volume level set by participant (left),MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,32796,0.0185797222063788,0.0245916225898106,-0.02961985806965,0.0667793024824075,0.44995062793114
Physical measures,X4270.Volume level set by participant (left),GLB1,Beta-galactosidase,32796,-0.0313482585089133,0.0415278375440253,-0.112742820095203,0.0500463030773764,0.450344868366247
Physical measures,X4270.Volume level set by participant (left),CRH,Corticoliberin,32610,-0.0151561609400463,0.0201154417209967,-0.0545824267131998,0.0242701048331072,0.451194409611057
Physical measures,X4270.Volume level set by participant (left),TFPI2,Tissue factor pathway inhibitor 2,32844,-0.0317423483371775,0.0421692835504976,-0.114394144096153,0.0509094474217978,0.45162815172823
Physical measures,X4270.Volume level set by participant (left),COL9A2,Collagen alpha-2(IX) chain,31632,0.0314781182207426,0.0418890680945739,-0.0506244552446221,0.113580691686107,0.452396342348131
Physical measures,X4270.Volume level set by participant (left),CASP10,Caspase-10,32644,-0.0191878258895124,0.0255975454823078,-0.0693590150348357,0.0309833632558108,0.453517949277658
Physical measures,X4270.Volume level set by participant (left),THRAP3,Thyroid hormone receptor-associated protein 3,31495,-0.0131723702738918,0.0175818118630775,-0.0476327215255238,0.0212879809777402,0.453757126339984
Physical measures,X4270.Volume level set by participant (left),DPT,Dermatopontin,32964,0.0468602047128979,0.0627750593098797,-0.0761789115344663,0.169899320960262,0.455397960035297
Physical measures,X4270.Volume level set by participant (left),EIF5A,Eukaryotic translation initiation factor 5A-1,32679,-0.0423737479973283,0.0568948610676435,-0.15388767568991,0.069140179695253,0.45642890127674
Physical measures,X4270.Volume level set by participant (left),DNAJA1,DnaJ homolog subfamily A member 1,31492,-0.0331253592477093,0.0445236736167492,-0.120391759536538,0.0541410410411191,0.456902838946803
Physical measures,X4270.Volume level set by participant (left),ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",31632,-0.0209271131853301,0.0281647842732399,-0.0761300903608802,0.0342758639902201,0.457489562821562
Physical measures,X4270.Volume level set by participant (left),RCOR1,REST corepressor 1,32685,0.025920503537274,0.0349678340270229,-0.0426164511556909,0.0944574582302389,0.458551260616123
Physical measures,X4270.Volume level set by participant (left),TOP2B,DNA topoisomerase 2-beta,31508,-0.0201089326057194,0.0271302785089159,-0.0732842784831945,0.0330664132717557,0.4585956159124
Physical measures,X4270.Volume level set by participant (left),MORF4L1,Mortality factor 4-like protein 1,31632,0.0352293436353323,0.0475625887620607,-0.0579933303383067,0.128452017608971,0.458901134314238
Physical measures,X4270.Volume level set by participant (left),CA12,Carbonic anhydrase 12,32832,-0.0403710839572319,0.0545208758875163,-0.147232000696764,0.0664898327823001,0.459034119018321
Physical measures,X4270.Volume level set by participant (left),HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,31751,-0.02402959594767,0.0324561359443852,-0.087643622398665,0.0395844305033249,0.45909668258345
Physical measures,X4270.Volume level set by participant (left),EPPK1,Epiplakin,31566,0.0196480679548508,0.0265391217155658,-0.0323686106076582,0.0716647465173597,0.45911411797734
Physical measures,X4270.Volume level set by participant (left),FGF5,Fibroblast growth factor 5,32679,-0.0377696795210208,0.051032427372435,-0.137793237170993,0.0622538781289518,0.459252131326099
Physical measures,X4270.Volume level set by participant (left),MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",31492,-0.0295009738542565,0.0399139571582976,-0.10773232988452,0.0487303821760067,0.459860373887078
Physical measures,X4270.Volume level set by participant (left),DHPS,Deoxyhypusine synthase,31724,-0.0360926153048532,0.0488976286591283,-0.131931967476745,0.0597467368670383,0.460459866704315
Physical measures,X4270.Volume level set by participant (left),OCLN,Occludin,31752,-0.0340516175205611,0.0461637450274548,-0.124532557774373,0.0564293227332504,0.460763177338759
Physical measures,X4270.Volume level set by participant (left),ZPR1,Zinc finger protein ZPR1,31514,-0.0162359223657205,0.0220403162554334,-0.0594349422263699,0.0269630974949289,0.461359920653462
Physical measures,X4270.Volume level set by participant (left),RAB37,Ras-related protein Rab-37,32679,-0.0152055572235673,0.0207247057177173,-0.0558259804302932,0.0254148659831585,0.463155796323391
Physical measures,X4270.Volume level set by participant (left),VAMP5,Vesicle-associated membrane protein 5,32685,-0.0241102277826216,0.0328717369139022,-0.0885388321338698,0.0403183765686267,0.46329511279298
Physical measures,X4270.Volume level set by participant (left),SNX15,Sorting nexin-15,31599,-0.0274385564742356,0.0374511195770317,-0.100842750845218,0.0459656378967466,0.463794226652242
Physical measures,X4270.Volume level set by participant (left),PON3,Serum paraoxonase/lactonase 3,32894,-0.0429002517606547,0.058556679944753,-0.157671344452371,0.0718708409310612,0.463804482766571
Physical measures,X4270.Volume level set by participant (left),ANXA5,Annexin A5,32622,0.0418085007259258,0.057068163046177,-0.0700450988445811,0.153662100296433,0.463818138120059
Physical measures,X4270.Volume level set by participant (left),CCL26,C-C motif chemokine 26,32843,-0.0136071777354505,0.0186031945224032,-0.0500694389993608,0.0228550835284597,0.464527650918011
Physical measures,X4270.Volume level set by participant (left),NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,31720,-0.0447710849190191,0.0612135353122098,-0.16474961413095,0.0752074442929121,0.464561613074842
Physical measures,X4270.Volume level set by participant (left),SNRPB2,U2 small nuclear ribonucleoprotein B'',31751,-0.0365964784162215,0.0501003308893922,-0.13479312695943,0.0616001701269873,0.465128422660916
Physical measures,X4270.Volume level set by participant (left),PCSK7,Proprotein convertase subtilisin/kexin type 7,31724,-0.0310033423719258,0.0424459048028396,-0.114197315785491,0.05219063104164,0.46515519802914
Physical measures,X4270.Volume level set by participant (left),PRSS2,Trypsin-2,32878,0.0244195250126009,0.0334459889127019,-0.0411346132562948,0.0899736632814966,0.46533691289865
Physical measures,X4270.Volume level set by participant (left),SCIN,Adseverin,31514,-0.0195538304666806,0.0267979990202602,-0.0720779085463906,0.0329702476130295,0.46561119188582
Physical measures,X4270.Volume level set by participant (left),CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,31773,0.0366777004826416,0.0502816149203126,-0.0618742647611711,0.135229665726454,0.465750759320018
Physical measures,X4270.Volume level set by participant (left),SAP18,Histone deacetylase complex subunit SAP18,31632,-0.0208830441725236,0.0286355191097417,-0.0770086616276173,0.0352425732825701,0.465858095059101
Physical measures,X4270.Volume level set by participant (left),GPHA2,Glycoprotein hormone alpha-2,31720,-0.0300017174219103,0.0413114483051197,-0.110972156099945,0.0509687212561243,0.46771786903649
Physical measures,X4270.Volume level set by participant (left),FOLH1,Glutamate carboxypeptidase 2,31508,0.0129020206979163,0.01776584793362,-0.0219190412519788,0.0477230826478115,0.467722467637676
Physical measures,X4270.Volume level set by participant (left),CCL2,C-C motif chemokine 2,32778,-0.025093907931707,0.0345844346611302,-0.0928793998675222,0.0426915840041082,0.468112958534741
Physical measures,X4270.Volume level set by participant (left),ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,32532,-0.0342488014088474,0.0473087623676894,-0.126973975649519,0.0584763728318239,0.469120860794966
Physical measures,X4270.Volume level set by participant (left),GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,31762,0.0534973271649963,0.0740528335519451,-0.091646226596816,0.198640880926809,0.470057024024227
Physical measures,X4270.Volume level set by participant (left),KLRK1,NKG2-D type II integral membrane protein,31751,-0.0319884816410917,0.0443005494262934,-0.118817558516627,0.0548405952344433,0.470267518445725
Physical measures,X4270.Volume level set by participant (left),EFNA4,Ephrin-A4,32778,0.0469828051582609,0.0650996885902558,-0.0806125844786405,0.174578194795162,0.470494469948172
Physical measures,X4270.Volume level set by participant (left),CXCL16,C-X-C motif chemokine 16,32935,0.0541476807466485,0.0750415216692857,-0.0929337017251515,0.201229063218448,0.470577731324069
Physical measures,X4270.Volume level set by participant (left),RRP15,RRP15-like protein,31514,-0.016005492116758,0.0222051610124257,-0.0595276077011125,0.0275166234675965,0.471054263530574
Physical measures,X4270.Volume level set by participant (left),MEGF9,Multiple epidermal growth factor-like domains protein 9,32922,0.0568058299687159,0.0790059548955321,-0.0980458416265271,0.211657501563959,0.472155188532705
Physical measures,X4270.Volume level set by participant (left),TMPRSS15,Enteropeptidase,32832,-0.0140090322203928,0.0194848159732379,-0.0521992715279391,0.0241812070871534,0.472177057230498
Physical measures,X4270.Volume level set by participant (left),TG,Thyroglobulin,31724,-0.0130407527555097,0.0182201140214589,-0.048752176237569,0.0226706707265497,0.474176950175434
Physical measures,X4270.Volume level set by participant (left),FGFBP1,Fibroblast growth factor-binding protein 1,32881,0.0381509650986776,0.0533607902447539,-0.06643618378104,0.142738113978395,0.474650710579261
Physical measures,X4270.Volume level set by participant (left),EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,32961,-0.0129419458387783,0.0181274386358186,-0.0484717255649827,0.0225878338874261,0.475281153412116
Physical measures,X4270.Volume level set by participant (left),PTP4A3,Protein tyrosine phosphatase type IVA 3,31508,-0.0279519708498285,0.0391563971192261,-0.104698509203512,0.0487945675038547,0.475338938540843
Physical measures,X4270.Volume level set by participant (left),APOBR,Apolipoprotein B receptor,31566,-0.0340935449301755,0.0477626724756657,-0.12770838298248,0.0595212931221293,0.475365373744063
Physical measures,X4270.Volume level set by participant (left),XG,Glycoprotein Xg,32899,0.040264394596296,0.0565137204652074,-0.0705024975155106,0.151031286708103,0.476191475320156
Physical measures,X4270.Volume level set by participant (left),ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,32864,-0.0397085813829212,0.0560100173026756,-0.149488215296165,0.070071052530323,0.478370768698823
Physical measures,X4270.Volume level set by participant (left),CCT5,T-complex protein 1 subunit epsilon,32638,-0.0252122979625073,0.035569812831212,-0.0949291311116829,0.0445045351866683,0.478460192893951
Physical measures,X4270.Volume level set by participant (left),CNTN2,Contactin-2,32948,-0.0266779883470583,0.0376661956349634,-0.100503731791587,0.0471477550974699,0.478793269642165
Physical measures,X4270.Volume level set by participant (left),IL24,Interleukin-24,32679,0.0262733980688446,0.037147163322579,-0.0465350420434104,0.0990818381810995,0.479411983024952
Physical measures,X4270.Volume level set by participant (left),ENOX2,Ecto-NOX disulfide-thiol exchanger 2,31495,-0.0492004666948423,0.0696386686312982,-0.185692257212187,0.0872913238225022,0.479892149403714
Physical measures,X4270.Volume level set by participant (left),CD46,Membrane cofactor protein,32769,-0.0442720963123793,0.062770945936116,-0.167303150347167,0.0787589577224081,0.480644502415961
Physical measures,X4270.Volume level set by participant (left),DCXR,L-xylulose reductase,32881,-0.0232992288172276,0.0330356836942563,-0.08804916885797,0.0414507112235148,0.480657575930136
Physical measures,X4270.Volume level set by participant (left),GPR101,Probable G-protein coupled receptor 101,31514,-0.0223789424614781,0.031817584548004,-0.084741408175566,0.0399835232526098,0.481858191269049
Physical measures,X4270.Volume level set by participant (left),VSTM2B,V-set and transmembrane domain-containing protein 2B,31632,-0.0322849850557078,0.0459595271261415,-0.122365658222945,0.0577956881115294,0.482409917045292
Physical measures,X4270.Volume level set by participant (left),ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",31508,-0.0280317742356334,0.039932977794855,-0.106300410713549,0.0502368622422823,0.482718901719523
Physical measures,X4270.Volume level set by participant (left),CPPED1,Serine/threonine-protein phosphatase CPPED1,32931,-0.0183065887631838,0.0260793729069977,-0.0694221596608992,0.0328089821345316,0.482724225689521
Physical measures,X4270.Volume level set by participant (left),TMEM25,Transmembrane protein 25,31752,-0.0308409738965025,0.0439442114331169,-0.116971628305412,0.0552896805124066,0.482811454967926
Physical measures,X4270.Volume level set by participant (left),BCR,Breakpoint cluster region protein,32843,-0.0138975559335069,0.0198090993524333,-0.0527233906642761,0.0249282787972623,0.482962835542284
Physical measures,X4270.Volume level set by participant (left),FABP1,"Fatty acid-binding protein, liver",32834,0.0129792437808465,0.0185021121962614,-0.0232848961238258,0.0492433836855188,0.483008824405408
Physical measures,X4270.Volume level set by participant (left),CENPF,Centromere protein F,31632,-0.0252607126533817,0.0360353983289301,-0.0958900933780847,0.0453686680713213,0.483325768955508
Physical measures,X4270.Volume level set by participant (left),TGOLN2,Trans-Golgi network integral membrane protein 2,31772,0.0566823912839243,0.0808702381784122,-0.101823275545764,0.215188058113612,0.483382638253607
Physical measures,X4270.Volume level set by participant (left),FYB1,FYN-binding protein 1,32846,-0.0132861774361571,0.0189943828326825,-0.0505151677882149,0.0239428129159007,0.484270662084954
Physical measures,X4270.Volume level set by participant (left),ACVRL1,Serine/threonine-protein kinase receptor R3,32778,0.0531824944770548,0.0760913880070312,-0.0959566260167265,0.202321614970836,0.484614498338115
Physical measures,X4270.Volume level set by participant (left),DMD,Dystrophin,31566,-0.0248725534723545,0.0355952736869492,-0.0946392898987748,0.0448941829540658,0.484723125270257
Physical measures,X4270.Volume level set by participant (left),CCDC28A,Coiled-coil domain-containing protein 28A,31546,-0.0485719766973292,0.0695476748886356,-0.184885419479055,0.0877414660843966,0.484949287893414
Physical measures,X4270.Volume level set by participant (left),PEBP1,Phosphatidylethanolamine-binding protein 1,32861,-0.0214051737228426,0.0306498716160754,-0.0814789220903503,0.0386685746446651,0.484959334300134
Physical measures,X4270.Volume level set by participant (left),KLK12,Kallikrein-12,32638,0.00894220321056653,0.0128048985224517,-0.0161553978934387,0.0340398043145718,0.484981611972687
Physical measures,X4270.Volume level set by participant (left),EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,31495,-0.0194107464629649,0.027848184244374,-0.073993187581938,0.0351716946560082,0.485811393325787
Physical measures,X4270.Volume level set by participant (left),IGHMBP2,DNA-binding protein SMUBP-2,31495,-0.0239329287498793,0.0343648506227433,-0.0912880359704561,0.0434221784706975,0.486176858010504
Physical measures,X4270.Volume level set by participant (left),CFH,Complement factor H,31278,0.0613318510169575,0.0881546018136402,-0.111451168537777,0.234114870571692,0.486619383682947
Physical measures,X4270.Volume level set by participant (left),LY96,Lymphocyte antigen 96,32796,0.0331253761603416,0.04789700094217,-0.0607527456863115,0.127003498006995,0.489209022773351
Physical measures,X4270.Volume level set by participant (left),VCAN,Versican core protein,32931,0.0395814457072852,0.0572826929404779,-0.0726926324560514,0.151855523870622,0.489593048517206
Physical measures,X4270.Volume level set by participant (left),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,32861,0.0308654222418535,0.0447138521691044,-0.0567737280095912,0.118504572493298,0.490031084355398
Physical measures,X4270.Volume level set by participant (left),DGCR6,Protein DGCR6,31514,0.0333958796312713,0.0485147095626848,-0.0616929511115909,0.128484710374133,0.491243159507942
Physical measures,X4270.Volume level set by participant (left),VWF,von Willebrand factor,32964,0.0158979178491254,0.0231006161132531,-0.0293792897328506,0.0611751254311014,0.491342371702324
Physical measures,X4270.Volume level set by participant (left),GASK1A,Golgi-associated kinase 1A,31495,-0.0326201666645622,0.0474335589525,-0.125589942211462,0.0603496088823378,0.491661182268197
Physical measures,X4270.Volume level set by participant (left),LRPAP1,Alpha-2-macroglobulin receptor-associated protein,32931,-0.0209749690259194,0.0305081359281466,-0.0807709154450868,0.0388209773932481,0.491772367467105
Physical measures,X4270.Volume level set by participant (left),ADGRG1,Adhesion G-protein coupled receptor G1,32832,-0.0215410231346419,0.0313661187631458,-0.0830186159104076,0.0399365696411239,0.492251184244015
Physical measures,X4270.Volume level set by participant (left),CEP20,Centrosomal protein 20,32638,-0.0168071715648598,0.0244814557956326,-0.0647908249242996,0.0311764817945801,0.492399211999594
Physical measures,X4270.Volume level set by participant (left),ENDOU,Poly(U)-specific endoribonuclease,31160,-0.0275778143597782,0.0401828575665396,-0.106336215190196,0.0511805864706395,0.492540746843991
Physical measures,X4270.Volume level set by participant (left),PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",31492,-0.0253252685836229,0.0369168595182503,-0.0976823132393936,0.0470317760721477,0.492728780174192
Physical measures,X4270.Volume level set by participant (left),IL18R1,Interleukin-18 receptor 1,32961,0.0358709235864415,0.052297127810939,-0.0666314469229989,0.138373294095882,0.492789745449358
Physical measures,X4270.Volume level set by participant (left),MAPK13,Mitogen-activated protein kinase 13,31492,0.0330355255712015,0.0481635483199138,-0.0613650291358294,0.127436080278232,0.492795078170076
Physical measures,X4270.Volume level set by participant (left),DNAJC21,DnaJ homolog subfamily C member 21,31751,-0.0333289153888719,0.0486513019726566,-0.128685467255279,0.0620276364775351,0.493328077181143
Physical measures,X4270.Volume level set by participant (left),SCGB3A2,Secretoglobin family 3A member 2,32883,0.015488992790541,0.0226522180823459,-0.0289093546508571,0.059887340231939,0.494135590492069
Physical measures,X4270.Volume level set by participant (left),VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,31599,-0.023041394881808,0.0337375346513894,-0.0891669627985311,0.0430841730349152,0.494652416247307
Physical measures,X4270.Volume level set by participant (left),GSTA3,Glutathione S-transferase A3,32638,0.0156891872199919,0.0229895011686209,-0.0293702350705052,0.0607486095104889,0.494972403976611
Physical measures,X4270.Volume level set by participant (left),MENT,Protein MENT,31599,0.0623549518959542,0.0914767186949441,-0.116939416746136,0.241649320538045,0.495481756913855
Physical measures,X4270.Volume level set by participant (left),PRRT3,Proline-rich transmembrane protein 3,31566,-0.0382984964861425,0.0562088110790513,-0.148467766201083,0.0718707732287981,0.495663523272357
Physical measures,X4270.Volume level set by participant (left),ERBB2,Receptor tyrosine-protein kinase erbB-2,32881,-0.0468919126580425,0.0688652668781704,-0.181867835739256,0.0880840104231715,0.495937985933668
Physical measures,X4270.Volume level set by participant (left),CCL19,C-C motif chemokine 19,32931,0.00983247944030055,0.0144904015763639,-0.0185687076493727,0.0382336665299738,0.497439585289482
Physical measures,X4270.Volume level set by participant (left),STX8,Syntaxin-8,32843,-0.0227847866710614,0.0336179467319161,-0.0886759622656168,0.0431063889234941,0.497943468003503
Physical measures,X4270.Volume level set by participant (left),GIT1,ARF GTPase-activating protein GIT1,31508,-0.0149304649838432,0.0221521253600897,-0.058348630689619,0.0284877007219326,0.500333628718183
Physical measures,X4270.Volume level set by participant (left),SCN2A,Sodium channel protein type 2 subunit alpha,31514,-0.0290346475897354,0.0431624950735702,-0.113633137933933,0.0555638427544622,0.501169728952294
Physical measures,X4270.Volume level set by participant (left),CD34,Hematopoietic progenitor cell antigen CD34,32893,0.0483151844986593,0.0719769663578291,-0.0927596695626857,0.189390038560004,0.502072736190005
Physical measures,X4270.Volume level set by participant (left),SLC44A4,Choline transporter-like protein 4,31546,0.0200174087372734,0.0299792074541063,-0.0387418378727749,0.0787766553473217,0.504338948626938
Physical measures,X4270.Volume level set by participant (left),MPHOSPH8,M-phase phosphoprotein 8,32685,-0.015649128504174,0.0234680099771305,-0.0616464280593498,0.0303481710510018,0.504899380733136
Physical measures,X4270.Volume level set by participant (left),NRXN3,Neurexin-3,31546,0.0377312985330603,0.0566121008088267,-0.07322841905224,0.148691016118361,0.505119100642956
Physical measures,X4270.Volume level set by participant (left),SH2D1A,SH2 domain-containing protein 1A,32843,0.0213231497127994,0.0319972920966194,-0.0413915427965747,0.0840378422221735,0.505169501480206
Physical measures,X4270.Volume level set by participant (left),ZCCHC8,Zinc finger CCHC domain-containing protein 8,31495,0.0219509112795607,0.0329607592299652,-0.0426521768111711,0.0865539993702925,0.505449735792398
Physical measures,X4270.Volume level set by participant (left),B4GAT1,"Beta-1,4-glucuronyltransferase 1",32861,-0.0469671571134584,0.0705640828574434,-0.185272759514047,0.0913384452871307,0.505686553407465
Physical measures,X4270.Volume level set by participant (left),FCAR,Immunoglobulin alpha Fc receptor,32843,0.0248540801559226,0.0373800546431967,-0.0484108269447429,0.0981189872565882,0.506130130029256
Physical measures,X4270.Volume level set by participant (left),CD2,T-cell surface antigen CD2,31495,0.0371905404015191,0.0559602603446368,-0.0724915698739691,0.146872650677007,0.50633386384058
Physical measures,X4270.Volume level set by participant (left),STX1B,Syntaxin-1B,31546,0.0308729425685956,0.0465080981374612,-0.0602829297808285,0.12202881491802,0.506826311165276
Physical measures,X4270.Volume level set by participant (left),IFNW1,Interferon omega-1,31495,-0.0400409970584262,0.0604621160563009,-0.158546744528776,0.0784647504119235,0.507831427811223
Physical measures,X4270.Volume level set by participant (left),CD55,Complement decay-accelerating factor,32546,0.048250647000634,0.0728647681048838,-0.0945642984849382,0.191065592486206,0.50786416767179
Physical measures,X4270.Volume level set by participant (left),PSAPL1,Proactivator polypeptide-like 1,31720,0.0264938578676952,0.0400113648901523,-0.0519284173170032,0.104916133052394,0.507889188112949
Physical measures,X4270.Volume level set by participant (left),FRMD7,FERM domain-containing protein 7,31546,0.040942543984428,0.0618450063045253,-0.0802736683724416,0.162158756341298,0.507979162122254
Physical measures,X4270.Volume level set by participant (left),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,31508,-0.0357235103455441,0.0539627733766051,-0.14149054616369,0.0700435254726019,0.507989341951812
Physical measures,X4270.Volume level set by participant (left),SLAMF6,SLAM family member 6,32638,-0.0302585588434306,0.0457859925286231,-0.119999104199532,0.0594819865126706,0.508713456715109
Physical measures,X4270.Volume level set by participant (left),KIF1C,Kinesin-like protein KIF1C,31495,0.0372098625823276,0.0563070267427564,-0.0731519098334748,0.14757163499813,0.508735705230412
Physical measures,X4270.Volume level set by participant (left),CLEC5A,C-type lectin domain family 5 member A,32822,0.0395828545959816,0.0599155492966993,-0.0778516220255489,0.157017331217512,0.508857561781656
Physical measures,X4270.Volume level set by participant (left),ADIPOQ,Adiponectin,31770,-0.0195084193401081,0.029545973410749,-0.0774185272251762,0.03840168854496,0.509097651572483
Physical measures,X4270.Volume level set by participant (left),PNMA2,Paraneoplastic antigen Ma2,31514,0.0313161862245642,0.0475483113672021,-0.0618785040551519,0.12451087650428,0.510160751125571
Physical measures,X4270.Volume level set by participant (left),UXS1,UDP-glucuronic acid decarboxylase 1,32638,0.0208470414232112,0.0317123727463393,-0.0413092091596139,0.0830032920060363,0.510954624059031
Physical measures,X4270.Volume level set by participant (left),CAT,Catalase,31641,-0.0237512886599804,0.0361317377041581,-0.0945694945601303,0.0470669172401696,0.510973727768906
Physical measures,X4270.Volume level set by participant (left),CXCL1,Growth-regulated alpha protein,32825,-0.0121941286864038,0.018572037010607,-0.0485953212271935,0.0242070638543859,0.511464385861808
Physical measures,X4270.Volume level set by participant (left),DPP4,Dipeptidyl peptidase 4,32654,-0.0390875124951707,0.0595513327302133,-0.155808124646389,0.0776330996560473,0.511605382389126
Physical measures,X4270.Volume level set by participant (left),NPDC1,Neural proliferation differentiation and control protein 1,32864,0.0385279647167997,0.0587540955900845,-0.0766300626397659,0.153685992073365,0.512002118978749
Physical measures,X4270.Volume level set by participant (left),SLITRK2,SLIT and NTRK-like protein 2,32948,0.0284574287896607,0.0434684754643459,-0.0567407831204573,0.113655640699779,0.51269797393352
Physical measures,X4270.Volume level set by participant (left),REST,RE1-silencing transcription factor,31492,-0.0394589061759583,0.060382976090815,-0.157809539313956,0.0788917269620391,0.513468291948779
Physical measures,X4270.Volume level set by participant (left),PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,31546,-0.0418726234046981,0.0641122829008478,-0.16753269789036,0.0837874510809636,0.513702391984641
Physical measures,X4270.Volume level set by participant (left),ANG,Angiogenin,32810,-0.0325851137502413,0.0499048296636149,-0.130398579890927,0.065228352390444,0.513808452457212
Physical measures,X4270.Volume level set by participant (left),DCTN6,Dynactin subunit 6,32644,-0.0162320855491815,0.0248674738901456,-0.0649723343738668,0.0325081632755037,0.51393864816628
Physical measures,X4270.Volume level set by participant (left),TMPRSS11B,Transmembrane protease serine 11B,31514,0.0174128850769042,0.0266840312927352,-0.0348878162568567,0.0697135864106652,0.514060706115275
Physical measures,X4270.Volume level set by participant (left),IL12RB1,Interleukin-12 receptor subunit beta-1,32679,-0.031007833879891,0.0475654305092927,-0.124236077678105,0.0622204099183228,0.514483632354717
Physical measures,X4270.Volume level set by participant (left),A1BG,Alpha-1B-glycoprotein,31770,-0.0732782473457863,0.112425227841937,-0.293631693915983,0.14707519922441,0.51455210830586
Physical measures,X4270.Volume level set by participant (left),GID8,Glucose-induced degradation protein 8 homolog,31752,-0.038853353813367,0.0596315101417129,-0.155731113691124,0.0780244060643903,0.514705693511094
Physical measures,X4270.Volume level set by participant (left),IL31RA,Interleukin-31 receptor subunit alpha,31487,0.0336212871644593,0.051674659925136,-0.0676610462888073,0.134903620617726,0.515302427726826
Physical measures,X4270.Volume level set by participant (left),ADH1B,All-trans-retinol dehydrogenase,31599,-0.0178061376339749,0.0274422699577356,-0.0715929867511367,0.035980711483187,0.516449396155504
Physical measures,X4270.Volume level set by participant (left),C2orf69,UPF0565 protein C2orf69,31546,-0.0235764697550577,0.0363416980439182,-0.0948061979211372,0.0476532584110219,0.516523049937572
Physical measures,X4270.Volume level set by participant (left),CDK5RAP3,CDK5 regulatory subunit-associated protein 3,31752,-0.0211867932801662,0.0327311639701605,-0.0853398746616808,0.0429662881013484,0.517458398419186
Physical measures,X4270.Volume level set by participant (left),COMT,Catechol O-methyltransferase,32606,-0.0140791599355916,0.0217513670354783,-0.0567118393251291,0.0285535194539459,0.517469668451783
Physical measures,X4270.Volume level set by participant (left),CREG1,Protein CREG1,32731,0.0302237283059552,0.0467028134500801,-0.0613137860562018,0.121761242668112,0.517551582635365
Physical measures,X4270.Volume level set by participant (left),CNTF,Ciliary neurotrophic factor,31514,0.0383116315684276,0.0592168983245056,-0.0777534891476035,0.154376752284459,0.517669950255615
Physical measures,X4270.Volume level set by participant (left),MB,Myoglobin,32964,0.0208917498065461,0.0322994142914318,-0.0424151022046602,0.0841986018177524,0.517767911815559
Physical measures,X4270.Volume level set by participant (left),IFNL1,Interferon lambda-1,32644,-0.0262840164398314,0.0406372637443938,-0.105933053378843,0.0533650204991804,0.517780938240948
Physical measures,X4270.Volume level set by participant (left),AHSP,Alpha-hemoglobin-stabilizing protein,32846,-0.0124809758418706,0.0193182945060087,-0.0503448330736476,0.0253828813899065,0.518250348798919
Physical measures,X4270.Volume level set by participant (left),ATXN2,Ataxin-2,31514,-0.0118177394595572,0.0183072998764747,-0.0477000472174476,0.0240645682983332,0.518609221630065
Physical measures,X4270.Volume level set by participant (left),CES1,Liver carboxylesterase 1,32866,0.0141667639641863,0.021957563692964,-0.0288700608740232,0.0572035888023958,0.518821585365563
Physical measures,X4270.Volume level set by participant (left),SIGLEC7,Sialic acid-binding Ig-like lectin 7,32864,0.0388237621029757,0.0602618233546412,-0.0792894116721211,0.156936935878073,0.519428862693255
Physical measures,X4270.Volume level set by participant (left),THOP1,Thimet oligopeptidase,32829,0.0348681571083489,0.054248392606391,-0.0714586924001774,0.141195006616875,0.520402734179458
Physical measures,X4270.Volume level set by participant (left),ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,31508,-0.0366064057758778,0.0569755021239643,-0.148278389938848,0.0750655783870922,0.520571892591805
Physical measures,X4270.Volume level set by participant (left),ASAH1,Acid ceramidase,31715,-0.0277766346604513,0.0432346973314907,-0.112516641430173,0.0569633721092704,0.520592244352442
Physical measures,X4270.Volume level set by participant (left),CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,32796,0.0183999393705766,0.0286475570289023,-0.0377492724060719,0.0745491511472251,0.520703655206511
Physical measures,X4270.Volume level set by participant (left),F12,Coagulation factor XII,31770,0.0301578984324782,0.0469758174985624,-0.0619147038647041,0.122230500729661,0.520899760911182
Physical measures,X4270.Volume level set by participant (left),CTSB,Cathepsin B,32845,-0.0214796049962338,0.0335284276465576,-0.0871953231834868,0.0442361131910191,0.521773857020376
Physical measures,X4270.Volume level set by participant (left),GUSB,Beta-glucuronidase,32872,0.0187667147979424,0.0293358369661677,-0.0387315256557463,0.0762649552516311,0.522371068751258
Physical measures,X4270.Volume level set by participant (left),IGDCC3,Immunoglobulin superfamily DCC subclass member 3,31514,-0.0264796317372687,0.0414037608822843,-0.107631003066546,0.0546717395920086,0.522486599996405
Physical measures,X4270.Volume level set by participant (left),ADAMTSL4,ADAMTS-like protein 4,31566,-0.0548480541659761,0.0858327966364346,-0.223080335573388,0.113384227241436,0.522835132603447
Physical measures,X4270.Volume level set by participant (left),NMRK2,Nicotinamide riboside kinase 2,31492,-0.0323771881900431,0.0506905196761621,-0.131730606755321,0.0669762303752345,0.523022483624709
Physical measures,X4270.Volume level set by participant (left),TIGIT,T-cell immunoreceptor with Ig and ITIM domains,31632,-0.0364775017748806,0.0573816813157346,-0.14894559715372,0.0759905936039592,0.524991076109466
Physical measures,X4270.Volume level set by participant (left),DDA1,DET1- and DDB1-associated protein 1,31495,-0.0337019988399411,0.0530213709193127,-0.137623885841794,0.0702198881619119,0.525036363722984
Physical measures,X4270.Volume level set by participant (left),DNAJA4,DnaJ homolog subfamily A member 4,31751,0.0171877673089794,0.0270430370682579,-0.0358165853448061,0.070192119962765,0.525074581371154
Physical measures,X4270.Volume level set by participant (left),ERI1,3'-5' exoribonuclease 1,31632,-0.038908320054444,0.0612873258819357,-0.159031478783038,0.0812148386741499,0.525544293233446
Physical measures,X4270.Volume level set by participant (left),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,32796,-0.0385754247832049,0.0608185117202764,-0.157779707754947,0.0806288581885369,0.525920150483027
Physical measures,X4270.Volume level set by participant (left),OSCAR,Osteoclast-associated immunoglobulin-like receptor,32864,0.0330487922337855,0.0521189469213549,-0.0691043437320702,0.135201928199641,0.526029573400777
Physical measures,X4270.Volume level set by participant (left),HMBS,Porphobilinogen deaminase,32948,0.0255580105162659,0.0403524596288141,-0.0535328103562097,0.104648831388741,0.526508428676521
Physical measures,X4270.Volume level set by participant (left),HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",31495,-0.028793840385349,0.0454697354528798,-0.117914521872993,0.0603268411022953,0.526587500938706
Physical measures,X4270.Volume level set by participant (left),C1RL,Complement C1r subcomponent-like protein,31756,0.0650363421874798,0.102718573640269,-0.136292062147447,0.266364746522406,0.526653545864526
Physical measures,X4270.Volume level set by participant (left),AXL,Tyrosine-protein kinase receptor UFO,32878,-0.0399449500588239,0.0630899310055362,-0.163601214829675,0.0837113147120269,0.526656305334772
Physical measures,X4270.Volume level set by participant (left),FGA,Fibrinogen alpha chain,31578,-0.0425219933020031,0.0671868845575604,-0.174208287034822,0.0891643004308154,0.526823401100465
Physical measures,X4270.Volume level set by participant (left),SHMT1,"Serine hydroxymethyltransferase, cytosolic",32883,-0.0129561551173251,0.0205222081604675,-0.0531796831118415,0.0272673728771912,0.527844931660018
Physical measures,X4270.Volume level set by participant (left),REG4,Regenerating islet-derived protein 4,32864,0.0234519635508815,0.0371786347999912,-0.0494181606571013,0.0963220877588642,0.52819293472543
Physical measures,X4270.Volume level set by participant (left),CLSTN2,Calsyntenin-2,32961,-0.0273403338374483,0.0434079722459998,-0.112419959439608,0.0577392917647112,0.528811221009604
Physical measures,X4270.Volume level set by participant (left),CKAP4,Cytoskeleton-associated protein 4,32905,0.0434683617746325,0.0690911748169892,-0.0919503408666662,0.178887064415931,0.529270077571208
Physical measures,X4270.Volume level set by participant (left),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,32638,-0.0235539400465364,0.0374413761531341,-0.0969390373066792,0.0498311572136065,0.529307479364855
Physical measures,X4270.Volume level set by participant (left),SMC3,Structural maintenance of chromosomes protein 3,31492,-0.022974258177794,0.0366441411339874,-0.0947967748004092,0.0488482584448213,0.530706945516947
Physical measures,X4270.Volume level set by participant (left),RIPK4,Receptor-interacting serine/threonine-protein kinase 4,31495,-0.0194210591350567,0.0309885901475854,-0.0801586958243241,0.0413165775542107,0.530863865805185
Physical measures,X4270.Volume level set by participant (left),SERPINB5,Serpin B5,32685,0.0227911176945107,0.0363961110138249,-0.0485452598925861,0.0941274952816075,0.531202257164367
Physical measures,X4270.Volume level set by participant (left),CRIM1,Cysteine-rich motor neuron 1 protein,32894,-0.0527118766838979,0.0842506845468207,-0.217843218395666,0.112419465027871,0.531556951347729
Physical measures,X4270.Volume level set by participant (left),DPEP1,Dipeptidase 1,32776,-0.0226315990671528,0.0361743033323438,-0.0935332335985465,0.048270035464241,0.531576038909297
Physical measures,X4270.Volume level set by participant (left),RGMA,Repulsive guidance molecule A,32931,-0.0346467268281643,0.0554667857077889,-0.143361626815431,0.0740681731591018,0.532223623009766
Physical measures,X4270.Volume level set by participant (left),NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,31599,-0.058013147407044,0.0928828902335768,-0.240063612264854,0.124037317450767,0.532262682468637
Physical measures,X4270.Volume level set by participant (left),CA1,Carbonic anhydrase 1,32659,0.0179715422506614,0.0288350175504319,-0.0385450921481852,0.0744881766495079,0.533133730049443
Physical measures,X4270.Volume level set by participant (left),MAMDC4,Apical endosomal glycoprotein,31724,-0.0225917375510894,0.0362656826552025,-0.0936724755552862,0.0484890004531075,0.53333489729473
Physical measures,X4270.Volume level set by participant (left),IL17RB,Interleukin-17 receptor B,32740,0.0205047599456243,0.0329688411407822,-0.0441141686903089,0.0851236885815574,0.533994923281583
Physical measures,X4270.Volume level set by participant (left),AGR2,Anterior gradient protein 2 homolog,32577,-0.0107919360747379,0.0173629704311841,-0.0448233581198589,0.023239485970383,0.534254755971206
Physical measures,X4270.Volume level set by participant (left),SPACA5_SPACA5B,Sperm acrosome-associated protein 5,31752,-0.0420727809775784,0.0677098515649948,-0.174784090044968,0.0906385280898115,0.534375029132234
Physical measures,X4270.Volume level set by participant (left),STX7,Syntaxin-7,31508,-0.0248176558521053,0.0399522139201447,-0.103123995135589,0.0534886834313784,0.534497418309237
Physical measures,X4270.Volume level set by participant (left),IKZF2,Zinc finger protein Helios,32638,0.0112323062758993,0.0181376117420172,-0.0243174127384544,0.046782025290253,0.535746321832556
Physical measures,X4270.Volume level set by participant (left),MXRA8,Matrix remodeling-associated protein 8,31599,-0.0414606291970411,0.0669599412792098,-0.172702114104292,0.0897808557102101,0.535812352323677
Physical measures,X4270.Volume level set by participant (left),KCNC4,Potassium voltage-gated channel subfamily C member 4,31514,-0.0233604566872289,0.0377549920093609,-0.0973602410255764,0.0506393276511185,0.536107245206223
Physical measures,X4270.Volume level set by participant (left),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,32761,-0.0445540655694392,0.0720429489963534,-0.185758245602292,0.0966501144634135,0.536302775397213
Physical measures,X4270.Volume level set by participant (left),CR1,Complement receptor type 1,31745,-0.0359301101786672,0.0581743548530897,-0.149951845690723,0.0780916253333887,0.536838428964791
Physical measures,X4270.Volume level set by participant (left),ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,32832,-0.022550204310585,0.0365220677938866,-0.0941334571866028,0.0490330485654328,0.53695988124644
Physical measures,X4270.Volume level set by participant (left),HSPA2,Heat shock-related 70 kDa protein 2,31724,-0.0346701116254874,0.0561548035232197,-0.144733526530998,0.0753933032800232,0.536987208758523
Physical measures,X4270.Volume level set by participant (left),TGFB2,Transforming growth factor beta-2 proprotein,31724,-0.0234041381785542,0.0379149909248883,-0.0977175203913353,0.0509092440342269,0.53706841201084
Physical measures,X4270.Volume level set by participant (left),ENAH,Protein enabled homolog,32679,0.0223052275328041,0.0361421044464255,-0.0485332971821898,0.0931437522477981,0.537149398356597
Physical measures,X4270.Volume level set by participant (left),WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,32796,-0.020700814264121,0.0335629029887637,-0.0864841041220978,0.0450824755938558,0.537397785650451
Physical measures,X4270.Volume level set by participant (left),CRACR2A,EF-hand calcium-binding domain-containing protein 4B,32638,-0.0122755461031367,0.0199327076620912,-0.0513436531208354,0.026792560914562,0.538009891549689
Physical measures,X4270.Volume level set by participant (left),CALCA,Calcitonin,32776,-0.0175538001621078,0.0285249873066486,-0.0734627752831391,0.0383551749589235,0.538317344672081
Physical measures,X4270.Volume level set by participant (left),NCR1,Natural cytotoxicity triggering receptor 1,32832,0.0299300011251393,0.0486431133796475,-0.0654105010989698,0.125270503349248,0.538373674991706
Physical measures,X4270.Volume level set by participant (left),PTPRM,Receptor-type tyrosine-protein phosphatase mu,32823,-0.0431443464257741,0.0701471665887844,-0.180632792939792,0.0943441000882434,0.538534198570862
Physical measures,X4270.Volume level set by participant (left),BMP4,Bone morphogenetic protein 4,32778,-0.0196938618564118,0.0320357481018739,-0.0824839281360847,0.0430962044232612,0.538737879814616
Physical measures,X4270.Volume level set by participant (left),CHAD,Chondroadherin,31599,-0.024508413938927,0.0399271460391304,-0.102765620175622,0.0537487922977685,0.539346813885393
Physical measures,X4270.Volume level set by participant (left),APOL1,Apolipoprotein L1,31772,0.018532891189662,0.0302088213169211,-0.0406763985915033,0.0777421809708273,0.539568254507047
Physical measures,X4270.Volume level set by participant (left),CINP,Cyclin-dependent kinase 2-interacting protein,31632,-0.0280682425254057,0.0457768872003524,-0.117790941438097,0.0616544563872851,0.539793029240869
Physical measures,X4270.Volume level set by participant (left),ITGB7,Integrin beta-7,32948,0.0230241570382729,0.037574164335613,-0.0506212050595285,0.0966695191360744,0.540046647796545
Physical measures,X4270.Volume level set by participant (left),VSIG10,V-set and immunoglobulin domain-containing protein 10,31724,-0.0327152621578554,0.0534725144950991,-0.13752139056825,0.0720908662525389,0.540678158589135
Physical measures,X4270.Volume level set by participant (left),CEP290,Centrosomal protein of 290 kDa,31632,0.0232724200368326,0.038048127863882,-0.0513019105763761,0.0978467506500413,0.540782331599278
Physical measures,X4270.Volume level set by participant (left),SERPINF1,Pigment epithelium-derived factor,31634,-0.0486782524997595,0.0796740346354339,-0.20483936038521,0.107482855385691,0.541238909883153
Physical measures,X4270.Volume level set by participant (left),RASSF2,Ras association domain-containing protein 2,32638,0.0195211456764812,0.0319696327712099,-0.0431393345550902,0.0821816259080526,0.541470131114528
Physical measures,X4270.Volume level set by participant (left),LSP1,Lymphocyte-specific protein 1,32843,-0.0261682413278657,0.0429938774594192,-0.110436241148327,0.0580997584925959,0.542771575767091
Physical measures,X4270.Volume level set by participant (left),LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,31770,-0.0614308276194555,0.100971439387567,-0.259334848819087,0.136473193580176,0.542940975111458
Physical measures,X4270.Volume level set by participant (left),ECE1,Endothelin-converting enzyme 1,32644,-0.0300143575242189,0.0493350829423078,-0.126711120091142,0.0666824050427044,0.54295282490792
Physical measures,X4270.Volume level set by participant (left),FGF2,Fibroblast growth factor 2,32843,-0.0156124099445018,0.0256745034654461,-0.065934436736776,0.0347096168477725,0.543143133579391
Physical measures,X4270.Volume level set by participant (left),CHRDL1,Chordin-like protein 1,32883,0.0344088877295541,0.0566317741748353,-0.0765893896531232,0.145407165112231,0.543474870376963
Physical measures,X4270.Volume level set by participant (left),PLA2G1B,Phospholipase A2,32944,0.0257403538296489,0.042417384687622,-0.0573977201580902,0.108878427817388,0.543975586004424
Physical measures,X4270.Volume level set by participant (left),AMFR,E3 ubiquitin-protein ligase AMFR,32644,0.0154524605303497,0.0254794922938912,-0.0344873443656769,0.0653922654263764,0.544220646692114
Physical measures,X4270.Volume level set by participant (left),NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,31724,-0.0119034894376988,0.0196435120427684,-0.0504047730415248,0.0265977941661272,0.544548437261593
Physical measures,X4270.Volume level set by participant (left),TDO2,"Tryptophan 2,3-dioxygenase",31546,-0.0311728075228879,0.0514703391833422,-0.132054672322239,0.0697090572764628,0.544767707614313
Physical measures,X4270.Volume level set by participant (left),PPM1B,Protein phosphatase 1B,31508,-0.0185790891263919,0.0307340505667578,-0.0788178282372371,0.0416596499844534,0.545521519732112
Physical measures,X4270.Volume level set by participant (left),SCARF2,Scavenger receptor class F member 2,32931,0.035603272112896,0.0588975141809512,-0.0798358556817683,0.15104239990756,0.545529498979418
Physical measures,X4270.Volume level set by participant (left),NCAM2,Neural cell adhesion molecule 2,32861,-0.0382950240737672,0.0635126526463506,-0.162779823260614,0.0861897751130801,0.546556413398428
Physical measures,X4270.Volume level set by participant (left),CLEC4A,C-type lectin domain family 4 member A,32843,-0.0297872968885881,0.0494517500036355,-0.126712726895714,0.0671381331185374,0.546955919151548
Physical measures,X4270.Volume level set by participant (left),AMBN,Ameloblastin,32679,-0.0371307226835003,0.0616612885335911,-0.157986848209339,0.0837254028423383,0.547074908928645
Physical measures,X4270.Volume level set by participant (left),CCL25,C-C motif chemokine 25,32961,0.0203070500384202,0.033729858437332,-0.0458034724987506,0.086417572575591,0.547156080055762
Physical measures,X4270.Volume level set by participant (left),MTPN,Myotrophin,32685,-0.0325962240209807,0.0541900328523677,-0.138808688411621,0.07361624036966,0.547511172873829
Physical measures,X4270.Volume level set by participant (left),NOS3,"Nitric oxide synthase, endothelial",32644,0.0205102185246882,0.0341188683211156,-0.0463627633846985,0.0873832004340748,0.547762220916204
Physical measures,X4270.Volume level set by participant (left),ATF2,Cyclic AMP-dependent transcription factor ATF-2,32644,-0.0152321575468202,0.0253504223598693,-0.0649189853721641,0.0344546702785236,0.547946045500522
Physical measures,X4270.Volume level set by participant (left),GP2,Pancreatic secretory granule membrane major glycoprotein GP2,32581,0.0124679079485765,0.0208492748945299,-0.0283966708447021,0.053332486741855,0.549854136777312
Physical measures,X4270.Volume level set by participant (left),NSFL1C,NSFL1 cofactor p47,32931,-0.016361625525701,0.0274126244208606,-0.0700903693905878,0.0373671183391859,0.550612674577379
Physical measures,X4270.Volume level set by participant (left),CDH6,Cadherin-6,32864,-0.0267747880964106,0.0448709925174312,-0.114721933430576,0.0611723572377546,0.55071872851398
Physical measures,X4270.Volume level set by participant (left),CRHR1,Corticotropin-releasing factor receptor 1,32685,0.0165990351452154,0.0278783314189606,-0.0380424944359475,0.0712405647263782,0.551584767533712
Physical measures,X4270.Volume level set by participant (left),SIRPB1,Signal-regulatory protein beta-1,32822,0.0231154248927192,0.0388839629638783,-0.0530971425164822,0.0993279923019207,0.552211516326885
Physical measures,X4270.Volume level set by participant (left),DLL4,Delta-like protein 4,31566,-0.0140078172659067,0.0235717822449252,-0.06020851046596,0.0321928759341466,0.552354262898285
Physical measures,X4270.Volume level set by participant (left),TGFBR3,Transforming growth factor beta receptor type 3,32964,-0.0300482421241137,0.0506725023494582,-0.129366346729052,0.0692698624808245,0.553203173963035
Physical measures,X4270.Volume level set by participant (left),CNTN5,Contactin-5,32872,-0.0281412585767634,0.0474941110941846,-0.121229716321365,0.0649471991678384,0.553516628495318
Physical measures,X4270.Volume level set by participant (left),PTN,Pleiotrophin,32685,-0.0206614746702735,0.0349512645581171,-0.0891659532041831,0.0478430038636361,0.55443440239919
Physical measures,X4270.Volume level set by participant (left),CDHR2,Cadherin-related family member 2,32832,0.013957647461049,0.0236246442562805,-0.0323466552812608,0.0602619502033588,0.55466343252685
Physical measures,X4270.Volume level set by participant (left),EDDM3B,Epididymal secretory protein E3-beta,31724,-0.023359747442624,0.0395471506433857,-0.10087216270366,0.0541526678184119,0.554751213503909
Physical measures,X4270.Volume level set by participant (left),STC1,Stanniocalcin-1,32931,0.0240133967873006,0.0406809730602106,-0.0557213104107123,0.103748103985313,0.55501383200001
Physical measures,X4270.Volume level set by participant (left),IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,31632,0.0235108007103445,0.0399319458822368,-0.0547558132188395,0.101777414639529,0.556031532106517
Physical measures,X4270.Volume level set by participant (left),LTBR,Tumor necrosis factor receptor superfamily member 3,32781,0.0382207275063289,0.0649849862817901,-0.0891498456059797,0.165591300618638,0.556448492930486
Physical measures,X4270.Volume level set by participant (left),RELT,Tumor necrosis factor receptor superfamily member 19L,32861,0.0397179002942371,0.0675927583169587,-0.092763906007002,0.172199706595476,0.556811627738033
Physical measures,X4270.Volume level set by participant (left),SH3GL3,Endophilin-A3,31575,-0.01418666298137,0.0242144725363812,-0.0616470291526772,0.0332737031899372,0.557976416683347
Physical measures,X4270.Volume level set by participant (left),BAP18,Chromatin complexes subunit BAP18,31751,0.0183993477354588,0.0314680776149539,-0.0432780843898508,0.0800767798607684,0.558766972930944
Physical measures,X4270.Volume level set by participant (left),CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",31495,0.0143144442944996,0.0245123047061276,-0.0337296729295106,0.0623585615185097,0.559257927098965
Physical measures,X4270.Volume level set by participant (left),CD200R1,Cell surface glycoprotein CD200 receptor 1,32808,0.0293593431979516,0.0503559307673442,-0.0693382811060431,0.128056967501946,0.55988345962807
Physical measures,X4270.Volume level set by participant (left),SERPIND1,Heparin cofactor 2,31758,0.0405895275904644,0.0696419616178567,-0.0959087171805347,0.177087772361464,0.560023396308089
Physical measures,X4270.Volume level set by participant (left),GFRA1,GDNF family receptor alpha-1,32940,0.0375265576346287,0.0644035517915155,-0.0887044038767416,0.163757519145999,0.560124299584296
Physical measures,X4270.Volume level set by participant (left),PGLYRP4,Peptidoglycan recognition protein 4,31495,0.0177507325483697,0.0304915069267593,-0.0420126210280785,0.077514086124818,0.56048059632099
Physical measures,X4270.Volume level set by participant (left),WNT9A,Protein Wnt-9a,32679,-0.0359925201792913,0.0619537090786706,-0.157421789973486,0.085436749614903,0.561283423711754
Physical measures,X4270.Volume level set by participant (left),LRP2,Low-density lipoprotein receptor-related protein 2,31546,-0.0323937529289445,0.0558482298472232,-0.141856283429502,0.077068777571613,0.561910138547446
Physical measures,X4270.Volume level set by participant (left),CTSO,Cathepsin O,32961,-0.0324622198639982,0.0560472447824597,-0.142314819637619,0.0773903799096229,0.562472715152966
Physical measures,X4270.Volume level set by participant (left),MAG,Myelin-associated glycoprotein,31546,0.0254548686807553,0.0441841932190508,-0.0611461500285843,0.112055887390095,0.564559036585549
Physical measures,X4270.Volume level set by participant (left),PGR,Progesterone receptor,31508,0.0107131965223647,0.0186124830024384,-0.0257672701624146,0.0471936632071441,0.564907923378271
Physical measures,X4270.Volume level set by participant (left),S100A11,Protein S100-A11,32786,0.0202604937627046,0.0352351435722563,-0.0488003876389177,0.089321375164327,0.56530030110973
Physical measures,X4270.Volume level set by participant (left),HDAC9,Histone deacetylase 9,31514,-0.0178875700442985,0.0311113680389039,-0.0788658514005501,0.0430907113119532,0.565340084389958
Physical measures,X4270.Volume level set by participant (left),GGA1,ADP-ribosylation factor-binding protein GGA1,32644,0.0140884485620761,0.0245307819059004,-0.0339918839734887,0.0621687810976408,0.565767922524982
Physical measures,X4270.Volume level set by participant (left),CPA2,Carboxypeptidase A2,32898,-0.0151395650587733,0.0263841504873319,-0.0668525000139437,0.0365733698963971,0.566108723313094
Physical measures,X4270.Volume level set by participant (left),LRRC25,Leucine-rich repeat-containing protein 25,32832,-0.0255562559307811,0.0445798464580547,-0.112932754988568,0.0618202431270062,0.566476762923766
Physical measures,X4270.Volume level set by participant (left),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,32864,-0.034013374143542,0.0595729539091549,-0.150776363805486,0.0827496155184017,0.568045558803439
Physical measures,X4270.Volume level set by participant (left),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",31566,0.0311627033069144,0.0546206468307803,-0.0758937644814149,0.138219171095244,0.568335099836176
Physical measures,X4270.Volume level set by participant (left),AKR1C4,Aldo-keto reductase family 1 member C4,32685,-0.0184081431811976,0.0322665775826144,-0.0816506352431218,0.0448343488807266,0.568351876897263
Physical measures,X4270.Volume level set by participant (left),TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,32679,-0.0242382185777493,0.042503278728365,-0.107544644885345,0.0590682077298461,0.568511130946867
Physical measures,X4270.Volume level set by participant (left),CD33,Myeloid cell surface antigen CD33,32881,0.0125461084621217,0.0220113553787669,-0.0305961480802615,0.0556883650045048,0.568703116362845
Physical measures,X4270.Volume level set by participant (left),CHIT1,Chitotriosidase-1,32875,-0.00640208644140895,0.0112414626228625,-0.0284353531822195,0.0156311802994016,0.569026630698197
Physical measures,X4270.Volume level set by participant (left),NPR1,Atrial natriuretic peptide receptor 1,31495,-0.0269684032273825,0.047358140326135,-0.119790358266607,0.0658535518118421,0.569063108374163
Physical measures,X4270.Volume level set by participant (left),NECTIN2,Nectin-2,32858,-0.0348053815209745,0.0611894047506078,-0.154736614832166,0.0851258517902168,0.569496668744841
Physical measures,X4270.Volume level set by participant (left),FCN2,Ficolin-2,32787,-0.0232847264789821,0.0410463137360604,-0.103735501401661,0.0571660484436963,0.570538668609414
Physical measures,X4270.Volume level set by participant (left),CALB2,Calretinin,32644,-0.03341322062584,0.0589243821263453,-0.148905009593477,0.0820785683417967,0.570692980051664
Physical measures,X4270.Volume level set by participant (left),PYDC1,Pyrin domain-containing protein 1,31566,-0.0269144618282333,0.0475120394069444,-0.120038059065844,0.0662091354093778,0.571086292304061
Physical measures,X4270.Volume level set by participant (left),INHBC,Inhibin beta C chain,32861,0.0234042326434966,0.0413693861068807,-0.0576797641259896,0.104488229412983,0.571586024371327
Physical measures,X4270.Volume level set by participant (left),CD300A,CMRF35-like molecule 8,31599,-0.0403018206089248,0.0714663408793109,-0.180375848732374,0.0997722075145245,0.57281995742008
Physical measures,X4270.Volume level set by participant (left),TDGF1,Teratocarcinoma-derived growth factor 1,32644,-0.00702504854337762,0.0124726476450527,-0.0314714379276809,0.0174213408409257,0.573288334353521
Physical measures,X4270.Volume level set by participant (left),SEZ6,Seizure protein 6 homolog,31546,-0.0362995998433057,0.0644590795208228,-0.162639395704118,0.0900401960175069,0.573354786699416
Physical measures,X4270.Volume level set by participant (left),SERPINA11,Serpin A11,32964,-0.0231516226738803,0.0411801223818657,-0.103864662542337,0.0575614171945765,0.573990995689601
Physical measures,X4270.Volume level set by participant (left),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,32881,-0.0210930260138089,0.0376580158513006,-0.0949027370823581,0.0527166850547404,0.575411173396514
Physical measures,X4270.Volume level set by participant (left),ADRA2A,Alpha-2A adrenergic receptor,31495,-0.0152838419842581,0.0272899063906112,-0.0687720585098561,0.0382043745413398,0.575458524173862
Physical measures,X4270.Volume level set by participant (left),SOX2,Transcription factor SOX-2,31726,0.0463999440037984,0.0828809072479531,-0.11604663420219,0.208846522209786,0.575605373327478
Physical measures,X4270.Volume level set by participant (left),ALMS1,Alstrom syndrome protein 1,31632,-0.0235798970602693,0.0421312589648626,-0.1061571646314,0.0589973705108614,0.575715901093749
Physical measures,X4270.Volume level set by participant (left),HMCN2,Hemicentin-2,31576,0.0196389370456276,0.0351276298209659,-0.0492112174034656,0.0884890914947207,0.576127595029878
Physical measures,X4270.Volume level set by participant (left),F9,Coagulation factor IX,32872,-0.0520954140657903,0.0931887762930936,-0.234745415600254,0.130554587468673,0.576154464565857
Physical measures,X4270.Volume level set by participant (left),S100A12,Protein S100-A12,32748,0.0132881327110736,0.0238619163810688,-0.0334812233958213,0.0600574888179686,0.577626060306883
Physical measures,X4270.Volume level set by participant (left),OSMR,Oncostatin-M-specific receptor subunit beta,32908,0.0465186850190698,0.0838268887344505,-0.117782016900453,0.210819386938593,0.578951125508226
Physical measures,X4270.Volume level set by participant (left),KRT8,"Keratin, type II cytoskeletal 8",31514,-0.0176952636914271,0.0319402248853976,-0.0802981044668064,0.0449075770839523,0.579586913824788
Physical measures,X4270.Volume level set by participant (left),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,32638,-0.0225740344288144,0.0407596612030829,-0.102462970386857,0.0573149015292281,0.57970743843597
Physical measures,X4270.Volume level set by participant (left),ASGR2,Asialoglycoprotein receptor 2,31772,-0.044102402184149,0.0796792191037788,-0.200273671627555,0.112068867259257,0.579937118317688
Physical measures,X4270.Volume level set by participant (left),PLA2G2A,"Phospholipase A2, membrane associated",32820,0.0168324529139556,0.0304271957819297,-0.0428048508186266,0.0764697566465379,0.580137388900708
Physical measures,X4270.Volume level set by participant (left),CA3,Carbonic anhydrase 3,32960,0.0147793904973211,0.0267818165426837,-0.037712969926339,0.0672717509209812,0.581068647479449
Physical measures,X4270.Volume level set by participant (left),DCUN1D2,DCN1-like protein 2,31492,-0.0141377626658032,0.0256652971420406,-0.0644417450642027,0.0361662197325963,0.581751734327204
Physical measures,X4270.Volume level set by participant (left),ALPI,Intestinal-type alkaline phosphatase,31508,-0.00924753549319578,0.016795655609533,-0.0421670204878805,0.023671949501489,0.581930221413509
Physical measures,X4270.Volume level set by participant (left),ISM1,Isthmin-1,32843,0.0233322415945453,0.0423904904223323,-0.0597531196332261,0.106417602822317,0.582050397699328
Physical measures,X4270.Volume level set by participant (left),GLI2,Zinc finger protein GLI2,31508,-0.0318701427594924,0.0579177632955201,-0.145388958818712,0.0816486732997269,0.582153410098141
Physical measures,X4270.Volume level set by participant (left),ITGBL1,Integrin beta-like protein 1,31773,-0.0303283107379318,0.0552497959872223,-0.138617910872888,0.077961289397024,0.583068483690286
Physical measures,X4270.Volume level set by participant (left),MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,32843,0.00626160312478152,0.0114213229852784,-0.0161241899263642,0.0286473961759272,0.583542129598072
Physical measures,X4270.Volume level set by participant (left),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,31632,-0.0257251947798267,0.0469270688944202,-0.11770224981289,0.0662518602532369,0.58357361576312
Physical measures,X4270.Volume level set by participant (left),IL9,Interleukin-9,31632,-0.0196310564133067,0.0358377531557618,-0.0898730525985999,0.0506109397719865,0.583861545933066
Physical measures,X4270.Volume level set by participant (left),ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",31762,0.0147118747363474,0.0269240019251696,-0.038059169036985,0.0674829185096798,0.584791126224465
Physical measures,X4270.Volume level set by participant (left),NPC2,NPC intracellular cholesterol transporter 2,31639,-0.0378712318600542,0.0693255869399944,-0.173749382262443,0.0980069185423348,0.584888656737364
Physical measures,X4270.Volume level set by participant (left),AK1,Adenylate kinase isoenzyme 1,32864,-0.0148815944206295,0.0272661399450228,-0.0683232287128741,0.0385600398716151,0.585223624462985
Physical measures,X4270.Volume level set by participant (left),CCNE1,G1/S-specific cyclin-E1,31508,0.0110701628596471,0.0202972598165133,-0.0287124663807189,0.0508527921000132,0.585493086452776
Physical measures,X4270.Volume level set by participant (left),HMOX2,Heme oxygenase 2,32644,0.0210319517950386,0.0385769795752685,-0.0545789281724878,0.0966428317625649,0.585633695220045
Physical measures,X4270.Volume level set by participant (left),VNN1,Pantetheinase,31772,0.0147927725878836,0.0271470410573382,-0.0384154278844993,0.0680009730602666,0.585828795143449
Physical measures,X4270.Volume level set by participant (left),MPRIP,Myosin phosphatase Rho-interacting protein,31709,-0.0245525297515089,0.0451718138276593,-0.113089284853721,0.0639842253507032,0.58677590695105
Physical measures,X4270.Volume level set by participant (left),CD79B,B-cell antigen receptor complex-associated protein beta chain,32961,0.0227150335690794,0.0418373960681423,-0.0592862627244795,0.104716329862638,0.587187084640218
Physical measures,X4270.Volume level set by participant (left),PODXL2,Podocalyxin-like protein 2,32881,0.0340036442105359,0.0626480587373988,-0.0887865509147658,0.156793839335838,0.587299854959454
Physical measures,X4270.Volume level set by participant (left),FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,32638,-0.0155585902186218,0.0286858432893827,-0.0717828430658118,0.0406656626285682,0.587571427494172
Physical measures,X4270.Volume level set by participant (left),SERPINA6,Corticosteroid-binding globulin,31770,0.0594481741211899,0.109927015489449,-0.156008776238129,0.274905124480509,0.588662908014263
Physical measures,X4270.Volume level set by participant (left),HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,32948,-0.0273938400069121,0.0506562473610733,-0.126680084834616,0.0718924048207917,0.58867310596958
Physical measures,X4270.Volume level set by participant (left),CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,31720,-0.0275515935337365,0.0510758746546944,-0.127660307856937,0.0725571207894645,0.589609057281755
Physical measures,X4270.Volume level set by participant (left),TBC1D5,TBC1 domain family member 5,32843,-0.0114890631815495,0.0213029738448137,-0.0532428919173845,0.0302647655542854,0.589681277198675
Physical measures,X4270.Volume level set by participant (left),NBL1,Neuroblastoma suppressor of tumorigenicity 1,32881,-0.0364422919670551,0.0677256289000569,-0.169184524611167,0.0962999406770565,0.59053014918065
Physical measures,X4270.Volume level set by participant (left),ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,31495,-0.0233328892710417,0.0433647243595331,-0.108327749015727,0.0616619704736432,0.590550270825082
Physical measures,X4270.Volume level set by participant (left),SYT1,Synaptotagmin-1,31751,-0.0296621617746917,0.0551400679753873,-0.137736695006451,0.0784123714570675,0.590632226473117
Physical measures,X4270.Volume level set by participant (left),PTPRF,Receptor-type tyrosine-protein phosphatase F,32964,-0.032215413700255,0.0599422891242227,-0.149702300383731,0.0852714729832215,0.590976515719703
Physical measures,X4270.Volume level set by participant (left),TPSAB1,Tryptase alpha/beta-1,32940,-0.0173682605203615,0.0324241132633576,-0.0809195225165423,0.0461830014758193,0.592207529814454
Physical measures,X4270.Volume level set by participant (left),PCBD1,Pterin-4-alpha-carbinolamine dehydratase,31582,-0.023497830293033,0.0438966675164547,-0.109535298625284,0.0625396380392182,0.592458726542127
Physical measures,X4270.Volume level set by participant (left),LAMP1,Lysosome-associated membrane glycoprotein 1,31558,0.0391683701682509,0.0731982862892523,-0.104300270958684,0.182637011295185,0.592596482312495
Physical measures,X4270.Volume level set by participant (left),DNLZ,DNL-type zinc finger protein,31514,-0.0122045687805779,0.0228548353560718,-0.0570000460784785,0.0325909085173228,0.593354423792228
Physical measures,X4270.Volume level set by participant (left),CNDP1,Beta-Ala-His dipeptidase,32878,-0.0188181460865812,0.0352458649250458,-0.0879000413396709,0.0502637491665084,0.593416450284551
Physical measures,X4270.Volume level set by participant (left),THBS2,Thrombospondin-2,32861,0.0245859675843758,0.0460806544942029,-0.0657321152242618,0.114904050393013,0.593671578654033
Physical measures,X4270.Volume level set by participant (left),IGFBPL1,Insulin-like growth factor-binding protein-like 1,32864,-0.0283521787747935,0.053210341237756,-0.132644447600795,0.0759400900512083,0.594162953155329
Physical measures,X4270.Volume level set by participant (left),CLNS1A,Methylosome subunit pICln,31546,-0.029805997798954,0.0559417751966418,-0.139451877184372,0.0798398815864639,0.594184721061057
Physical measures,X4270.Volume level set by participant (left),BLNK,B-cell linker protein,31508,-0.0285906904490409,0.0537173336803785,-0.133876664462583,0.076695283564501,0.594572970558334
Physical measures,X4270.Volume level set by participant (left),IDO1,"Indoleamine 2,3-dioxygenase 1",31566,-0.0164159038949809,0.0308521985071344,-0.0768862129689643,0.0440544051790025,0.59468444998226
Physical measures,X4270.Volume level set by participant (left),C1S,Complement C1s subcomponent,31770,-0.0497265136652662,0.0935058025757956,-0.232997886713826,0.133544859383293,0.594878515979468
Physical measures,X4270.Volume level set by participant (left),ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,32578,-0.0107045448254953,0.0201390472767896,-0.0501770774880029,0.0287679878370122,0.595063831501242
Physical measures,X4270.Volume level set by participant (left),PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",32679,-0.0131915707485398,0.0248793780942277,-0.0619551518132261,0.0355720103161465,0.595972010252488
Physical measures,X4270.Volume level set by participant (left),ZHX2,Zinc fingers and homeoboxes protein 2,31751,-0.0350577037557906,0.0662307601339523,-0.164869993618337,0.0947545861067558,0.596593794719183
Physical measures,X4270.Volume level set by participant (left),GAD1,Glutamate decarboxylase 1,31492,-0.0412427789696716,0.0780695345955264,-0.194259066776903,0.11177350883756,0.597318552743009
Physical measures,X4270.Volume level set by participant (left),KLK1,Kallikrein-1,32776,-0.00725429560419952,0.0137989412823267,-0.0343002205175598,0.0197916293091608,0.599100064740898
Physical measures,X4270.Volume level set by participant (left),CEND1,Cell cycle exit and neuronal differentiation protein 1,31514,-0.0180599391009985,0.0344424345380628,-0.0855671107956016,0.0494472325936045,0.600049336185407
Physical measures,X4270.Volume level set by participant (left),RPL14,60S ribosomal protein L14,31566,-0.0261067234570175,0.0498321062110629,-0.123777651630701,0.0715642047166657,0.600367591809187
Physical measures,X4270.Volume level set by participant (left),NDRG1,Protein NDRG1,32644,-0.0131088184005476,0.0250912791728451,-0.0622877255793241,0.0360700887782288,0.601373570905341
Physical measures,X4270.Volume level set by participant (left),ENPEP,Glutamyl aminopeptidase,31495,-0.0262179172092977,0.0501889688603211,-0.124588296175527,0.0721524617569316,0.601418115617204
Physical measures,X4270.Volume level set by participant (left),ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,32961,0.025177778176143,0.048324897841203,-0.0695390215926149,0.119894577944901,0.602372151676658
Physical measures,X4270.Volume level set by participant (left),IGFBP7,Insulin-like growth factor-binding protein 7,32964,0.0298861270297819,0.0575704351366707,-0.0829519258380927,0.142724179897656,0.603687714068216
Physical measures,X4270.Volume level set by participant (left),CSNK1D,Casein kinase I isoform delta,31508,-0.0162157295843294,0.0312504283673331,-0.0774665691843024,0.0450351100156436,0.603848123749355
Physical measures,X4270.Volume level set by participant (left),GLO1,Lactoylglutathione lyase,32685,-0.0162280353197567,0.0313054050736435,-0.077586629264098,0.0451305586245846,0.604207516214071
Physical measures,X4270.Volume level set by participant (left),CTSV,Cathepsin L2,32939,-0.0210842689395659,0.0407489554735453,-0.100952221667715,0.0587836837885829,0.604876563377756
Physical measures,X4270.Volume level set by participant (left),IL1RAP,Interleukin-1 receptor accessory protein,32861,-0.0208240736268913,0.0402483014251407,-0.0997107444201671,0.0580625971663846,0.604896571407511
Physical measures,X4270.Volume level set by participant (left),ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,32630,-0.0160353835388036,0.0310226815943705,-0.0768398394637698,0.0447690723861625,0.605244420303097
Physical measures,X4270.Volume level set by participant (left),SNCG,Gamma-synuclein,32796,0.0138596695103467,0.0268381571873131,-0.038743118576787,0.0664624575974804,0.60557626706532
Physical measures,X4270.Volume level set by participant (left),CASC3,Protein CASC3,31546,-0.0250661828636492,0.0485756966153652,-0.120274548229765,0.0701421825024665,0.605853106396025
Physical measures,X4270.Volume level set by participant (left),TIMP1,Metalloproteinase inhibitor 1,32725,-0.0329859721546435,0.064036933041214,-0.158498360915423,0.0925264166061359,0.606490011486264
Physical measures,X4270.Volume level set by participant (left),DLGAP5,Disks large-associated protein 5,31752,-0.0191291096558382,0.037150084898052,-0.0919432760560201,0.0536850567443437,0.606627339498662
Physical measures,X4270.Volume level set by participant (left),TAFA5,Chemokine-like protein TAFA-5,32832,-0.0264542679476545,0.0514167769763824,-0.127231150821364,0.074322614926055,0.606910567505275
Physical measures,X4270.Volume level set by participant (left),GIMAP8,GTPase IMAP family member 8,31492,-0.0215471028808439,0.0420225205396284,-0.103911243138516,0.0608170373768278,0.608140131184011
Physical measures,X4270.Volume level set by participant (left),C1GALT1C1,C1GALT1-specific chaperone 1,31495,0.0327836820669161,0.0639773126846444,-0.0926118507949868,0.158179214928819,0.608367249776869
Physical measures,X4270.Volume level set by participant (left),TRAF2,TNF receptor-associated factor 2,32843,-0.0127418859699852,0.0248822935003202,-0.0615111812306129,0.0360274092906424,0.608603082958868
Physical measures,X4270.Volume level set by participant (left),SAT1,Diamine acetyltransferase 1,31495,-0.0218612701077381,0.0427616018397366,-0.105674009713622,0.0619514694981457,0.609200605185079
Physical measures,X4270.Volume level set by participant (left),PENK,Proenkephalin-A,31599,0.0353973502741803,0.0693004554161177,-0.10043154234141,0.171226242889771,0.609519047174239
Physical measures,X4270.Volume level set by participant (left),PON1,Serum paraoxonase/arylesterase 1,31772,0.0386607441831466,0.0757284920694955,-0.109767100273065,0.187088588639358,0.609702986029193
Physical measures,X4270.Volume level set by participant (left),NAGA,Alpha-N-acetylgalactosaminidase,31494,-0.0166920689013169,0.0327772619416512,-0.0809355023069533,0.0475513645043195,0.610586416785205
Physical measures,X4270.Volume level set by participant (left),PPL,Periplakin,31508,-0.0319287104023638,0.0627841566729926,-0.154985657481429,0.0911282366767016,0.611084284002535
Physical measures,X4270.Volume level set by participant (left),ANXA3,Annexin A3,32923,-0.0130905689098005,0.0257574261155003,-0.0635751240961812,0.0373939862765801,0.611307906064117
Physical measures,X4270.Volume level set by participant (left),ELOB,Elongin-B,31495,-0.0259712313459414,0.051138604168119,-0.126202895515455,0.0742604328235719,0.61156648142969
Physical measures,X4270.Volume level set by participant (left),DNAJB1,DnaJ homolog subfamily B member 1,32832,-0.0107526258350197,0.0212064446483379,-0.052317257345762,0.0308120056757226,0.612135574278528
Physical measures,X4270.Volume level set by participant (left),LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,32870,-0.0145446748770977,0.0287183904849245,-0.0708327202275497,0.0417433704733543,0.61254716585309
Physical measures,X4270.Volume level set by participant (left),MFAP3L,Microfibrillar-associated protein 3-like,31546,-0.0160433184133728,0.0317062748244244,-0.0781876170692447,0.046100980242499,0.61287242147006
Physical measures,X4270.Volume level set by participant (left),LAG3,Lymphocyte activation gene 3 protein,32832,-0.0218996901677748,0.0433008878944383,-0.106769430440874,0.0629700501053243,0.613040277254978
Physical measures,X4270.Volume level set by participant (left),STX6,Syntaxin-6,32638,0.0120247569939617,0.0238176261649423,-0.0346577902893253,0.0587073042772486,0.613664237992538
Physical measures,X4270.Volume level set by participant (left),VEGFD,Vascular endothelial growth factor D,32945,-0.0241391475169405,0.0478677663716933,-0.117959969605459,0.0696816745715783,0.614071134494768
Physical measures,X4270.Volume level set by participant (left),CKB,Creatine kinase B-type,31773,-0.0172511166582353,0.0342773736296436,-0.0844347689723368,0.0499325356558661,0.614781438428378
Physical measures,X4270.Volume level set by participant (left),NEB,Nebulin,31495,-0.0263258982896228,0.052337781506466,-0.128907950042296,0.0762561534630507,0.614978865104327
Physical measures,X4270.Volume level set by participant (left),SUSD5,Sushi domain-containing protein 5,31549,-0.030198692531295,0.0600640230645089,-0.147924177737732,0.0875267926751424,0.615136838819333
Physical measures,X4270.Volume level set by participant (left),IGLON5,IgLON family member 5,31492,-0.0119620023627769,0.0238355955842699,-0.058679769707946,0.0347557649823922,0.615784312664995
Physical measures,X4270.Volume level set by participant (left),PSMA1,Proteasome subunit alpha type-1,32638,-0.0187345415368019,0.0373625506170993,-0.0919651407463166,0.0544960576727128,0.616084164668329
Physical measures,X4270.Volume level set by participant (left),DCLRE1C,Protein artemis,31492,-0.0312267368960088,0.0623107461441122,-0.153355799338469,0.090902325546451,0.616283334306443
Physical measures,X4270.Volume level set by participant (left),LGALS3BP,Galectin-3-binding protein,31770,-0.0322108753651108,0.0643845418783664,-0.158404577446709,0.0939828267164873,0.616885551275828
Physical measures,X4270.Volume level set by participant (left),CD99,CD99 antigen,32861,0.0453051018771278,0.09093665885613,-0.132930749480887,0.223540953235143,0.61835170611582
Physical measures,X4270.Volume level set by participant (left),CXCL14,C-X-C motif chemokine 14,32679,-0.0136811977324031,0.0274685702345064,-0.0675195953920357,0.0401571999272294,0.618449002878329
Physical measures,X4270.Volume level set by participant (left),LPL,Lipoprotein lipase,32864,-0.0177580847832392,0.0357896023150975,-0.0879057053208303,0.052389535754352,0.6197795378591
Physical measures,X4270.Volume level set by participant (left),AMBP,Protein AMBP,32933,0.0435487812617683,0.0877886942858736,-0.128517059538544,0.21561462206208,0.619861515402652
Physical measures,X4270.Volume level set by participant (left),SERPING1,Plasma protease C1 inhibitor,31758,-0.0524329180208126,0.105815177090237,-0.259830665117678,0.154964829076052,0.620251024591121
Physical measures,X4270.Volume level set by participant (left),CPB2,Carboxypeptidase B2,31758,0.0434878561661001,0.0878797712316115,-0.128756495447858,0.215732207780059,0.620715348489854
Physical measures,X4270.Volume level set by participant (left),PALM3,Paralemmin-3,31495,-0.0124410339496023,0.0251586683257932,-0.0617520238681569,0.0368699559689523,0.620965306146298
Physical measures,X4270.Volume level set by participant (left),SKAP1,Src kinase-associated phosphoprotein 1,32776,0.0122125176881276,0.0247564341646851,-0.0363100932746551,0.0607351286509103,0.621807967685505
Physical measures,X4270.Volume level set by participant (left),ESR1,Estrogen receptor,31508,0.0165880558386444,0.0336324427464906,-0.0493315319444772,0.0825076436217659,0.621874204393536
Physical measures,X4270.Volume level set by participant (left),DDI2,Protein DDI1 homolog 2,31599,0.0128228706508163,0.0260320698564013,-0.0381999862677302,0.0638457275693629,0.622323533468791
Physical measures,X4270.Volume level set by participant (left),LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,31773,0.00689867218603921,0.0140181902696778,-0.0205769807425292,0.0343743251146077,0.622646134980819
Physical measures,X4270.Volume level set by participant (left),FZD10,Frizzled-10,31546,-0.0165762718757041,0.0336841415504351,-0.0825971893145569,0.0494446455631487,0.622656294728386
Physical measures,X4270.Volume level set by participant (left),LRG1,Leucine-rich alpha-2-glycoprotein,31770,0.0382041718080452,0.0779967334841407,-0.114669425820871,0.191077769436961,0.624276573465917
Physical measures,X4270.Volume level set by participant (left),GLYR1,Putative oxidoreductase GLYR1,31724,-0.0157296492217502,0.0321419188414623,-0.0787278101510164,0.047268511707516,0.624585533061887
Physical measures,X4270.Volume level set by participant (left),VEGFB,Vascular endothelial growth factor B,31508,-0.0339456181062703,0.069499013359308,-0.170163684290514,0.102272448077973,0.625257115016417
Physical measures,X4270.Volume level set by participant (left),RAB44,Ras-related protein Rab-44,31724,-0.0227884637227034,0.0467023936693876,-0.114325155314703,0.0687482278692963,0.625598400125067
Physical measures,X4270.Volume level set by participant (left),ACP1,Low molecular weight phosphotyrosine protein phosphatase,31508,-0.0216872152099358,0.0445104188577837,-0.108927636171192,0.0655532057513202,0.626102888919627
Physical measures,X4270.Volume level set by participant (left),TPM3,Tropomyosin alpha-3 chain,31495,-0.0216002827838848,0.0444032409705343,-0.108630635086132,0.0654300695183625,0.626656907900312
Physical measures,X4270.Volume level set by participant (left),ERC2,ERC protein 2,31546,-0.0133199284807119,0.0274373548512911,-0.0670971439892425,0.0404572870278188,0.627359007011671
Physical measures,X4270.Volume level set by participant (left),ITGB5,Integrin beta-5,32881,-0.0220968277480619,0.0455886946463107,-0.111450669254831,0.067257013758707,0.627901134119491
Physical measures,X4270.Volume level set by participant (left),LGALS1,Galectin-1,32864,0.0248911329193579,0.0513808657554869,-0.0758153639613964,0.125597629800112,0.628082850959469
Physical measures,X4270.Volume level set by participant (left),CLEC6A,C-type lectin domain family 6 member A,32638,-0.0184211897669975,0.0380898742593636,-0.0930773433153502,0.0562349637813551,0.628664575088443
Physical measures,X4270.Volume level set by participant (left),CLSPN,Claspin,32624,-0.0222488592073547,0.0460527622022534,-0.112512273123771,0.068014554709062,0.629024938535699
Physical measures,X4270.Volume level set by participant (left),MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,31495,-0.0155291371305548,0.0321521389728912,-0.0785473295174216,0.047489055256312,0.629117231082013
Physical measures,X4270.Volume level set by participant (left),CRTAP,Cartilage-associated protein,31546,-0.018783159940858,0.0389835455279898,-0.0951909091757179,0.0576245892940019,0.629945575634866
Physical measures,X4270.Volume level set by participant (left),IL7R,Interleukin-7 receptor subunit alpha,32861,-0.0160403066900762,0.0333592575150552,-0.0814244514195844,0.049343838039432,0.63064529099193
Physical measures,X4270.Volume level set by participant (left),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,32861,0.0314109645917513,0.0653314098508393,-0.0966385987158936,0.159460527899396,0.630674444564479
Physical measures,X4270.Volume level set by participant (left),IGSF9,Protein turtle homolog A,31762,0.0116435873834931,0.0242627204817442,-0.0359113447607255,0.0591985195277116,0.631314490434784
Physical measures,X4270.Volume level set by participant (left),PECR,Peroxisomal trans-2-enoyl-CoA reductase,31566,-0.0348659779096526,0.0729183728052431,-0.177785988607929,0.108054032788624,0.632556450348103
Physical measures,X4270.Volume level set by participant (left),BTLA,B- and T-lymphocyte attenuator,31492,0.0107782439870809,0.0226033085664872,-0.033524240803234,0.0550807287773958,0.633487123830853
Physical measures,X4270.Volume level set by participant (left),XRCC4,DNA repair protein XRCC4,32644,-0.0226586912621647,0.0476154971567458,-0.115985065689387,0.0706676831650571,0.634180261527677
Physical measures,X4270.Volume level set by participant (left),PAIP2B,Polyadenylate-binding protein-interacting protein 2B,31481,-0.0179486246935896,0.0377218708383052,-0.0918834915366678,0.0559862421494885,0.634219963887173
Physical measures,X4270.Volume level set by participant (left),FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,32624,-0.0185315355597406,0.0392058856755072,-0.0953750714837347,0.0583120003642535,0.636458777102564
Physical measures,X4270.Volume level set by participant (left),LAMB1,Laminin subunit beta-1,31566,-0.0310182337495467,0.0656603041768565,-0.159712429936185,0.097675962437092,0.63665136086468
Physical measures,X4270.Volume level set by participant (left),FURIN,Furin,32881,-0.0236898368737177,0.0502515744717274,-0.122182922838304,0.0748032490908681,0.637348836119964
Physical measures,X4270.Volume level set by participant (left),SGSH,N-sulphoglucosamine sulphohydrolase,31656,0.0172188818961383,0.0366430276228723,-0.0546014522446914,0.089039216036968,0.638433310735261
Physical measures,X4270.Volume level set by participant (left),WARS,"Tryptophan--tRNA ligase, cytoplasmic",32861,-0.0219451495561435,0.0467472370161237,-0.113569734107746,0.069679434995459,0.638764601962206
Physical measures,X4270.Volume level set by participant (left),RASA1,Ras GTPase-activating protein 1,32644,-0.0251166930105597,0.0535161686810018,-0.130008383625323,0.0797749976042038,0.638846101208127
Physical measures,X4270.Volume level set by participant (left),CD8A,T-cell surface glycoprotein CD8 alpha chain,32931,0.0166323400100032,0.0355377759993263,-0.0530217009486764,0.0862863809686828,0.639782539825344
Physical measures,X4270.Volume level set by participant (left),RARRES2,Retinoic acid receptor responder protein 2,32908,0.0167913032207238,0.0358783649250723,-0.053530292032418,0.0871128984738655,0.639791312925637
Physical measures,X4270.Volume level set by participant (left),TP53,Cellular tumor antigen p53,32638,0.018818328440514,0.0404887225871438,-0.0605395678302878,0.0981762247113158,0.642100898187873
Physical measures,X4270.Volume level set by participant (left),BRME1,Break repair meiotic recombinase recruitment factor 1,31514,-0.0228436607535777,0.0492029106443521,-0.119281365616508,0.0735940441093524,0.642464242465838
Physical measures,X4270.Volume level set by participant (left),RNF5,E3 ubiquitin-protein ligase RNF5,31566,-0.0137198729793455,0.0295609137166439,-0.0716592638639676,0.0442195179052766,0.642573393630094
Physical measures,X4270.Volume level set by participant (left),TRPV3,Transient receptor potential cation channel subfamily V member 3,31495,0.018255540276807,0.0394526770039889,-0.0590717066510113,0.0955827872046253,0.643578316865375
Physical measures,X4270.Volume level set by participant (left),CBX2,Chromobox protein homolog 2,31495,0.0238279742083376,0.0515321392234626,-0.0771750186696492,0.124830967086324,0.64381445619027
Physical measures,X4270.Volume level set by participant (left),CLASP1,CLIP-associating protein 1,31492,-0.0125557717648046,0.0272278946308885,-0.0659224452413461,0.040810901711737,0.644713934636349
Physical measures,X4270.Volume level set by participant (left),SIT1,Signaling threshold-regulating transmembrane adapter 1,32679,0.0149409669917487,0.0324517593458233,-0.048664481326065,0.0785464153095624,0.645236576176352
Physical measures,X4270.Volume level set by participant (left),SCN3A,Sodium channel protein type 3 subunit alpha,31546,-0.0253738818082761,0.055151402419758,-0.133470630551002,0.0827228669344496,0.645474101465346
Physical measures,X4270.Volume level set by participant (left),KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,32832,-0.0177745636023794,0.0386364487880544,-0.0935020032269661,0.0579528760222073,0.645493985429508
Physical measures,X4270.Volume level set by participant (left),LYPLA2,Acyl-protein thioesterase 2,31514,0.00857238538338052,0.018634142546702,-0.0279505340081554,0.0450953047749164,0.645503107186668
Physical measures,X4270.Volume level set by participant (left),CXCL11,C-X-C motif chemokine 11,32931,-0.010137920364564,0.0220616441596785,-0.0533787429175339,0.0331029021884059,0.645866809335566
Physical measures,X4270.Volume level set by participant (left),NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",32679,-0.0135189902455589,0.0294503253568125,-0.0712416279449114,0.0442036474537936,0.646214006474147
Physical measures,X4270.Volume level set by participant (left),OMD,Osteomodulin,32894,-0.0175984272935017,0.0383385838271898,-0.0927420515947937,0.0575451970077903,0.64622615846377
Physical measures,X4270.Volume level set by participant (left),SEMA3F,Semaphorin-3F,32864,0.0306580313685097,0.0673057632254786,-0.101261264553428,0.162577327290448,0.64875781704771
Physical measures,X4270.Volume level set by participant (left),S100G,Protein S100-G,31752,-0.0195326380177643,0.0429382865546188,-0.103691679664817,0.0646264036292885,0.649193508234981
Physical measures,X4270.Volume level set by participant (left),ARHGAP5,Rho GTPase-activating protein 5,31492,-0.0122055844282474,0.0268398798427458,-0.0648117489200291,0.0404005800635343,0.649298048324025
Physical measures,X4270.Volume level set by participant (left),CDH5,Cadherin-5,32964,-0.025323707889015,0.0557181407099106,-0.13453126368044,0.0838838479024098,0.649482247355279
Physical measures,X4270.Volume level set by participant (left),FUS,RNA-binding protein FUS,32634,-0.0207739345334114,0.0457220695963634,-0.110389190942284,0.0688413218754609,0.649586410958235
Physical measures,X4270.Volume level set by participant (left),SPRING1,SREBP regulating gene protein,31492,-0.0149653190018249,0.0329840290132059,-0.0796140158677084,0.0496833778640587,0.650047523549566
Physical measures,X4270.Volume level set by participant (left),TEK,Angiopoietin-1 receptor,32881,-0.0356448429296852,0.0787098182893038,-0.189916086776721,0.11862640091735,0.650657571830749
Physical measures,X4270.Volume level set by participant (left),DPEP2,Dipeptidase 2,32832,-0.0267590171578687,0.0590907415616464,-0.142576870618696,0.0890588363029583,0.650670454552569
Physical measures,X4270.Volume level set by participant (left),TEX101,Testis-expressed protein 101,31546,-0.0191538389114006,0.042299998098171,-0.102061835183816,0.0637541573610146,0.650698743610835
Physical measures,X4270.Volume level set by participant (left),RNF149,E3 ubiquitin-protein ligase RNF149,31566,-0.0318342764502406,0.0703640252302161,-0.169747765901464,0.106079213000983,0.650977296888366
Physical measures,X4270.Volume level set by participant (left),PAMR1,Inactive serine protease PAMR1,32861,0.0279916028197747,0.0620399884885331,-0.0936067746177502,0.1495899802573,0.65186604007077
Physical measures,X4270.Volume level set by participant (left),IL2,Interleukin-2,32679,0.0250259070864397,0.055555301428251,-0.0838624837129322,0.133914297885812,0.652383820508602
Physical measures,X4270.Volume level set by participant (left),HLA_A,,31752,-0.0275093107124023,0.0610703624420133,-0.147207221098748,0.0921885996739437,0.652396418777626
Physical measures,X4270.Volume level set by participant (left),FSHB,Follitropin subunit beta,31566,0.0138627842738334,0.0307809144831365,-0.0464678081131142,0.074193376660781,0.652456726652323
Physical measures,X4270.Volume level set by participant (left),AHNAK,Neuroblast differentiation-associated protein AHNAK,31566,-0.0298138500802805,0.066244648453748,-0.159653361049626,0.100025660889066,0.65268219817023
Physical measures,X4270.Volume level set by participant (left),CDH1,Cadherin-1,32540,0.0200173975092893,0.0444825102695747,-0.0671683226190772,0.107203117637656,0.652717339939286
Physical measures,X4270.Volume level set by participant (left),CNTN3,Contactin-3,32861,-0.0230309974800093,0.0511826717649148,-0.123349034139242,0.0772870391792237,0.652738253839558
Physical measures,X4270.Volume level set by participant (left),BGN,Biglycan,32623,0.00680127552848139,0.0151174597042901,-0.0228289454919272,0.0364314965488899,0.652796999238016
Physical measures,X4270.Volume level set by participant (left),NPTX1,Neuronal pentraxin-1,32861,0.0189222706919579,0.0421831725601443,-0.0637567475259249,0.101601288909841,0.653749858965473
Physical measures,X4270.Volume level set by participant (left),MUC13,Mucin-13,32644,-0.0154072732269693,0.0343562987072782,-0.0827456186932346,0.051931072239296,0.653835515905567
Physical measures,X4270.Volume level set by participant (left),CAPG,Macrophage-capping protein,32809,-0.0131141372723758,0.0292860766870465,-0.070514847578987,0.0442865730342354,0.654312523595941
Physical measures,X4270.Volume level set by participant (left),CD276,CD276 antigen,32834,-0.0215094452456866,0.0480664288538314,-0.115719645799196,0.072700755307823,0.654529122523873
Physical measures,X4270.Volume level set by participant (left),CCL22,C-C motif chemokine 22,32724,0.0155227844208426,0.0347450291714077,-0.0525774727551164,0.0836230415968017,0.655057295280584
Physical measures,X4270.Volume level set by participant (left),LGALS8,Galectin-8,32931,-0.0125156413937649,0.0280404717343251,-0.067474965993042,0.0424436832055122,0.655360849990934
Physical measures,X4270.Volume level set by participant (left),FGF3,Fibroblast growth factor 3,31508,0.0287497630117693,0.0644532178305491,-0.0975785439361069,0.155078069959646,0.655569220290273
Physical measures,X4270.Volume level set by participant (left),CSF3R,Granulocyte colony-stimulating factor receptor,31508,0.0279560397418673,0.0629350022800678,-0.0953965647270657,0.1513086442108,0.656906984501225
Physical measures,X4270.Volume level set by participant (left),PARP1,Poly [ADP-ribose] polymerase 1,32843,-0.01418428236215,0.0320337694166941,-0.0769704704188703,0.0486019056945704,0.657927182363428
Physical measures,X4270.Volume level set by participant (left),F7,Coagulation factor VII,32865,0.025474092737384,0.0576429310832606,-0.0875060521858068,0.138454237660575,0.658551076788205
Physical measures,X4270.Volume level set by participant (left),ELOA,Elongin-A,32832,0.0151173133738977,0.0342680305389159,-0.0520480264823775,0.0822826532301729,0.659115639399528
Physical measures,X4270.Volume level set by participant (left),PAK4,Serine/threonine-protein kinase PAK 4,32644,-0.0128660393015258,0.0291682796498102,-0.0700358674151538,0.0443037888121022,0.659153668548188
Physical measures,X4270.Volume level set by participant (left),NOTCH1,Neurogenic locus notch homolog protein 1,32964,-0.0478171342355255,0.108419342270617,-0.260319045085935,0.164684776614884,0.65919540025501
Physical measures,X4270.Volume level set by participant (left),CD80,T-lymphocyte activation antigen CD80,31762,0.0268650455575402,0.0609855254103597,-0.0926665842467648,0.146396675361845,0.659576123973929
Physical measures,X4270.Volume level set by participant (left),SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,31514,0.0152511082381412,0.0346332078171863,-0.0526299790835439,0.0831321955598264,0.659688227974324
Physical measures,X4270.Volume level set by participant (left),SMARCA2,Probable global transcription activator SNF2L2,32644,-0.010706069977384,0.0244162245632077,-0.0585618701212712,0.0371497301665031,0.661047851186808
Physical measures,X4270.Volume level set by participant (left),CLEC3B,Tetranectin,31592,0.040426159477142,0.0925292813028009,-0.140931231876348,0.221783550830632,0.662195164364571
Physical measures,X4270.Volume level set by participant (left),HDGF,Hepatoma-derived growth factor,32934,-0.00828193034114354,0.0189628145536882,-0.0454490468663723,0.0288851861840852,0.662306077650089
Physical measures,X4270.Volume level set by participant (left),ASS1,Argininosuccinate synthase,31495,-0.0111292823114258,0.0255255069818582,-0.0611592759958679,0.0389007113730162,0.662844477600864
Physical measures,X4270.Volume level set by participant (left),ECSCR,Endothelial cell-specific chemotaxis regulator,31514,-0.0175316135177659,0.040211508294672,-0.096346169775323,0.0612829427397911,0.662859930013375
Physical measures,X4270.Volume level set by participant (left),CEMIP2,Cell surface hyaluronidase,31508,-0.0284121875571859,0.0653442724114604,-0.156486961483648,0.0996625863692765,0.663714346269521
Physical measures,X4270.Volume level set by participant (left),MAGEA3,Melanoma-associated antigen 3,31632,-0.0101622915521643,0.0234236363585074,-0.0560726188148389,0.0357480357105103,0.664411062783341
Physical measures,X4270.Volume level set by participant (left),SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",32644,-0.0137602584850605,0.0317527331693393,-0.0759956154969655,0.0484750985268444,0.664766323949977
Physical measures,X4270.Volume level set by participant (left),OLFM4,Olfactomedin-4,31270,0.00728132412339534,0.0168171293336083,-0.025680249370477,0.0402428976172676,0.665048668568274
Physical measures,X4270.Volume level set by participant (left),DLL1,Delta-like protein 1,32881,0.0266289360309668,0.0616369422213165,-0.0941794707228135,0.147437342784747,0.66573078887981
Physical measures,X4270.Volume level set by participant (left),KLF4,Krueppel-like factor 4,31514,-0.0226221167592863,0.0524620910570541,-0.125447815231112,0.0802035817125398,0.666328684729066
Physical measures,X4270.Volume level set by participant (left),DTX2,Probable E3 ubiquitin-protein ligase DTX2,31546,-0.0131176203024273,0.0304831087274509,-0.0728645134082311,0.0466292728033765,0.666971873710535
Physical measures,X4270.Volume level set by participant (left),USP28,Ubiquitin carboxyl-terminal hydrolase 28,31751,-0.0226076707581819,0.0525766716376888,-0.125657947168052,0.0804426056516881,0.667211511051884
Physical measures,X4270.Volume level set by participant (left),GLT8D2,Glycosyltransferase 8 domain-containing protein 2,32644,0.0152088015844084,0.0354615125284389,-0.0542957629713319,0.0847133661401486,0.668019679196684
Physical measures,X4270.Volume level set by participant (left),MILR1,Allergin-1,32679,-0.0149484656133075,0.0348915015038051,-0.0833358085607655,0.0534388773341505,0.668350647737158
Physical measures,X4270.Volume level set by participant (left),MANSC4,MANSC domain-containing protein 4,31495,-0.0138421175984184,0.0323575190043399,-0.0772628548469246,0.0495786196500877,0.668818461117961
Physical measures,X4270.Volume level set by participant (left),TNPO1,Transportin-1,31632,0.023221076903591,0.0543354838289533,-0.0832764714011575,0.129718625208339,0.669125435693434
Physical measures,X4270.Volume level set by participant (left),HDAC8,Histone deacetylase 8,31508,0.013406940952994,0.031387283968667,-0.0481121356255933,0.0749260175315812,0.669285294033171
Physical measures,X4270.Volume level set by participant (left),TIE1,Tyrosine-protein kinase receptor Tie-1,32964,-0.0174577056240173,0.0409468504081506,-0.0977135324239926,0.062798121175958,0.669862628967641
Physical measures,X4270.Volume level set by participant (left),SEMA4C,Semaphorin-4C,32832,-0.0269753822992694,0.063378118749934,-0.15119649504914,0.0972457304506013,0.670390522067918
Physical measures,X4270.Volume level set by participant (left),YAP1,Transcriptional coactivator YAP1,31751,-0.0327365298806372,0.0770572339715813,-0.183768708464936,0.118295648703662,0.67096930680997
Physical measures,X4270.Volume level set by participant (left),AMN,Protein amnionless,32679,0.0154145860078712,0.0363552386129895,-0.0558416816735883,0.0866708536893307,0.671576863622074
Physical measures,X4270.Volume level set by participant (left),CTBS,Di-N-acetylchitobiase,31666,0.0299115298613305,0.0705721979530598,-0.108409978126667,0.168233037849328,0.671692022316084
Physical measures,X4270.Volume level set by participant (left),CLINT1,Clathrin interactor 1,31492,-0.0168830294141672,0.0398384664288981,-0.0949664236148076,0.0612003647864731,0.671733011560573
Physical measures,X4270.Volume level set by participant (left),IL17F,Interleukin-17F,32679,0.00932063980660451,0.0220125835362281,-0.0338240239244027,0.0524653035376117,0.671996808922405
Physical measures,X4270.Volume level set by participant (left),GRPEL1,"GrpE protein homolog 1, mitochondrial",32832,-0.0120717219891166,0.0285855066115944,-0.0680993149478416,0.0439558709696083,0.672814583981476
Physical measures,X4270.Volume level set by participant (left),NAPRT,Nicotinate phosphoribosyltransferase,31751,-0.0244528189991571,0.0579813723873662,-0.138096308878395,0.0891906708800806,0.673229381639279
Physical measures,X4270.Volume level set by participant (left),CA8,Carbonic anhydrase-related protein,31508,-0.0349631046175752,0.0830220896327591,-0.197686400297783,0.127760191062633,0.673671889193233
Physical measures,X4270.Volume level set by participant (left),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,31508,0.0189335681743734,0.0449956508661263,-0.0692579075232342,0.107125043871981,0.673922725323003
Physical measures,X4270.Volume level set by participant (left),NFKB2,Nuclear factor NF-kappa-B p100 subunit,31632,0.0148680051930759,0.03538704364131,-0.0544906003438918,0.0842266107300436,0.674384632452682
Physical measures,X4270.Volume level set by participant (left),C9,Complement component C9,31772,0.0157999325781624,0.0378141870113246,-0.0583158739640338,0.0899157391203586,0.676082162041219
Physical measures,X4270.Volume level set by participant (left),LDLR,Low-density lipoprotein receptor,32872,0.0137564293881804,0.0329297874513728,-0.0507859540165103,0.0782988127928712,0.676139629867047
Physical measures,X4270.Volume level set by participant (left),FABP2,"Fatty acid-binding protein, intestinal",32864,-0.00917708425782102,0.0221537475557606,-0.0525984294671118,0.0342442609514697,0.678704391126267
Physical measures,X4270.Volume level set by participant (left),CBLN1,Cerebellin-1,31514,-0.00866645308157005,0.0209240874464629,-0.0496776644766374,0.0323447583134973,0.678749889684586
Physical measures,X4270.Volume level set by participant (left),TOP1MT,"DNA topoisomerase I, mitochondrial",31492,0.0168601330087134,0.0407338611934741,-0.0629782349304958,0.0966985009479226,0.678952005718994
Physical measures,X4270.Volume level set by participant (left),CEP85,Centrosomal protein of 85 kDa,32638,-0.0109651521777989,0.026535643980125,-0.0629750143788439,0.0410447100232461,0.679452955553331
Physical measures,X4270.Volume level set by participant (left),RNF4,E3 ubiquitin-protein ligase RNF4,31632,-0.0127866830284977,0.0309693151917507,-0.073486540804329,0.0479131747473337,0.679704221424315
Physical measures,X4270.Volume level set by participant (left),TPK1,Thiamin pyrophosphokinase 1,31762,-0.0301803194972954,0.0731079393244608,-0.173471880573238,0.113111241578648,0.6797507040717
Physical measures,X4270.Volume level set by participant (left),CES2,Cocaine esterase,32832,-0.0130341265267959,0.0315884111293777,-0.0749474123403762,0.0488791592867845,0.679892209899782
Physical measures,X4270.Volume level set by participant (left),PDRG1,p53 and DNA damage-regulated protein 1,31546,0.0162154083372527,0.0393013222826782,-0.0608151833367965,0.093246000011302,0.679917128660716
Physical measures,X4270.Volume level set by participant (left),EPHB6,Ephrin type-B receptor 6,32776,-0.0240249987247671,0.0583361683867651,-0.138363888762827,0.0903138913132925,0.680468726027365
Physical measures,X4270.Volume level set by participant (left),F13B,Coagulation factor XIII B chain,31741,0.0334808997726087,0.0814874566492995,-0.126234515260018,0.193196314805236,0.681177700448019
Physical measures,X4270.Volume level set by participant (left),LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,32925,0.0201448264035659,0.0490792575066172,-0.0760505183094038,0.116340171116535,0.681481914886743
Physical measures,X4270.Volume level set by participant (left),HBQ1,Hemoglobin subunit theta-1,32948,0.010803859909284,0.0263520191817877,-0.0408460976870199,0.0624538175055878,0.681828641032356
Physical measures,X4270.Volume level set by participant (left),PPP1R9B,Neurabin-2,32961,-0.00735532612826371,0.0179581288526897,-0.0425532586795354,0.027842606423008,0.682122254163312
Physical measures,X4270.Volume level set by participant (left),KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,31720,-0.00479180427820961,0.0117768971144339,-0.0278745226225001,0.0182909140660809,0.684105938043332
Physical measures,X4270.Volume level set by participant (left),ANKRD54,Ankyrin repeat domain-containing protein 54,32638,-0.0124428273058066,0.0305812399334445,-0.0723820575753579,0.0474964029637446,0.684107673125044
Physical measures,X4270.Volume level set by participant (left),CLEC4C,C-type lectin domain family 4 member C,32843,-0.0150443781135626,0.037118936847055,-0.0877974943337905,0.0577087381066652,0.68526521601922
Physical measures,X4270.Volume level set by participant (left),LMNB1,Lamin-B1,31707,-0.0141841692369633,0.0350038818310711,-0.0827917776258626,0.0544234391519361,0.685329034554799
Physical measures,X4270.Volume level set by participant (left),ARG2,"Arginase-2, mitochondrial",31724,-0.0185675967627747,0.0458933824512992,-0.108518626367321,0.0713834328417717,0.685796435297151
Physical measures,X4270.Volume level set by participant (left),RAB39B,Ras-related protein Rab-39B,31495,-0.00865090321373321,0.0214082860186612,-0.0506111438103091,0.0333093373828426,0.686156867561674
Physical measures,X4270.Volume level set by participant (left),ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",31514,-0.016648121595006,0.0413505656696465,-0.0976952303075131,0.0643989871175011,0.687246927654959
Physical measures,X4270.Volume level set by participant (left),AGR3,Anterior gradient protein 3,32631,0.0120572770964175,0.0299620783655092,-0.0466683964999805,0.0707829506928156,0.687386297853277
Physical measures,X4270.Volume level set by participant (left),LBR,Delta(14)-sterol reductase LBR,32931,0.0103449707917609,0.0257283524832464,-0.0400826000754021,0.0607725416589239,0.687631343483828
Physical measures,X4270.Volume level set by participant (left),NAAA,N-acylethanolamine-hydrolyzing acid amidase,32744,0.0114229799611272,0.0284279148934199,-0.0442957332299758,0.0671416931522303,0.687824224306749
Physical measures,X4270.Volume level set by participant (left),GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,32679,0.0164915387478261,0.0410503386296852,-0.0639671249663568,0.096950202462009,0.687885557012302
Physical measures,X4270.Volume level set by participant (left),SCRG1,Scrapie-responsive protein 1,31762,0.0304239303247149,0.0759047464766712,-0.118349372769561,0.179197233418991,0.688565532313408
Physical measures,X4270.Volume level set by participant (left),CNGB3,Cyclic nucleotide-gated cation channel beta-3,31514,0.0146993459701629,0.0368178596406796,-0.0574636589255691,0.086862350865895,0.689723839934391
Physical measures,X4270.Volume level set by participant (left),LEPR,Leptin receptor,32864,-0.0225068777473978,0.0564695227424587,-0.133187142322617,0.0881733868278213,0.690221872579962
Physical measures,X4270.Volume level set by participant (left),FUCA1,Tissue alpha-L-fucosidase,32909,0.00841256235318267,0.0211421030331342,-0.0330259595917603,0.0498510842981256,0.690709121119052
Physical measures,X4270.Volume level set by participant (left),NME3,Nucleoside diphosphate kinase 3,32864,-0.0287186898420965,0.0722109167264777,-0.170252086625993,0.1128147069418,0.690856600695311
Physical measures,X4270.Volume level set by participant (left),PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",32644,-0.023371827036844,0.0588107633982919,-0.138640923297496,0.0918972692238081,0.691076788350276
Physical measures,X4270.Volume level set by participant (left),CGN,Cingulin,31546,-0.0205272457559931,0.0516675906154036,-0.121795723362184,0.080741231850198,0.691161393705957
Physical measures,X4270.Volume level set by participant (left),MYOM3,Myomesin-3,31599,0.00840636056654587,0.0211665283046902,-0.0330800349106469,0.0498927560437386,0.691265234453936
Physical measures,X4270.Volume level set by participant (left),TRAF3,"TNF receptor-associated factor 3, Isoform 2",31508,0.0215063171491715,0.0542213347050008,-0.08476749887263,0.127780133170973,0.691644471674946
Physical measures,X4270.Volume level set by participant (left),RGMB,RGM domain family member B,32931,-0.0270385905358259,0.0682573055844756,-0.160822909481398,0.106745728409746,0.692020349364228
Physical measures,X4270.Volume level set by participant (left),B4GALT1,"Beta-1,4-galactosyltransferase 1",32894,-0.0253170379498023,0.0640637058532266,-0.150881901422126,0.100247825522522,0.692715438028799
Physical measures,X4270.Volume level set by participant (left),SERPINA5,Plasma serine protease inhibitor,31673,-0.0232201037046586,0.0588752395352975,-0.138615573193842,0.0921753657845245,0.693300158165435
Physical measures,X4270.Volume level set by participant (left),CD248,Endosialin,31773,-0.0196429844408823,0.0498287284630982,-0.117307292228555,0.0780213233467902,0.693436609692589
Physical measures,X4270.Volume level set by participant (left),FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,32793,0.0115306266565483,0.0292987702981941,-0.0458949631279121,0.0689562164410087,0.693920288398983
Physical measures,X4270.Volume level set by participant (left),CLC,Galectin-10,32852,0.00941538166681363,0.0239658912631761,-0.0375577652090115,0.0563885285426388,0.694427837512154
Physical measures,X4270.Volume level set by participant (left),TIMP4,Metalloproteinase inhibitor 4,32861,0.0172346705821241,0.0438767648815254,-0.0687637885856657,0.103233129749914,0.694478574446977
Physical measures,X4270.Volume level set by participant (left),COL18A1,Collagen alpha-1(XVIII) chain,32874,0.0300163159660223,0.0764805928750376,-0.119885646069051,0.179918278001096,0.694720471794589
Physical measures,X4270.Volume level set by participant (left),ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,32964,-0.0247309583884673,0.0630619982309283,-0.148332474921087,0.0988705581441521,0.694942558854431
Physical measures,X4270.Volume level set by participant (left),SIGLEC15,Sialic acid-binding Ig-like lectin 15,32644,-0.00868956358802986,0.0221680615351371,-0.0521389641968986,0.0347598370208389,0.695078276945471
Physical measures,X4270.Volume level set by participant (left),DEFB4A_DEFB4B,Beta-defensin 4A,32734,-0.00474781849107773,0.0121285118120674,-0.0285197016427298,0.0190240646605743,0.695467184752145
Physical measures,X4270.Volume level set by participant (left),PTPRC,Receptor-type tyrosine-protein phosphatase C,31773,0.035096964727849,0.0897737345753316,-0.140859555039801,0.211053484495499,0.695845356174485
Physical measures,X4270.Volume level set by participant (left),MYOC,Myocilin,32861,-0.0145084869364437,0.0372054109720052,-0.087431092441574,0.0584141185686865,0.69657804100455
Physical measures,X4270.Volume level set by participant (left),KLRB1,Killer cell lectin-like receptor subfamily B member 1,32961,-0.0185762106733169,0.0477273515118048,-0.112121819636454,0.0749693982898205,0.697126069344643
Physical measures,X4270.Volume level set by participant (left),PKLR,Pyruvate kinase PKLR,32871,0.00983842539300426,0.0253747070118516,-0.0398960003502248,0.0595728511362333,0.698228214816943
Physical measures,X4270.Volume level set by participant (left),AGER,Advanced glycosylation end product-specific receptor,32825,-0.0169688910192999,0.0437942772300603,-0.102805674390218,0.0688678923516182,0.698418802821744
Physical measures,X4270.Volume level set by participant (left),PTPRB,Receptor-type tyrosine-protein phosphatase beta,31762,-0.0259380829429549,0.0671038499328349,-0.157461628811311,0.105585462925402,0.699109835637471
Physical measures,X4270.Volume level set by participant (left),SFRP4,Secreted frizzled-related protein 4,31599,-0.0182507818951016,0.047259556068041,-0.110879511788462,0.0743779479982587,0.699372629022438
Physical measures,X4270.Volume level set by participant (left),GGT5,Glutathione hydrolase 5 proenzyme,32796,-0.0290081348917357,0.0752997343466021,-0.176595614211076,0.118579344427604,0.700072075991103
Physical measures,X4270.Volume level set by participant (left),GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,31632,0.0149038249862422,0.0388601073580675,-0.0612619854355702,0.0910696354080546,0.70134098774315
Physical measures,X4270.Volume level set by participant (left),CD2AP,CD2-associated protein,32864,-0.0107224750154095,0.0280193600454401,-0.0656404207044722,0.0441954706736531,0.701965384913882
Physical measures,X4270.Volume level set by participant (left),GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,31546,-0.0145504767950576,0.0380856982171136,-0.0891984453006003,0.0600974917104851,0.70243804237785
Physical measures,X4270.Volume level set by participant (left),VCAM1,Vascular cell adhesion protein 1,32872,-0.0244595793727507,0.0644151322011762,-0.150713238487056,0.101794079741555,0.704163774405277
Physical measures,X4270.Volume level set by participant (left),CEP152,Centrosomal protein of 152 kDa,31492,-0.0185656809277191,0.0489251806905727,-0.114459035081242,0.0773276732258034,0.704348793063685
Physical measures,X4270.Volume level set by participant (left),PRAP1,Proline-rich acidic protein 1,31773,0.0184309276061542,0.0486448071341595,-0.0769128943767984,0.113774749589107,0.704781297745847
Physical measures,X4270.Volume level set by participant (left),SETMAR,Histone-lysine N-methyltransferase SETMAR,32763,-0.0224830003306845,0.0595559715768832,-0.139212704621376,0.0942467039600066,0.705803317901836
Physical measures,X4270.Volume level set by participant (left),BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,31514,-0.0104009508569005,0.0276300037632115,-0.0645557582327951,0.043753856518994,0.706602612669485
Physical measures,X4270.Volume level set by participant (left),TMOD4,Tropomodulin-4,31492,0.0190790882209439,0.0507440964010701,-0.0803793407251535,0.118537517167041,0.706937489155443
Physical measures,X4270.Volume level set by participant (left),TCP11,T-complex protein 11 homolog,31632,-0.0130926936880079,0.0349296006448509,-0.0815547109519157,0.0553693235758998,0.707796462388224
Physical measures,X4270.Volume level set by participant (left),VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,31495,-0.0221709815606293,0.0591962788946878,-0.138195688194218,0.0938537250729589,0.708017943579488
Physical measures,X4270.Volume level set by participant (left),MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",31751,-0.0297479771366033,0.0797628133042675,-0.186083091212968,0.126587136939761,0.709191611219507
Physical measures,X4270.Volume level set by participant (left),MEP1A,Meprin A subunit alpha,31720,-0.0102504869391148,0.0274929438837012,-0.0641366569511692,0.0436356830729395,0.709277107156098
Physical measures,X4270.Volume level set by participant (left),AFP,Alpha-fetoprotein,32763,-0.00957719338158293,0.0256916691460175,-0.0599328649077772,0.0407784781446114,0.709325326342923
Physical measures,X4270.Volume level set by participant (left),FGFR2,Fibroblast growth factor receptor 2,32881,0.0295966396505583,0.0794327246197093,-0.126091500604072,0.185284779905189,0.709454868584123
Physical measures,X4270.Volume level set by participant (left),HAVCR1,Hepatitis A virus cellular receptor 1,32933,-0.010483988412655,0.0281670032710764,-0.0656913148239648,0.0447233379986548,0.709746568273611
Physical measures,X4270.Volume level set by participant (left),DCC,Netrin receptor DCC,31546,-0.0332058449617457,0.0895245134048187,-0.20867389123519,0.142262201311699,0.710712233001561
Physical measures,X4270.Volume level set by participant (left),ANGPTL7,Angiopoietin-related protein 7,32948,0.0173593319723969,0.0468067485036796,-0.0743818950948151,0.109100559039609,0.710741207220573
Physical measures,X4270.Volume level set by participant (left),SHBG,Sex hormone-binding globulin,31772,0.0140836641580321,0.0379755995226785,-0.0603485109064178,0.088515839222482,0.710751088353586
Physical measures,X4270.Volume level set by participant (left),LMNB2,Lamin-B2,31751,-0.0269854178573613,0.072777627620138,-0.169629567992832,0.115658732278109,0.710801846702926
Physical measures,X4270.Volume level set by participant (left),KLK11,Kallikrein-11,32795,-0.0220401379233203,0.0594928480783364,-0.13864612015686,0.0945658443102191,0.711043332820914
Physical measures,X4270.Volume level set by participant (left),AGXT,Serine--pyruvate aminotransferase,32864,0.00825976997452312,0.022406818948107,-0.0356575951637667,0.0521771351128129,0.712414053759195
Physical measures,X4270.Volume level set by participant (left),INHBB,Inhibin beta B chain,31599,0.0152569846371193,0.0415005004161205,-0.0660839961784769,0.0965979654527156,0.713156402155808
Physical measures,X4270.Volume level set by participant (left),CPQ,Carboxypeptidase Q,31760,-0.0186051427948608,0.050650773220837,-0.117880658307701,0.0806703727179797,0.713388696413215
Physical measures,X4270.Volume level set by participant (left),GHR,Growth hormone receptor,31599,0.0254562056439571,0.0693206779754536,-0.110412323187932,0.161324734475846,0.713462101870347
Physical measures,X4270.Volume level set by participant (left),ZBP1,Z-DNA-binding protein 1,31508,0.0176580244209545,0.0481124802205975,-0.0766424368114166,0.111958485653326,0.713617638555492
Physical measures,X4270.Volume level set by participant (left),ANGPTL3,Angiopoietin-related protein 3,32851,-0.0177348444239759,0.0483347143819797,-0.112470884612656,0.0770011957647042,0.713689320726333
Physical measures,X4270.Volume level set by participant (left),HYOU1,Hypoxia up-regulated protein 1,32964,0.0294318471183495,0.0803674750648339,-0.128088404008725,0.186952098245424,0.714212491942652
Physical measures,X4270.Volume level set by participant (left),KDM3A,Lysine-specific demethylase 3A,31508,-0.00770976539331247,0.0210924216958263,-0.0490509119171321,0.0336313811305071,0.71473114892464
Physical measures,X4270.Volume level set by participant (left),FOS,Proto-oncogene c-Fos,31481,0.0209922563010662,0.0577118422133823,-0.0921229544371632,0.134107467039296,0.716060313076567
Physical measures,X4270.Volume level set by participant (left),REG3G,Regenerating islet-derived protein 3-gamma,31724,-0.0181363716068348,0.0499029702596109,-0.115946193315672,0.0796734501020025,0.716291445141859
Physical measures,X4270.Volume level set by participant (left),UNC5D,Netrin receptor UNC5D,31508,-0.0271413622934591,0.0749002398539215,-0.173945832407145,0.119663107820227,0.717087941651496
Physical measures,X4270.Volume level set by participant (left),PVR,Poliovirus receptor,32931,0.0165745851722005,0.0459309171379621,-0.0734500124182052,0.106599182762606,0.718213254849623
Physical measures,X4270.Volume level set by participant (left),CD207,C-type lectin domain family 4 member K,32690,-0.0166212467253646,0.0461148942252821,-0.107006439406918,0.0737639459561884,0.718533321252641
Physical measures,X4270.Volume level set by participant (left),KLB,Beta-klotho,32644,0.00855163896448521,0.0237809527457238,-0.0380590284171333,0.0551623063461038,0.719154668102275
Physical measures,X4270.Volume level set by participant (left),ANXA2,Annexin A2,31446,-0.0104238223265198,0.0290037941454133,-0.0672712588515299,0.0464236141984903,0.719309525663851
Physical measures,X4270.Volume level set by participant (left),SIL1,Nucleotide exchange factor SIL1,31566,-0.0207041120219898,0.0576216932507453,-0.133642630793451,0.092234406749471,0.71937224571496
Physical measures,X4270.Volume level set by participant (left),BHLHE40,Class E basic helix-loop-helix protein 40,31514,-0.0103676217550149,0.0289165144824534,-0.0670439901406236,0.0463087466305938,0.719951857201216
Physical measures,X4270.Volume level set by participant (left),KLRF1,Killer cell lectin-like receptor subfamily F member 1,31508,0.0165276325527299,0.0461234819132291,-0.0738743919971992,0.106929657102659,0.720102933463297
Physical measures,X4270.Volume level set by participant (left),CES3,Carboxylesterase 3,32832,-0.00752996624972801,0.021042021553304,-0.0487723284942039,0.0337123959947478,0.72046118724678
Physical measures,X4270.Volume level set by participant (left),SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,32854,-0.0107287429698518,0.0300444425438674,-0.069615850355832,0.0481583644161284,0.721028501146321
Physical measures,X4270.Volume level set by participant (left),CXCL9,C-X-C motif chemokine 9,32894,-0.00940866276635237,0.0263918453069322,-0.0611366795679396,0.0423193540352348,0.721475333963402
Physical measures,X4270.Volume level set by participant (left),SH3GLB2,Endophilin-B2,31751,-0.0108145181651231,0.0304280696564648,-0.0704535346917941,0.0488244983615479,0.722290043173791
Physical measures,X4270.Volume level set by participant (left),PLB1,"Phospholipase B1, membrane-associated",31751,0.0117909961597118,0.0331912677782335,-0.0532638886856258,0.0768458810050495,0.722416360591369
Physical measures,X4270.Volume level set by participant (left),CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,32541,0.00997977935036581,0.0281707132488805,-0.0452348186174399,0.0651943773181715,0.723152051290656
Physical measures,X4270.Volume level set by participant (left),CDCP1,CUB domain-containing protein 1,32796,0.012218705957287,0.0345437052221459,-0.0554869562781189,0.0799243681926929,0.723559107835554
Physical measures,X4270.Volume level set by participant (left),PGM2,Phosphoglucomutase-2,31546,0.0114947102432598,0.0325447222899435,-0.0522929454450295,0.0752823659315491,0.723950171239216
Physical measures,X4270.Volume level set by participant (left),HCG22,Protein PBMUCL2,31495,-0.0134113341946615,0.0380382398026859,-0.0879662842079259,0.0611436158186029,0.724416783092816
Physical measures,X4270.Volume level set by participant (left),HNRNPK,Heterogeneous nuclear ribonucleoprotein K,32663,-0.00805504379940013,0.022881357415769,-0.0529025043343074,0.0367924167355072,0.724820275285798
Physical measures,X4270.Volume level set by participant (left),DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,32882,-0.0119725006609531,0.0340142642202315,-0.0786404585326069,0.0546954572107007,0.724857958756364
Physical measures,X4270.Volume level set by participant (left),DENND2B,DENN domain-containing protein 2B,31495,-0.0145044299925441,0.0412528802733008,-0.0953600753282138,0.0663512153431255,0.725149475419473
Physical measures,X4270.Volume level set by participant (left),HRAS,GTPase Hras,31609,-0.0072794240198453,0.0207564100409115,-0.0479619877000318,0.0334031396603412,0.725817503539086
Physical measures,X4270.Volume level set by participant (left),CSH1,Chorionic somatomammotropin hormone 1,31772,-0.0188625906410904,0.0538076155910341,-0.124325517199517,0.0866003359173364,0.725930693344059
Physical measures,X4270.Volume level set by participant (left),MRPL46,"39S ribosomal protein L46, mitochondrial",32644,0.022285658013238,0.0638687864911101,-0.102897163509338,0.147468479535814,0.727151141192626
Physical measures,X4270.Volume level set by participant (left),GH1,Somatotropin,32858,0.00333616773603125,0.00957577810276695,-0.015432357345392,0.0221046928174545,0.727550571562875
Physical measures,X4270.Volume level set by participant (left),CST3,Cystatin-C,32865,0.022914949775529,0.0658773443578929,-0.106204645165941,0.152034544716999,0.727966493226412
Physical measures,X4270.Volume level set by participant (left),BSG,Basigin,32946,-0.0314679062136615,0.0906296198050251,-0.209101961031511,0.146166148604188,0.728438321475516
Physical measures,X4270.Volume level set by participant (left),KLRD1,Natural killer cells antigen CD94,32961,0.0130224698896701,0.0377001721601175,-0.0608698675441602,0.0869148073235005,0.729785105711284
Physical measures,X4270.Volume level set by participant (left),SLITRK6,SLIT and NTRK-like protein 6,32685,-0.0174543677773872,0.0507079408142517,-0.116841931773321,0.0819331962185462,0.730693786427964
Physical measures,X4270.Volume level set by participant (left),TREH,Trehalase,31773,0.00894702424325609,0.0260025278537468,-0.0420179303500876,0.0599119788365997,0.73079311616895
Physical measures,X4270.Volume level set by participant (left),OPTC,Opticin,32832,-0.0133709972044344,0.038863770098077,-0.0895439865966653,0.0628019921877965,0.730818353759084
Physical measures,X4270.Volume level set by participant (left),CBS,Cystathionine beta-synthase,31566,0.0138942675687629,0.0404855988884381,-0.0654575062525758,0.0932460413901016,0.731464616048938
Physical measures,X4270.Volume level set by participant (left),ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,32923,-0.0213778868875897,0.0626799415748588,-0.144230572374313,0.101474798599134,0.733063127060842
Physical measures,X4270.Volume level set by participant (left),PTK7,Inactive tyrosine-protein kinase 7,32644,0.015575846183169,0.0457607752373832,-0.074115273282102,0.10526696564844,0.733581918059825
Physical measures,X4270.Volume level set by participant (left),CORO1A,Coronin-1A,32660,-0.00647640542673759,0.0190738868373365,-0.0438612236279172,0.030908412774442,0.734208788851851
Physical measures,X4270.Volume level set by participant (left),EVI5,Ecotropic viral integration site 5 protein homolog,31508,-0.00784889572767693,0.0231456778393788,-0.0532144242928593,0.0375166328375055,0.734537321250215
Physical measures,X4270.Volume level set by participant (left),STX3,Syntaxin-3,31751,-0.0176654157083714,0.0524099766909639,-0.120388970022661,0.0850581386059178,0.736079070578213
Physical measures,X4270.Volume level set by participant (left),SLC16A1,Monocarboxylate transporter 1,32644,0.0101276326820359,0.0302491444764248,-0.0491606904917567,0.0694159558558284,0.737778492968752
Physical measures,X4270.Volume level set by participant (left),IDI2,Isopentenyl-diphosphate delta-isomerase 2,32644,0.0122610160749324,0.036660010643332,-0.0595926047859982,0.0841146369358631,0.738046448408303
Physical measures,X4270.Volume level set by participant (left),RUVBL1,RuvB-like 1,32638,0.0058559013597281,0.0175849490564238,-0.0286105987908626,0.0403224015103188,0.739137374189372
Physical measures,X4270.Volume level set by participant (left),CA2,Carbonic anhydrase 2,32837,0.00817495708903503,0.0246077910932638,-0.040056313453762,0.0564062276318321,0.739738365944895
Physical measures,X4270.Volume level set by participant (left),PRDX2,Peroxiredoxin-2,31616,0.010539709744125,0.0317616551289873,-0.0517131343086901,0.0727925537969401,0.740020900222286
Physical measures,X4270.Volume level set by participant (left),SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,32878,0.0132526850052073,0.0400048461714462,-0.0651568134908272,0.0916621835012418,0.74044297067308
Physical measures,X4270.Volume level set by participant (left),ITGAV,Integrin alpha-V,32948,-0.0344031269553961,0.104047257647925,-0.238335751945329,0.169529498034537,0.740917216111749
Physical measures,X4270.Volume level set by participant (left),TSPAN15,Tetraspanin-15,31495,0.0137112452242278,0.0415227649786852,-0.0676733741339952,0.0950958645824508,0.741250118231027
Physical measures,X4270.Volume level set by participant (left),EPGN,Epigen,31724,0.0135198710767808,0.0410021247258127,-0.0668442933858121,0.0938840355393737,0.741608337013752
Physical measures,X4270.Volume level set by participant (left),PIGR,Polymeric immunoglobulin receptor,32746,0.0155585888526817,0.0474151741498224,-0.0773751524809701,0.108492330186334,0.742817155087723
Physical measures,X4270.Volume level set by participant (left),PAM,Peptidyl-glycine alpha-amidating monooxygenase,32916,-0.0202020374168706,0.0615793909033925,-0.14089764358752,0.100493568753779,0.742870170651327
Physical measures,X4270.Volume level set by participant (left),CLEC7A,C-type lectin domain family 7 member A,32961,-0.00926598109773226,0.0282831169467045,-0.0647008903132731,0.0461689281178085,0.743210110191401
Physical measures,X4270.Volume level set by participant (left),MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",31752,-0.00911807669001737,0.0278812007610707,-0.0637652301817159,0.0455290768016812,0.743651494994243
Physical measures,X4270.Volume level set by participant (left),DSCAM,Down syndrome cell adhesion molecule,31752,-0.0184191575079102,0.0563284104702098,-0.128822842029521,0.0919845270137009,0.743679685460564
Physical measures,X4270.Volume level set by participant (left),BRK1,Protein BRICK1,32644,-0.0128943504472666,0.0394496982494868,-0.0902157590162607,0.0644270581217274,0.743784978059951
Physical measures,X4270.Volume level set by participant (left),SMPD3,Sphingomyelin phosphodiesterase 3,31508,0.0105533383371277,0.032588050440909,-0.053319240527054,0.0744259172013093,0.746067470122658
Physical measures,X4270.Volume level set by participant (left),CRTAM,Cytotoxic and regulatory T-cell molecule,32796,0.0114210432957499,0.0353411333325674,-0.0578475780360822,0.0806896646275821,0.746577294227843
Physical measures,X4270.Volume level set by participant (left),HGFAC,Hepatocyte growth factor activator,31695,0.0230212849745138,0.0714227842848411,-0.116967372223775,0.163009942172802,0.747215777322135
Physical measures,X4270.Volume level set by participant (left),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,32935,-0.0206536102435975,0.0643490887868435,-0.146777824265811,0.105470603778616,0.748246604890696
Physical measures,X4270.Volume level set by participant (left),FGL1,Fibrinogen-like protein 1,31772,-0.0103105392413587,0.0322601388250136,-0.0735404113383853,0.0529193328556679,0.749275342193448
Physical measures,X4270.Volume level set by participant (left),RBP2,Retinol-binding protein 2,32832,-0.00717552648541166,0.022482653263251,-0.0512415268813835,0.0368904739105602,0.749613872279032
Physical measures,X4270.Volume level set by participant (left),CENPJ,Centromere protein J,31632,0.00915979757908126,0.0287355980562937,-0.0471619746112543,0.0654815697694168,0.749916069758372
Physical measures,X4270.Volume level set by participant (left),CELA3A,Chymotrypsin-like elastase family member 3A,32943,-0.00973366024419942,0.0305654342677701,-0.0696419114090289,0.0501745909206301,0.750148516068757
Physical measures,X4270.Volume level set by participant (left),VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,32685,-0.00974082182245703,0.030588421146163,-0.0696941272689366,0.0502124836240225,0.750152664249741
Physical measures,X4270.Volume level set by participant (left),CGREF1,Cell growth regulator with EF hand domain protein 1,32864,-0.0130058812209558,0.0409494805152349,-0.0932668630308162,0.0672551005889045,0.750789697987968
Physical measures,X4270.Volume level set by participant (left),EPB41L5,Band 4.1-like protein 5,31546,-0.00969974458712487,0.0306158910935841,-0.0697068911305497,0.0503074019563,0.751388350111925
Physical measures,X4270.Volume level set by participant (left),IL15,Interleukin-15,32843,-0.0166312101740224,0.0526303328375532,-0.119786662535627,0.0865242421875818,0.75200949170509
Physical measures,X4270.Volume level set by participant (left),IL32,Interleukin-32,32843,-0.0128759178071006,0.0407559906932851,-0.0927576595659395,0.0670058239517382,0.752065261100958
Physical measures,X4270.Volume level set by participant (left),VASN,Vasorin,32671,0.0202184719266719,0.0640506873964052,-0.105320875370282,0.145757819223626,0.752265320751114
Physical measures,X4270.Volume level set by participant (left),CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,31599,-0.0228206315020836,0.0723447790278962,-0.16461639839676,0.118975135392593,0.752434068976776
Physical measures,X4270.Volume level set by participant (left),APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,32928,-0.00988064166644578,0.0313860364030783,-0.0713972730164793,0.0516359896835877,0.752913078399606
Physical measures,X4270.Volume level set by participant (left),IL10,Interleukin-10,32679,0.00687490213887506,0.0219388902698005,-0.036125322789934,0.0498751270676841,0.754010030828209
Physical measures,X4270.Volume level set by participant (left),ICAM2,Intercellular adhesion molecule 2,32964,0.0169131555515251,0.0543251889714458,-0.0895642148325086,0.123390525935559,0.755555571976793
Physical measures,X4270.Volume level set by participant (left),HIP1R,Huntingtin-interacting protein 1-related protein,31738,0.0153820154318404,0.049530041127166,-0.081696865177405,0.112460896041086,0.756143882755742
Physical measures,X4270.Volume level set by participant (left),MAEA,E3 ubiquitin-protein transferase MAEA,32638,-0.0136339945027237,0.0440616491804312,-0.0999948268963688,0.0727268378909215,0.757001827309847
Physical measures,X4270.Volume level set by participant (left),IL3RA,Interleukin-3 receptor subunit alpha,32679,0.0168617760575737,0.0545875225118859,-0.0901297680657227,0.12385332018087,0.757409211064728
Physical measures,X4270.Volume level set by participant (left),ENTR1,Endosome-associated-trafficking regulator 1,31566,-0.0106205648627483,0.0343921062833199,-0.0780290931780554,0.0567879634525588,0.757475772925369
Physical measures,X4270.Volume level set by participant (left),CDHR5,Cadherin-related family member 5,32864,0.0136476959592041,0.0441976326968046,-0.0729796641265328,0.100275056044941,0.757489989985215
Physical measures,X4270.Volume level set by participant (left),ACTN4,Alpha-actinin-4,32679,0.016818298471691,0.0544882390422765,-0.089978650051171,0.123615246994553,0.757588045408009
Physical measures,X4270.Volume level set by participant (left),REG1B,Lithostathine-1-beta,32964,0.00972936930723446,0.0315442470406518,-0.052097354892443,0.0715560935069119,0.757757942707778
Physical measures,X4270.Volume level set by participant (left),TFRC,Transferrin receptor protein 1,32891,-0.0130704768374899,0.0425228628618583,-0.0964152880467321,0.0702743343717523,0.758564832421542
Physical measures,X4270.Volume level set by participant (left),SHPK,Sedoheptulokinase,31632,-0.0147691378933488,0.0481779112526697,-0.109197843948581,0.0796595681618837,0.759190984048178
Physical measures,X4270.Volume level set by participant (left),RNF31,E3 ubiquitin-protein ligase RNF31,31508,-0.0163342614695009,0.0533367892996223,-0.120874368496761,0.0882058455577588,0.759424504165261
Physical measures,X4270.Volume level set by participant (left),REG1A,Lithostathine-1-alpha,32798,-0.0114127953666678,0.0374919450195404,-0.084897007604967,0.0620714168716313,0.760825232304329
Physical measures,X4270.Volume level set by participant (left),TNC,Tenascin,32878,0.0110746757321999,0.0364007699767786,-0.0602708334222861,0.082420184886686,0.760949867539314
Physical measures,X4270.Volume level set by participant (left),CRX,Cone-rod homeobox protein,32685,0.00487334000523468,0.0161107889763915,-0.0267038063884926,0.036450486398962,0.762286280665067
Physical measures,X4270.Volume level set by participant (left),IL4,Interleukin-4,32679,-0.00608130855573261,0.0201075751939659,-0.0454921559359058,0.0333295388244405,0.762324804858818
Physical measures,X4270.Volume level set by participant (left),PSG1,Pregnancy-specific beta-1-glycoprotein 1,32796,0.00480162472296284,0.0158911781688373,-0.0263450844879584,0.035948333933884,0.762539704244459
Physical measures,X4270.Volume level set by participant (left),LAMP2,Lysosome-associated membrane glycoprotein 2,32563,-0.0281146674255879,0.0931269387275925,-0.210643467331669,0.154414132480493,0.762738420966103
Physical measures,X4270.Volume level set by participant (left),CLEC4D,C-type lectin domain family 4 member D,32843,0.00836222995046323,0.02778317175459,-0.0460927866885332,0.0628172465894596,0.763435316352095
Physical measures,X4270.Volume level set by participant (left),ITM2A,Integral membrane protein 2A,32843,-0.00849047281037704,0.0282290864812778,-0.0638194823136815,0.0468385366929274,0.763596566497553
Physical measures,X4270.Volume level set by participant (left),F11R,Junctional adhesion molecule A,32861,-0.00908160752841888,0.0302198235246651,-0.0683124616367625,0.0501492465799248,0.763788844791044
Physical measures,X4270.Volume level set by participant (left),KRT6C,"Keratin, type II cytoskeletal 6C",31495,0.0141809040927233,0.0474315083400261,-0.0787848522537279,0.107146660439174,0.764966152927521
Physical measures,X4270.Volume level set by participant (left),ADAMTSL2,ADAMTS-like protein 2,31773,-0.0189575252030057,0.0634382393360449,-0.143296474301654,0.105381423895642,0.765074288327184
Physical measures,X4270.Volume level set by participant (left),GIPR,Gastric inhibitory polypeptide receptor,31508,-0.0132746995622878,0.0444231972007667,-0.10034416607579,0.0737947669512149,0.765082767627198
Physical measures,X4270.Volume level set by participant (left),AMPD3,AMP deaminase 3,31751,0.00812217250746234,0.0272866680702206,-0.0453596969101701,0.0616040419250948,0.76596987423724
Physical measures,X4270.Volume level set by participant (left),DPP7,Dipeptidyl peptidase 2,32795,-0.00859515358709012,0.0288768648967033,-0.0651938087846285,0.0480035016104483,0.765978427207162
Physical measures,X4270.Volume level set by participant (left),CLPS,Colipase,32846,-0.00751619408319786,0.0253025191237888,-0.0571091315658239,0.0420767433994282,0.766432767502687
Physical measures,X4270.Volume level set by participant (left),THY1,Thy-1 membrane glycoprotein,32931,-0.018707598857345,0.0630198632594058,-0.14222653084578,0.10481133313109,0.766585982598535
Physical measures,X4270.Volume level set by participant (left),FCRLB,Fc receptor-like B,32638,0.00898440379791068,0.0302731674009672,-0.0503510043079851,0.0683198119038064,0.766643185047584
Physical measures,X4270.Volume level set by participant (left),CCL13,C-C motif chemokine 13,32945,-0.00732578924093672,0.0247343457739244,-0.0558051069578284,0.041153528475955,0.767100297970935
Physical measures,X4270.Volume level set by participant (left),PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,31762,-0.0180784935537345,0.0610842012644167,-0.137803528031991,0.101646540924522,0.767268242119413
Physical measures,X4270.Volume level set by participant (left),RNASE1,Ribonuclease pancreatic,31772,-0.0263281517033926,0.0895257298924999,-0.201798582292692,0.149142278885907,0.768700862609045
Physical measures,X4270.Volume level set by participant (left),NPPB,Natriuretic peptides B,32685,-0.00405963963448483,0.0138313278877813,-0.0311690422945361,0.0230497630255665,0.769138897289454
Physical measures,X4270.Volume level set by participant (left),SNU13,NHP2-like protein 1,31495,-0.00896516031226112,0.0306883161079933,-0.069114259883928,0.0511839392594058,0.770190623142219
Physical measures,X4270.Volume level set by participant (left),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,32861,0.0204333444948518,0.0700425263771462,-0.116850007204355,0.157716696194058,0.770501560392425
Physical measures,X4270.Volume level set by participant (left),AKR1B10,Aldo-keto reductase family 1 member B10,31546,-0.00968117078298827,0.0332834568136192,-0.0749167461376819,0.0555544045717054,0.771158328729541
Physical measures,X4270.Volume level set by participant (left),ASPN,Asporin,31762,-0.0211965122958239,0.0729071502739155,-0.164094526832698,0.12170150224105,0.771263186964322
Physical measures,X4270.Volume level set by participant (left),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,32881,-0.0145888259428007,0.0501801732958462,-0.112941965602659,0.0837643137170578,0.771265362157539
Physical measures,X4270.Volume level set by participant (left),IL12B,Interleukin-12 subunit beta,32961,0.00948312924081312,0.0327512117620995,-0.054709245812902,0.0736755042945282,0.772166750284834
Physical measures,X4270.Volume level set by participant (left),DSC2,Desmocollin-2,32761,-0.0152288276943008,0.0526145979927947,-0.118353439760178,0.0878957843715768,0.772250582214556
Physical measures,X4270.Volume level set by participant (left),DNER,Delta and Notch-like epidermal growth factor-related receptor,32838,-0.0195961605043609,0.0677292446495455,-0.15234548001747,0.113153159008748,0.772334882911926
Physical measures,X4270.Volume level set by participant (left),PLXDC1,Plexin domain-containing protein 1,32638,-0.0140867082407728,0.0487029895857135,-0.109544567828771,0.0813711513472256,0.772406826487864
Physical measures,X4270.Volume level set by participant (left),HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",32925,0.00680683278974871,0.0235629329582197,-0.0393765158083619,0.0529901813878593,0.772680703079057
Physical measures,X4270.Volume level set by participant (left),IZUMO1,Izumo sperm-egg fusion protein 1,31492,-0.0126828819574316,0.0440187567505849,-0.098959645188578,0.0735938812737148,0.773259271739207
Physical measures,X4270.Volume level set by participant (left),OFD1,Oral-facial-digital syndrome 1 protein,31632,0.00874468557809974,0.030449985779377,-0.0509372865494793,0.0684266577056787,0.773980683299668
Physical measures,X4270.Volume level set by participant (left),MYL1,"Myosin light chain 1/3, skeletal muscle isoform",31495,0.0137769164510397,0.047999044105901,-0.0803012099965262,0.107855042898606,0.774101116444391
Physical measures,X4270.Volume level set by participant (left),SDC1,Syndecan-1,32864,0.0125226967198104,0.0436865210350834,-0.0731028845089529,0.0981482779485738,0.774387703965023
Physical measures,X4270.Volume level set by participant (left),SERPINA1,Alpha-1-antitrypsin,31621,-0.0690225207955484,0.241587298999045,-0.542533626833676,0.40448858524258,0.775112268328653
Physical measures,X4270.Volume level set by participant (left),IFNG,Interferon gamma,32679,-0.00428242781789299,0.0149976591111827,-0.0336778396758111,0.0251129840400251,0.7752373642086
Physical measures,X4270.Volume level set by participant (left),FGR,Tyrosine-protein kinase Fgr,32644,0.00870074403795666,0.0307523888045273,-0.0515739380189169,0.0689754260948302,0.777237897230213
Physical measures,X4270.Volume level set by participant (left),PALLD,Palladin,31508,-0.0141585199060097,0.0501557355848069,-0.112463761652231,0.0841467218402118,0.777727918342361
Physical measures,X4270.Volume level set by participant (left),UPB1,Beta-ureidopropionase,31762,-0.006115095286248,0.0216973854982394,-0.0486419708627973,0.0364117802903013,0.778076968502704
Physical measures,X4270.Volume level set by participant (left),MKI67,Proliferation marker protein Ki-67,31508,-0.0142040173545675,0.0504016809360795,-0.112991311989283,0.0845832772801483,0.778091967387955
Physical measures,X4270.Volume level set by participant (left),ATP5PO,"ATP synthase subunit O, mitochondrial",32644,-0.011178583910257,0.0396998856848577,-0.0889903598525781,0.0666331920320641,0.778274335625027
Physical measures,X4270.Volume level set by participant (left),SCN3B,Sodium channel subunit beta-3,31514,0.0130413493261478,0.0463465022381099,-0.0777977950605475,0.103880493712843,0.778420434697095
Physical measures,X4270.Volume level set by participant (left),SOD1,Superoxide dismutase [Cu-Zn],32681,-0.0102838160866781,0.0366642697349517,-0.0821457847671833,0.0615781525938272,0.779111208770146
Physical measures,X4270.Volume level set by participant (left),VSIG2,V-set and immunoglobulin domain-containing protein 2,31724,-0.0107073799781234,0.0381968331481723,-0.0855731729485412,0.0641584129922944,0.779238506313126
Physical measures,X4270.Volume level set by participant (left),ICAM3,Intercellular adhesion molecule 3,32964,-0.018884286607386,0.0674070247954102,-0.15100205520639,0.113233481991618,0.779366418396713
Physical measures,X4270.Volume level set by participant (left),SCLY,Selenocysteine lyase,32925,-0.00990930246822348,0.0353751057987345,-0.0792445098337431,0.0594259048972962,0.779391231189197
Physical measures,X4270.Volume level set by participant (left),GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,31425,-0.022213000745502,0.0795196249926067,-0.178071465731011,0.133645464240007,0.779991660327874
Physical measures,X4270.Volume level set by participant (left),MET,Hepatocyte growth factor receptor,32881,-0.0243697760794374,0.0873317772192613,-0.195540059429189,0.146800507270315,0.780214226429676
Physical measures,X4270.Volume level set by participant (left),CA5A,"Carbonic anhydrase 5A, mitochondrial",32685,-0.00543766501370387,0.0194876989423021,-0.0436335549406159,0.0327582249132082,0.780227855148852
Physical measures,X4270.Volume level set by participant (left),TPR,Nucleoprotein TPR,31495,0.0123890322049579,0.0444703311597396,-0.0747728168681317,0.0995508812780476,0.780566299423486
Physical measures,X4270.Volume level set by participant (left),KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,31724,-0.00656754729354962,0.0236399822479066,-0.0529019124994466,0.0397668179123473,0.781161499284631
Physical measures,X4270.Volume level set by participant (left),TPSG1,Tryptase gamma,31508,-0.0204901949868355,0.0737845571297919,-0.165107926961228,0.124127536987557,0.781247844633927
Physical measures,X4270.Volume level set by participant (left),C2CD2L,Phospholipid transfer protein C2CD2L,32624,-0.011394035392141,0.0414523153195208,-0.0926405734184017,0.0698525026341197,0.783421903010077
Physical measures,X4270.Volume level set by participant (left),MAP3K5,Mitogen-activated protein kinase kinase kinase 5,32638,-0.00471229433679149,0.0172190395653933,-0.0384616118849623,0.0290370232113793,0.784346470631033
Physical measures,X4270.Volume level set by participant (left),CD300C,CMRF35-like molecule 6,32931,-0.0142039940149875,0.0519097959431342,-0.11594719406353,0.0875392060335554,0.784376444353942
Physical measures,X4270.Volume level set by participant (left),GAS6,Growth arrest-specific protein 6,32882,0.0178957022969681,0.0655777724952389,-0.1106367317937,0.146428136387636,0.784941865141232
Physical measures,X4270.Volume level set by participant (left),SMOC2,SPARC-related modular calcium-binding protein 2,32894,0.0122213991378158,0.045109395533095,-0.0761930161070504,0.100635814382682,0.786452586952364
Physical measures,X4270.Volume level set by participant (left),CDH4,Cadherin-4,31514,-0.0120719908014667,0.0445881664195894,-0.0994647969838619,0.0753208153809284,0.786595024684166
Physical measures,X4270.Volume level set by participant (left),THBS4,Thrombospondin-4,32851,-0.0102150080625898,0.0378866558989231,-0.084472853624479,0.0640428374992994,0.787458641276441
Physical measures,X4270.Volume level set by participant (left),VWC2,Brorin,32758,-0.0123031061004952,0.0456944307918377,-0.101864190452497,0.0772579782515068,0.787745561459855
Physical measures,X4270.Volume level set by participant (left),IL18BP,Interleukin-18-binding protein,32878,0.015848601232196,0.059019833190169,-0.0998302718205352,0.131527474284927,0.788297459556366
Physical measures,X4270.Volume level set by participant (left),TLR2,Toll-like receptor 2,31632,0.023203698520704,0.0866247746506717,-0.146580859794613,0.192988256836021,0.788810761863344
Physical measures,X4270.Volume level set by participant (left),IL22RA1,Interleukin-22 receptor subunit alpha-1,32679,-0.0102151924127043,0.0381849631653446,-0.0850577202167797,0.0646273353913711,0.789076061885461
Physical measures,X4270.Volume level set by participant (left),GIP,Gastric inhibitory polypeptide,31566,0.0128178676371786,0.0480700416881365,-0.0813994140715689,0.107035149345926,0.789745935835943
Physical measures,X4270.Volume level set by participant (left),PSIP1,PC4 and SFRS1-interacting protein,32843,-0.00756693654662098,0.0283830927102268,-0.0631977982586655,0.0480639251654236,0.789783167603823
Physical measures,X4270.Volume level set by participant (left),HNMT,Histamine N-methyltransferase,32758,0.0101210604104219,0.0380149156897211,-0.0643881743414315,0.0846302951622753,0.790061172509559
Physical measures,X4270.Volume level set by participant (left),RNASE6,Ribonuclease K6,31712,-0.020164221051858,0.0757883945505306,-0.168709474370898,0.128381032267182,0.790200386986033
Physical measures,X4270.Volume level set by participant (left),IL21R,Interleukin-21 receptor,31508,-0.0100255686894183,0.0381324553408631,-0.0847651811575099,0.0647140437786734,0.792623701031645
Physical measures,X4270.Volume level set by participant (left),MBL2,Mannose-binding protein C,31669,-0.00482920505893435,0.0183875965727217,-0.0408688943414689,0.0312104842236002,0.792839747243628
Physical measures,X4270.Volume level set by participant (left),H2AP,Huntingtin-interacting protein M,31492,-0.0118469315603725,0.0451545492830255,-0.100349848155103,0.0766559850343576,0.79304785060096
Physical measures,X4270.Volume level set by participant (left),SERPINI2,Serpin I2,31720,-0.0088657326024902,0.0337942926664428,-0.0751025462287182,0.0573710810237378,0.793063058950862
Physical measures,X4270.Volume level set by participant (left),PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,31632,-0.00705153470676816,0.027030872806779,-0.060032045408055,0.0459289759945187,0.794199933904525
Physical measures,X4270.Volume level set by participant (left),DAND5,DAN domain family member 5,31508,-0.00928768975684967,0.0357009896272939,-0.0792616294263458,0.0606862499126464,0.794753406574394
Physical measures,X4270.Volume level set by participant (left),NPL,N-acetylneuraminate lyase,31762,0.0118601818707005,0.0457634559002759,-0.0778361916938403,0.101556555435241,0.795516444384158
Physical measures,X4270.Volume level set by participant (left),TCN2,Transcobalamin-2,32940,0.0151100451367588,0.0584012084297096,-0.099356323385472,0.12957641365899,0.79585075225658
Physical measures,X4270.Volume level set by participant (left),DOCK9,Dedicator of cytokinesis protein 9,31514,0.00463901892106585,0.0179407525730354,-0.0305248561220836,0.0398028939642153,0.79597061065942
Physical measures,X4270.Volume level set by participant (left),C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,31585,-0.0106363746481743,0.041447044428048,-0.0918725817271484,0.0705998324307998,0.797474610023284
Physical measures,X4270.Volume level set by participant (left),CRTAC1,Cartilage acidic protein 1,32964,-0.01480981141737,0.0577566023881061,-0.128012752098058,0.0983931292633181,0.797634167580079
Physical measures,X4270.Volume level set by participant (left),TGM2,Protein-glutamine gamma-glutamyltransferase 2,32855,0.00587156819002291,0.023001305001746,-0.0392109896133993,0.0509541259934451,0.79851956585221
Physical measures,X4270.Volume level set by participant (left),KRT5,"Keratin, type II cytoskeletal 5",32644,0.00887171453956699,0.0347750820533336,-0.0592874462849668,0.0770308753641008,0.798638710679847
Physical measures,X4270.Volume level set by participant (left),FCRL1,Fc receptor-like protein 1,32864,-0.0101271376004152,0.0397165894194014,-0.0879716528624419,0.0677173776616116,0.798740450939159
Physical measures,X4270.Volume level set by participant (left),VNN2,Vascular non-inflammatory molecule 2,32832,0.00933360378927882,0.0366159355208328,-0.0624336298315535,0.0811008374101111,0.798801923347691
Physical measures,X4270.Volume level set by participant (left),OSTN,Osteocrin,31546,-0.012357467976672,0.0486413777083597,-0.107694568285057,0.082979632331713,0.799461728274949
Physical measures,X4270.Volume level set by participant (left),IL20,Interleukin-20,32679,-0.00885528092016147,0.0349762960702957,-0.0774088212179411,0.0596982593776181,0.800135415573525
Physical measures,X4270.Volume level set by participant (left),COL6A3,Collagen alpha-3(VI) chain,32964,0.013537464323858,0.0534807551556195,-0.0912848157811563,0.118359744428872,0.800175196855409
Physical measures,X4270.Volume level set by participant (left),CFHR2,Complement factor H-related protein 2,31717,0.00906407695587065,0.0358638472225043,-0.0612290636002378,0.0793572175119791,0.800479020487378
Physical measures,X4270.Volume level set by participant (left),POSTN,Periostin,31773,-0.0132527885215163,0.0525444770119759,-0.116239963464989,0.0897343864219564,0.800877271057139
Physical measures,X4270.Volume level set by participant (left),GBP2,Guanylate-binding protein 2,32679,0.00725298118304028,0.0288742454254096,-0.0493405398507626,0.0638465022168431,0.80167147754384
Physical measures,X4270.Volume level set by participant (left),TNFSF8,Tumor necrosis factor ligand superfamily member 8,31773,0.0143051676608404,0.0570891656796616,-0.0975895970712963,0.126199932392977,0.802148543481048
Physical measures,X4270.Volume level set by participant (left),TCL1B,T-cell leukemia/lymphoma protein 1B,32685,-0.00540612512735972,0.0216065239977897,-0.0477549121630275,0.0369426619083081,0.802432326115398
Physical measures,X4270.Volume level set by participant (left),RBKS,Ribokinase,32648,-0.00832161984830478,0.0332840915062376,-0.0735584392005305,0.056915199503921,0.802579324421114
Physical measures,X4270.Volume level set by participant (left),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,32755,-0.00941108106138758,0.0380750311363418,-0.0840381420886176,0.0652159799658424,0.80478083112103
Physical measures,X4270.Volume level set by participant (left),TSLP,Thymic stromal lymphopoietin,32685,-0.00694086783303845,0.0280895391502392,-0.0619963645675072,0.0481146289014303,0.804838162000299
Physical measures,X4270.Volume level set by participant (left),PROC,Vitamin K-dependent protein C,32872,0.0163183778867234,0.0660420028652683,-0.113123947729203,0.145760703502649,0.804843506960224
Physical measures,X4270.Volume level set by participant (left),TSPAN1,Tetraspanin-1,32685,-0.0107878712093751,0.0439186852809052,-0.0968684943599494,0.0752927519411992,0.805972182460469
Physical measures,X4270.Volume level set by participant (left),LTA,Lymphotoxin-alpha,32843,-0.0106293261553046,0.0432981077775939,-0.0954936173993886,0.0742349650887794,0.8060813427695
Physical measures,X4270.Volume level set by participant (left),CCL11,Eotaxin,32961,-0.0109022251684969,0.0444719066127887,-0.0980671621295627,0.0762627117925689,0.806346910778429
Physical measures,X4270.Volume level set by participant (left),EPHA4,Ephrin type-A receptor 4,31599,-0.017772541120103,0.0728374524174555,-0.160533947858316,0.12498886561811,0.807235134797793
Physical measures,X4270.Volume level set by participant (left),SPP1,Osteopontin,32940,0.00882583852901097,0.0364155560586068,-0.0625486513458583,0.0802003284038803,0.808503204503091
Physical measures,X4270.Volume level set by participant (left),CD160,CD160 antigen,32961,0.00922644731141758,0.0381448078484071,-0.0655373760714603,0.0839902706942955,0.808878981366075
Physical measures,X4270.Volume level set by participant (left),HEPH,Hephaestin,31762,-0.0181341711537213,0.0751308076936202,-0.165390554233217,0.129122211925774,0.809276193851055
Physical measures,X4270.Volume level set by participant (left),ENO3,Beta-enolase,31566,0.00802890656484786,0.0332986994750955,-0.0572365444063394,0.0732943575360351,0.809470295123626
Physical measures,X4270.Volume level set by participant (left),IL1RL1,Interleukin-1 receptor-like 1,32922,-0.00875673446066003,0.0366612628285531,-0.0806128096046242,0.0630993406833041,0.811223243068701
Physical measures,X4270.Volume level set by participant (left),FCER2,Low affinity immunoglobulin epsilon Fc receptor,32861,0.00877449955069174,0.0367752433498188,-0.0633049774149532,0.0808539765163366,0.811422748798768
Physical measures,X4270.Volume level set by participant (left),SMNDC1,Survival of motor neuron-related-splicing factor 30,31720,-0.00834264078767174,0.0349815211720324,-0.0769064222848553,0.0602211407095118,0.811509555584262
Physical measures,X4270.Volume level set by participant (left),C7orf50,Uncharacterized protein C7orf50,31751,0.024289456403531,0.101926458305565,-0.175486401875377,0.224065314682439,0.811651709436151
Physical measures,X4270.Volume level set by participant (left),PON2,Serum paraoxonase/arylesterase 2,32685,-0.0120418508005013,0.0505437672671664,-0.111107634644147,0.0870239330431447,0.811695828017975
Physical measures,X4270.Volume level set by participant (left),NGF,Beta-nerve growth factor,32796,0.0329203661974231,0.140126462616323,-0.241727500530569,0.307568232925416,0.814265921592588
Physical measures,X4270.Volume level set by participant (left),JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,31492,-0.00870984050539153,0.0372206967615185,-0.0816624061579679,0.0642427251471848,0.814987139084959
Physical measures,X4270.Volume level set by participant (left),PRKCQ,Protein kinase C theta type,32679,0.00908862847073346,0.0390384102049602,-0.0674266555309885,0.0856039124724554,0.815912438549303
Physical measures,X4270.Volume level set by participant (left),PPY,Pancreatic prohormone,32822,-0.00407141647223812,0.0175581543206335,-0.0384853989406798,0.0303425659962035,0.816635114892714
Physical measures,X4270.Volume level set by participant (left),CD1C,T-cell surface glycoprotein CD1c,32881,-0.0170812007886401,0.0741798232002597,-0.162473654261149,0.128311252683869,0.817889153606966
Physical measures,X4270.Volume level set by participant (left),SFTPD,Pulmonary surfactant-associated protein D,32864,-0.00597761735137013,0.0259786987769246,-0.0568958669541424,0.0449406322514022,0.818021723555133
Physical measures,X4270.Volume level set by participant (left),CEBPA,CCAAT/enhancer-binding protein alpha,31508,0.0119328967162309,0.0519657800730286,-0.0899200322269052,0.113785825659367,0.818385516422005
Physical measures,X4270.Volume level set by participant (left),LCN15,Lipocalin-15,31752,-0.00734784898089655,0.0320037566376955,-0.0700752119907798,0.0553795140289867,0.818413744369834
Physical measures,X4270.Volume level set by participant (left),MFAP3,Microfibril-associated glycoprotein 3,32685,-0.00824692976627917,0.0360182279662369,-0.0788426565801035,0.0623487970475452,0.818901077320837
Physical measures,X4270.Volume level set by participant (left),NOS1,"Nitric oxide synthase, brain",32644,-0.00735221436296814,0.0321352854590512,-0.0703373738627084,0.0556329451367721,0.819037893055703
Physical measures,X4270.Volume level set by participant (left),KRT18,"Keratin, type I cytoskeletal 18",32832,-0.00494373598951064,0.0216417370301207,-0.0473615405685472,0.0374740685895259,0.819313082361041
Physical measures,X4270.Volume level set by participant (left),ATF4,Cyclic AMP-dependent transcription factor ATF-4,31492,-0.0141190083123273,0.0620744878646759,-0.135785004527092,0.107546987902437,0.820077859645531
Physical measures,X4270.Volume level set by participant (left),PNLIPRP1,Inactive pancreatic lipase-related protein 1,31751,-0.00582976463139698,0.0256564375599499,-0.0561163822488987,0.0444568529861047,0.820255265222218
Physical measures,X4270.Volume level set by participant (left),IL12A_IL12B,Interleukin-12,32832,-0.00537118398205294,0.0237144231321814,-0.0518514533211284,0.0411090853570225,0.820822077566685
Physical measures,X4270.Volume level set by participant (left),CHCHD6,MICOS complex subunit MIC25,31724,-0.0147712780179236,0.0652780122431081,-0.142716182014415,0.113173625978568,0.820987517597111
Physical measures,X4270.Volume level set by participant (left),ISM2,Isthmin-2,31773,-0.00976510049617938,0.0432224692827985,-0.0944811402904644,0.0749509392981057,0.821264436538021
Physical measures,X4270.Volume level set by participant (left),BTN2A1,Butyrophilin subfamily 2 member A1,32894,0.0160333461278396,0.0710599069627992,-0.123244071519247,0.155310763774926,0.821493224282797
Physical measures,X4270.Volume level set by participant (left),TCTN3,Tectonic-3,31762,0.0152724217983839,0.067910866215996,-0.117832875984968,0.148377719581736,0.822071272157924
Physical measures,X4270.Volume level set by participant (left),TBC1D17,TBC1 domain family member 17,32644,0.00855561982177952,0.0380521134662837,-0.0660265225721366,0.0831377622156956,0.822109333981574
Physical measures,X4270.Volume level set by participant (left),CD109,CD109 antigen,32861,0.0116686273570342,0.0522135321293149,-0.0906698956164229,0.114007150330491,0.823167807462116
Physical measures,X4270.Volume level set by participant (left),CCL24,C-C motif chemokine 24,32883,-0.00462135718561603,0.0207765852437346,-0.0453434642633358,0.0361007498921037,0.823983397023324
Physical measures,X4270.Volume level set by participant (left),HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,32832,-0.00966710889024905,0.0436999693527684,-0.0953190488216752,0.0759848310411771,0.824929706686814
Physical measures,X4270.Volume level set by participant (left),ARSA,Arylsulfatase A,32861,0.00830639946864595,0.0377088283233035,-0.0656029040450289,0.0822157029823208,0.825660183341165
Physical measures,X4270.Volume level set by participant (left),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,32832,-0.013045356365163,0.059695406105249,-0.130048352331451,0.103957639601125,0.82701960200063
Physical measures,X4270.Volume level set by participant (left),CTSS,Cathepsin S,30864,0.0190355787470625,0.0877812510037412,-0.15301567322027,0.191086830714395,0.828329659097303
Physical measures,X4270.Volume level set by participant (left),SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,32931,-0.00703796463392525,0.0325161089773991,-0.0707695382296275,0.056693608961777,0.828645391589287
Physical measures,X4270.Volume level set by participant (left),NPPC,C-type natriuretic peptide,32843,-0.00820555852199862,0.0379614689672643,-0.0826100376978366,0.0661989206538394,0.828871896287353
Physical measures,X4270.Volume level set by participant (left),CTRB1,Chymotrypsinogen B,32861,0.0069059253888702,0.0320765539673546,-0.0559641203871447,0.0697759711648852,0.829542117157109
Physical measures,X4270.Volume level set by participant (left),MYOM2,Myomesin-2,31495,-0.00819705826793645,0.0380767577264557,-0.0828275034117897,0.0664333868759168,0.829556947163573
Physical measures,X4270.Volume level set by participant (left),TNF,Tumor necrosis factor,32669,-0.0100341075453429,0.0466619177593462,-0.101491466353662,0.0814232512629757,0.829742302652868
Physical measures,X4270.Volume level set by participant (left),EGFLAM,Pikachurin,31720,-0.0140117068144633,0.0652463940594812,-0.141894639171046,0.11387122554212,0.829967288787603
Physical measures,X4270.Volume level set by participant (left),SART1,U4/U6.U5 tri-snRNP-associated protein 1,31495,0.0122516244913646,0.0571082358961303,-0.0996805178650508,0.12418376684778,0.83013684889433
Physical measures,X4270.Volume level set by participant (left),ANPEP,Aminopeptidase N,32855,0.0132011437207371,0.0617120924841392,-0.107754557548176,0.13415684498965,0.830618174395289
Physical measures,X4270.Volume level set by participant (left),INSL3,Insulin-like 3,31751,-0.00587927268446778,0.0277668414054803,-0.0603022818392091,0.0485437364702736,0.832317550915365
Physical measures,X4270.Volume level set by participant (left),MARCO,Macrophage receptor MARCO,32864,0.0138841166176691,0.0656169846674132,-0.114725173330461,0.142493406565799,0.832429100052162
Physical measures,X4270.Volume level set by participant (left),GPKOW,G-patch domain and KOW motifs-containing protein,32644,0.0134217918566372,0.0642020474184653,-0.112414221083555,0.139257804796829,0.834409753330696
Physical measures,X4270.Volume level set by participant (left),ING1,Inhibitor of growth protein 1,32624,-0.00834775348171831,0.0402154752913961,-0.0871700850528547,0.0704745780894181,0.835565142185659
Physical measures,X4270.Volume level set by participant (left),TET2,Methylcytosine dioxygenase TET2,31609,0.00420273002855768,0.0203135421660062,-0.0356118126168145,0.0440172726739299,0.83609884813866
Physical measures,X4270.Volume level set by participant (left),CASQ2,Calsequestrin-2,31495,0.00839672855795672,0.0407001055052428,-0.0713754782323193,0.0881689353482327,0.836556385846995
Physical measures,X4270.Volume level set by participant (left),RIDA,2-iminobutanoate/2-iminopropanoate deaminase,31599,-0.00849907741580297,0.0411998757570997,-0.0892508338997185,0.0722526790681125,0.836570670287706
Physical measures,X4270.Volume level set by participant (left),CPA1,Carboxypeptidase A1,32964,0.00595711445500263,0.0289334450989218,-0.050752437938884,0.0626666668488893,0.83688124116265
Physical measures,X4270.Volume level set by participant (left),PROK1,Prokineticin-1,32843,-0.00533218358093012,0.025958215041782,-0.0562102850628228,0.0455459179009625,0.837253254929864
Physical measures,X4270.Volume level set by participant (left),RBP5,Retinol-binding protein 5,32832,-0.00643502506340963,0.0313325168372552,-0.0678467580644297,0.0549767079376105,0.837281083767182
Physical measures,X4270.Volume level set by participant (left),RALY,RNA-binding protein Raly,31724,-0.00838521972633475,0.041177056837672,-0.0890922511281718,0.0723218116755023,0.838641548462239
Physical measures,X4270.Volume level set by participant (left),PCSK9,Proprotein convertase subtilisin/kexin type 9,32964,0.00864519417737014,0.0425425473870761,-0.0747381987012991,0.0920285870560394,0.838973178056474
Physical measures,X4270.Volume level set by participant (left),SEMA3G,Semaphorin-3G,31599,-0.00917769509505417,0.0459309528129225,-0.0992023626083823,0.0808469724182739,0.841630491555435
Physical measures,X4270.Volume level set by participant (left),LRP1,Prolow-density lipoprotein receptor-related protein 1,32832,-0.013115060792591,0.0656442430804702,-0.141777777230312,0.115547655645131,0.841649382005426
Physical measures,X4270.Volume level set by participant (left),MFAP5,Microfibrillar-associated protein 5,32964,-0.00840659913548988,0.0421073560048966,-0.0909370169050873,0.0741238186341075,0.841761279062125
Physical measures,X4270.Volume level set by participant (left),EXOSC10,Exosome component 10,31495,0.0065297684553554,0.0327364660532834,-0.0576337050090802,0.070693241919791,0.841904589719499
Physical measures,X4270.Volume level set by participant (left),NUDT15,Nucleotide triphosphate diphosphatase NUDT15,31495,-0.00772411938687901,0.0389098637722363,-0.0839874523804622,0.0685392136067041,0.842648889547267
Physical measures,X4270.Volume level set by participant (left),BGLAP,Osteocalcin,31773,0.00431388701634101,0.0217987621435397,-0.0384116867849968,0.0470394608176788,0.843131548402244
Physical measures,X4270.Volume level set by participant (left),ACTN2,Alpha-actinin-2,31495,-0.00648597170766571,0.0328204221197565,-0.0708139990623885,0.057842055647057,0.843347651196215
Physical measures,X4270.Volume level set by participant (left),DDX4,Probable ATP-dependent RNA helicase DDX4,31508,0.00751285978043265,0.0380182676936797,-0.0670029448991796,0.0820286644600449,0.843354025275932
Physical measures,X4270.Volume level set by participant (left),BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",31762,-0.0130183810645746,0.0659693363249582,-0.142318280261493,0.116281518132343,0.843566648898157
Physical measures,X4270.Volume level set by participant (left),KIRREL1,Kin of IRRE-like protein 1,31514,0.00685169108865878,0.0347293484623552,-0.0612178318975575,0.0749212140748751,0.843607243597574
Physical measures,X4270.Volume level set by participant (left),VWA1,von Willebrand factor A domain-containing protein 1,32940,0.00792438644802978,0.0402602553658844,-0.0709857140691036,0.0868344869651632,0.843965750492345
Physical measures,X4270.Volume level set by participant (left),CDH2,Cadherin-2,32864,0.00923496940341174,0.0469813651692945,-0.0828485063284056,0.101318445135229,0.844171111299855
Physical measures,X4270.Volume level set by participant (left),VSTM1,V-set and transmembrane domain-containing protein 1,32644,0.00725803764834476,0.0369986158213759,-0.065259249361552,0.0797753246582416,0.844481242043808
Physical measures,X4270.Volume level set by participant (left),ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,32685,-0.00406839976629029,0.0207818161501301,-0.0448007594205453,0.0366639598879648,0.844796824569927
Physical measures,X4270.Volume level set by participant (left),CD14,Monocyte differentiation antigen CD14,32634,-0.00835663681645564,0.0429205095313402,-0.0924808354978824,0.0757675618649712,0.845632073038921
Physical measures,X4270.Volume level set by participant (left),JUN,Transcription factor AP-1,32679,-0.00619627314089861,0.0318283496939054,-0.0685798385409532,0.056187292259156,0.845649677154006
Physical measures,X4270.Volume level set by participant (left),TMED10,Transmembrane emp24 domain-containing protein 10,31495,0.0079280505389765,0.0407666247084144,-0.0719745338895157,0.0878306349674687,0.845809890459104
Physical measures,X4270.Volume level set by participant (left),EFNA1,Ephrin-A1,32843,0.0131503938643294,0.0677639864712525,-0.119667019619325,0.145967807347984,0.846131966293199
Physical measures,X4270.Volume level set by participant (left),AGT,Angiotensinogen,31772,-0.0153310871280325,0.0790346090763099,-0.1702389209176,0.139576746661535,0.846196982951647
Physical measures,X4270.Volume level set by participant (left),PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,31599,0.00575681507642366,0.0296782886019585,-0.0524126305834149,0.0639262607362622,0.846201366871585
Physical measures,X4270.Volume level set by participant (left),SPINT3,Kunitz-type protease inhibitor 3,31720,0.00260014700955468,0.0135775481555939,-0.0240118473754094,0.0292121413945188,0.848136143910264
Physical measures,X4270.Volume level set by participant (left),CRNN,Cornulin,32595,-0.00513741763641491,0.0268567951063265,-0.0577767360448148,0.0475019007719849,0.848303388209305
Physical measures,X4270.Volume level set by participant (left),CYTH3,Cytohesin-3,31492,-0.00513280370794162,0.0271167634329737,-0.0582816600365701,0.0480160526206868,0.849874280030619
Physical measures,X4270.Volume level set by participant (left),DGKZ,Diacylglycerol kinase zeta,32679,0.00917207585092181,0.0486792859809148,-0.0862393246716711,0.104583476373515,0.850552970630267
Physical measures,X4270.Volume level set by participant (left),NRTN,Neurturin,32679,-0.00642646253508384,0.0342265320920856,-0.0735104654355717,0.060657540365404,0.851067079063027
Physical measures,X4270.Volume level set by participant (left),GNAS,Neuroendocrine secretory protein 55,31752,-0.00390004213699674,0.0207921544877353,-0.0446526649329579,0.0368525806589644,0.85121639289056
Physical measures,X4270.Volume level set by participant (left),LPCAT2,Lysophosphatidylcholine acyltransferase 2,32832,0.00797554960219644,0.0426602975398931,-0.0756386335759941,0.091589732780387,0.851700260419247
Physical measures,X4270.Volume level set by participant (left),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",32763,-0.00801873157660975,0.0430199096779099,-0.0923377545453132,0.0763002913920937,0.852138614081308
Physical measures,X4270.Volume level set by participant (left),KDR,Vascular endothelial growth factor receptor 2,32881,0.0122625351888635,0.0659100655736224,-0.116921193335436,0.141446263713163,0.852410122857481
Physical measures,X4270.Volume level set by participant (left),NTF3,Neurotrophin-3,32843,-0.00941895450777912,0.0506967413063498,-0.108784567468225,0.0899466584526665,0.852613535746804
Physical measures,X4270.Volume level set by participant (left),FABP3,"Fatty acid-binding protein, heart",31762,0.00732025158333581,0.0394370955348864,-0.0699764556650415,0.0846169588317131,0.852748769109479
Physical measures,X4270.Volume level set by participant (left),TNXB,Tenascin-X,32861,-0.0119305491278743,0.0649182273050998,-0.13917027464587,0.115309176390121,0.854191670293192
Physical measures,X4270.Volume level set by participant (left),CSF2,Granulocyte-macrophage colony-stimulating factor,31495,0.0100036772355751,0.0544830563681475,-0.096783113245994,0.116790467717144,0.854323672422029
Physical measures,X4270.Volume level set by participant (left),SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",31492,-0.00625645008072938,0.0342179178697051,-0.0733235691053513,0.0608106689438925,0.85492736632805
Physical measures,X4270.Volume level set by participant (left),OLR1,Oxidized low-density lipoprotein receptor 1,32768,0.00518967236116133,0.0285779578390044,-0.0508231250032872,0.0612024697256099,0.855903110352239
Physical measures,X4270.Volume level set by participant (left),GIMAP7,GTPase IMAP family member 7,31599,0.0118252651146665,0.0651936989143589,-0.115954384757477,0.13960491498681,0.856068867275896
Physical measures,X4270.Volume level set by participant (left),UPK3BL1,Uroplakin-3b-like protein 1,31606,-0.00636031404759412,0.0351279222558921,-0.0752110416691426,0.0624904135739544,0.856324048092769
Physical measures,X4270.Volume level set by participant (left),SPINK2,Serine protease inhibitor Kazal-type 2,31599,-0.00963241512503656,0.053724453963658,-0.114932344893806,0.0956675146437331,0.857712388153225
Physical measures,X4270.Volume level set by participant (left),MME,Neprilysin,32832,0.00392889237494017,0.0219701699003751,-0.0391326406297949,0.0469904253796753,0.858076410881626
Physical measures,X4270.Volume level set by participant (left),ACY1,Aminoacylase-1,32864,-0.00500662723019392,0.028025428108571,-0.0599364663229931,0.0499232118626052,0.85821978852033
Physical measures,X4270.Volume level set by participant (left),MLN,Promotilin,32843,-0.00346575616715189,0.0194173073910636,-0.0415236786536365,0.0345921663193327,0.858343778681881
Physical measures,X4270.Volume level set by participant (left),CPA4,Carboxypeptidase A4,31442,0.00845209652156243,0.0475069923572096,-0.0846616084985684,0.101565801541693,0.858796304087659
Physical measures,X4270.Volume level set by participant (left),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,32961,-0.00845088540770213,0.0477187784504882,-0.101979691170659,0.0850779203552547,0.859435599012592
Physical measures,X4270.Volume level set by participant (left),SLAMF7,SLAM family member 7,32843,0.00529137959183368,0.0298907426870123,-0.0532944760747105,0.0638772352583778,0.859493510408457
Physical measures,X4270.Volume level set by participant (left),TSHB,Thyrotropin subunit beta,32864,0.00402920185487614,0.0229356445705612,-0.0409246615034238,0.0489830652131761,0.86055382833296
Physical measures,X4270.Volume level set by participant (left),CX3CL1,Fractalkine,32796,0.00906137833334211,0.051618079713791,-0.0921100579056883,0.110232814572373,0.860654137477525
Physical measures,X4270.Volume level set by participant (left),MERTK,Tyrosine-protein kinase Mer,32961,-0.0116615293486401,0.0665658157021044,-0.142130528124765,0.118807469427485,0.860935844347784
Physical measures,X4270.Volume level set by participant (left),IL17RA,Interleukin-17 receptor A,32861,0.0066951999607431,0.0382654165073631,-0.0683050163936886,0.0816954163151748,0.861109195906107
Physical measures,X4270.Volume level set by participant (left),TGFBR1,TGF-beta receptor type-1,31508,-0.0156774910610665,0.0898820232065994,-0.191846256546001,0.160491274423868,0.861537667939191
Physical measures,X4270.Volume level set by participant (left),TF,Serotransferrin,31770,-0.0154737185308114,0.0890335450381825,-0.189979466805649,0.159032029744026,0.862029843996699
Physical measures,X4270.Volume level set by participant (left),PLA2G15,Phospholipase A2 group XV,32881,0.0113431566452336,0.0653443618829642,-0.116731792645376,0.139418105935843,0.862191240534765
Physical measures,X4270.Volume level set by participant (left),IL34,Interleukin-34,32629,0.00858167399311306,0.0494430340642565,-0.0883266727728298,0.105490020759056,0.862209857209514
Physical measures,X4270.Volume level set by participant (left),PKD1,Polycystin-1,31762,0.0132199703043705,0.0762182645450004,-0.13616782820383,0.162607768812571,0.862303074892563
Physical measures,X4270.Volume level set by participant (left),LY75,Lymphocyte antigen 75,32843,-0.00773822019749921,0.0447508980970557,-0.0954499804677284,0.07997354007273,0.862720053913943
Physical measures,X4270.Volume level set by participant (left),LGALS7_LGALS7B,Galectin-7,32874,0.00741317523096781,0.0429570011234738,-0.0767825469710408,0.0916088974329764,0.862991744816766
Physical measures,X4270.Volume level set by participant (left),CCER2,Coiled-coil domain-containing glutamate-rich protein 2,31566,-0.00550556119747888,0.0320631707888062,-0.0683493759435391,0.0573382535485813,0.863670177889511
Physical measures,X4270.Volume level set by participant (left),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",32964,-0.0101047724669133,0.0594590402366435,-0.126644491330735,0.106434946396908,0.865057090602217
Physical measures,X4270.Volume level set by participant (left),FAP,Prolyl endopeptidase FAP,32964,-0.0106203615527814,0.0625334979234574,-0.133186017482758,0.111945294377195,0.865143865067974
Physical measures,X4270.Volume level set by participant (left),HSDL2,Hydroxysteroid dehydrogenase-like protein 2,31566,-0.00734203225456114,0.0432778918123574,-0.0921667002067816,0.0774826356976593,0.86529098140763
Physical measures,X4270.Volume level set by participant (left),NPTX2,Neuronal pentraxin-2,31773,0.00975141540591039,0.0575493563990113,-0.103045323136152,0.122548153947973,0.865451445552734
Physical measures,X4270.Volume level set by participant (left),APCS,Serum amyloid P-component,31716,0.00954082375897535,0.0564459793150565,-0.101093295698535,0.120174943216486,0.865780743741339
Physical measures,X4270.Volume level set by participant (left),KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,32638,-0.00400210903970251,0.0237511610617001,-0.0505543847206347,0.0425501666412297,0.866192555346069
Physical measures,X4270.Volume level set by participant (left),CD70,CD70 antigen,32843,0.00682017843347831,0.040607712669182,-0.0727709383981184,0.0864112952650751,0.866624205650191
Physical measures,X4270.Volume level set by participant (left),CD5,T-cell surface glycoprotein CD5,32933,0.00893275011930183,0.0532879593753528,-0.0955116502563896,0.113377150494993,0.866876784610718
Physical measures,X4270.Volume level set by participant (left),AKR7L,Aflatoxin B1 aldehyde reductase member 4,31508,0.00479012074385064,0.0286224426127457,-0.0513098667771309,0.0608901082648322,0.867094830911524
Physical measures,X4270.Volume level set by participant (left),PRSS53,Serine protease 53,31751,-0.00870238760503006,0.0521218192145819,-0.11086115326561,0.0934563780555504,0.867403859739163
Physical measures,X4270.Volume level set by participant (left),DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,31724,-0.00687853468783403,0.0414186084358594,-0.0880590072221186,0.0743019378464505,0.868103352427748
Physical measures,X4270.Volume level set by participant (left),HIF1A,Hypoxia-inducible factor 1-alpha,31508,-0.00481487488734203,0.0290305694785864,-0.0617147910653713,0.0520850412906873,0.868275182093337
Physical measures,X4270.Volume level set by participant (left),IL1A,Interleukin-1 alpha,32679,0.00547233293834153,0.0330891791096881,-0.059382458116647,0.0703271239933301,0.868647628206277
Physical measures,X4270.Volume level set by participant (left),WIF1,Wnt inhibitory factor 1,32948,0.00824248892094446,0.0499154921988554,-0.0895918757888121,0.106076853630701,0.868846222356781
Physical measures,X4270.Volume level set by participant (left),TSC1,Hamartin,31508,-0.00420852151156481,0.0255211268144055,-0.0542299300677995,0.0458128870446699,0.869024347461944
Physical measures,X4270.Volume level set by participant (left),C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,31599,0.00877832780989458,0.0532554881922947,-0.0956024290470031,0.113159084666792,0.869078761404162
Physical measures,X4270.Volume level set by participant (left),IL15RA,Interleukin-15 receptor subunit alpha,32679,-0.00833924281500051,0.0506225371520585,-0.107559415633035,0.0908809300030341,0.869157290121232
Physical measures,X4270.Volume level set by participant (left),PSMG3,Proteasome assembly chaperone 3,32843,-0.00552854356780555,0.0337020833369524,-0.0715846269082322,0.0605275397726211,0.869702089601143
Physical measures,X4270.Volume level set by participant (left),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,32796,0.00530139922136732,0.0325400227154798,-0.0584770453009732,0.0690798437437078,0.870585623601774
Physical measures,X4270.Volume level set by participant (left),SIRT1,NAD-dependent protein deacetylase sirtuin-1,31508,-0.00359123430278607,0.0220466499382548,-0.0468026681817654,0.0396201995761933,0.870607367947664
Physical measures,X4270.Volume level set by participant (left),MTUS1,Microtubule-associated tumor suppressor 1,31632,-0.00591410686658735,0.0363076707583298,-0.0770771415529138,0.0652489278197391,0.870610357171881
Physical measures,X4270.Volume level set by participant (left),IGF2R,Cation-independent mannose-6-phosphate receptor,32861,0.0119268889700051,0.0732757862073924,-0.131693651996484,0.155547429936494,0.870705449461697
Physical measures,X4270.Volume level set by participant (left),IDUA,Alpha-L-iduronidase,32948,-0.00589277057564492,0.0362037719392192,-0.0768521635765146,0.0650666224252248,0.870705702752834
Physical measures,X4270.Volume level set by participant (left),DUSP29,Dual specificity phosphatase 29,31546,0.00512125025625481,0.0315604219920608,-0.0567371768481844,0.066979677360694,0.87109898787067
Physical measures,X4270.Volume level set by participant (left),PSCA,Prostate stem cell antigen,31720,0.00126569358187578,0.00781065483392176,-0.0140431898926109,0.0165745770563624,0.871272969070573
Physical measures,X4270.Volume level set by participant (left),KIF20B,Kinesin-like protein KIF20B,31514,-0.00440052759931263,0.0272180483048193,-0.0577479022767585,0.0489468470781332,0.871564625410168
Physical measures,X4270.Volume level set by participant (left),CPVL,Probable serine carboxypeptidase CPVL,32945,-0.00679645712578265,0.0422206934696195,-0.089549016326237,0.0759561020746717,0.872117025893436
Physical measures,X4270.Volume level set by participant (left),BCL2,Apoptosis regulator Bcl-2,31720,-0.00651068366363148,0.0406840785403746,-0.0862514776027657,0.0732301102755028,0.872861351185122
Physical measures,X4270.Volume level set by participant (left),TREML2,Trem-like transcript 2 protein,32861,-0.008358756330688,0.0524671029816032,-0.11119427817463,0.0944767655132543,0.87342488240034
Physical measures,X4270.Volume level set by participant (left),AMY2A,Pancreatic alpha-amylase,32506,0.00612036185830666,0.0384509313715974,-0.0692434636300242,0.0814841873466375,0.873536053729742
Physical measures,X4270.Volume level set by participant (left),MYO9B,Unconventional myosin-IXb,32679,0.00392859854769435,0.0248758775799042,-0.0448281215089178,0.0526853186043066,0.874517120891446
Physical measures,X4270.Volume level set by participant (left),IL22,Interleukin-22,31724,0.00482710757751529,0.0306104525460781,-0.0551693794127979,0.0648235945678284,0.874701390025882
Physical measures,X4270.Volume level set by participant (left),STC2,Stanniocalcin-2,32845,0.00972286524070652,0.0617902273706325,-0.111385980405733,0.130831710887146,0.874970347618441
Physical measures,X4270.Volume level set by participant (left),PLXNB2,Plexin-B2,32913,-0.0112112405823427,0.0716704806359574,-0.151685382628819,0.129262901464134,0.875699480126157
Physical measures,X4270.Volume level set by participant (left),SLC39A14,Zinc transporter ZIP14,32644,0.00896408820535387,0.0573323678490396,-0.103407352778764,0.121335529189472,0.875758369543
Physical measures,X4270.Volume level set by participant (left),BTN1A1,Butyrophilin subfamily 1 member A1,31721,0.00769306142353586,0.0493926102832854,-0.0891164547317036,0.104502577578775,0.876231493162352
Physical measures,X4270.Volume level set by participant (left),IFNGR1,Interferon gamma receptor 1,32894,0.0131409741319175,0.0847917936974148,-0.153050941515016,0.179332889778851,0.87684108766263
Physical measures,X4270.Volume level set by participant (left),ARHGEF5,Rho guanine nucleotide exchange factor 5,31514,-0.00429235063413203,0.0278630710603329,-0.0589039699123845,0.0503192686441204,0.877573114523746
Physical measures,X4270.Volume level set by participant (left),F10,Coagulation factor X,31772,-0.0116585606374639,0.0757514662499659,-0.160131434487397,0.136814313212469,0.87768824335023
Physical measures,X4270.Volume level set by participant (left),MAMDC2,MAM domain-containing protein 2,31762,-0.00909939841785192,0.0593323869213654,-0.125390876783728,0.107192079948024,0.878115864977003
Physical measures,X4270.Volume level set by participant (left),SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,31720,-0.00597303912167198,0.0399891444805175,-0.0843517623034862,0.0724056840601422,0.881268266595297
Physical measures,X4270.Volume level set by participant (left),FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",31617,0.00474590685822302,0.0318108498111049,-0.0576033587715427,0.0670951724879887,0.881406445062421
Physical measures,X4270.Volume level set by participant (left),TRIM40,E3 ubiquitin ligase TRIM40,31546,-0.00414577182177033,0.0278394957943444,-0.0587111835786853,0.0504196399351446,0.881623102378264
Physical measures,X4270.Volume level set by participant (left),TCOF1,Treacle protein,31762,-0.00985444516848509,0.066823116779531,-0.140827754056366,0.121118863719396,0.882764347091708
Physical measures,X4270.Volume level set by participant (left),CCL18,C-C motif chemokine 18,32729,0.00358100592097879,0.0244218112636335,-0.0442857441557428,0.0514477559977004,0.883426251839214
Physical measures,X4270.Volume level set by participant (left),APOA2,Apolipoprotein A-II,31772,-0.00613300438070737,0.0420443808928959,-0.0885399909307833,0.0762739821693686,0.884027909799289
Physical measures,X4270.Volume level set by participant (left),ALDH1A1,Retinal dehydrogenase 1,32861,0.00458849593385902,0.0315424914268263,-0.0572347872627205,0.0664117791304385,0.884342815748131
Physical measures,X4270.Volume level set by participant (left),SEPTIN3,Neuronal-specific septin-3,31752,-0.00377728675143717,0.0259684439035311,-0.0546754368023581,0.0471208632994837,0.884353937600055
Physical measures,X4270.Volume level set by participant (left),C9orf40,Uncharacterized protein C9orf40,31720,-0.00350760968210024,0.0241170080522522,-0.0507769454645145,0.043761726100314,0.88436616719724
Physical measures,X4270.Volume level set by participant (left),FAS,Tumor necrosis factor receptor superfamily member 6,32922,0.00778267374323991,0.0535752711257183,-0.0972248576631679,0.112790205149648,0.884503965909808
Physical measures,X4270.Volume level set by participant (left),RELB,Transcription factor RelB,31508,0.00593916467788364,0.0411295937133777,-0.0746748390003366,0.0865531683561039,0.885187437354271
Physical measures,X4270.Volume level set by participant (left),ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,31724,-0.00742917524851415,0.051771855453296,-0.108902011936974,0.094043661439946,0.885900301297617
Physical measures,X4270.Volume level set by participant (left),TSPAN8,Tetraspanin-8,31720,-0.002862448150802,0.0199994340764178,-0.042061338940581,0.036336442638977,0.886193980253537
Physical measures,X4270.Volume level set by participant (left),FGF16,Fibroblast growth factor 16,31508,0.00604006848002733,0.0422065130106046,-0.0766846970207576,0.0887648339808123,0.886209054786113
Physical measures,X4270.Volume level set by participant (left),FBP1,"Fructose-1,6-bisphosphatase 1",32864,0.00330937901313662,0.0231957294786606,-0.0421542507650381,0.0487730087913113,0.886552496223358
Physical measures,X4270.Volume level set by participant (left),PREB,Prolactin regulatory element-binding protein,32679,0.00847829532600584,0.0600960959839547,-0.109310052802545,0.126266643454557,0.88781078024344
Physical measures,X4270.Volume level set by participant (left),SIGLEC9,Sialic acid-binding Ig-like lectin 9,32933,0.00774146826975763,0.0548974049175559,-0.099857445368652,0.115340381908167,0.887859630879111
Physical measures,X4270.Volume level set by participant (left),FGF23,Fibroblast growth factor 23,32944,0.00402171864574526,0.0285885000852519,-0.0520117415213485,0.0600551788128391,0.888128948297185
Physical measures,X4270.Volume level set by participant (left),PLAU,Urokinase-type plasminogen activator,32861,0.00858426682972035,0.0611131458784259,-0.111197499091994,0.128366032751435,0.888295634664458
Physical measures,X4270.Volume level set by participant (left),FUOM,Fucose mutarotase,31599,0.00447526912583922,0.0320960258151167,-0.0584329414717895,0.0673834797234679,0.889111036645905
Physical measures,X4270.Volume level set by participant (left),ZNF830,Zinc finger protein 830,31724,0.00329525062597921,0.0237345921985171,-0.0432245500831143,0.0498150513350727,0.889582143851557
Physical measures,X4270.Volume level set by participant (left),CD83,CD83 antigen,32843,0.00728502831708074,0.0538436950486794,-0.0982486139783309,0.112818670612492,0.89237806442213
Physical measures,X4270.Volume level set by participant (left),DIPK1C,Divergent protein kinase domain 1C,31546,-0.00642728169254054,0.0476860667667833,-0.0998919725554359,0.0870374091703548,0.892786802822067
Physical measures,X4270.Volume level set by participant (left),GBP1,Guanylate-binding protein 1,31726,0.00415195237269666,0.0310647211901409,-0.0567349011599794,0.0650388059053728,0.893678885810633
Physical measures,X4270.Volume level set by participant (left),TINAGL1,Tubulointerstitial nephritis antigen-like,32840,0.0102884325788273,0.0770657480228939,-0.140760433546045,0.161337298703699,0.893799364001012
Physical measures,X4270.Volume level set by participant (left),PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",32679,-0.00189413282308249,0.0142233207555546,-0.0297718415039694,0.0259835758578045,0.894061241643052
Physical measures,X4270.Volume level set by participant (left),HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",31495,0.00432361176466281,0.0325261523749877,-0.059427646890313,0.0680748704196386,0.894254425630508
Physical measures,X4270.Volume level set by participant (left),PRKD2,Serine/threonine-protein kinase D2,31495,-0.00563077610030036,0.0425544778403858,-0.0890375526674566,0.0777760004668559,0.894735279226119
Physical measures,X4270.Volume level set by participant (left),TPBGL,Trophoblast glycoprotein-like,31546,-0.00640459996187465,0.0485497750164195,-0.101562158994057,0.0887529590703075,0.895052430422618
Physical measures,X4270.Volume level set by participant (left),FOSB,Protein fosB,32644,0.00589638800565946,0.04504699574011,-0.0823957236449561,0.094188499656275,0.895862044733872
Physical measures,X4270.Volume level set by participant (left),AHNAK2,Protein AHNAK2,31566,-0.00899965136808448,0.0693980395154522,-0.145019808818371,0.127020506082202,0.896821697397845
Physical measures,X4270.Volume level set by participant (left),FOLR2,Folate receptor beta,32931,-0.00755191271480077,0.0588224055284054,-0.122843827550475,0.107740002120874,0.897847172721141
Physical measures,X4270.Volume level set by participant (left),FCRL6,Fc receptor-like protein 6,32843,-0.00329607504000571,0.0257986788197697,-0.0538614855267544,0.047269335446743,0.898340667492709
Physical measures,X4270.Volume level set by participant (left),NRP2,Neuropilin-2,32861,0.00750951939488634,0.0593812524187416,-0.108877735345847,0.12389677413562,0.899368420184851
Physical measures,X4270.Volume level set by participant (left),PDCD1,Programmed cell death protein 1,32931,-0.00547014370953777,0.0435333946254153,-0.0907955971753517,0.0798553097562762,0.900008627937581
Physical measures,X4270.Volume level set by participant (left),PLA2G10,Group 10 secretory phospholipase A2,32796,-0.00363706691802121,0.0290389060190049,-0.0605533227152708,0.0532791888792283,0.900329981297029
Physical measures,X4270.Volume level set by participant (left),NXPE4,NXPE family member 4,31495,0.00697664578169777,0.0558173043308116,-0.102425270706693,0.116378562270089,0.900534178752524
Physical measures,X4270.Volume level set by participant (left),TACSTD2,Tumor-associated calcium signal transducer 2,31877,0.00767151325427901,0.0620129131581448,-0.113873796535685,0.129216823044243,0.90154932689391
Physical measures,X4270.Volume level set by participant (left),CD72,B-cell differentiation antigen CD72,31599,0.00609434647460665,0.0498673043594944,-0.0916455700700025,0.103834263019216,0.902734877549766
Physical measures,X4270.Volume level set by participant (left),USP47,Ubiquitin carboxyl-terminal hydrolase 47,31495,0.00283806352883696,0.0232485640764935,-0.0427291220610902,0.0484052491187642,0.902843002875706
Physical measures,X4270.Volume level set by participant (left),PER3,Period circadian protein homolog 3,31508,-0.00209267877933425,0.0171730811575841,-0.035751917848199,0.0315665602895305,0.903014614454014
Physical measures,X4270.Volume level set by participant (left),CALCB,Calcitonin gene-related peptide 2,31751,0.00633480548144722,0.0521279589797807,-0.0958359941189229,0.108505605081817,0.903278989462363
Physical measures,X4270.Volume level set by participant (left),CD22,B-cell receptor CD22,32961,0.00527678705575956,0.0434935812519802,-0.0799706321981215,0.0905242063096407,0.903437603943883
Physical measures,X4270.Volume level set by participant (left),SLK,STE20-like serine/threonine-protein kinase,31632,-0.00312645681830129,0.0257923622620444,-0.0536794868519084,0.0474265732153058,0.903522784225653
Physical measures,X4270.Volume level set by participant (left),SEPTIN7,Septin-7,31632,-0.00474964312570858,0.0392099641966511,-0.0816011729511446,0.0721018866997275,0.903588368888848
Physical measures,X4270.Volume level set by participant (left),GFAP,Glial fibrillary acidic protein,32623,0.0049024577646974,0.0406872402031334,-0.074844533033444,0.0846494485628388,0.904096748002771
Physical measures,X4270.Volume level set by participant (left),GPNMB,Transmembrane glycoprotein NMB,32599,0.00735587977600537,0.0617793052188887,-0.113731558453017,0.128443318005027,0.90522497104741
Physical measures,X4270.Volume level set by participant (left),PXDNL,Peroxidasin-like protein,31724,0.00380482830774201,0.0326681931984101,-0.0602248303611417,0.0678344869766258,0.90728391301123
Physical measures,X4270.Volume level set by participant (left),HSPB6,Heat shock protein beta-6,32948,0.00528410090518815,0.0454582740119764,-0.0838141161582855,0.0943823179686618,0.907464362625508
Physical measures,X4270.Volume level set by participant (left),LTBP2,Latent-transforming growth factor beta-binding protein 2,32964,-0.00632550097087159,0.0546782541851073,-0.113494879173682,0.100843877231939,0.907904063768818
Physical measures,X4270.Volume level set by participant (left),ERBB3,Receptor tyrosine-protein kinase erbB-3,32811,-0.0104445715713162,0.09034966062495,-0.187529906396218,0.166640763253586,0.907970834056086
Physical measures,X4270.Volume level set by participant (left),CD93,Complement component C1q receptor,32498,-0.00662080962435478,0.057581468997525,-0.119480488859504,0.106238869610794,0.908462377235867
Physical measures,X4270.Volume level set by participant (left),NCLN,Nicalin,32679,-0.0035049204428906,0.030629258280241,-0.0635382666721629,0.0565284257863817,0.908899166346886
Physical measures,X4270.Volume level set by participant (left),CFB,Complement factor B,31631,-0.00680350040078457,0.0598192170503625,-0.124049165819495,0.110442165017926,0.909451312644984
Physical measures,X4270.Volume level set by participant (left),TNFRSF17,Tumor necrosis factor receptor superfamily member 17,31599,-0.00586986981133642,0.0517036255427236,-0.107208975875075,0.0954692362524018,0.909613982418578
Physical measures,X4270.Volume level set by participant (left),LRP11,Low-density lipoprotein receptor-related protein 11,32864,0.00551758265829039,0.0494145708736881,-0.0913349762541383,0.102370141570719,0.91109626147384
Physical measures,X4270.Volume level set by participant (left),AMY2B,Alpha-amylase 2B,32229,0.00429720130961806,0.0387807021406647,-0.0717129748860847,0.0803073775053208,0.911771478843522
Physical measures,X4270.Volume level set by participant (left),CUZD1,CUB and zona pellucida-like domain-containing protein 1,31546,0.00591103533880963,0.0536853827664624,-0.0993123148834567,0.111134385561076,0.912328885976296
Physical measures,X4270.Volume level set by participant (left),CD209,CD209 antigen,32856,-0.00481593796666949,0.044082657457247,-0.0912179465828737,0.0815860706495347,0.913008302593713
Physical measures,X4270.Volume level set by participant (left),PALM2,Paralemmin-2,31751,-0.00588971627540173,0.0543719998526243,-0.112458835986545,0.100679403435742,0.913742552716615
Physical measures,X4270.Volume level set by participant (left),MSMB,Beta-microseminoprotein,32821,0.00281473493335864,0.0259952682587916,-0.048135990853873,0.0537654607205903,0.913777010303272
Physical measures,X4270.Volume level set by participant (left),CLEC10A,C-type lectin domain family 10 member A,32796,-0.0050705137468125,0.0472216450993687,-0.0976249381415751,0.0874839106479501,0.91449239299559
Physical measures,X4270.Volume level set by participant (left),DPY30,Protein dpy-30 homolog,32928,-0.00301491324147585,0.0284582114364745,-0.0587930076569659,0.0527631811740142,0.915630898372309
Physical measures,X4270.Volume level set by participant (left),RSPO1,R-spondin-1,32796,0.00511568711267817,0.0483066096199558,-0.0895652677424351,0.0997966419677915,0.915663790157971
Physical measures,X4270.Volume level set by participant (left),FH,"Fumarate hydratase, mitochondrial",31514,-0.00265782639620575,0.0251176178771816,-0.0518883574354816,0.0465727046430701,0.915731730525681
Physical measures,X4270.Volume level set by participant (left),FCN1,Ficolin-1,31762,0.00365964514054464,0.0347948911193485,-0.0645383414533783,0.0718576317344676,0.91623750966346
Physical measures,X4270.Volume level set by participant (left),MFAP4,Microfibril-associated glycoprotein 4,31599,0.00670649501423468,0.0639122242935743,-0.118561464601171,0.13197445462964,0.916431773374484
Physical measures,X4270.Volume level set by participant (left),C19orf12,Protein C19orf12,32644,-0.00282182658504861,0.0269228044343756,-0.0555905232764247,0.0499468701063275,0.916527570174932
Physical measures,X4270.Volume level set by participant (left),CA11,Carbonic anhydrase-related protein 11,32638,-0.00569454118460525,0.0547942927791473,-0.113091355031734,0.101702272662523,0.917230600726107
Physical measures,X4270.Volume level set by participant (left),DDX58,Antiviral innate immune response receptor RIG-I,32638,-0.00324635992755342,0.0312687606924149,-0.0645331308846866,0.0580404110295798,0.917313623213795
Physical measures,X4270.Volume level set by participant (left),ITGAX,Integrin alpha-X,31632,0.00391313947391366,0.0379323533546241,-0.0704342731011495,0.0782605520489768,0.917837855471905
Physical measures,X4270.Volume level set by participant (left),IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",32685,0.00188667686710532,0.0184794842433071,-0.0343331122497767,0.0381064659839873,0.918682992017575
Physical measures,X4270.Volume level set by participant (left),HGF,Hepatocyte growth factor,32961,-0.00499524131927833,0.0490300254707716,-0.101094091241991,0.0911036086034341,0.918853161249446
Physical measures,X4270.Volume level set by participant (left),IL5,Interleukin-5,32679,0.00125024207297226,0.0124045741733445,-0.023062723306783,0.0255632074527275,0.919720414420808
Physical measures,X4270.Volume level set by participant (left),AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,31724,-0.00285024180731699,0.0284645366605321,-0.0586407336619599,0.0529402500473259,0.920241224464334
Physical measures,X4270.Volume level set by participant (left),DLK1,Protein delta homolog 1,32964,-0.00305744922270539,0.0306338457515673,-0.0630997868957773,0.0569848884503665,0.920500345496025
Physical measures,X4270.Volume level set by participant (left),LRRC38,Leucine-rich repeat-containing protein 38,31546,-0.00403773911555527,0.0413218422162842,-0.0850285498594723,0.0769530716283617,0.922161627788251
Physical measures,X4270.Volume level set by participant (left),NFYA,Nuclear transcription factor Y subunit alpha,31495,-0.00565292459543879,0.0578589532128973,-0.119056472892717,0.10775062370184,0.922171641924818
Physical measures,X4270.Volume level set by participant (left),CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,31772,0.00402387538043182,0.0414594192806587,-0.0772365864096591,0.0852843371705228,0.92268457385301
Physical measures,X4270.Volume level set by participant (left),IFNLR1,Interferon lambda receptor 1,32843,0.00440824958054141,0.0459352215833466,-0.0856247847228179,0.0944412838839007,0.923549196839484
Physical measures,X4270.Volume level set by participant (left),LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,32796,0.00161197792312286,0.0167975918993359,-0.0313113021995755,0.0345352580458212,0.923550663881818
Physical measures,X4270.Volume level set by participant (left),FSTL1,Follistatin-related protein 1,31566,-0.00846733038170355,0.0888855987330169,-0.182683103898417,0.16574844313501,0.924110002820919
Physical measures,X4270.Volume level set by participant (left),ACP6,Lysophosphatidic acid phosphatase type 6,32940,0.00243519519979484,0.0256192462623329,-0.0477785274743776,0.0526489178739673,0.924274549162107
Physical measures,X4270.Volume level set by participant (left),KHDC3L,KH domain-containing protein 3,31492,-0.00288776257157859,0.0305281677483992,-0.062722971358441,0.0569474462152838,0.92464029250715
Physical measures,X4270.Volume level set by participant (left),IL2RB,Interleukin-2 receptor subunit beta,32679,0.00439983825460101,0.0470572744488294,-0.0878324196651046,0.0966320961743066,0.925508759785945
Physical measures,X4270.Volume level set by participant (left),GZMH,Granzyme H,32685,-0.00212919973127658,0.023138135256073,-0.0474799448331796,0.0432215453706264,0.926683259202849
Physical measures,X4270.Volume level set by participant (left),PFDN6,Prefoldin subunit 6,31546,-0.00281713412137851,0.0306827936085724,-0.0629554095941804,0.0573211413514234,0.926847590055965
Physical measures,X4270.Volume level set by participant (left),CDH17,Cadherin-17,32864,0.00234465481505959,0.0260393767963333,-0.0486925237057537,0.0533818333358729,0.928255316220703
Physical measures,X4270.Volume level set by participant (left),GAL,Galanin peptides,32894,-0.00232685705150954,0.0262004032946989,-0.0536796475091194,0.0490259334061003,0.929234902696791
Physical measures,X4270.Volume level set by participant (left),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,32843,0.00182180135309929,0.0205320390039161,-0.0384209950945763,0.0420645978007749,0.929298718982453
Physical measures,X4270.Volume level set by participant (left),AMOT,Angiomotin,31599,0.00422476900632665,0.0484800010153075,-0.0907960329836761,0.0992455709963294,0.93055885113697
Physical measures,X4270.Volume level set by participant (left),ROBO2,Roundabout homolog 2,32931,-0.0064781526446942,0.0743549540525384,-0.152213862587669,0.139257557298281,0.930574320480557
Physical measures,X4270.Volume level set by participant (left),TCL1A,T-cell leukemia/lymphoma protein 1A,32780,-0.00159287332537293,0.0183613608630711,-0.0375811406169923,0.0343953939662464,0.930871085783167
Physical measures,X4270.Volume level set by participant (left),CD6,T-cell differentiation antigen CD6,32946,-0.00283918962214833,0.0329004558941134,-0.0673240831746105,0.0616457039303138,0.931232733248799
Physical measures,X4270.Volume level set by participant (left),NBN,Nibrin,32679,0.00300081216382501,0.0351967189081511,-0.0659847568961512,0.0719863812238012,0.932057984336975
Physical measures,X4270.Volume level set by participant (left),BPIFA2,BPI fold-containing family A member 2,31321,-0.00163808802555173,0.0192335635005671,-0.0393358724866633,0.0360596964355598,0.93212995574122
Physical measures,X4270.Volume level set by participant (left),PTGDS,Prostaglandin-H2 D-isomerase,32772,0.00522049118830241,0.0623068606104675,-0.116900955608214,0.127341937984819,0.933227842022169
Physical measures,X4270.Volume level set by participant (left),SLAMF8,SLAM family member 8,32638,-0.00289988560226416,0.0346716346751973,-0.070856289565651,0.0650565183611226,0.93334571560377
Physical measures,X4270.Volume level set by participant (left),HSBP1,Heat shock factor-binding protein 1,31566,-0.0017808961157236,0.0214783950774738,-0.0438785504675722,0.040316758236125,0.933920726404514
Physical measures,X4270.Volume level set by participant (left),B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,31495,0.00803410031756338,0.0985077516844447,-0.185041092983948,0.201109293619075,0.935000298538071
Physical measures,X4270.Volume level set by participant (left),SERPINA3,Alpha-1-antichymotrypsin,31745,-0.0110286417361871,0.137261725893488,-0.280061624487423,0.258004341015049,0.935962890415986
Physical measures,X4270.Volume level set by participant (left),CTAG1A_CTAG1B,Cancer/testis antigen 1,31619,-0.00309764102266365,0.0390873467314577,-0.0797088406163207,0.0735135585709934,0.936836454864164
Physical measures,X4270.Volume level set by participant (left),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,32679,0.00325675651841972,0.0423832692973743,-0.0798144513044339,0.0863279643412733,0.938752083072612
Physical measures,X4270.Volume level set by participant (left),MFGE8,Lactadherin,32861,0.0030536913877093,0.0397896206193409,-0.0749339650261989,0.0810413478016175,0.938827372724102
Physical measures,X4270.Volume level set by participant (left),CAMLG,Guided entry of tail-anchored proteins factor CAMLG,31546,0.00272713217228106,0.0367462616920577,-0.069295540744152,0.0747498050887141,0.940841061528162
Physical measures,X4270.Volume level set by participant (left),TBR1,T-box brain protein 1,31546,-0.00309274718605734,0.043105916214966,-0.0875803429673907,0.081394848595276,0.942804620661649
Physical measures,X4270.Volume level set by participant (left),RGS8,Regulator of G-protein signaling 8,32679,-0.00198673541658769,0.0278846022327189,-0.0566405557927166,0.0526670849595413,0.94320161716736
Physical measures,X4270.Volume level set by participant (left),LPA,Apolipoprotein(a),31587,-0.000817390921184848,0.0115649419591066,-0.0234846771610338,0.0218498953186641,0.943655588195966
Physical measures,X4270.Volume level set by participant (left),PTX3,Pentraxin-related protein PTX3,32843,0.00236794314109706,0.0343954960294914,-0.0650472290767062,0.0697831153589003,0.945114873153669
Physical measures,X4270.Volume level set by participant (left),MED21,Mediator of RNA polymerase II transcription subunit 21,31495,-0.00269202416658734,0.0409827750727361,-0.0830182633091502,0.0776342149759755,0.947628964088101
Physical measures,X4270.Volume level set by participant (left),MATN2,Matrilin-2,32864,0.0036704087426229,0.0569883489164584,-0.108026755133636,0.115367572618881,0.948648143368854
Physical measures,X4270.Volume level set by participant (left),ACRV1,Acrosomal protein SP-10,31508,-0.00188145938025654,0.029250523873493,-0.0592124861723028,0.0554495674117897,0.948715322421094
Physical measures,X4270.Volume level set by participant (left),RAC3,Ras-related C3 botulinum toxin substrate 3,31546,-0.00194609884085374,0.0304073616595129,-0.061544527693499,0.0576523300117915,0.948971166592486
Physical measures,X4270.Volume level set by participant (left),LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,31546,-0.00272807003220617,0.0430017430326779,-0.0870114863762548,0.0815553463118425,0.949417055772631
Physical measures,X4270.Volume level set by participant (left),IGSF8,Immunoglobulin superfamily member 8,32864,0.0035841828835746,0.0567819822509428,-0.107708502328273,0.114876868095423,0.949670889189312
Physical measures,X4270.Volume level set by participant (left),ASAH2,Neutral ceramidase,32796,-0.00209028052175338,0.0333105855189013,-0.0673790281388,0.0631984670952932,0.949965998676586
Physical measures,X4270.Volume level set by participant (left),NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",32638,-0.00138114684547501,0.0220761153896164,-0.0446503330091232,0.0418880393181732,0.950115960217248
Physical measures,X4270.Volume level set by participant (left),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,32796,0.00288443325727296,0.0476461221893686,-0.0905019662338896,0.0962708327484355,0.951727965861531
Physical measures,X4270.Volume level set by participant (left),SHC1,SHC-transforming protein 1,31492,-0.00104583516508404,0.0177267418027813,-0.0357902490985354,0.0336985787683673,0.952955567501043
Physical measures,X4270.Volume level set by participant (left),CLIC5,Chloride intracellular channel protein 5,31546,-0.00352347302193004,0.0597841360092004,-0.120700379599963,0.113653433556103,0.953004148068563
Physical measures,X4270.Volume level set by participant (left),PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,31508,0.00200309854203331,0.034071125951229,-0.0647763083223756,0.0687825054064422,0.953119576483519
Physical measures,X4270.Volume level set by participant (left),TP73,Tumor protein p73,31546,0.00340567122573769,0.0585448150171812,-0.111342166207937,0.118153508659413,0.953613105964684
Physical measures,X4270.Volume level set by participant (left),WAS,Wiskott-Aldrich syndrome protein,32679,0.00146129185861444,0.0251421224101137,-0.0478172680652084,0.0507398517824373,0.953653356442131
Physical measures,X4270.Volume level set by participant (left),PGLYRP1,Peptidoglycan recognition protein 1,32898,0.00235301305129525,0.0407021928011102,-0.0774232848388807,0.0821293109414712,0.953900873659124
Physical measures,X4270.Volume level set by participant (left),IL1B,Interleukin-1 beta,32634,-0.00170276209788781,0.0294607919600803,-0.0594459143396452,0.0560403901438696,0.953911192785364
Physical measures,X4270.Volume level set by participant (left),CTRL,Chymotrypsin-like protease CTRL-1,31751,0.00170138958404697,0.0297866535567819,-0.0566804513872455,0.0600832305553395,0.954451695115797
Physical measures,X4270.Volume level set by participant (left),CHRDL2,Chordin-like protein 2,32864,0.00166054403218517,0.0295884722720573,-0.0563328616210472,0.0596539496854176,0.955246407822792
Physical measures,X4270.Volume level set by participant (left),RNASE4,Ribonuclease 4,31523,0.00432574834975491,0.0794019014408635,-0.151301978474338,0.159953475173847,0.956554838036783
Physical measures,X4270.Volume level set by participant (left),EPHA2,Ephrin type-A receptor 2,32586,0.00332003825698731,0.0619777968894174,-0.118156443646271,0.124796520160245,0.957280429337205
Physical measures,X4270.Volume level set by participant (left),CADPS,Calcium-dependent secretion activator 1,31546,0.00254909372590129,0.0476391382460473,-0.0908236172363514,0.0959218046881539,0.957328234859199
Physical measures,X4270.Volume level set by participant (left),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",32881,-0.00265725619027764,0.0497039750166881,-0.100077047222986,0.0947625348424311,0.957365275215948
Physical measures,X4270.Volume level set by participant (left),RRM2,Ribonucleoside-diphosphate reductase subunit M2,32638,-0.00186268631314287,0.0352785761858403,-0.0710086956373899,0.0672833230111041,0.957892971757238
Physical measures,X4270.Volume level set by participant (left),MYBPC1,"Myosin-binding protein C, slow-type",31762,0.00147086403483402,0.0280137926310983,-0.0534361695221186,0.0563778975917867,0.958127643292779
Physical measures,X4270.Volume level set by participant (left),CRISP2,Cysteine-rich secretory protein 2,32948,-0.0015632184524185,0.0301151568430964,-0.0605889258648874,0.0574624889600504,0.958603117432622
Physical measures,X4270.Volume level set by participant (left),AIDA,"Axin interactor, dorsalization-associated protein",31546,-0.00119577622199636,0.0233358521802482,-0.0469340464952828,0.0445424940512901,0.95913400017992
Physical measures,X4270.Volume level set by participant (left),METAP1,Methionine aminopeptidase 1,32644,0.00295154129003426,0.0581706404455418,-0.111062913983228,0.116965996563296,0.959534363298359
Physical measures,X4270.Volume level set by participant (left),EPHA10,Ephrin type-A receptor 10,32644,-0.00137932682449876,0.0272266977265308,-0.0547436543684991,0.0519850007195016,0.959596950167035
Physical measures,X4270.Volume level set by participant (left),SPAG1,Sperm-associated antigen 1,31752,0.00163600150187547,0.0325447685289271,-0.0621517448148217,0.0654237478185727,0.959909090640616
Physical measures,X4270.Volume level set by participant (left),SERPINB8,Serpin B8,32961,-0.00153267678558974,0.0305267641709189,-0.0613651345605908,0.0582997809894113,0.959958025560044
Physical measures,X4270.Volume level set by participant (left),DAPK2,Death-associated protein kinase 2,31508,0.00184241169773941,0.0371203958943388,-0.0709135642551646,0.0745983876506434,0.960415821507789
Physical measures,X4270.Volume level set by participant (left),DYNLT3,Dynein light chain Tctex-type 3,31724,0.00219070454198741,0.0442981832653629,-0.0846337346581239,0.0890151437420988,0.960559071834629
Physical measures,X4270.Volume level set by participant (left),LAP3,Cytosol aminopeptidase,32679,0.0017544680710305,0.035646602395238,-0.0681128726236359,0.0716218087656969,0.960746377755546
Physical measures,X4270.Volume level set by participant (left),EPO,Erythropoietin,32843,-0.00107198551452801,0.0221130342219649,-0.0444135325895791,0.0422695615605231,0.961336741460038
Physical measures,X4270.Volume level set by participant (left),CXCL13,C-X-C motif chemokine 13,32931,0.00135178547191321,0.028660431061011,-0.0548226594076684,0.0575262303514948,0.962382309435024
Physical measures,X4270.Volume level set by participant (left),DOC2B,Double C2-like domain-containing protein beta,31546,-0.00254682250412039,0.0540779147522838,-0.108539535418597,0.103445890410356,0.962438395817977
Physical measures,X4270.Volume level set by participant (left),AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,31773,-0.00353139167611946,0.0768395216648671,-0.154136854139259,0.14707407078702,0.963344876068099
Physical measures,X4270.Volume level set by participant (left),ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,32638,-0.0021670142878378,0.0473831579424469,-0.0950380038550338,0.0907039752793582,0.963523423468769
Physical measures,X4270.Volume level set by participant (left),MYL4,Myosin light chain 4,31566,-0.00163682804657034,0.0361382402735028,-0.0724677789826358,0.0691941228894951,0.963874527867685
Physical measures,X4270.Volume level set by participant (left),PGF,Placenta growth factor,32961,0.00278414696943641,0.0673432453929184,-0.129208614000684,0.134776907939556,0.967023654375032
Physical measures,X4270.Volume level set by participant (left),ITGA5,Integrin alpha-5,32861,0.00288627724377655,0.0698565621150671,-0.134032584501755,0.139805138989308,0.967043941339261
Physical measures,X4270.Volume level set by participant (left),HEBP1,Heme-binding protein 1,32685,0.00128471864547412,0.0321123409228482,-0.0616554695633084,0.0642249068542566,0.968088445348277
Physical measures,X4270.Volume level set by participant (left),CTSL,Cathepsin L1,32864,0.00277509773860978,0.0709871113745074,-0.136359640555425,0.141909836032644,0.96881712467932
Physical measures,X4270.Volume level set by participant (left),SOD2,"Superoxide dismutase [Mn], mitochondrial",32861,0.0017993943837737,0.0471494031906194,-0.0906134358698403,0.0942122246373877,0.969558031528003
Physical measures,X4270.Volume level set by participant (left),OMP,Olfactory marker protein,31514,0.00156889361721262,0.0420176468826526,-0.0807856942727865,0.0839234815072117,0.970215746408477
Physical measures,X4270.Volume level set by participant (left),COLEC12,Collectin-12,32834,-0.00261935236139081,0.071473466813646,-0.142707347316137,0.137468642593355,0.970766567039037
Physical measures,X4270.Volume level set by participant (left),TGFBR2,TGF-beta receptor type-2,32881,-0.00213094013724641,0.0587459854932116,-0.117273071703941,0.113011191429448,0.971064843505023
Physical measures,X4270.Volume level set by participant (left),SLC4A1,Band 3 anion transport protein,31773,0.0013804344329276,0.0386904247293675,-0.0744527980366327,0.0772136669024879,0.971539241126615
Physical measures,X4270.Volume level set by participant (left),NOTCH2,Neurogenic locus notch homolog protein 2,31773,-0.00314998819460871,0.0885160633274589,-0.176641472316428,0.170341495927211,0.971612869049302
Physical measures,X4270.Volume level set by participant (left),SORD,Sorbitol dehydrogenase,32905,0.000915682430076578,0.0258751702260793,-0.0497996512130388,0.051631016073192,0.971770767591523
Physical measures,X4270.Volume level set by participant (left),CALY,Neuron-specific vesicular protein calcyon,31495,-0.00186414493021305,0.0537037992913764,-0.107123591541311,0.103395301680885,0.972310616858041
Physical measures,X4270.Volume level set by participant (left),PI16,Peptidase inhibitor 16,31772,0.00279983047169347,0.0817171741107755,-0.157365830785426,0.162965491728813,0.97266873363028
Physical measures,X4270.Volume level set by participant (left),MLLT1,Protein ENL,31492,0.000986101696851848,0.028979211574326,-0.0558131529888271,0.0577853563825308,0.972855793263943
Physical measures,X4270.Volume level set by participant (left),RNASE3,Eosinophil cationic protein,32810,-0.000493870033192977,0.0150099894479943,-0.0299134493512618,0.0289257092848758,0.97375286828111
Physical measures,X4270.Volume level set by participant (left),CNTN1,Contactin-1,32964,-0.00203495699630833,0.0634726846151977,-0.126441418842096,0.122371504849479,0.974424619859433
Physical measures,X4270.Volume level set by participant (left),CA6,Carbonic anhydrase 6,32838,0.000857081016669557,0.0269835074561055,-0.0520305935972972,0.0537447556306363,0.974661645392671
Physical measures,X4270.Volume level set by participant (left),CXADR,Coxsackievirus and adenovirus receptor,32843,-0.0010559702271768,0.0338041203975857,-0.0673120462064447,0.0652001057520911,0.975080497365554
Physical measures,X4270.Volume level set by participant (left),CPB1,Carboxypeptidase B,32964,-0.000897739314672011,0.0295331547574137,-0.0587827226392028,0.0569872440098588,0.975750563605683
Physical measures,X4270.Volume level set by participant (left),GZMA,Granzyme A,32961,-0.00151704408169703,0.051009659470469,-0.101495976643816,0.0984618884804223,0.976274800152147
Physical measures,X4270.Volume level set by participant (left),ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,31508,0.00173362547644833,0.0594659211261537,-0.114819579930813,0.11828683088371,0.976743119234072
Physical measures,X4270.Volume level set by participant (left),CPXM2,Inactive carboxypeptidase-like protein X2,31762,-0.00235438411044149,0.0830877472609212,-0.165206368741847,0.160497600520964,0.977394790961113
Physical measures,X4270.Volume level set by participant (left),DEFB118,Beta-defensin 118,31514,-0.000941883645604263,0.0340599002930421,-0.0676992882199667,0.0658155209287582,0.977939040509106
Physical measures,X4270.Volume level set by participant (left),IL10RA,Interleukin-10 receptor subunit alpha,32679,-0.000843522706779934,0.0305932704382518,-0.0608063327657534,0.0591192873521935,0.978004006245359
Physical measures,X4270.Volume level set by participant (left),CDC25A,M-phase inducer phosphatase 1,31492,-0.00126564408858602,0.0472211498916179,-0.093819097876157,0.091287809698985,0.978617973451472
Physical measures,X4270.Volume level set by participant (left),ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,32685,0.0021299383354669,0.0815295726595317,-0.157668024077215,0.161927900748149,0.979158440424438
Physical measures,X4270.Volume level set by participant (left),MYL3,Myosin light chain 3,31566,-0.000697675090636473,0.0274643000430555,-0.0545277031750252,0.0531323529937523,0.979734191445006
Physical measures,X4270.Volume level set by participant (left),NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,32796,0.000586807743941747,0.0246188830896545,-0.0476662031117811,0.0488398185996646,0.980984214431112
Physical measures,X4270.Volume level set by participant (left),PDIA5,Protein disulfide-isomerase A5,31492,0.000736215019751559,0.0321575359772178,-0.0622925554955954,0.0637649855350985,0.981735415491789
Physical measures,X4270.Volume level set by participant (left),EDA2R,Tumor necrosis factor receptor superfamily member 27,32948,0.00107355718920979,0.0470268739383922,-0.0910991157300389,0.0932462301084584,0.981787504384366
Physical measures,X4270.Volume level set by participant (left),CYTL1,Cytokine-like protein 1,31773,0.00198263349128384,0.0871809799668175,-0.168892087243678,0.172857354226246,0.981856979598741
Physical measures,X4270.Volume level set by participant (left),GP1BA,Platelet glycoprotein Ib alpha chain,32807,0.00117687878064435,0.0528996306267163,-0.10250639724772,0.104860154809008,0.982251110446851
Physical measures,X4270.Volume level set by participant (left),IL18RAP,Interleukin-18 receptor accessory protein,32738,0.00022467377137863,0.0101470926342528,-0.0196636277917568,0.0201129753345141,0.982335429209426
Physical measures,X4270.Volume level set by participant (left),TGFBI,Transforming growth factor-beta-induced protein ig-h3,32778,-0.00141962641550492,0.0646600369846761,-0.12815329890547,0.12531404607446,0.982484154233795
Physical measures,X4270.Volume level set by participant (left),SFRP1,Secreted frizzled-related protein 1,32755,-0.000837763762270933,0.0406796606257539,-0.0805698985887487,0.0788943710642068,0.983569854871523
Physical measures,X4270.Volume level set by participant (left),ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,31495,-0.000925221577281451,0.0504445703116007,-0.0997965793880188,0.0979461362334559,0.985367019011409
Physical measures,X4270.Volume level set by participant (left),KLHL41,Kelch-like protein 41,31752,-0.000662465337596476,0.0361902422863576,-0.0715953402188573,0.0702704095436644,0.985395936537865
Physical measures,X4270.Volume level set by participant (left),PSMD5,26S proteasome non-ATPase regulatory subunit 5,31546,-0.000676140017389265,0.0372456786224094,-0.0736776701173116,0.0723253900825331,0.985516856876095
Physical measures,X4270.Volume level set by participant (left),PPM1A,Protein phosphatase 1A,32638,0.000892220956893111,0.0538482531085651,-0.104650355135895,0.106434797049681,0.986780695213756
Physical measures,X4270.Volume level set by participant (left),IL1RL2,Interleukin-1 receptor-like 2,32679,-0.000714851859641731,0.0437454848432815,-0.0864560021524734,0.08502629843319,0.986962592726424
Physical measures,X4270.Volume level set by participant (left),VWA5A,von Willebrand factor A domain-containing protein 5A,31492,0.000384172086664941,0.024659438403639,-0.0479483271844675,0.0487166713577974,0.987570579389735
Physical measures,X4270.Volume level set by participant (left),GRIK2,"Glutamate receptor ionotropic, kainate 2",31752,-0.000758054782198484,0.0517456575253705,-0.102179543531925,0.100663433967528,0.988312074223641
Physical measures,X4270.Volume level set by participant (left),VIT,Vitrin,31762,-0.000759193187851713,0.0528333987327743,-0.104312654704089,0.102794268328386,0.988535499915102
Physical measures,X4270.Volume level set by participant (left),TTR,Transthyretin,31701,-0.00111372647453352,0.0800619423554446,-0.158035133491205,0.155807680542138,0.98890149141828
Physical measures,X4270.Volume level set by participant (left),PADI2,Protein-arginine deiminase type-2,32679,0.000407645378830129,0.0295070558763809,-0.0574261841388764,0.0582414748965366,0.98897774195867
Physical measures,X4270.Volume level set by participant (left),CD3E,T-cell surface glycoprotein CD3 epsilon chain,31632,-0.000750282809057499,0.0557412497083808,-0.110003132237484,0.108502566619369,0.989261063723458
Physical measures,X4270.Volume level set by participant (left),RNASE10,Inactive ribonuclease-like protein 10,31566,-0.000576104032918902,0.0436312758373014,-0.0860934046740296,0.0849411966081919,0.989465441273526
Physical measures,X4270.Volume level set by participant (left),CD7,T-cell antigen CD7,31494,0.000622388087331705,0.0476374234310808,-0.0927469618375868,0.0939917380122502,0.989576190054578
Physical measures,X4270.Volume level set by participant (left),PECAM1,Platelet endothelial cell adhesion molecule,32861,0.000711208509716404,0.0557717652523083,-0.108601451384808,0.110023868404241,0.989825834990007
Physical measures,X4270.Volume level set by participant (left),KCNH2,Potassium voltage-gated channel subfamily H member 2,31546,0.000333908883085181,0.0261851931707189,-0.0509890697315239,0.0516568874976943,0.989826126130066
Physical measures,X4270.Volume level set by participant (left),RET,Proto-oncogene tyrosine-protein kinase receptor Ret,32832,-0.000555173256069625,0.0438055040090595,-0.0864139611138263,0.0853036146016871,0.989888486074239
Physical measures,X4270.Volume level set by participant (left),GPC1,Glypican-1,32948,-0.000658282526546685,0.0587636528384214,-0.115835042089853,0.114518477036759,0.991062365932228
Physical measures,X4270.Volume level set by participant (left),MUCL3,Mucin-like protein 3,31492,-0.000501341237962785,0.0459827058458253,-0.0906274446957804,0.0896247622198548,0.99130126441269
Physical measures,X4270.Volume level set by participant (left),TMED4,Transmembrane emp24 domain-containing protein 4,31495,-0.000376987507196209,0.0362035995264678,-0.0713360425790731,0.0705820675646807,0.991692063042928
Physical measures,X4270.Volume level set by participant (left),INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",31752,-0.000515168395278108,0.0496244813598676,-0.0977791518606185,0.0967488150700623,0.991717303877411
Physical measures,X4270.Volume level set by participant (left),JAM2,Junctional adhesion molecule B,32931,0.000647663649424738,0.070902238169052,-0.138320723161917,0.139616050460767,0.99271194526182
Physical measures,X4270.Volume level set by participant (left),LELP1,Late cornified envelope-like proline-rich protein 1,31514,-0.000168332975987109,0.0282381917329203,-0.055515188772511,0.0551785228205368,0.995243849189663
Physical measures,X4270.Volume level set by participant (left),FBN2,Fibrillin-2,31546,-0.000201164635480047,0.0337887948854817,-0.0664272026110242,0.0660248733400641,0.995249904993521
Physical measures,X4270.Volume level set by participant (left),LYPD1,Ly6/PLAUR domain-containing protein 1,32644,0.000145642338518204,0.027674164657415,-0.0540957203900151,0.0543870050670515,0.995801068256835
Physical measures,X4270.Volume level set by participant (left),CYB5A,Cytochrome b5,31492,0.000125219310065958,0.0278480007114436,-0.0544568620843634,0.0547073007044953,0.996412419528551
Physical measures,X4270.Volume level set by participant (left),FCRL2,Fc receptor-like protein 2,32914,0.000151730943610146,0.0367279840517628,-0.071835117797845,0.0721385796850653,0.996703873295815
Physical measures,X4270.Volume level set by participant (left),LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,31469,0.000298129246810621,0.0730725837603633,-0.142924134923502,0.143520393417123,0.996744822305894
Physical measures,X4270.Volume level set by participant (left),CPTP,Ceramide-1-phosphate transfer protein,31495,0.000178405772970455,0.0478232003212978,-0.0935550668567732,0.0939118784027141,0.997023573958079
Physical measures,X4270.Volume level set by participant (left),MAN2B2,Epididymis-specific alpha-mannosidase,31762,9.80861457789215e-05,0.0337978866920118,-0.0661457717705643,0.0663419440621221,0.997684505090846
Physical measures,X4270.Volume level set by participant (left),PLTP,Phospholipid transfer protein,32920,0.000113092924617585,0.0482826062306836,-0.0945208152875223,0.0947470011367575,0.998131158769312
Physical measures,X4270.Volume level set by participant (left),GLA,Alpha-galactosidase A,31578,-0.000126859949671199,0.054388415959997,-0.106728155231265,0.106474435331923,0.998139011373224
Physical measures,X4270.Volume level set by participant (left),RBP7,Retinoid-binding protein 7,31720,6.91203775223854e-05,0.0312509030811728,-0.0611826496615763,0.061320890416621,0.998235305963179
Physical measures,X4270.Volume level set by participant (left),TMED1,Transmembrane emp24 domain-containing protein 1,31632,-7.89723282898081e-05,0.0367338752174245,-0.0720773677544418,0.0719194230978622,0.998284724250986
Physical measures,X4270.Volume level set by participant (left),ART5,Ecto-ADP-ribosyltransferase 5,31514,-6.67558498931118e-05,0.0328616969158275,-0.064475681804915,0.0643421701051288,0.998379216840433
Physical measures,X4270.Volume level set by participant (left),RYR1,Ryanodine receptor 1,31495,7.00483202218895e-05,0.0588176690769554,-0.115212583070611,0.115352679711054,0.999049798638483
Physical measures,X4270.Volume level set by participant (left),CLMP,CXADR-like membrane protein,32948,2.96169461713593e-05,0.0859674549782383,-0.168466594811176,0.168525828703518,0.99972512559127
